alleleSymbol,alleleName,acc,project,geneSymbol,gacc
1110051M20Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 1110051M20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431671,EUCOMM,1110051M20Rik,MGI:1915079
1110059G10Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 1110059G10 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419470,KOMP-CSD,1110059G10Rik,MGI:1913452
1500011B03Rik<tm2(KOMP)Wtsi>,"RIKEN cDNA 1500011B03 gene; targeted mutation 2, Wellcome Trust Sanger Institute",MGI:4419497,KOMP-CSD,1500011B03Rik,MGI:1913486
1500015O10Rik<tm1a(EUCOMM)Hmgu>,"RIKEN cDNA 1500015O10 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841752,EUCOMM,1500015O10Rik,MGI:1926146
1600029I14Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 1600029I14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451242,KOMP-CSD,1600029I14Rik,MGI:1917047
1600029I14Rik<tm1b(KOMP)Wtsi>,"RIKEN cDNA 1600029I14 gene; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613647,KOMP-CSD,1600029I14Rik,MGI:1917047
1700001C02Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 1700001C02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432273,EUCOMM,1700001C02Rik,MGI:1922684
1700007K13Rik<tm2a(EUCOMM)Wtsi>,"RIKEN cDNA 1700007K13 gene; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5472700,EUCOMM,1700007K13Rik,MGI:1916577
1700007K13Rik<tm2b(EUCOMM)Wtsi>,"RIKEN cDNA 1700007K13 gene; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637039,EUCOMM,1700007K13Rik,MGI:1916577
1700008O03Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 1700008O03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451336,KOMP-CSD,1700008O03Rik,MGI:1916599
1700016L21Rik<Tg(Itgax-DTR/EGFP)57Lan>,"RIKEN cDNA 1700016L21 gene; transgene insertion 57, Richard A Lang",MGI:3057163,0,1700016L21Rik,MGI:1919458
1700024P04Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 1700024P04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5473122,EUCOMM,1700024P04Rik,MGI:1916632
1700024P04Rik<tm1b(EUCOMM)Wtsi>,"RIKEN cDNA 1700024P04 gene; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637040,EUCOMM,1700024P04Rik,MGI:1916632
1700028K03Rik<tm1(EGFP/cre/ERT2)Wtsi>,"RIKEN cDNA 1700028K03 gene; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:5811633,EUCOMMTOOLS,1700028K03Rik,MGI:1923671
1700029H14Rik<tm2a(KOMP)Wtsi>,"RIKEN cDNA 1700029H14 gene; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4419600,KOMP-CSD,1700029H14Rik,MGI:1913751
1700029H14Rik<tm2b(KOMP)Wtsi>,"RIKEN cDNA 1700029H14 gene; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637012,KOMP-CSD,1700029H14Rik,MGI:1913751
1700034J05Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 1700034J05 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849971,KOMP-CSD,1700034J05Rik,MGI:1920594
1700067K01Rik<tm2a(KOMP)Wtsi>,"RIKEN cDNA 1700067K01 gene; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5289829,KOMP-CSD,1700067K01Rik,MGI:1920703
1700123O20Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 1700123O20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434270,EUCOMM,1700123O20Rik,MGI:1920893
2010111I01Rik<tm1a(KOMP)Wtsi>,"aminopeptidase O; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4941982,KOMP-CSD,Aopep,MGI:1919311
2010111I01Rik<tm1b(KOMP)Wtsi>,,MGI:1919311,,,
2010300C02Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 2010300C02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364312,KOMP-CSD,2010300C02Rik,MGI:1919347
2010300C02Rik<tm1b(KOMP)Wtsi>,"RIKEN cDNA 2010300C02 gene; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637062,KOMP-CSD,2010300C02Rik,MGI:1919347
2210010C04Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 2210010C04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4888876,KOMP-CSD,2210010C04Rik,MGI:1914623
2210016L21Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 2210016L21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419127,KOMP-CSD,2210016L21Rik,MGI:1919607
2310007B03Rik<tm1a(KOMP)Wtsi>,"mab-21-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362992,KOMP-CSD,Mab21l4,MGI:1919124
2310022B05Rik<tm1a(EUCOMM)Hmgu>,"RIKEN cDNA 2310022B05 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436328,EUCOMM,2310022B05Rik,MGI:1916801
2310057J18Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 2310057J18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364593,KOMP-CSD,2310057J18Rik,MGI:1914969
2610318N02Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 2610318N02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451963,EUCOMM,2610318N02Rik,MGI:1917708
2610318N02Rik<tm1b(EUCOMM)Wtsi>,"RIKEN cDNA 2610318N02 gene; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548598,EUCOMM,2610318N02Rik,MGI:1917708
2700049A03Rik<tm1.1Arte>,"RIKEN cDNA 2700049A03 gene; targeted mutation 1.1, TaconicArtemis",MGI:5287574,0,2700049A03Rik,MGI:1924217
2810006K23Rik<tm1(KOMP)Mbp>,"RIKEN cDNA 2810006K23 gene; targeted mutation 1, Mouse Biology Program, UCDavis",MGI:4456523,KOMP-CSD,2810006K23Rik,MGI:1919900
2810408A11Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 2810408A11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431683,EUCOMM,2810408A11Rik,MGI:1917669
2900026A02Rik<tm1a(EUCOMM)Hmgu>,"RIKEN cDNA 2900026A02 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435426,EUCOMM,2900026A02Rik,MGI:1920194
3110001I22Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 3110001I22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434304,EUCOMM,3110001I22Rik,MGI:1913848
3300002A11Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 3300002A11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887592,KOMP-CSD,3300002A11Rik,MGI:1919073
3830406C13Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 3830406C13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286250,KOMP-CSD,3830406C13Rik,MGI:1917937
3830406C13Rik<tm1b(KOMP)Wtsi>,"RIKEN cDNA 3830406C13 gene; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637049,KOMP-CSD,3830406C13Rik,MGI:1917937
3830417A13Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 3830417A13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841046,KOMP-CSD,3830417A13Rik,MGI:1917946
4921536K21Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 4921536K21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363036,KOMP-CSD,4921536K21Rik,MGI:1914680
4930404H24Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 4930404H24 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050148,KOMP-CSD,4930404H24Rik,MGI:1925401
4930449E01Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 4930449E01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841164,KOMP-CSD,4930449E01Rik,MGI:1922114
4930590J08Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 4930590J08 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4882021,EUCOMM,4930590J08Rik,MGI:2685917
4930591A17Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 4930591A17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944391,KOMP-CSD,4930591A17Rik,MGI:1915425
4931429L15Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 4931429L15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460419,EUCOMM,4931429L15Rik,MGI:1921611
4932414N04Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 4932414N04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364741,KOMP-CSD,4932414N04Rik,MGI:1922971
4932438A13Rik<tm1a(EUCOMM)Hmgu>,"RIKEN cDNA 4932438A13 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841479,EUCOMM,4932438A13Rik,MGI:2444631
4932438A13Rik<tm1b(EUCOMM)Hmgu>,"RIKEN cDNA 4932438A13 gene; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613665,EUCOMM,4932438A13Rik,MGI:2444631
4932438H23Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 4932438H23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433980,EUCOMM,4932438H23Rik,MGI:1921637
4933402N03Rik<tm2a(KOMP)Wtsi>,"RIKEN cDNA 4933402N03 gene; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4820121,KOMP-CSD,4933402N03Rik,MGI:1914681
4933425L06Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 4933425L06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363980,KOMP-CSD,4933425L06Rik,MGI:1914013
4933430I17Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 4933430I17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432117,EUCOMM,4933430I17Rik,MGI:3045314
4933434E20Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA 4933434E20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432969,EUCOMM,4933434E20Rik,MGI:1914027
5330417C22Rik<tm1a(EUCOMM)Hmgu>,"RIKEN cDNA 5330417C22 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436415,EUCOMM,5330417C22Rik,MGI:1923930
8030411F24Rik<tm2a(EUCOMM)Wtsi>,"cystatin domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840668,EUCOMM,Cstdc1,MGI:1925859
9330182L06Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA 9330182L06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841114,KOMP-CSD,9330182L06Rik,MGI:2443264
A1cf<Tg(Myh6-cre/Esr1*)1Jmk>,"APOBEC1 complementation factor; transgene insertion 1, Jeffery D Molkentin",MGI:3050453,0,A1cf,MGI:1917115
A430005L14Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA A430005L14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419175,KOMP-CSD,A430005L14Rik,MGI:2140680
A430078G23Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA A430078G23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5426632,KOMP-CSD,A430078G23Rik,MGI:2442135
A830019P07Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA A830019P07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820036,KOMP-CSD,A830019P07Rik,MGI:3028035
A830031A19Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA A830031A19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841190,KOMP-CSD,A830031A19Rik,MGI:2685508
A830031A19Rik<tm1b(KOMP)Wtsi>,,MGI:2685508,,,
A930004D18Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA A930004D18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441782,EUCOMM,A930004D18Rik,MGI:1925190
AI182371<tm2a(KOMP)Wtsi>,"expressed sequence AI182371; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5286211,KOMP-CSD,AI182371,MGI:2138853
Aak1<tm1a(EUCOMM)Hmgu>,"AP2 associated kinase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4847759,EUCOMM,Aak1,MGI:1098687
Aatk<tm1a(KOMP)Wtsi>,"apoptosis-associated tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939710,KOMP-CSD,Aatk,MGI:1197518
Abca3<tm1.1Holz>,"ATP-binding cassette, sub-family A (ABC1), member 3; targeted mutation 1.1, Andreas Holzinger",MGI:5788724,0,Abca3,MGI:1351617
Abca3<tm1Holz>,"ATP-binding cassette, sub-family A (ABC1), member 3; targeted mutation 1, Andreas Holzinger",MGI:3716562,0,Abca3,MGI:1351617
Abca4<tm1a(EUCOMM)Wtsi>,"ATP-binding cassette, sub-family A (ABC1), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441732,EUCOMM,Abca4,MGI:109424
Abcb11<tm1a(EUCOMM)Hmgu>,"ATP-binding cassette, sub-family B (MDR/TAP), member 11; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434682,EUCOMM,Abcb11,MGI:1351619
Abcb11<tm1b(EUCOMM)Hmgu>,"ATP-binding cassette, sub-family B (MDR/TAP), member 11; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548476,EUCOMM,Abcb11,MGI:1351619
Abcb6<tm1a(KOMP)Wtsi>,"ATP-binding cassette, sub-family B (MDR/TAP), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362220,KOMP-CSD,Abcb6,MGI:1921354
Abcc2<tm2a(KOMP)Wtsi>,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4947743,KOMP-CSD,Abcc2,MGI:1352447
Abcd1<tm1a(EUCOMM)Wtsi>,"ATP-binding cassette, sub-family D (ALD), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433571,EUCOMM,Abcd1,MGI:1349215
Abcd4<tm1a(EUCOMM)Hmgu>,"ATP-binding cassette, sub-family D (ALD), member 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434636,EUCOMM,Abcd4,MGI:1349217
Abcg1<tm1Yah>,"ATP binding cassette subfamily G member 1; targeted mutation 1, Yann Herault",MGI:4421206,0,Abcg1,MGI:107704
Abhd14a<tm2a(EUCOMM)Wtsi>,"abhydrolase domain containing 14A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4842383,EUCOMM,Abhd14a,MGI:1915894
Abhd16a<tm1a(EUCOMM)Wtsi>,"abhydrolase domain containing 16A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820220,EUCOMM,Abhd16a,MGI:99476
Abhd17a<tm1a(KOMP)Wtsi>,"abhydrolase domain containing 17A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013744,KOMP-CSD,Abhd17a,MGI:106388
Abhd17a<tm1c(KOMP)Wtsi>,,MGI:106388,,,
Abhd5<tm1a(KOMP)Wtsi>,"abhydrolase domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364049,KOMP-CSD,Abhd5,MGI:1914719
Abracl<tm1e(KOMP)Wtsi>,"ABRA C-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4944406,KOMP-CSD,Abracl,MGI:1920362
Abtb2<tm1a(KOMP)Wtsi>,"ankyrin repeat and BTB (POZ) domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451397,KOMP-CSD,Abtb2,MGI:2139365
Aby,mutant Aby,MGI:5752853,0,Aby,MGI:5752851
Aca15,ACMaster abnormality 15,MGI:5618623,0,Aca15,MGI:5618620
Acaa1a<tm1a(KOMP)Wtsi>,"acetyl-Coenzyme A acyltransferase 1A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451483,KOMP-CSD,Acaa1a,MGI:2148491
Acaa1b<tm1Vnf>,"acetyl-Coenzyme A acyltransferase 1B; targeted mutation 1, Valerie Nicolas-Frances",MGI:3617359,0,Acaa1b,MGI:3605455
Acad12<tm1a(EUCOMM)Wtsi>,"acyl-Coenzyme A dehydrogenase family, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842615,EUCOMM,Acad12,MGI:2443320
Acad12<tm1b(EUCOMM)Wtsi>,,MGI:2443320,,,
Acap3<tm1a(EUCOMM)Hmgu>,"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436565,EUCOMM,Acap3,MGI:2153589
Acbd3<tm1a(EUCOMM)Hmgu>,"acyl-Coenzyme A binding domain containing 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458770,EUCOMM,Acbd3,MGI:2181074
Acbd3<tm1b(EUCOMM)Hmgu>,"acyl-Coenzyme A binding domain containing 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548778,EUCOMM,Acbd3,MGI:2181074
Acbd5<tm1a(EUCOMM)Wtsi>,"acyl-Coenzyme A binding domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842354,EUCOMM,Acbd5,MGI:1921409
Acbd5<tm1b(EUCOMM)Wtsi>,"acyl-Coenzyme A binding domain containing 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637073,EUCOMM,Acbd5,MGI:1921409
Acer1<tm1a(EUCOMM)Wtsi>,"alkaline ceramidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432648,EUCOMM,Acer1,MGI:2181962
Ackr3<tm2a(EUCOMM)Wtsi>,"atypical chemokine receptor 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5085477,EUCOMM,Ackr3,MGI:109562
Acmsd<tm1a(EUCOMM)Hmgu>,"amino carboxymuconate semialdehyde decarboxylase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5014638,EUCOMM,Acmsd,MGI:2386323
Acot13<tm1a(EUCOMM)Wtsi>,"acyl-CoA thioesterase 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434369,EUCOMM,Acot13,MGI:1914084
Acot5<tm1a(KOMP)Wtsi>,"acyl-CoA thioesterase 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364061,KOMP-CSD,Acot5,MGI:2384969
Acot6<tm1a(KOMP)Wtsi>,"acyl-CoA thioesterase 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362231,KOMP-CSD,Acot6,MGI:1921287
Acox2<em1Pvv>,"acyl-Coenzyme A oxidase 2, branched chain; endonuclease-mediated mutation 1, Paul Van Veldhoven",MGI:5749441,0,Acox2,MGI:1934852
Acp2<tm1a(EUCOMM)Wtsi>,"acid phosphatase 2, lysosomal; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431704,EUCOMM,Acp2,MGI:87882
Acsbg2<tm1a(EUCOMM)Wtsi>,"acyl-CoA synthetase bubblegum family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432785,EUCOMM,Acsbg2,MGI:3587728
Acsl3<Gt(OST148301)Lex>,"acyl-CoA synthetase long-chain family member 3; gene trap OST148301, Lexicon Genetics",MGI:3529071,Lexicon,Acsl3,MGI:1921455
Acsl4<tm1a(EUCOMM)Wtsi>,"acyl-CoA synthetase long-chain family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431605,EUCOMM,Acsl4,MGI:1354713
Actl10<tm1a(EUCOMM)Wtsi>,"actin-like 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5473172,EUCOMM,Actl10,MGI:1917612
Actn4<tm1a(EUCOMM)Wtsi>,"actinin alpha 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441842,EUCOMM,Actn4,MGI:1890773
Actr3<Gt(A009F03)Vau>,"ARP3 actin-related protein 3; gene trap mutation A009F03, Franz Vauti",MGI:3765916,0,Actr3,MGI:1921367
Actr6<tm1a(EUCOMM)Wtsi>,"ARP6 actin-related protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434280,EUCOMM,Actr6,MGI:1914269
Acvr1c<tm1Cfi>,"activin A receptor, type IC; targeted mutation 1, Carlos F Ibanez",MGI:3512292,0,Acvr1c,MGI:2661081
Adal<tm1a(EUCOMM)Wtsi>,"adenosine deaminase-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5302350,EUCOMM,Adal,MGI:1923144
Adam10<tm2Psa>,"a disintegrin and metallopeptidase domain 10; targeted mutation 2, Paul Saftig",MGI:4838238,0,Adam10,MGI:109548
Adam17<tm1a(EUCOMM)Wtsi>,"a disintegrin and metallopeptidase domain 17; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434074,EUCOMM,Adam17,MGI:1096335
Adam23<tm1a(EUCOMM)Hmgu>,"a disintegrin and metallopeptidase domain 23; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4462649,EUCOMM,Adam23,MGI:1345162
Adam3<tm1(KOMP)Wtsi>,"a disintegrin and metallopeptidase domain 3 (cyritestin); targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4364424,KOMP-CSD,Adam3,MGI:102518
Adamts19<tm4a(EUCOMM)Wtsi>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19; targeted mutation 4a, Wellcome Trust Sanger Institute",MGI:5527601,EUCOMM,Adamts19,MGI:2442875
Adamts1<tm1Dgen>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1; targeted mutation 1, Deltagen",MGI:5427602,Deltagen,Adamts1,MGI:109249
Adamts2<tm1Dgen>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 2; targeted mutation 1, Deltagen",MGI:5427636,Deltagen,Adamts2,MGI:1347356
Adamts3<tm1a(KOMP)Wtsi>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841315,KOMP-CSD,Adamts3,MGI:3045353
Adamts3<tm1b(KOMP)Wtsi>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5585728,KOMP-CSD,Adamts3,MGI:3045353
Adamts5<tm1Lex>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2); targeted mutation 1, Lexicon Genetics",MGI:3529332,Lexicon,Adamts5,MGI:1346321
Adamts9<Mhdaund3>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9; Martin Hrabe de Angelis undefined 3",MGI:3530329,0,Adamts9,MGI:1916320
Adamts9<Mhdaund4>,"a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9; Martin Hrabe de Angelis undefined mutation 4",MGI:5629512,0,Adamts9,MGI:1916320
Adamtsl5<tm1a(EUCOMM)Hmgu>,"ADAMTS-like 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5430118,EUCOMM,Adamtsl5,MGI:1913798
Adap1<tm1a(EUCOMM)Wtsi>,"ArfGAP with dual PH domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944490,EUCOMM,Adap1,MGI:2442201
Adar<tm1a(EUCOMM)Wtsi>,"adenosine deaminase, RNA-specific; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432463,EUCOMM,Adar,MGI:1889575
Adcy1<tm1a(EUCOMM)Wtsi>,"adenylate cyclase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441907,EUCOMM,Adcy1,MGI:99677
Adcy2<tm1a(KOMP)Wtsi>,"adenylate cyclase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451651,KOMP-CSD,Adcy2,MGI:99676
Adcy3<tm1a(EUCOMM)Wtsi>,"adenylate cyclase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432916,EUCOMM,Adcy3,MGI:99675
Adcy9<tm1a(EUCOMM)Wtsi>,"adenylate cyclase 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433478,EUCOMM,Adcy9,MGI:108450
Adcy9<tm1b(EUCOMM)Wtsi>,"adenylate cyclase 9; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636912,EUCOMM,Adcy9,MGI:108450
Adcyap1r1<tm1Dgen>,"adenylate cyclase activating polypeptide 1 receptor 1; targeted mutation 1, Deltagen",MGI:5427637,Deltagen,Adcyap1r1,MGI:108449
Add2<tm1Feb>,"adducin 2 (beta); targeted mutation 1, Francisco E Baralle",MGI:2149087,0,Add2,MGI:87919
Adgrb1<tm2a(EUCOMM)Wtsi>,"adhesion G protein-coupled receptor B1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5006776,EUCOMM,Adgrb1,MGI:1933736
Adgrd1<tm1a(EUCOMM)Wtsi>,"adhesion G protein-coupled receptor D1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432831,EUCOMM,Adgrd1,MGI:3041203
Adgrd1<tm1b(EUCOMM)Wtsi>,"adhesion G protein-coupled receptor D1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548892,EUCOMM,Adgrd1,MGI:3041203
Adgrg1<tm1Dgen>,"adhesion G protein-coupled receptor G1; targeted mutation 1, Deltagen",MGI:5427671,Deltagen,Adgrg1,MGI:1340051
Adgrg6<m1Mhda>,"adhesion G protein-coupled receptor G6; mutation 1, Martin Hrabe de Angelis",MGI:5818737,0,Adgrg6,MGI:1916151
Adgrl2<tm1Dgen>,"adhesion G protein-coupled receptor L2; targeted mutation 1, Deltagen",MGI:5427677,Deltagen,Adgrl2,MGI:2139714
Adgrl4<tm1Dgen>,"adhesion G protein-coupled receptor L4; targeted mutation 1, Deltagen",MGI:5427665,Deltagen,Adgrl4,MGI:2655562
Adh5<tm1a(EUCOMM)Wtsi>,"alcohol dehydrogenase 5 (class III), chi polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432854,EUCOMM,Adh5,MGI:87929
Adipor1<tm1a(EUCOMM)Hmgu>,"adiponectin receptor 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5289879,EUCOMM,Adipor1,MGI:1919924
Adipor2<tm1a(EUCOMM)Hmgu>,"adiponectin receptor 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286361,EUCOMM,Adipor2,MGI:93830
Adora2a<tm1Map>,"adenosine A2a receptor; targeted mutation 1, Marc Parmentier",MGI:2152583,0,Adora2a,MGI:99402
Adpgk<tm2a(EUCOMM)Wtsi>,"ADP-dependent glucokinase; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840602,EUCOMM,Adpgk,MGI:1919391
Afap1l1<tm1a(EUCOMM)Wtsi>,"actin filament associated protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842406,EUCOMM,Afap1l1,MGI:2147199
Afap1l1<tm1b(EUCOMM)Wtsi>,,MGI:2147199,,,
Aff1<Rob>,"AF4/FMR2 family, member 1; robotic",MGI:1862020,0,Aff1,MGI:1100819
Aff3<tm1a(EUCOMM)Wtsi>,"AF4/FMR2 family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434291,EUCOMM,Aff3,MGI:106927
Afm<tm1a(KOMP)Wtsi>,"afamin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455621,KOMP-CSD,Afm,MGI:2429409
Afmid<tm1a(EUCOMM)Wtsi>,"arylformamidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432070,EUCOMM,Afmid,MGI:2448704
Afp<tm1Ibmm>,"alpha fetoprotein; targeted mutation 1, Claude Szpirer",MGI:2388722,0,Afp,MGI:87951
Aga<tm1Pltn>,"aspartylglucosaminidase; targeted mutation 1, Leena Peltonen",MGI:2156980,0,Aga,MGI:104873
Agap1<tm1a(EUCOMM)Wtsi>,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820274,EUCOMM,Agap1,MGI:2653690
Agl<tm1a(EUCOMM)Wtsi>,"amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432988,EUCOMM,Agl,MGI:1924809
Agl<tm1b(EUCOMM)Wtsi>,"amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548686,EUCOMM,Agl,MGI:1924809
Ago1<tm1a(KOMP)Wtsi>,"argonaute RISC catalytic subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362358,KOMP-CSD,Ago1,MGI:2446630
Ago3<tm1a(KOMP)Wtsi>,"argonaute RISC catalytic subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880894,KOMP-CSD,Ago3,MGI:2446634
Agpat3<tm1a(EUCOMM)Wtsi>,"1-acylglycerol-3-phosphate O-acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432492,EUCOMM,Agpat3,MGI:1336186
Agpat4<Gt(CC0173)Wtsi>,"1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta); gene trap CC0173, Wellcome Trust Sanger Institute",MGI:3858467,Sanger Inst. Gene Trap Res.,Agpat4,MGI:1915512
Agpat4<tm1a(KOMP)Wtsi>,"1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362437,KOMP-CSD,Agpat4,MGI:1915512
Agtr2<tm1a(EUCOMM)Wtsi>,"angiotensin II receptor, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433535,EUCOMM,Agtr2,MGI:87966
Ahcyl1<tm1a(EUCOMM)Wtsi>,"S-adenosylhomocysteine hydrolase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431930,EUCOMM,Ahcyl1,MGI:2385184
Ahnak<tm1a(KOMP)Mbp>,"AHNAK nucleoprotein (desmoyokin); targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4462489,KOMP-CSD,Ahnak,MGI:1316648
Ahr<tm1Bra>,"aryl-hydrocarbon receptor; targeted mutation 1, Christopher A Bradfield",MGI:1857427,0,Ahr,MGI:105043
Ahsa2<tm1a(EUCOMM)Wtsi>,"AHA1, activator of heat shock protein ATPase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434221,EUCOMM,Ahsa2,MGI:1916133
Aicda<tm1.1(cre/ERT2)Crey>,"activation-induced cytidine deaminase; targeted mutation 1.1, Claude-Agnes Reynaud",MGI:4437052,0,Aicda,MGI:1342279
Aicda<tm1a(EUCOMM)Hmgu>,"activation-induced cytidine deaminase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4460367,EUCOMM,Aicda,MGI:1342279
Aicda<tm1b(EUCOMM)Hmgu>,"activation-induced cytidine deaminase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636974,EUCOMM,Aicda,MGI:1342279
Aif1<tm1(KOMP)Wtsi>,"allograft inflammatory factor 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419468,KOMP-CSD,Aif1,MGI:1343098
Aif1l<tm1a(EUCOMM)Wtsi>,"allograft inflammatory factor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432419,EUCOMM,Aif1l,MGI:1919598
Aire<tm1Pltn>,"autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy); targeted mutation 1, Leena Peltonen",MGI:2182940,0,Aire,MGI:1338803
Airn<tm1Dpb>,"antisense Igf2r RNA; targeted mutation 1, Denise P Barlow",MGI:2677157,0,Airn,MGI:1353471
Ajuba<tm1Gdl>,"ajuba LIM protein; targeted mutation 1, Gregory D Longmore",MGI:3578221,0,Ajuba,MGI:1341886
Akap9<tm1a(KOMP)Wtsi>,"A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362642,KOMP-CSD,Akap9,MGI:2178217
Akr1c20<tm1a(KOMP)Wtsi>,"aldo-keto reductase family 1, member C20; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4950952,KOMP-CSD,Akr1c20,MGI:2151104
Akr7a5<tm1a(EUCOMM)Hmgu>,"aldo-keto reductase family 7, member A5 (aflatoxin aldehyde reductase); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950217,EUCOMM,Akr7a5,MGI:107796
Akr7a5<tm1b(EUCOMM)Hmgu>,"aldo-keto reductase family 7, member A5 (aflatoxin aldehyde reductase); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5617786,EUCOMM,Akr7a5,MGI:107796
Akt1s1<tm1a(EUCOMM)Wtsi>,"AKT1 substrate 1 (proline-rich); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431959,EUCOMM,Akt1s1,MGI:1914855
Aldh16a1<tm1a(EUCOMM)Wtsi>,"aldehyde dehydrogenase 16 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432547,EUCOMM,Aldh16a1,MGI:1916998
Aldh18a1<tm1a(KOMP)Wtsi>,"aldehyde dehydrogenase 18 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363671,KOMP-CSD,Aldh18a1,MGI:1888908
Aldh1b1<tm2a(EUCOMM)Wtsi>,"aldehyde dehydrogenase 1 family, member B1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840594,EUCOMM,Aldh1b1,MGI:1919785
Aldh1l1<tm1a(KOMP)Wtsi>,"aldehyde dehydrogenase 1 family, member L1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364886,KOMP-CSD,Aldh1l1,MGI:1340024
Aldh1l1<tm1b(KOMP)Wtsi>,"aldehyde dehydrogenase 1 family, member L1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548445,KOMP-CSD,Aldh1l1,MGI:1340024
Aldh2<tm1a(EUCOMM)Wtsi>,"aldehyde dehydrogenase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431566,EUCOMM,Aldh2,MGI:99600
Aldh3a1<tm1a(EUCOMM)Wtsi>,"aldehyde dehydrogenase family 3, subfamily A1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842540,EUCOMM,Aldh3a1,MGI:1353451
Aldh3a2<tm1a(EUCOMM)Wtsi>,"aldehyde dehydrogenase family 3, subfamily A2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432633,EUCOMM,Aldh3a2,MGI:1353452
Aldh3b1<tm1a(EUCOMM)Wtsi>,"aldehyde dehydrogenase 3 family, member B1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5003007,EUCOMM,Aldh3b1,MGI:1914939
Aldh3b1<tm1b(EUCOMM)Wtsi>,"aldehyde dehydrogenase 3 family, member B1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548549,EUCOMM,Aldh3b1,MGI:1914939
Alg13<tm1a(KOMP)Wtsi>,"asparagine-linked glycosylation 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841293,KOMP-CSD,Alg13,MGI:1914824
Alkbh1<tm1a(EUCOMM)Hmgu>,"alkB homolog 1, histone H2A dioxygenase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286299,EUCOMM,Alkbh1,MGI:2384034
Alkbh6<tm1a(EUCOMM)Hmgu>,"alkB homolog 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5427267,EUCOMM,Alkbh6,MGI:2142037
Alkbh8<tm1a(EUCOMM)Hmgu>,"alkB homolog 8, tRNA methyltransferase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008907,EUCOMM,Alkbh8,MGI:1914917
Alms1<tm1a(EUCOMM)Hmgu>,"ALMS1, centrosome and basal body associated; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434567,EUCOMM,Alms1,MGI:1934606
Alox12e<tm1a(EUCOMM)Wtsi>,"arachidonate lipoxygenase, epidermal; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441885,EUCOMM,Alox12e,MGI:1274790
Alox12e<tm1b(EUCOMM)Wtsi>,"arachidonate lipoxygenase, epidermal; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548415,EUCOMM,Alox12e,MGI:1274790
Alpk3<tm1a(EUCOMM)Hmgu>,"alpha-kinase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286300,EUCOMM,Alpk3,MGI:2151224
Alpl<BAP023>,"alkaline phosphatase, liver/bone/kidney; bone alkaline phospatase mutant 023",MGI:5424920,0,Alpl,MGI:87983
Alpl<Hpp>,"alkaline phosphatase, liver/bone/kidney; hypophosphatasia",MGI:3051587,0,Alpl,MGI:87983
Alpl<Mhdabap020>,"alkaline phosphatase, liver/bone/kidney; Martin Hrabe de Angelis bone alkaline phospatase mutant 020",MGI:5424919,0,Alpl,MGI:87983
Alpl<Mhdabap26>,"alkaline phosphatase, liver/bone/kidney; Martin Hrabe de Angelis bone alkaline phospatase mutant 26",MGI:5424922,0,Alpl,MGI:87983
Alpl<Mhdabap27>,"alkaline phosphatase, liver/bone/kidney; Martin Hrabe de Angelis bone alkaline phospatase mutant 27",MGI:5424923,0,Alpl,MGI:87983
Alpl<Mhdabap32>,"alkaline phosphatase, liver/bone/kidney; Martin Hrabe de Angelis bone alkaline phospatase mutant 32",MGI:5424924,0,Alpl,MGI:87983
Alpl<SAP007>,"alkaline phosphatase, liver/bone/kidney; serum alkaline phosphatase mutant 007",MGI:5425009,0,Alpl,MGI:87983
Amacr<tm1Jkh>,"alpha-methylacyl-CoA racemase; targeted mutation 1, J Kalervo Hiltunen",MGI:3044171,0,Amacr,MGI:1098273
Amfr<tm1a(KOMP)Wtsi>,"autocrine motility factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362704,KOMP-CSD,Amfr,MGI:1345634
Amotl1<tm1a(EUCOMM)Wtsi>,"angiomotin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433551,EUCOMM,Amotl1,MGI:1922973
Ampd3<tm2a(KOMP)Wtsi>,"adenosine monophosphate deaminase 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4364610,KOMP-CSD,Ampd3,MGI:1096344
Amz2<tm1e(KOMP)Wtsi>,"archaelysin family metallopeptidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4451419,KOMP-CSD,Amz2,MGI:104837
Anapc4<tm1a(EUCOMM)Wtsi>,"anaphase promoting complex subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434153,EUCOMM,Anapc4,MGI:1098673
Angptl4<tm1a(EUCOMM)Hmgu>,"angiopoietin-like 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458671,EUCOMM,Angptl4,MGI:1888999
Ankhd1<tm1a(KOMP)Wtsi>,"ankyrin repeat and KH domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4847680,KOMP-CSD,Ankhd1,MGI:1921733
Ankib1<tm1a(EUCOMM)Hmgu>,"ankyrin repeat and IBR domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946703,EUCOMM,Ankib1,MGI:1918047
Ankrd10<tm2a(EUCOMM)Hmgu>,"ankyrin repeat domain 10; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511763,EUCOMM,Ankrd10,MGI:1921840
Ankrd11<Yod>,ankyrin repeat domain 11; yoda,MGI:3797584,Harwell ENU Mutagenesis,Ankrd11,MGI:1924337
Ankrd11<tm1a(EUCOMM)Wtsi>,"ankyrin repeat domain 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842657,EUCOMM,Ankrd11,MGI:1924337
Ankrd13a<Gt(RRH308)Byg>,"ankyrin repeat domain 13a; gene trap RRH308, BayGenomics",MGI:4128768,0,Ankrd13a,MGI:1915670
Ankrd13d<tm2a(KOMP)Wtsi>,"ankyrin repeat domain 13 family, member D; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5503344,KOMP-CSD,Ankrd13d,MGI:1915673
Ankrd27<tm1a(EUCOMM)Hmgu>,"ankyrin repeat domain 27 (VPS9 domain); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841657,EUCOMM,Ankrd27,MGI:2444103
Ankrd6<tm1(KOMP)Wtsi>,"ankyrin repeat domain 6; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419782,KOMP-CSD,Ankrd6,MGI:2154278
Ankrd6<tm1.1(KOMP)Wtsi>,,MGI:2154278,,,
Ankrd9<tm1(KOMP)Wtsi>,"ankyrin repeat domain 9; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419197,KOMP-CSD,Ankrd9,MGI:1921501
Anks1b<tm1a(KOMP)Wtsi>,"ankyrin repeat and sterile alpha motif domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820106,KOMP-CSD,Anks1b,MGI:1924781
Anks4b<tm2a(EUCOMM)Wtsi>,"ankyrin repeat and sterile alpha motif domain containing 4B; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4433863,EUCOMM,Anks4b,MGI:1919324
Anks6<tm1a(KOMP)Wtsi>,"ankyrin repeat and sterile alpha motif domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363754,KOMP-CSD,Anks6,MGI:1922941
Anks6<tm1b(KOMP)Wtsi>,"ankyrin repeat and sterile alpha motif domain containing 6; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637085,KOMP-CSD,Anks6,MGI:1922941
Ano10<tm1a(EUCOMM)Wtsi>,"anoctamin 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820361,EUCOMM,Ano10,MGI:2143103
Anp32a<tm1Mak>,"acidic (leucine-rich) nuclear phosphoprotein 32 family, member A; targeted mutation 1, Tak Mak",MGI:4949091,0,Anp32a,MGI:108447
Anp32e<tm1Mak>,"acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; targeted mutation 1, Tak Mak",MGI:4867888,0,Anp32e,MGI:1913721
Anp32e<tm1e(KOMP)Wtsi>,"acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4451429,KOMP-CSD,Anp32e,MGI:1913721
Anpep<tm1Afk>,"alanyl (membrane) aminopeptidase; targeted mutation 1, Andreas Kolb",MGI:5582781,0,Anpep,MGI:5000466
Anxa3<tm1a(EUCOMM)Hmgu>,"annexin A3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946803,EUCOMM,Anxa3,MGI:1201378
Anxa3<tm1b(EUCOMM)Hmgu>,"annexin A3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5617787,EUCOMM,Anxa3,MGI:1201378
Anxa6<tm1Moss>,"annexin A6; targeted mutation 1, Stephen E Moss",MGI:2159012,0,Anxa6,MGI:88255
Anxa6<tm1a(EUCOMM)Wtsi>,"annexin A6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432672,EUCOMM,Anxa6,MGI:88255
Anxa9<tm1a(EUCOMM)Wtsi>,"annexin A9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441796,EUCOMM,Anxa9,MGI:1923711
Anxa9<tm1b(EUCOMM)Wtsi>,"annexin A9; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548668,EUCOMM,Anxa9,MGI:1923711
Aoc1<tm1a(EUCOMM)Hmgu>,"amine oxidase, copper-containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451772,EUCOMM,Aoc1,MGI:1923757
Aoc1<tm1b(EUCOMM)Hmgu>,"amine oxidase, copper-containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548670,EUCOMM,Aoc1,MGI:1923757
Aox4<tm1Enga>,"aldehyde oxidase 4; targeted mutation 1, Enrico Garattini",MGI:3833684,0,Aox4,MGI:1919122
Ap2a2<tm1a(EUCOMM)Wtsi>,"adaptor-related protein complex 2, alpha 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4888954,EUCOMM,Ap2a2,MGI:101920
Ap2a2<tm1b(EUCOMM)Wtsi>,"adaptor-related protein complex 2, alpha 2 subunit; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548327,EUCOMM,Ap2a2,MGI:101920
Ap3m1<tm1e(EUCOMM)Hmgu>,"adaptor-related protein complex 3, mu 1 subunit; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH",MGI:4436527,EUCOMM,Ap3m1,MGI:1929212
Ap3s1<tm1a(EUCOMM)Hmgu>,"adaptor-related protein complex 3, sigma 1 subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455691,EUCOMM,Ap3s1,MGI:1337062
Ap3s1<tm1b(EUCOMM)Hmgu>,"adaptor-related protein complex 3, sigma 1 subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548436,EUCOMM,Ap3s1,MGI:1337062
Ap3s2<tm1a(EUCOMM)Hmgu>,"adaptor-related protein complex 3, sigma 2 subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435108,EUCOMM,Ap3s2,MGI:1337060
Ap4e1<tm1b(KOMP)Wtsi>,"adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548434,KOMP-CSD,Ap4e1,MGI:1336993
Ap4m1<tm1a(EUCOMM)Wtsi>,"adaptor-related protein complex AP-4, mu 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014709,EUCOMM,Ap4m1,MGI:1337063
Ap4m1<tm1b(EUCOMM)Wtsi>,"adaptor-related protein complex AP-4, mu 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636962,EUCOMM,Ap4m1,MGI:1337063
Apaf1<Gt(IRESBetageo)XIX18Pgr>,"apoptotic peptidase activating factor 1; gene trap XIX18, Peter Gruss",MGI:1857868,0,Apaf1,MGI:1306796
Apc<Min>,"APC, WNT signaling pathway regulator; multiple intestinal neoplasia",MGI:1856318,0,Apc,MGI:88039
Apc<tm2.1Cip>,"APC, WNT signaling pathway regulator; targeted mutation 2, Christine Perret",MGI:3521822,0,Apc,MGI:88039
Aph1c<tm1a(KOMP)Wtsi>,"aph1 homolog C, gamma secretase subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458639,KOMP-CSD,Aph1c,MGI:1915568
Apip<tm1a(EUCOMM)Wtsi>,"APAF1 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441695,EUCOMM,Apip,MGI:1926788
Apip<tm1b(EUCOMM)Wtsi>,"APAF1 interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637096,EUCOMM,Apip,MGI:1926788
Apoc4<tm1(KOMP)Mbp>,"apolipoprotein C-IV; targeted mutation 1, Mouse Biology Program, UCDavis",MGI:4453980,KOMP-CSD,Apoc4,MGI:87878
Apoe<tm1Bres>,"apolipoprotein E; targeted mutation 1, Jan L Breslow",MGI:2137814,0,Apoe,MGI:88057
Apoe<tm1Unc>,"apolipoprotein E; targeted mutation 1, University of North Carolina",MGI:1857129,0,Apoe,MGI:88057
Apol7a<tm1a(KOMP)Wtsi>,"apolipoprotein L 7a; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419740,KOMP-CSD,Apol7a,MGI:1923011
Apol9b<tm2a(KOMP)Wtsi>,"apolipoprotein L 9b; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5287779,KOMP-CSD,Apol9b,MGI:1919148
Apoo<tm1a(KOMP)Wtsi>,"apolipoprotein O; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052398,KOMP-CSD,Apoo,MGI:1915566
Apoo<tm1b(KOMP)Wtsi>,"apolipoprotein O; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637032,KOMP-CSD,Apoo,MGI:1915566
Apool<tm1a(KOMP)Wtsi>,"apolipoprotein O-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364721,KOMP-CSD,Apool,MGI:1915367
App<tm1Yah>,"amyloid beta (A4) precursor protein; targeted mutation 1, Yann Herault",MGI:5431210,0,App,MGI:88059
App<tm1a(KOMP)Wtsi>,"amyloid beta (A4) precursor protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008790,KOMP-CSD,App,MGI:88059
Appl2<tm1a(KOMP)Wtsi>,"adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363019,KOMP-CSD,Appl2,MGI:2384914
Aqp1<tm1a(EUCOMM)Wtsi>,"aquaporin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441703,EUCOMM,Aqp1,MGI:103201
Aqp3<tm2a(EUCOMM)Wtsi>,"aquaporin 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840639,EUCOMM,Aqp3,MGI:1333777
Aqp6<tm1a(EUCOMM)Hmgu>,"aquaporin 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5287826,EUCOMM,Aqp6,MGI:1341204
Aqp6<tm1b(EUCOMM)Hmgu>,"aquaporin 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636970,EUCOMM,Aqp6,MGI:1341204
Ar<tm1Fcl>,"androgen receptor; targeted mutation 1, Frank Claessens",MGI:3706240,0,Ar,MGI:88064
Ar<tm1Verh>,"androgen receptor; targeted mutation 1, Guido Verhoeven",MGI:3034098,0,Ar,MGI:88064
Arap2<Gt(PT1-ATG)9AVal>,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2; gene trap mutation 9A, Katherine A Vallis",MGI:5514159,0,Arap2,MGI:2684416
Arap2<tm2a(EUCOMM)Wtsi>,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527598,EUCOMM,Arap2,MGI:2684416
Arcn1<tm1a(EUCOMM)Hmgu>,"archain 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435514,EUCOMM,Arcn1,MGI:2387591
Areg<tm2a(EUCOMM)Hmgu>,"amphiregulin; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5299794,EUCOMM,Areg,MGI:88068
Arel1<m1Mhda>,"apoptosis resistant E3 ubiquitin protein ligase 1; mutation 1, Martin Hrabe de Angelis",MGI:5817493,0,Arel1,MGI:1915747
Arf3<tm1a(EUCOMM)Hmgu>,"ADP-ribosylation factor 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436411,EUCOMM,Arf3,MGI:99432
Arf3<tm1b(EUCOMM)Hmgu>,"ADP-ribosylation factor 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5614714,EUCOMM,Arf3,MGI:99432
Arfip2<tm1a(EUCOMM)Wtsi>,"ADP-ribosylation factor interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842653,EUCOMM,Arfip2,MGI:1924182
Arfip2<tm1b(EUCOMM)Wtsi>,"ADP-ribosylation factor interacting protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548677,EUCOMM,Arfip2,MGI:1924182
Arg1<tm1Ekoe>,"arginase, liver; targeted mutation 1, Eleonore Kohler",MGI:5426515,0,Arg1,MGI:88070
Arhgap12<Gt(OST237375)Lex>,"Rho GTPase activating protein 12; gene trap OST237375, Lexicon Genetics",MGI:3529984,Lexicon,Arhgap12,MGI:1922665
Arhgap17<tm1a(EUCOMM)Wtsi>,"Rho GTPase activating protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842587,EUCOMM,Arhgap17,MGI:1917747
Arhgap17<tm1b(EUCOMM)Wtsi>,"Rho GTPase activating protein 17; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637047,EUCOMM,Arhgap17,MGI:1917747
Arhgap18<tm1a(KOMP)Wtsi>,"Rho GTPase activating protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363220,KOMP-CSD,Arhgap18,MGI:1921160
Arhgap22<tm1a(KOMP)Wtsi>,"Rho GTPase activating protein 22; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363166,KOMP-CSD,Arhgap22,MGI:2443418
Arhgap25<m1Mhda>,"Rho GTPase activating protein 25; mutation 1, Martin Hrabe de Angelis",MGI:5817498,0,Arhgap25,MGI:2443687
Arhgap25<tm1a(KOMP)Wtsi>,"Rho GTPase activating protein 25; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362243,KOMP-CSD,Arhgap25,MGI:2443687
Arhgap26<tm1a(EUCOMM)Hmgu>,"Rho GTPase activating protein 26; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5428627,EUCOMM,Arhgap26,MGI:1918552
Arhgap26<tm1b(EUCOMM)Hmgu>,,MGI:1918552,,,
Arhgef11<tm1a(KOMP)Wtsi>,"Rho guanine nucleotide exchange factor (GEF) 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014576,KOMP-CSD,Arhgef11,MGI:2441869
Arhgef18<Gt(OSTGST002860)Lex>,"rho/rac guanine nucleotide exchange factor (GEF) 18; gene trap OSTGST002860, Lexicon Genetics",MGI:3531196,Lexicon,Arhgef18,MGI:2142567
Arhgef1<tm1a(EUCOMM)Wtsi>,"Rho guanine nucleotide exchange factor (GEF) 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434048,EUCOMM,Arhgef1,MGI:1353510
Arhgef28<tm1a(EUCOMM)Wtsi>,"Rho guanine nucleotide exchange factor (GEF) 28; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842257,EUCOMM,Arhgef28,MGI:1346016
Arhgef38<tm1a(KOMP)Wtsi>,"Rho guanine nucleotide exchange factor (GEF) 38; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4949326,KOMP-CSD,Arhgef38,MGI:1924919
Arhgef4<tm1a(KOMP)Wtsi>,"Rho guanine nucleotide exchange factor (GEF) 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364388,KOMP-CSD,Arhgef4,MGI:2442507
Arhgef6<tm1Kkut>,"Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; targeted mutation 1, Kerstin Kutsche",MGI:5305716,0,Arhgef6,MGI:1920591
Arhgef7<tm1a(EUCOMM)Wtsi>,"Rho guanine nucleotide exchange factor (GEF7); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5009652,EUCOMM,Arhgef7,MGI:1860493
Arid1b<tm1.2(IMPC)Wtsi>,,MGI:1926129,,,
Arid1b<tm1a(EUCOMM)Hmgu>,"AT rich interactive domain 1B (SWI-like); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435087,EUCOMM,Arid1b,MGI:1926129
Arid2<tm1a(EUCOMM)Wtsi>,"AT rich interactive domain 2 (ARID, RFX-like); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433303,EUCOMM,Arid2,MGI:1924294
Arid4a<tm1a(EUCOMM)Wtsi>,"AT rich interactive domain 4A (RBP1-like); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432398,EUCOMM,Arid4a,MGI:2444354
Arl4d<tm1a(EUCOMM)Wtsi>,"ADP-ribosylation factor-like 4D; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432430,EUCOMM,Arl4d,MGI:1933155
Arl6ip1<tm1a(EUCOMM)Hmgu>,"ADP-ribosylation factor-like 6 interacting protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5289885,EUCOMM,Arl6ip1,MGI:1858943
Armc7<tm1(KOMP)Wtsi>,"armadillo repeat containing 7; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419537,KOMP-CSD,Armc7,MGI:2679719
Armc7<tm1.1(KOMP)Wtsi>,,MGI:2679719,,,
Armh3<tm1a(EUCOMM)Wtsi>,"armadillo-like helical domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455980,EUCOMM,Armh3,MGI:1918867
Armt1<tm1a(EUCOMM)Wtsi>,"acidic residue methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433265,EUCOMM,Armt1,MGI:1920669
Arpc1b<tm1a(EUCOMM)Wtsi>,"actin related protein 2/3 complex, subunit 1B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431851,EUCOMM,Arpc1b,MGI:1343142
Arpc2<tm1a(EUCOMM)Wtsi>,"actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431694,EUCOMM,Arpc2,MGI:1923959
Arpc3<tm1a(EUCOMM)Wtsi>,"actin related protein 2/3 complex, subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842449,EUCOMM,Arpc3,MGI:1928375
Arpc4<tm1a(EUCOMM)Wtsi>,"actin related protein 2/3 complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433308,EUCOMM,Arpc4,MGI:1915339
Arpin<tm1a(EUCOMM)Wtsi>,"actin-related protein 2/3 complex inhibitor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842572,EUCOMM,Arpin,MGI:1917670
Arpin<tm1b(EUCOMM)Wtsi>,"actin-related protein 2/3 complex inhibitor; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637045,EUCOMM,Arpin,MGI:1917670
Arrdc5<tm1a(EUCOMM)Wtsi>,"arrestin domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433019,EUCOMM,Arrdc5,MGI:1924170
Arrdc5<tm1b(EUCOMM)Wtsi>,"arrestin domain containing 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637088,EUCOMM,Arrdc5,MGI:1924170
Arsg<tm1a(KOMP)Wtsi>,"arylsulfatase G; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362292,KOMP-CSD,Arsg,MGI:1921258
Art4<tm1a(KOMP)Wtsi>,"ADP-ribosyltransferase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363180,KOMP-CSD,Art4,MGI:1202710
Arvcf<tm1e(EUCOMM)Wtsi>,"armadillo repeat gene deleted in velocardiofacial syndrome; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4432634,EUCOMM,Arvcf,MGI:109620
Asb3<tm2a(EUCOMM)Wtsi>,"ankyrin repeat and SOCS box-containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840680,EUCOMM,Asb3,MGI:1929749
Asb6<tm1a(KOMP)Wtsi>,"ankyrin repeat and SOCS box-containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5427187,KOMP-CSD,Asb6,MGI:1919573
Ascc3<tm1a(EUCOMM)Hmgu>,"activating signal cointegrator 1 complex subunit 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436301,EUCOMM,Ascc3,MGI:1925237
Asf1b<Gt(ROSABetageo)437Muv>,"anti-silencing function 1B histone chaperone; gene trap 437, Muriel Vernet",MGI:3696542,0,Asf1b,MGI:1914179
Asgr1<Mhdabap005>,asialoglycoprotein receptor 1; Martin Hrabe de Angelis bone alkaline phospatase mutant 005,MGI:5424890,0,Asgr1,MGI:88081
Asic3<tm1Pig>,"acid-sensing (proton-gated) ion channel 3; targeted mutation 1, Andreas Zimmer",MGI:2451051,0,Asic3,MGI:2159339
Asns<tm1a(EUCOMM)Wtsi>,"asparagine synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441742,EUCOMM,Asns,MGI:1350929
Aspa<tm1b(EUCOMM)Wtsi>,"aspartoacylase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5614710,EUCOMM,Aspa,MGI:87914
Aspm<tm1a(KOMP)Wtsi>,"abnormal spindle microtubule assembly; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362345,KOMP-CSD,Aspm,MGI:1334448
Aspn<tm1a(EUCOMM)Hmgu>,"asporin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455676,EUCOMM,Aspn,MGI:1913945
Aspn<tm1b(EUCOMM)Hmgu>,"asporin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548526,EUCOMM,Aspn,MGI:1913945
Ass1<tm1.1Ekoe>,"argininosuccinate synthetase 1; targeted mutation 1.1, Eleonore Kohler",MGI:5529834,0,Ass1,MGI:88090
Aste1<tm1a(KOMP)Wtsi>,"asteroid homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364811,KOMP-CSD,Aste1,MGI:1913845
Asxl1<tm1a(EUCOMM)Wtsi>,"additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431878,EUCOMM,Asxl1,MGI:2684063
Atad2b<tm1a(EUCOMM)Hmgu>,"ATPase family, AAA domain containing 2B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435777,EUCOMM,Atad2b,MGI:2444798
Atad3a<tm1a(KOMP)Wtsi>,"ATPase family, AAA domain containing 3A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364878,KOMP-CSD,Atad3a,MGI:1919214
Atat1<tm1.1Phep>,"alpha tubulin acetyltransferase 1; targeted mutation 1.1, Paul A Heppenstall",MGI:5549959,0,Atat1,MGI:1913869
Atf1<tm1Gsc>,"activating transcription factor 1; targeted mutation 1, Gunther Schutz",MGI:2445229,0,Atf1,MGI:1298366
Atf2<tm1a(EUCOMM)Hmgu>,"activating transcription factor 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5289859,EUCOMM,Atf2,MGI:109349
Atf3<tm2a(EUCOMM)Wtsi>,"activating transcription factor 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840692,EUCOMM,Atf3,MGI:109384
Atg16l1<tm1a(EUCOMM)Wtsi>,"autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432181,EUCOMM,Atg16l1,MGI:1924290
Atg16l2<tm1a(EUCOMM)Wtsi>,"autophagy related 16-like 2 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433064,EUCOMM,Atg16l2,MGI:1920933
Atg3<tm1a(EUCOMM)Hmgu>,"autophagy related 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436012,EUCOMM,Atg3,MGI:1915091
Atg4b<tm1a(EUCOMM)Hmgu>,"autophagy related 4B, cysteine peptidase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286293,EUCOMM,Atg4b,MGI:1913865
Atl2<tm2a(EUCOMM)Hmgu>,"atlastin GTPase 2; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4451773,EUCOMM,Atl2,MGI:1929492
Atn1<tm1a(EUCOMM)Wtsi>,"atrophin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433256,EUCOMM,Atn1,MGI:104725
Atp11a<tm1a(KOMP)Wtsi>,"ATPase, class VI, type 11A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363953,KOMP-CSD,Atp11a,MGI:1354735
Atp1a3<tm1a(EUCOMM)Hmgu>,"ATPase, Na+/K+ transporting, alpha 3 polypeptide; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5438364,EUCOMM,Atp1a3,MGI:88107
Atp1a4<tm1a(KOMP)Wtsi>,"ATPase, Na+/K+ transporting, alpha 4 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880927,KOMP-CSD,Atp1a4,MGI:1351335
Atp1b2<tm1Msch>,"ATPase, Na+/K+ transporting, beta 2 polypeptide; targeted mutation 1, Melitta Schachner",MGI:2157776,0,Atp1b2,MGI:88109
Atp2a2<tm1a(EUCOMM)Hmgu>,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4942050,EUCOMM,Atp2a2,MGI:88110
Atp2b2<Obv>,"ATPase, Ca++ transporting, plasma membrane 2; oblivion",MGI:4355879,0,Atp2b2,MGI:105368
Atp2b2<Tmy>,"ATPase, Ca++ transporting, plasma membrane 2; tommy",MGI:2158375,0,Atp2b2,MGI:105368
Atp5a1<tm1a(EUCOMM)Wtsi>,"ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432141,EUCOMM,Atp5a1,MGI:88115
Atp5e<tm1a(EUCOMM)Wtsi>,"ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842692,EUCOMM,Atp5e,MGI:1855697
Atp5e<tm1b(EUCOMM)Wtsi>,"ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636990,EUCOMM,Atp5e,MGI:1855697
Atp5f1<tm1a(EUCOMM)Wtsi>,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431782,EUCOMM,Atp5f1,MGI:1100495
Atp5f1<tm1b(EUCOMM)Wtsi>,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636929,EUCOMM,Atp5f1,MGI:1100495
Atp5g2<tm2a(EUCOMM)Hmgu>,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9); targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511784,EUCOMM,Atp5g2,MGI:1915192
Atp5g2<tm2b(EUCOMM)Hmgu>,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9); targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5588276,EUCOMM,Atp5g2,MGI:1915192
Atp5l<tm1a(EUCOMM)Hmgu>,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4461503,EUCOMM,Atp5l,MGI:1351597
Atp5s<tm1a(EUCOMM)Hmgu>,"distal membrane arm assembly complex 2 like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4456684,EUCOMM,Dmac2l,MGI:1915305
Atp6v1d<tm1a(EUCOMM)Hmgu>,"ATPase, H+ transporting, lysosomal V1 subunit D; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434885,EUCOMM,Atp6v1d,MGI:1921084
Atp8a1<tm1a(EUCOMM)Wtsi>,"ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434463,EUCOMM,Atp8a1,MGI:1330848
Atp8b2<tm1a(KOMP)Wtsi>,"ATPase, class I, type 8B, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419232,KOMP-CSD,Atp8b2,MGI:1859660
Atpaf2<tm1a(KOMP)Wtsi>,"ATP synthase mitochondrial F1 complex assembly factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362266,KOMP-CSD,Atpaf2,MGI:2180561
Atpif1<tm1a(EUCOMM)Wtsi>,"ATPase inhibitory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433166,EUCOMM,Atpif1,MGI:1196457
Atr<tm1Ofc>,"ataxia telangiectasia and Rad3 related; targeted mutation 1, Oscar Fernandez-Capetillo",MGI:4355008,0,Atr,MGI:108028
Atr<tm2Ofc>,"ataxia telangiectasia and Rad3 related; targeted mutation 2, Oscar Fernandez-Capetillo",MGI:4355009,0,Atr,MGI:108028
Atxn10<tm1a(KOMP)Wtsi>,"ataxin 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4942022,KOMP-CSD,Atxn10,MGI:1859293
Atxn10<tm1b(KOMP)Wtsi>,,MGI:1859293,,,
Atxn2<tm2.1Geno>,"ataxin 2; targeted mutation 2.1, Genoway",MGI:5467982,0,Atxn2,MGI:1277223
Atxn3<Gt(A041D06)Wrst>,"ataxin 3; gene trap A041D06, German Gene Trap Consortium",MGI:4337660,0,Atxn3,MGI:1099442
Atxn3<tm1a(KOMP)Wtsi>,"ataxin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363482,KOMP-CSD,Atxn3,MGI:1099442
Aurkb<tm1.1Mama>,"aurora kinase B; targeted mutation 1.1, Marcos Malumbres",MGI:5056426,0,Aurkb,MGI:107168
Aven<tm1.1Zrng>,"apoptosis, caspase activation inhibitor; targeted mutation 1.1, Martin Zoernig",MGI:5317759,0,Aven,MGI:1921518
Avil<tm1(HBEGF)Phep>,"advillin; targeted mutation 1, Paul A Heppenstall",MGI:5805490,0,Avil,MGI:1333798
Avp<tm1a(EUCOMM)Wtsi>,"arginine vasopressin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431847,EUCOMM,Avp,MGI:88121
Avpi1<tm1a(EUCOMM)Hmgu>,"arginine vasopressin-induced 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434813,EUCOMM,Avpi1,MGI:1916784
Avpi1<tm1b(EUCOMM)Hmgu>,"arginine vasopressin-induced 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548586,EUCOMM,Avpi1,MGI:1916784
Avpr1a<tm1Lex>,"arginine vasopressin receptor 1A; targeted mutation 1, Lexicon Genetics",MGI:5430761,Lexicon,Avpr1a,MGI:1859216
Axd,axial defects,MGI:1856670,0,Axd,MGI:88125
Axin2<tm1Wbm>,"axin 2; targeted mutation 1, Walter Birchmeier",MGI:3579503,0,Axin2,MGI:1270862
Azgp1<tm1.1Sbah>,"alpha-2-glycoprotein 1, zinc; targeted mutation 1.1, Seiamak Bahram",MGI:5431920,0,Azgp1,MGI:103163
B2m<tm1Unc>,"beta-2 microglobulin; targeted mutation 1, University of North Carolina",MGI:1857133,0,B2m,MGI:88127
B430306N03Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA B430306N03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363728,KOMP-CSD,B430306N03Rik,MGI:2443478
B430306N03Rik<tm1b(KOMP)Wtsi>,,MGI:2443478,,,
B4galnt3<tm1a(EUCOMM)Wtsi>,"beta-1,4-N-acetyl-galactosaminyl transferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434237,EUCOMM,B4galnt3,MGI:3041155
B9d1<tm1a(EUCOMM)Wtsi>,"B9 protein domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432284,EUCOMM,B9d1,MGI:1351471
B9d2<tm1a(EUCOMM)Wtsi>,"B9 protein domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441794,EUCOMM,B9d2,MGI:2387643
BC049762<tm1e(KOMP)Wtsi>,"cDNA sequence BC049762; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:5050166,KOMP-CSD,BC049762,MGI:3039622
BC053393<tm1a(KOMP)Wtsi>,"cDNA sequence BC053393; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939735,KOMP-CSD,BC053393,MGI:3039605
BC055324<tm1a(EUCOMM)Hmgu>,"cDNA sequence BC055324; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434838,EUCOMM,BC055324,MGI:3590554
Bace2<tm1Bdes>,"beta-site APP-cleaving enzyme 2; targeted mutation 1, Bart De Strooper",MGI:3603144,0,Bace2,MGI:1860440
Bach2<tm1a(EUCOMM)Wtsi>,"BTB and CNC homology, basic leucine zipper transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4882014,EUCOMM,Bach2,MGI:894679
Bach2<tm1b(EUCOMM)Wtsi>,"BTB and CNC homology, basic leucine zipper transcription factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5605836,EUCOMM,Bach2,MGI:894679
Bag1<tm1a(EUCOMM)Hmgu>,"BCL2-associated athanogene 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434714,EUCOMM,Bag1,MGI:108047
Bag3<tm1a(EUCOMM)Hmgu>,"BCL2-associated athanogene 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436101,EUCOMM,Bag3,MGI:1352493
Bag6<tm1Mak>,"BCL2-associated athanogene 6; targeted mutation 1, Tak Mak",MGI:5645515,0,Bag6,MGI:1919439
Baiap2l2<tm1a(EUCOMM)Hmgu>,"BAI1-associated protein 2-like 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435406,EUCOMM,Baiap2l2,MGI:2652819
Bap1<tm1a(EUCOMM)Hmgu>,"Brca1 associated protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436674,EUCOMM,Bap1,MGI:1206586
Barx2<tm1a(EUCOMM)Hmgu>,"BarH-like homeobox 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455664,EUCOMM,Barx2,MGI:109617
Baz1b<tm2a(KOMP)Wtsi>,"bromodomain adjacent to zinc finger domain, 1B; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4363543,KOMP-CSD,Baz1b,MGI:1353499
Bbn,bobbin,MGI:3044541,0,Bbn,MGI:2386115
Bbs5<tm1a(EUCOMM)Wtsi>,"Bardet-Biedl syndrome 5 (human); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433255,EUCOMM,Bbs5,MGI:1919819
Bbx<tm1a(EUCOMM)Wtsi>,"bobby sox HMG box containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432372,EUCOMM,Bbx,MGI:1917758
Bccip<tm1b(EUCOMM)Hmgu>,"BRCA2 and CDKN1A interacting protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548513,EUCOMM,Bccip,MGI:1913415
Bcl10<tm1Mak>,"B cell leukemia/lymphoma 10; targeted mutation 1, Tak W Mak",MGI:2158304,0,Bcl10,MGI:1337994
Bcl2l11<tm1.1Ast>,"BCL2-like 11 (apoptosis facilitator); targeted mutation 1.1, Andreas Strasser",MGI:2156498,0,Bcl2l11,MGI:1197519
Bcl2l15<tm1b(EUCOMM)Hmgu>,"BCLl2-like 15; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5637171,EUCOMM,Bcl2l15,MGI:2685412
Bclaf1<tm1Lfmp>,"BCL2-associated transcription factor 1; targeted mutation 1, Leibniz-Institute of Molecular Pharmacology",MGI:4839481,0,Bclaf1,MGI:1917580
Bdh2<tm1a(EUCOMM)Wtsi>,"3-hydroxybutyrate dehydrogenase, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433163,EUCOMM,Bdh2,MGI:1917022
Bdkrb1<tm1Bdr>,"bradykinin receptor, beta 1; targeted mutation 1, Michael Bader",MGI:2158501,0,Bdkrb1,MGI:88144
Bdkrb2<tm1Jfh>,"bradykinin receptor, beta 2; targeted mutation 1, J Fred Hess",MGI:1857135,0,Bdkrb2,MGI:102845
Bdnf<tm1(Ntf3)Pern>,"brain derived neurotrophic factor; targeted mutation 1, Patrik Ernfors",MGI:2655761,0,Bdnf,MGI:88145
Becn1<tm1a(KOMP)Wtsi>,"beclin 1, autophagy related; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362198,KOMP-CSD,Becn1,MGI:1891828
Becn1<tm1b(KOMP)Wtsi>,"beclin 1, autophagy related; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548507,KOMP-CSD,Becn1,MGI:1891828
Begain<tm1a(EUCOMM)Wtsi>,"brain-enriched guanylate kinase-associated; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460489,EUCOMM,Begain,MGI:3044626
Bex2<tm1a(EUCOMM)Hmgu>,"brain expressed X-linked 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951053,EUCOMM,Bex2,MGI:1338017
Bhlhe40<tm1a(KOMP)Wtsi>,"basic helix-loop-helix family, member e40; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362482,KOMP-CSD,Bhlhe40,MGI:1097714
Bhv11,behavioral mutant 11; behavioral mutant Bhv11,MGI:5646491,0,Bhv11,MGI:5646394
Bhv26,behavioral mutation 26,MGI:5646243,0,Bhv26,MGI:5646241
Bhv31,behavioral mutation 31,MGI:5308750,Harwell ENU Mutagenesis,Bhv31,MGI:5308748
Bhv32,behavioral mutant 32,MGI:5646449,0,Bhv32,MGI:5646392
Bhv43,behavioral mutant 43; behavioral mutation 43,MGI:5646493,0,Bhv43,MGI:5646396
Bicral<Gt(M019E03)Wrst>,"BRD4 interacting chromatin remodeling complex associated protein like; gene trap M019E03, German Gene Trap Consortium",MGI:5306775,0,Bicral,MGI:2673855
Bivm<tm1a(KOMP)Wtsi>,"basic, immunoglobulin-like variable motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5296109,KOMP-CSD,Bivm,MGI:2179809
Bivm<tm1b(KOMP)Wtsi>,"basic, immunoglobulin-like variable motif containing; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637122,KOMP-CSD,Bivm,MGI:2179809
Blite,blite,MGI:3847096,0,Blite,MGI:3847094
Bloc1s1<tm1a(EUCOMM)Hmgu>,"biogenesis of lysosomal organelles complex-1, subunit 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434990,EUCOMM,Bloc1s1,MGI:1195276
Blzf1<tm1a(EUCOMM)Wtsi>,"basic leucine zipper nuclear factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441856,EUCOMM,Blzf1,MGI:1201607
Bmp6<tm1Rob>,"bone morphogenetic protein 6; targeted mutation 1, Elizabeth J Robertson",MGI:2136985,0,Bmp6,MGI:88182
Bmp7<tm1Rob>,"bone morphogenetic protein 7; targeted mutation 1, Elizabeth J Robertson",MGI:1857654,0,Bmp7,MGI:103302
Bmp7<tm1a(EUCOMM)Hmgu>,"bone morphogenetic protein 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436150,EUCOMM,Bmp7,MGI:103302
Bmp7<tm2Rob>,"bone morphogenetic protein 7; targeted mutation 2, Elizabeth J Robertson",MGI:2136986,0,Bmp7,MGI:103302
Bms1<tm1a(EUCOMM)Hmgu>,"BMS1, ribosome biogenesis factor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435886,EUCOMM,Bms1,MGI:2446132
Bms1<tm1b(EUCOMM)Hmgu>,"BMS1, ribosome biogenesis factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548836,EUCOMM,Bms1,MGI:2446132
Bmx<tm1Ali>,"BMX non-receptor tyrosine kinase; targeted mutation 1, Kari Alitalo",MGI:2660714,0,Bmx,MGI:1101778
Bmx<tm1a(EUCOMM)Wtsi>,"BMX non-receptor tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433142,EUCOMM,Bmx,MGI:1101778
Bnc2<Gt(pU21)18Imeg>,"basonuclin 2; gene trap 18, Institute of Molecular Embryology and Genetics",MGI:3639337,0,Bnc2,MGI:2443805
Bnip2<tm1a(EUCOMM)Wtsi>,"BCL2/adenovirus E1B interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432551,EUCOMM,Bnip2,MGI:109327
Bnip2<tm1b(EUCOMM)Wtsi>,"BCL2/adenovirus E1B interacting protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636917,EUCOMM,Bnip2,MGI:109327
Boc<tm1Aok>,"biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein; targeted mutation 1, Ami Okada",MGI:3692939,0,Boc,MGI:2151153
Boc<tm1a(KOMP)Wtsi>,"biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364249,KOMP-CSD,Boc,MGI:2151153
Bola3<tm1a(EUCOMM)Wtsi>,"bolA-like 3 (E. coli); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842419,EUCOMM,Bola3,MGI:1925903
Bpgm<tm1a(KOMP)Wtsi>,"2,3-bisphosphoglycerate mutase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363424,KOMP-CSD,Bpgm,MGI:1098242
Bphl<tm1a(EUCOMM)Hmgu>,"biphenyl hydrolase-like (serine hydrolase, breast epithelial mucin-associated antigen); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436026,EUCOMM,Bphl,MGI:1915271
Bpifa3<tm1a(KOMP)Wtsi>,"BPI fold containing family A, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363898,KOMP-CSD,Bpifa3,MGI:1920638
Bpifb3<tm1a(EUCOMM)Hmgu>,"BPI fold containing family B, member 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435026,EUCOMM,Bpifb3,MGI:2675077
Bpifb5<tm2a(KOMP)Wtsi>,"BPI fold containing family B, member 5; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4843822,KOMP-CSD,Bpifb5,MGI:2385160
Bptf<Gt(A012C04)Wrst>,"bromodomain PHD finger transcription factor; gene trap A012C04, Wolfgang Wurst",MGI:3823037,0,Bptf,MGI:2444008
Braf<tm1Bbd>,"Braf transforming gene; targeted mutation 1, Mariano Barbacid",MGI:4946645,0,Braf,MGI:88190
Braf<tm1Zim>,"Braf transforming gene; targeted mutation 1, Andreas Zimmer",MGI:1857579,0,Braf,MGI:88190
Brca1<tm1Brn>,"breast cancer 1, early onset; targeted mutation 1, Anton Berns",MGI:3696057,0,Brca1,MGI:104537
Brca2<tm1Brn>,"breast cancer 2, early onset; targeted mutation 1, Anton Berns",MGI:2156556,0,Brca2,MGI:109337
Brca2<tm2Mak>,"breast cancer 2, early onset; targeted mutation 2, Tak W Mak",MGI:2429691,0,Brca2,MGI:109337
Brd7<tm2a(EUCOMM)Wtsi>,"bromodomain containing 7; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4842893,EUCOMM,Brd7,MGI:1349766
Brd8<tm1a(EUCOMM)Wtsi>,"bromodomain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433628,EUCOMM,Brd8,MGI:1925906
Brdt<tm1a(EUCOMM)Wtsi>,"bromodomain, testis-specific; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455954,EUCOMM,Brdt,MGI:1891374
Brpf1<tm1a(EUCOMM)Wtsi>,"bromodomain and PHD finger containing, 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433631,EUCOMM,Brpf1,MGI:1926033
Brpf3<tm1a(EUCOMM)Wtsi>,"bromodomain and PHD finger containing, 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432544,EUCOMM,Brpf3,MGI:2146836
Bspry<tm1a(EUCOMM)Wtsi>,"B-box and SPRY domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432968,EUCOMM,Bspry,MGI:2177191
Btbd11<tm1a(EUCOMM)Wtsi>,"BTB (POZ) domain containing 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441636,EUCOMM,Btbd11,MGI:1921257
Btbd1<tm1a(KOMP)Wtsi>,"BTB (POZ) domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419700,KOMP-CSD,Btbd1,MGI:1933765
Btbd3<tm1a(EUCOMM)Hmgu>,"BTB (POZ) domain containing 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5050175,EUCOMM,Btbd3,MGI:2385155
Btbd3<tm1b(EUCOMM)Hmgu>,"BTB (POZ) domain containing 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588286,EUCOMM,Btbd3,MGI:2385155
Btbd9<tm1a(EUCOMM)Wtsi>,"BTB (POZ) domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842263,EUCOMM,Btbd9,MGI:1916625
Btbd9<tm1b(EUCOMM)Wtsi>,"BTB (POZ) domain containing 9; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548584,EUCOMM,Btbd9,MGI:1916625
Btk<tm1a(EUCOMM)Hmgu>,"Bruton agammaglobulinemia tyrosine kinase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434935,EUCOMM,Btk,MGI:88216
Btnt,blatant,MGI:3847258,0,Btnt,MGI:3847254
Btrc<tm1a(KOMP)Wtsi>,"beta-transducin repeat containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419962,KOMP-CSD,Btrc,MGI:1338871
C1qbp<tm1a(EUCOMM)Wtsi>,"complement component 1, q subcomponent binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432129,EUCOMM,C1qbp,MGI:1194505
C1qtnf2<tm2a(KOMP)Wtsi>,"C1q and tumor necrosis factor related protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4419335,KOMP-CSD,C1qtnf2,MGI:1916433
C1rl<tm1a(EUCOMM)Hmgu>,"complement component 1, r subcomponent-like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435790,EUCOMM,C1rl,MGI:2660692
C8b<tm1a(EUCOMM)Hmgu>,"complement component 8, beta polypeptide; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458718,EUCOMM,C8b,MGI:88236
Cab39l<tm1a(EUCOMM)Wtsi>,"calcium binding protein 39-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433220,EUCOMM,Cab39l,MGI:1914081
Cabp1<tm1a(EUCOMM)Wtsi>,"calcium binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441861,EUCOMM,Cabp1,MGI:1352750
Cacna1b<tm1a(KOMP)Wtsi>,"calcium channel, voltage-dependent, N type, alpha 1B subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363249,KOMP-CSD,Cacna1b,MGI:88296
Cacna2d1<tm1Aschw>,"calcium channel, voltage-dependent, alpha2/delta subunit 1; targeted mutation 1, Arnold Schwartz",MGI:4353680,0,Cacna2d1,MGI:88295
Cacna2d2<ent>,"calcium channel, voltage-dependent, alpha 2/delta subunit 2; entla",MGI:3038918,0,Cacna2d2,MGI:1929813
Cacna2d2<m1Mhda>,"calcium channel, voltage-dependent, alpha 2/delta subunit 2; mutation 1, Martin Hrabe de Angelis",MGI:5707604,0,Cacna2d2,MGI:1929813
Cacnb4<tm1a(EUCOMM)Hmgu>,"calcium channel, voltage-dependent, beta 4 subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435787,EUCOMM,Cacnb4,MGI:103301
Cadm1<tm1.2Brd>,"cell adhesion molecule 1; targeted mutation 1.2, Allan Bradley",MGI:3625158,0,Cadm1,MGI:1889272
Cadm1<tm1a(EUCOMM)Wtsi>,"cell adhesion molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432825,EUCOMM,Cadm1,MGI:1889272
Calb1<tm1Mpin>,"calbindin 1; targeted mutation 1, Max-Planck-Institute for Neurobiology",MGI:1857460,0,Calb1,MGI:88248
Calb1<tm2.1Mpin>,"calbindin 1; targeted mutation 2.1, Max-Planck-Institute for Neurobiology",MGI:2181196,0,Calb1,MGI:88248
Calcoco2<tm1(KOMP)Wtsi>,"calcium binding and coiled-coil domain 2; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419466,KOMP-CSD,Calcoco2,MGI:1343177
Calr4<tm1a(KOMP)Wtsi>,"calreticulin 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008777,KOMP-CSD,Calr4,MGI:2140435
Camk2b<tm1a(EUCOMM)Hmgu>,"calcium/calmodulin-dependent protein kinase II, beta; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841596,EUCOMM,Camk2b,MGI:88257
Camk4<tm1Gsc>,"calcium/calmodulin-dependent protein kinase IV; targeted mutation 1, Gunther Schutz",MGI:2181436,0,Camk4,MGI:88258
Camkmt<tm1a(EUCOMM)Wtsi>,"calmodulin-lysine N-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820305,EUCOMM,Camkmt,MGI:1920832
Camkmt<tm1b(EUCOMM)Wtsi>,"calmodulin-lysine N-methyltransferase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637069,EUCOMM,Camkmt,MGI:1920832
Camsap3<tm1a(EUCOMM)Wtsi>,"calmodulin regulated spectrin-associated protein family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431915,EUCOMM,Camsap3,MGI:1916947
Cand2<tm1a(EUCOMM)Wtsi>,"cullin-associated and neddylation-dissociated 2 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432020,EUCOMM,Cand2,MGI:1914338
Candy,Candy,MGI:5499480,Harwell ENU Mutagenesis,Candy,MGI:5499471
Candy2,Candy2,MGI:5499481,Harwell ENU Mutagenesis,Candy2,MGI:5499473
Candy3,Candy3,MGI:5499491,Harwell ENU Mutagenesis,Candy3,MGI:5499475
Candy4,Candy4,MGI:5499492,Harwell ENU Mutagenesis,Candy4,MGI:5499477
Candy5,Candy5,MGI:4830605,Harwell ENU Mutagenesis,Candy5,MGI:4833646
Cant1<tm1a(EUCOMM)Hmgu>,"calcium activated nucleotidase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455761,EUCOMM,Cant1,MGI:1923275
Cant1<tm1b(EUCOMM)Hmgu>,"calcium activated nucleotidase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5612825,EUCOMM,Cant1,MGI:1923275
Cap2<tm1a(EUCOMM)Wtsi>,"CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431970,EUCOMM,Cap2,MGI:1914502
Capn11<tm1a(EUCOMM)Wtsi>,"calpain 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432998,EUCOMM,Capn11,MGI:1352490
Capn12<tm1a(EUCOMM)Hmgu>,"calpain 12; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4881978,EUCOMM,Capn12,MGI:1891369
Capn12<tm1b(EUCOMM)Hmgu>,"calpain 12; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5605772,EUCOMM,Capn12,MGI:1891369
Capn1<tm1Dgen>,"calpain 1; targeted mutation 1, Deltagen",MGI:5319092,Deltagen,Capn1,MGI:88263
Capn5<tm1Nde>,"calpain 5; targeted mutation 1, T Neil Dear",MGI:3029041,0,Capn5,MGI:1100859
Capn5<tm1a(EUCOMM)Hmgu>,"calpain 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436604,EUCOMM,Capn5,MGI:1100859
Caprin1<tm3a(EUCOMM)Wtsi>,"cell cycle associated protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:5511946,EUCOMM,Caprin1,MGI:1858234
Caprin2<tm2a(EUCOMM)Wtsi>,"caprin family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4434168,EUCOMM,Caprin2,MGI:2448541
Capza2<tm1a(KOMP)Wtsi>,"capping protein (actin filament) muscle Z-line, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880887,KOMP-CSD,Capza2,MGI:106222
Capza2<tm1b(KOMP)Wtsi>,"capping protein (actin filament) muscle Z-line, alpha 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5638561,KOMP-CSD,Capza2,MGI:106222
Capzb<tm1a(EUCOMM)Wtsi>,"capping protein (actin filament) muscle Z-line, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432323,EUCOMM,Capzb,MGI:104652
Car14<tm1a(EUCOMM)Hmgu>,"carbonic anhydrase 14; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5050211,EUCOMM,Car14,MGI:1344341
Car4<tm1a(EUCOMM)Wtsi>,"carbonic anhydrase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433993,EUCOMM,Car4,MGI:1096574
Car4<tm1b(EUCOMM)Wtsi>,"carbonic anhydrase 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548394,EUCOMM,Car4,MGI:1096574
Car6<tm1Pwp>,"carbonic anhydrase 6; targeted mutation 1, Pei-wen Pan",MGI:5013650,0,Car6,MGI:1333786
Car9<tm1Spas>,"carbonic anhydrase 9; targeted mutation 1, Silvia Pastorekova",MGI:2448129,0,Car9,MGI:2447188
Card11<unm>,"caspase recruitment domain family, member 11; unmodulated",MGI:3045963,APF ENU Mutagenesis,Card11,MGI:1916978
Card6<tm1Aldu>,"caspase recruitment domain family, member 6; targeted mutation 1, Almut Dufner",MGI:3776907,0,Card6,MGI:3032959
Card9<tm1a(EUCOMM)Hmgu>,"caspase recruitment domain family, member 9; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841496,EUCOMM,Card9,MGI:2685628
Carmil1<tm1a(KOMP)Wtsi>,"capping protein regulator and myosin 1 linker 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362921,KOMP-CSD,Carmil1,MGI:1915982
Casc4<tm2a(EUCOMM)Wtsi>,"cancer susceptibility candidate 4; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4458827,EUCOMM,Casc4,MGI:2443129
Casc4<tm2b(EUCOMM)Wtsi>,"cancer susceptibility candidate 4; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637147,EUCOMM,Casc4,MGI:2443129
Casp12<tm1a(KOMP)Wtsi>,"caspase 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939736,KOMP-CSD,Casp12,MGI:1312922
Casp1<tm1a(EUCOMM)Wtsi>,"caspase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4946804,EUCOMM,Casp1,MGI:96544
Casp3<m1H>,"caspase 3; mutation 1, MRC Mammalian Genetics Unit, Harwell",MGI:5646608,0,Casp3,MGI:107739
Casp3<tm1Mak>,"caspase 3; targeted mutation 1, Tak W Mak",MGI:2178778,0,Casp3,MGI:107739
Casp9<tm1Mak>,"caspase 9; targeted mutation 1, Tak W Mak",MGI:2158754,0,Casp9,MGI:1277950
Casq1<tm1a(EUCOMM)Wtsi>,"calsequestrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431740,EUCOMM,Casq1,MGI:1309468
Casr<BCH003>,calcium-sensing receptor; bone calcium high mutant 003,MGI:5424980,0,Casr,MGI:1351351
Casr<BCH004>,calcium-sensing receptor; bone calcium high mutant 004,MGI:5424981,0,Casr,MGI:1351351
Casr<BCH007>,calcium-sensing receptor; bone calcium high mutant 007,MGI:5424982,0,Casr,MGI:1351351
Casr<BCH011>,calcium-sensing receptor; bone calcium high mutant 011,MGI:5424983,0,Casr,MGI:1351351
Casr<BCH013>,calcium-sensing receptor; bone calcium high mutant 013,MGI:5424984,0,Casr,MGI:1351351
Casr<Nuf>,calcium-sensing receptor; nuclear flecks,MGI:3054788,0,Casr,MGI:1351351
Casz1<tm1a(EUCOMM)Hmgu>,"castor zinc finger 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841554,EUCOMM,Casz1,MGI:1196251
Catip<tm1a(KOMP)Wtsi>,"ciliogenesis associated TTC17 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362227,KOMP-CSD,Catip,MGI:2685062
Catip<tm1b(KOMP)Wtsi>,"ciliogenesis associated TTC17 interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637170,KOMP-CSD,Catip,MGI:2685062
Cbl<tm1a(EUCOMM)Hmgu>,"Casitas B-lineage lymphoma; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841759,EUCOMM,Cbl,MGI:88279
Cbr2<tm1a(EUCOMM)Hmgu>,"carbonyl reductase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4947775,EUCOMM,Cbr2,MGI:107200
Cbx1<tm1a(EUCOMM)Wtsi>,"chromobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432508,EUCOMM,Cbx1,MGI:105369
Cbx2<tm1a(KOMP)Wtsi>,"chromobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4420062,KOMP-CSD,Cbx2,MGI:88289
Cbx3<tm1Pbs>,"chromobox 3; targeted mutation 1, Prim B Singh",MGI:5433765,0,Cbx3,MGI:108515
Cbx5<Gt(W205C07)Wrst>,"chromobox 5; gene trap W205C07, German Gene Trap Consortium",MGI:4336248,0,Cbx5,MGI:109372
Cbx5<tm1a(EUCOMM)Wtsi>,"chromobox 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441648,EUCOMM,Cbx5,MGI:109372
Cbx6<tm1a(EUCOMM)Wtsi>,"chromobox 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441849,EUCOMM,Cbx6,MGI:3512628
Cbx7<tm1a(KOMP)Wtsi>,"chromobox 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363230,KOMP-CSD,Cbx7,MGI:1196439
Cc2d1b<tm1a(KOMP)Wtsi>,"coiled-coil and C2 domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362981,KOMP-CSD,Cc2d1b,MGI:2443076
Cc2d2a<tm1a(EUCOMM)Wtsi>,"coiled-coil and C2 domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431801,EUCOMM,Cc2d2a,MGI:1924487
Ccdc106<tm1a(EUCOMM)Wtsi>,"coiled-coil domain containing 106; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433912,EUCOMM,Ccdc106,MGI:2385900
Ccdc122<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 122; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363388,KOMP-CSD,Ccdc122,MGI:1918358
Ccdc127<tm1a(EUCOMM)Wtsi>,"coiled-coil domain containing 127; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432124,EUCOMM,Ccdc127,MGI:1914683
Ccdc127<tm1b(EUCOMM)Wtsi>,"coiled-coil domain containing 127; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637023,EUCOMM,Ccdc127,MGI:1914683
Ccdc134<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 134; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362536,KOMP-CSD,Ccdc134,MGI:1923707
Ccdc137<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 137; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363458,KOMP-CSD,Ccdc137,MGI:1914541
Ccdc14<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880921,KOMP-CSD,Ccdc14,MGI:2443448
Ccdc151<tm1b(EUCOMM)Hmgu>,"coiled-coil domain containing 151; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548687,EUCOMM,Ccdc151,MGI:1924859
Ccdc159<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 159; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419403,KOMP-CSD,Ccdc159,MGI:1914369
Ccdc160<tm1a(EUCOMM)Wtsi>,"coiled-coil domain containing 160; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453700,EUCOMM,Ccdc160,MGI:3588225
Ccdc18<tm1a(EUCOMM)Wtsi>,"coiled-coil domain containing 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460455,EUCOMM,Ccdc18,MGI:1922974
Ccdc24<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 24; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455549,KOMP-CSD,Ccdc24,MGI:2685874
Ccdc50<tm1a(EUCOMM)Hmgu>,"coiled-coil domain containing 50; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841765,EUCOMM,Ccdc50,MGI:1914751
Ccdc57<tm1a(EUCOMM)Wtsi>,"coiled-coil domain containing 57; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431914,EUCOMM,Ccdc57,MGI:1918526
Ccdc69<tm1a(KOMP)Wtsi>,"coiled-coil domain containing 69; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364083,KOMP-CSD,Ccdc69,MGI:1196234
Ccdc69<tm1b(KOMP)Wtsi>,"coiled-coil domain containing 69; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636931,KOMP-CSD,Ccdc69,MGI:1196234
Ccdc77<tm1a(EUCOMM)Wtsi>,"coiled-coil domain containing 77; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432801,EUCOMM,Ccdc77,MGI:1914450
Cckar<tm1b(EUCOMM)Hmgu>,,MGI:99478,,,
Ccl22<tm1a(EUCOMM)Wtsi>,"chemokine (C-C motif) ligand 22; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441963,EUCOMM,Ccl22,MGI:1306779
Ccl25<tm1Lex>,"chemokine (C-C motif) ligand 25; targeted mutation 1, Lexicon Genetics",MGI:3529266,Lexicon,Ccl25,MGI:1099448
Ccl6<tm1Roes>,"chemokine (C-C motif) ligand 6; targeted mutation 1, Jurgen Roes",MGI:5494646,0,Ccl6,MGI:98263
Ccnb1<tm1a(KOMP)Wtsi>,"cyclin B1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419820,KOMP-CSD,Ccnb1,MGI:88302
Ccnc<tm1a(EUCOMM)Wtsi>,"cyclin C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5301390,EUCOMM,Ccnc,MGI:1858199
Ccnyl1<tm1a(EUCOMM)Wtsi>,"cyclin Y-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432945,EUCOMM,Ccnyl1,MGI:2138614
Ccpg1<tm1a(EUCOMM)Hmgu>,"cell cycle progression 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5000356,EUCOMM,Ccpg1,MGI:1196419
Ccpg1<tm1b(EUCOMM)Hmgu>,"cell cycle progression 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588268,EUCOMM,Ccpg1,MGI:1196419
Ccr1<tm1Gao>,"chemokine (C-C motif) receptor 1; targeted mutation 1, Ji-Liang Gao",MGI:1931850,0,Ccr1,MGI:104618
Ccr2<tm1Blck>,"chemokine (C-C motif) receptor 2; targeted mutation 1, Bruno Luckow",MGI:3613374,0,Ccr2,MGI:106185
Ccr5<tm1Blck>,"chemokine (C-C motif) receptor 5; targeted mutation 1, Bruno Luckow",MGI:3613371,0,Ccr5,MGI:107182
Ccr5<tm2Blck>,"chemokine (C-C motif) receptor 5; targeted mutation 2, Bruno Luckow",MGI:4360353,0,Ccr5,MGI:107182
Ccr6<tm1Dgen>,"chemokine (C-C motif) receptor 6; targeted mutation 1, Deltagen",MGI:3604541,Deltagen,Ccr6,MGI:1333797
Ccr6<tm1Gma>,"chemokine (C-C motif) receptor 6; targeted mutation 1, Gabriel Marquez",MGI:2179613,0,Ccr6,MGI:1333797
Ccr8<tm1Gma>,"chemokine (C-C motif) receptor 8; targeted mutation 1, Gabriel Marquez",MGI:2450726,0,Ccr8,MGI:1201402
Ccr9<tm1Dgen>,"chemokine (C-C motif) receptor 9; targeted mutation 1, Deltagen",MGI:5009291,Deltagen,Ccr9,MGI:1341902
Cd14<tm1Frm>,"CD14 antigen; targeted mutation 1, Mason W Freeman",MGI:1934009,0,Cd14,MGI:88318
Cd19<tm1(cre)Cgn>,"CD19 antigen; targeted mutation 1, University of Cologne",MGI:1931143,0,Cd19,MGI:88319
Cd1d1<tm1Luc>,"CD1d1 antigen; targeted mutation 1, Luc Van Kaer",MGI:2180711,0,Cd1d1,MGI:107674
Cd200<tm1a(KOMP)Wtsi>,"CD200 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362965,KOMP-CSD,Cd200,MGI:1196990
Cd207<tm1Mal>,"CD207 antigen; targeted mutation 1, Bernard Malissen",MGI:3526083,0,Cd207,MGI:2180021
Cd207<tm2Mal>,"CD207 antigen; targeted mutation 1, Bernard Malissen",MGI:3581825,0,Cd207,MGI:2180021
Cd207<tm3(DTR/GFP)Mal>,"CD207 antigen; targeted mutation 3, Bernard Malissen",MGI:3581827,0,Cd207,MGI:2180021
Cd209e<tm1a(KOMP)Wtsi>,"CD209e antigen; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363909,KOMP-CSD,Cd209e,MGI:2157948
Cd209e<tm1b(KOMP)Wtsi>,,MGI:2157948,,,
Cd247<tm1Lov>,"CD247 antigen; targeted mutation 1, Paul Love",MGI:1857142,0,Cd247,MGI:88334
Cd247<tm1Mal>,"CD247 antigen; targeted mutation 1, Bernard Malissen",MGI:2180466,0,Cd247,MGI:88334
Cd28<tm1a(EUCOMM)Hmgu>,"CD28 antigen; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435635,EUCOMM,Cd28,MGI:88327
Cd300lg<tm1a(KOMP)Wtsi>,"CD300 molecule like family member G; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364847,KOMP-CSD,Cd300lg,MGI:1289168
Cd34<tm1Szk>,"CD34 antigen; targeted mutation 1, Akira Suzuki",MGI:2180755,0,Cd34,MGI:88329
Cd3e<tm1Mal>,"CD3 antigen, epsilon polypeptide; targeted mutation 1, Bernard Malissen",MGI:2155092,0,Cd3e,MGI:88332
Cd40<tm1Kik>,"CD40 antigen; targeted mutation 1, Hitoshi Kikutani",MGI:1857457,0,Cd40,MGI:88336
Cd44<tm1.1Ugu>,"CD44 antigen; targeted mutation 1.1, Ursula Gunthert",MGI:2679706,0,Cd44,MGI:88338
Cd44<tm1Mak>,"CD44 antigen; targeted mutation 1, Tak W Mak",MGI:2181292,0,Cd44,MGI:88338
Cd44<tm1Ugu>,"CD44 antigen; targeted mutation 1, Ursula Gunthert",MGI:2679704,0,Cd44,MGI:88338
Cd44<tm2.1Ugu>,"CD44 antigen; targeted mutation 2.1, Ursula Gunthert",MGI:4835490,0,Cd44,MGI:88338
Cd4<tm1Litt>,"CD4 antigen; targeted mutation 1, Dan R Littman",MGI:1857281,0,Cd4,MGI:88335
Cd55b<tm1a(KOMP)Wtsi>,"CD55 molecule, decay accelerating factor for complement B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4868034,KOMP-CSD,Cd55b,MGI:104849
Cd5l<tm1a(KOMP)Mbp>,"CD5 antigen-like; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4840877,KOMP-CSD,Cd5l,MGI:1334419
Cd74<tm1Doi>,"CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); targeted mutation 1, Christophe Benoist and Diane Mathis",MGI:1927205,0,Cd74,MGI:96534
Cd7<tm1a(KOMP)Wtsi>,"CD7 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364048,KOMP-CSD,Cd7,MGI:88344
Cd81<tm1Lvy>,"CD81 antigen; targeted mutation 1, Shoshana Levy",MGI:2180805,0,Cd81,MGI:1096398
Cd8a<tm1Mak>,"CD8 antigen, alpha chain; targeted mutation 1, Tak Mak",MGI:1857149,0,Cd8a,MGI:88346
Cd9<tm1Bcx>,"CD9 antigen; targeted mutation 1, Claude Boucheix",MGI:2180795,0,Cd9,MGI:88348
Cd9<tm1a(EUCOMM)Hmgu>,"CD9 antigen; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435382,EUCOMM,Cd9,MGI:88348
Cdc123<tm1a(KOMP)Wtsi>,"cell division cycle 123; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4940785,KOMP-CSD,Cdc123,MGI:2138811
Cdc123<tm1b(KOMP)Wtsi>,"cell division cycle 123; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548737,KOMP-CSD,Cdc123,MGI:2138811
Cdc20<tm1.1Mama>,"cell division cycle 20; targeted mutation 1.1, Marcos Malumbres",MGI:4887480,0,Cdc20,MGI:1859866
Cdc26<tm1a(EUCOMM)Hmgu>,"cell division cycle 26; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436708,EUCOMM,Cdc26,MGI:1913690
Cdc42<tm1a(EUCOMM)Hmgu>,"cell division cycle 42; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951033,EUCOMM,Cdc42,MGI:106211
Cdc42bpa<tm1a(EUCOMM)Wtsi>,"CDC42 binding protein kinase alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431983,EUCOMM,Cdc42bpa,MGI:2441841
Cdc6<tm1a(KOMP)Wtsi>,"cell division cycle 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4454064,KOMP-CSD,Cdc6,MGI:1345150
Cdca8<tm1a(KOMP)Wtsi>,"cell division cycle associated 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362476,KOMP-CSD,Cdca8,MGI:1196274
Cdh13<tm1a(EUCOMM)Hmgu>,"cadherin 13; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436162,EUCOMM,Cdh13,MGI:99551
Cdh19<tm1a(EUCOMM)Wtsi>,"cadherin 19, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432826,EUCOMM,Cdh19,MGI:3588198
Cdh1<tm1a(EUCOMM)Wtsi>,"cadherin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432805,EUCOMM,Cdh1,MGI:88354
Cdh23<tm2a(EUCOMM)Wtsi>,"cadherin 23 (otocadherin); targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527600,EUCOMM,Cdh23,MGI:1890219
Cdh23<v-Alb>,cadherin 23 (otocadherin); Albany waltzer,MGI:1857310,0,Cdh23,MGI:1890219
Cdh23<v>,cadherin 23 (otocadherin); waltzer,MGI:1856228,0,Cdh23,MGI:1890219
Cdh26<tm1a(KOMP)Wtsi>,"cadherin-like 26; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4942041,KOMP-CSD,Cdh26,MGI:2685856
Cdk13<tm1a(EUCOMM)Hmgu>,"cyclin-dependent kinase 13; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842225,EUCOMM,Cdk13,MGI:1916812
Cdk13<tm1b(EUCOMM)Hmgu>,"cyclin-dependent kinase 13; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588278,EUCOMM,Cdk13,MGI:1916812
Cdk14<tm1a(KOMP)Wtsi>,"cyclin-dependent kinase 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362247,KOMP-CSD,Cdk14,MGI:894318
Cdk2<tm1Sgo>,"cyclin-dependent kinase 2; targeted mutation 1, Sagrario Ortega",MGI:2675585,0,Cdk2,MGI:104772
Cdk2<tm2Sgo>,"cyclin-dependent kinase 2; targeted mutation 2, Sagrario Ortega",MGI:3759555,0,Cdk2,MGI:104772
Cdk4<tm1Bbd>,"cyclin-dependent kinase 4; targeted mutation 1, Mariano Barbacid",MGI:2154520,0,Cdk4,MGI:88357
Cdk4<tm2.1Bbd>,"cyclin-dependent kinase 4; targeted mutation 2.1, Mariano Barbacid",MGI:3759558,0,Cdk4,MGI:88357
Cdk5rap2<an>,CDK5 regulatory subunit associated protein 2; Hertwig's anemia,MGI:1856646,0,Cdk5rap2,MGI:2384875
Cdk5rap2<tm1a(EUCOMM)Wtsi>,"CDK5 regulatory subunit associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433427,EUCOMM,Cdk5rap2,MGI:2384875
Cdk5rap3<tm1a(EUCOMM)Hmgu>,"CDK5 regulatory subunit associated protein 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435510,EUCOMM,Cdk5rap3,MGI:1933126
Cdk5rap3<tm1b(EUCOMM)Hmgu>,"CDK5 regulatory subunit associated protein 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548726,EUCOMM,Cdk5rap3,MGI:1933126
Cdk6<tm1Bbd>,"cyclin-dependent kinase 6; targeted mutation 1, Mariano Barbacid",MGI:3053975,0,Cdk6,MGI:1277162
Cdk6<tm2.1Phin>,"cyclin-dependent kinase 6; targeted mutation 2.1, Philip Hinds",MGI:5141514,0,Cdk6,MGI:1277162
Cdk7<Gt(D032B11)1.1Wrst>,"cyclin-dependent kinase 7; gene trap D032B11, 1.1, German Gene Trap Consortium",MGI:5429213,0,Cdk7,MGI:102956
Cdk7<Gt(D032B11)Wrst>,"cyclin-dependent kinase 7; gene trap D032B11, German Gene Trap Consortium",MGI:3873807,0,Cdk7,MGI:102956
Cdk8<tm1a(EUCOMM)Hmgu>,"cyclin-dependent kinase 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842014,EUCOMM,Cdk8,MGI:1196224
Cdkal1<tm2a(EUCOMM)Wtsi>,"CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4842388,EUCOMM,Cdkal1,MGI:1921765
Cdkal1<tm2b(EUCOMM)Wtsi>,"CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548648,EUCOMM,Cdkal1,MGI:1921765
Cdkl5<tm1.1Cogr>,"cyclin-dependent kinase-like 5; targeted mutation 1.1, Cornelius Gross",MGI:5573232,0,Cdkl5,MGI:1278336
Cdkl5<tm1.2Cogr>,"cyclin-dependent kinase-like 5; targeted mutation 1.2, Cornelius Gross",MGI:5573238,0,Cdkl5,MGI:1278336
Cdkn1a<tm1Tyj>,"cyclin-dependent kinase inhibitor 1A (P21); targeted mutation 1, Tyler Jacks",MGI:1933751,0,Cdkn1a,MGI:104556
Cdkn1c<tm1Bbd>,"cyclin-dependent kinase inhibitor 1C (P57); targeted mutation 1, Mariano Barbacid",MGI:1933757,0,Cdkn1c,MGI:104564
Cdkn2a<tm1.1Brn>,"cyclin dependent kinase inhibitor 2A; targeted mutation 1.1, Anton Berns",MGI:2384165,0,Cdkn2a,MGI:104738
Cdkn2a<tm1Cjs>,"cyclin dependent kinase inhibitor 2A; targeted mutation 1, Charles J Scherr",MGI:1926877,0,Cdkn2a,MGI:104738
Cdkn2a<tm1Rdp>,"cyclin dependent kinase inhibitor 2A; targeted mutation 1, Ronald DePinho",MGI:1857942,0,Cdkn2a,MGI:104738
Cdkn2a<tm1a(EUCOMM)Wtsi>,"cyclin dependent kinase inhibitor 2A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460436,EUCOMM,Cdkn2a,MGI:104738
Cdkn2a<tm2.1Rdp>,"cyclin dependent kinase inhibitor 2A; targeted mutation 2.1, Ronald DePinho",MGI:2384177,0,Cdkn2a,MGI:104738
Cdkn2a<tm2Brn>,"cyclin dependent kinase inhibitor 2A; targeted mutation 2, Anton Berns",MGI:2384163,0,Cdkn2a,MGI:104738
Cdkn2aipnl<tm1a(KOMP)Wtsi>,"CDKN2A interacting protein N-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362329,KOMP-CSD,Cdkn2aipnl,MGI:1261797
Cdkn2aipnl<tm1b(KOMP)Wtsi>,"CDKN2A interacting protein N-terminal like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548411,KOMP-CSD,Cdkn2aipnl,MGI:1261797
Cdkn2b<tm1Bbd>,"cyclin dependent kinase inhibitor 2B; targeted mutation 1, Mariano Barbacid",MGI:1933760,0,Cdkn2b,MGI:104737
Cdkn2c<tm1Bbd>,"cyclin dependent kinase inhibitor 2C; targeted mutation 1, Mariano Barbacid",MGI:1933761,0,Cdkn2c,MGI:105388
Cdon<tm1a(EUCOMM)Hmgu>,"cell adhesion molecule-related/down-regulated by oncogenes; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451853,EUCOMM,Cdon,MGI:1926387
Cds2<tm1a(KOMP)Wtsi>,"CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363703,KOMP-CSD,Cds2,MGI:1332236
Cdsn<tm1a(EUCOMM)Hmgu>,"corneodesmosin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436163,EUCOMM,Cdsn,MGI:3505689
Cdsn<tm1b(EUCOMM)Hmgu>,"corneodesmosin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5637180,EUCOMM,Cdsn,MGI:3505689
Ceacam10<tm1Wzm>,"carcinoembryonic antigen-related cell adhesion molecule 10; targeted mutation 1, Wolfgang Zimmermann",MGI:2448242,0,Ceacam10,MGI:1347248
Ceacam16<tm1Wzm>,"carcinoembryonic antigen-related cell adhesion molecule 16; targeted mutation 1, Wolfgang Zimmermann",MGI:5437595,0,Ceacam16,MGI:2685615
Ceacam9<tm1Wzm>,"carcinoembryonic antigen-related cell adhesion molecule 9; targeted mutation 1, Wolfgang Zimmermann",MGI:2183316,0,Ceacam9,MGI:1347247
Cebpz<m1Mhda>,"CCAAT/enhancer binding protein zeta; mutation 1, Martin Hrabe de Angelis",MGI:5817502,0,Cebpz,MGI:109386
Celf2<tm1a(EUCOMM)Wtsi>,"CUGBP, Elav-like family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434482,EUCOMM,Celf2,MGI:1338822
Celf2<tm1c(EUCOMM)Wtsi>,,MGI:1338822,,,
Celf4<tm1a(EUCOMM)Wtsi>,"CUGBP, Elav-like family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433345,EUCOMM,Celf4,MGI:1932407
Celf6<tm1a(KOMP)Wtsi>,"CUGBP, Elav-like family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4843838,KOMP-CSD,Celf6,MGI:1923433
Celsr1<Scy>,"cadherin, EGF LAG seven-pass G-type receptor 1; spin cycle",MGI:1862019,0,Celsr1,MGI:1100883
Cenpe<tm1a(EUCOMM)Hmgu>,"centromere protein E; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436086,EUCOMM,Cenpe,MGI:1098230
Cenpe<tm1b(EUCOMM)Hmgu>,"centromere protein E; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548395,EUCOMM,Cenpe,MGI:1098230
Cenph<tm1a(EUCOMM)Hmgu>,"centromere protein H; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436053,EUCOMM,Cenph,MGI:1349448
Cenph<tm1b(EUCOMM)Hmgu>,"centromere protein H; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588273,EUCOMM,Cenph,MGI:1349448
Cenpj<tm1a(EUCOMM)Wtsi>,"centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432238,EUCOMM,Cenpj,MGI:2684927
Cenpl<tm1a(EUCOMM)Wtsi>,"centromere protein L; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433140,EUCOMM,Cenpl,MGI:1917704
Cenpl<tm1b(EUCOMM)Wtsi>,"centromere protein L; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637046,EUCOMM,Cenpl,MGI:1917704
Cep164<tm1a(EUCOMM)Wtsi>,"centrosomal protein 164; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432075,EUCOMM,Cep164,MGI:2384878
Cep250<tm1a(EUCOMM)Wtsi>,"centrosomal protein 250; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431949,EUCOMM,Cep250,MGI:108084
Cep41<tm1a(EUCOMM)Wtsi>,"centrosomal protein 41; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432442,EUCOMM,Cep41,MGI:1891414
Cers1<tm1.1Kwi>,"ceramide synthase 1; targeted mutation 1.1,  Klaus Willecke",MGI:5475110,0,Cers1,MGI:2136690
Cers2<Gt(S16-4B1)Sor>,"ceramide synthase 2; gene trap S16-4B1, Philippe Soriano",MGI:4346044,0,Cers2,MGI:1924143
Cers4<tm1.1Kwi>,"ceramide synthase 4; targeted mutation 1.1, Klaus Willecke",MGI:5638668,0,Cers4,MGI:1914510
Cers6<tm1.1Kwi>,"ceramide synthase 6; targeted mutation 1.1, Klaus Willecke",MGI:5523623,0,Cers6,MGI:2442564
Cfap299<m1Mhda>,"cilia and flagella associated protein 299; mutation 1, Martin Hrabe de Angelis",MGI:5818777,0,Cfap299,MGI:1916571
Cfap36<tm1a(EUCOMM)Wtsi>,"cilia and flagella associated protein 36; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433419,EUCOMM,Cfap36,MGI:1913994
Cfap44<tm1a(EUCOMM)Wtsi>,"cilia and flagella associated protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431950,EUCOMM,Cfap44,MGI:1277238
Cfap61<tm2a(EUCOMM)Wtsi>,"cilia and flagella associated protein 61; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527609,EUCOMM,Cfap61,MGI:1926024
Cfap65<tm1b(KOMP)Wtsi>,,MGI:2444274,,,
Cfh<tm1a(EUCOMM)Wtsi>,"complement component factor h; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434438,EUCOMM,Cfh,MGI:88385
Cfi<tm1a(EUCOMM)Hmgu>,"complement component factor i; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4820199,EUCOMM,Cfi,MGI:105937
Cflar<tm1a(EUCOMM)Wtsi>,"CASP8 and FADD-like apoptosis regulator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433525,EUCOMM,Cflar,MGI:1336166
Cftr<tm1Unc>,"cystic fibrosis transmembrane conductance regulator; targeted mutation 1, University of North Carolina",MGI:1856709,0,Cftr,MGI:88388
Cgas<tm1a(EUCOMM)Hmgu>,"cyclic GMP-AMP synthase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435548,EUCOMM,Cgas,MGI:2442261
Cgrrf1<tm1a(KOMP)Wtsi>,"cell growth regulator with ring finger domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5294970,KOMP-CSD,Cgrrf1,MGI:1916368
Cgrrf1<tm1b(KOMP)Wtsi>,"cell growth regulator with ring finger domain 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637038,KOMP-CSD,Cgrrf1,MGI:1916368
Chchd6<tm1a(EUCOMM)Wtsi>,"coiled-coil-helix-coiled-coil-helix domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842800,EUCOMM,Chchd6,MGI:1913348
Chchd6<tm1b(EUCOMM)Wtsi>,,MGI:1913348,,,
Chd1<tm1.1Alsr>,"chromodomain helicase DNA binding protein 1; targeted mutation 1.1, Alexandra Lusser",MGI:5776692,0,Chd1,MGI:88393
Chd4<tm1.1Bhlab>,"chromodomain helicase DNA binding protein 4; targeted mutation 1.1, Brian Hendrich",MGI:5775974,0,Chd4,MGI:1344380
Chd7<Cycn>,chromodomain helicase DNA binding protein 7; cyclone,MGI:1862039,0,Chd7,MGI:2444748
Chd7<Dz>,chromodomain helicase DNA binding protein 7; dizzy,MGI:1862009,0,Chd7,MGI:2444748
Chd7<Edy>,chromodomain helicase DNA binding protein 7; eddy,MGI:1862012,0,Chd7,MGI:2444748
Chd7<Flo>,chromodomain helicase DNA binding protein 7; flouncer,MGI:3511552,0,Chd7,MGI:2444748
Chd7<Mt>,chromodomain helicase DNA binding protein 7; metis,MGI:2177297,0,Chd7,MGI:2444748
Chd7<Todo>,chromodomain helicase DNA binding protein 7; tornado,MGI:1862003,0,Chd7,MGI:2444748
Chd7<Whi>,chromodomain helicase DNA binding protein 7; whirligig,MGI:3588650,0,Chd7,MGI:2444748
Chd7<tm2a(EUCOMM)Wtsi>,"chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4433295,EUCOMM,Chd7,MGI:2444748
Chd8<tm1.1Mabn>,"chromodomain helicase DNA binding protein 8; targeted mutation 1.1, Michiel A Basson",MGI:6115343,0,Chd8,MGI:1915022
Chd9<tm1a(EUCOMM)Wtsi>,"chromodomain helicase DNA binding protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820270,EUCOMM,Chd9,MGI:1924001
Chek2<tm1Mak>,"checkpoint kinase 2; targeted mutation 1, Tak Mak",MGI:2386905,0,Chek2,MGI:1355321
Chia1<tm1a(KOMP)Wtsi>,"chitinase, acidic 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363305,KOMP-CSD,Chia1,MGI:1932052
Chic2<tm1a(EUCOMM)Wtsi>,"cysteine-rich hydrophobic domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4868091,EUCOMM,Chic2,MGI:1921527
Chka<tm2a(KOMP)Wtsi>,"choline kinase alpha; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5050150,KOMP-CSD,Chka,MGI:107760
Chmp4c<tm1a(EUCOMM)Wtsi>,"charged multivesicular body protein 4C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431890,EUCOMM,Chmp4c,MGI:1913621
Chmp6<tm1a(KOMP)Wtsi>,"charged multivesicular body protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5006732,KOMP-CSD,Chmp6,MGI:3583942
Chmp6<tm1b(KOMP)Wtsi>,"charged multivesicular body protein 6; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637182,KOMP-CSD,Chmp6,MGI:3583942
Chold1,dominant hypocholesterolemia 1,MGI:3800756,0,Chold1,MGI:3800720
Chold11,dominant hypocholesterolemia 11,MGI:3800767,0,Chold11,MGI:3800741
Chold2,dominant hypocholesterolemia 2,MGI:3800757,0,Chold2,MGI:3800722
Chold4,dominant hypocholesterolemia 4,MGI:3800759,0,Chold4,MGI:3800727
Chold5,dominant hypocholesterolemia 5,MGI:3800760,0,Chold5,MGI:3800729
Chold6,dominant hypocholesterolemia 6,MGI:3800761,0,Chold6,MGI:3800731
Chold7,dominant hypocholesterolemia 7,MGI:3800762,0,Chold7,MGI:3800733
Chold8,dominant hypocholesterolemia 8,MGI:3800763,0,Chold8,MGI:3800735
Chold9,dominant hypocholesterolemia 9,MGI:3800765,0,Chold9,MGI:3800737
Chrna1<tm1a(EUCOMM)Hmgu>,"cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435231,EUCOMM,Chrna1,MGI:87885
Chrna7<tm1a(EUCOMM)Hmgu>,"cholinergic receptor, nicotinic, alpha polypeptide 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434762,EUCOMM,Chrna7,MGI:99779
Chrna9<tm2a(EUCOMM)Wtsi>,"cholinergic receptor, nicotinic, alpha polypeptide 9; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4432564,EUCOMM,Chrna9,MGI:1202403
Chrnb2<tm1a(EUCOMM)Hmgu>,"cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5050253,EUCOMM,Chrnb2,MGI:87891
Chst11<tm1a(KOMP)Wtsi>,"carbohydrate sulfotransferase 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363643,KOMP-CSD,Chst11,MGI:1927166
Chst5<tm1a(EUCOMM)Wtsi>,"carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432310,EUCOMM,Chst5,MGI:1931825
Chst5<tm1b(EUCOMM)Wtsi>,"carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637102,EUCOMM,Chst5,MGI:1931825
Chtop<tm1a(EUCOMM)Wtsi>,"chromatin target of PRMT1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842477,EUCOMM,Chtop,MGI:1913761
Churc1<tm1a(EUCOMM)Wtsi>,"churchill domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441753,EUCOMM,Churc1,MGI:1923684
Ciao2a<tm2a(EUCOMM)Wtsi>,"cytosolic iron-sulfur assembly component 2A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4451949,EUCOMM,Ciao2a,MGI:1915500
Cib2<tm1a(EUCOMM)Wtsi>,"calcium and integrin binding family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432101,EUCOMM,Cib2,MGI:1929293
Cib2<tm1c(EUCOMM)Wtsi>,"calcium and integrin binding family member 2; targeted mutation 1c, Wellcome Trust Sanger Institute",MGI:5659516,EUCOMM,Cib2,MGI:1929293
Cidec<tm1a(EUCOMM)Wtsi>,"cell death-inducing DFFA-like effector c; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433521,EUCOMM,Cidec,MGI:95585
Cilp2<tm1a(EUCOMM)Wtsi>,"cartilage intermediate layer protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842704,EUCOMM,Cilp2,MGI:1915959
Cilp2<tm1b(EUCOMM)Wtsi>,"cartilage intermediate layer protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5635169,EUCOMM,Cilp2,MGI:1915959
Cir1<tm3a(KOMP)Wtsi>,"corepressor interacting with RBPJ, 1; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:5577261,KOMP-CSD,Cir1,MGI:1914185
Cisd2<tm1a(EUCOMM)Wtsi>,"CDGSH iron sulfur domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434148,EUCOMM,Cisd2,MGI:1914256
Cish<tm1a(KOMP)Wtsi>,"cytokine inducible SH2-containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362236,KOMP-CSD,Cish,MGI:103159
Cit<tm1a(KOMP)Wtsi>,"citron; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364407,KOMP-CSD,Cit,MGI:105313
Cited1<tm1a(EUCOMM)Hmgu>,"Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5497176,EUCOMM,Cited1,MGI:108023
Cited2<m1H>,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; mutation 1, MRC Mammalian Genetics Unit, Harwell",MGI:5646605,0,Cited2,MGI:1306784
Cited2<tm1Bha>,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; targeted mutation 1, Shoumo Bhattacharya",MGI:2179740,0,Cited2,MGI:1306784
Cited2<tm2Bha>,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; targeted mutation 2, Shoumo Bhattacharya",MGI:3803778,0,Cited2,MGI:1306784
Clcn1<adr>,"chloride channel, voltage-sensitive 1; arrested development of righting response",MGI:1856316,0,Clcn1,MGI:88417
Cldn16<tm1a(KOMP)Wtsi>,"claudin 16; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364889,KOMP-CSD,Cldn16,MGI:2148742
Cldn34b2<tm1a(KOMP)Wtsi>,"claudin 34B2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939725,KOMP-CSD,Cldn34b2,MGI:1920597
Clec2i<tm1a(EUCOMM)Hmgu>,"C-type lectin domain family 2, member i; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946790,EUCOMM,Clec2i,MGI:2136650
Clec4a3<tm1a(KOMP)Wtsi>,"C-type lectin domain family 4, member a3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840936,KOMP-CSD,Clec4a3,MGI:1920399
Clec4a3<tm1b(KOMP)Wtsi>,,MGI:1920399,,,
Clec9a<tm1.1Crs>,"C-type lectin domain family 9, member a; targeted mutation 1.1, Caetano Reis e Sousa",MGI:5298406,0,Clec9a,MGI:2444608
Clec9a<tm1a(KOMP)Wtsi>,"C-type lectin domain family 9, member a; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947751,KOMP-CSD,Clec9a,MGI:2444608
Clk1<tm1a(EUCOMM)Wtsi>,"CDC-like kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432186,EUCOMM,Clk1,MGI:107403
Cln3<tm1Nbm>,"ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease); targeted mutation 1, Robert L Nussbaum",MGI:1933976,0,Cln3,MGI:107537
Clpp<tm1a(EUCOMM)Wtsi>,"caseinolytic mitochondrial matrix peptidase proteolytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820264,EUCOMM,Clpp,MGI:1858213
Clstn1<tm1a(EUCOMM)Hmgu>,"calsyntenin 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950238,EUCOMM,Clstn1,MGI:1929895
Clstn3<tm1a(EUCOMM)Hmgu>,"calsyntenin 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435060,EUCOMM,Clstn3,MGI:2178323
Clu<tm1a(EUCOMM)Hmgu>,"clusterin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951032,EUCOMM,Clu,MGI:88423
Cluap1<tm1a(KOMP)Wtsi>,"clusterin associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363468,KOMP-CSD,Cluap1,MGI:1924029
Cmbl<tm1a(KOMP)Wtsi>,"carboxymethylenebutenolidase-like (Pseudomonas); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286220,KOMP-CSD,Cmbl,MGI:1916824
Cmbl<tm1b(KOMP)Wtsi>,"carboxymethylenebutenolidase-like (Pseudomonas); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637042,KOMP-CSD,Cmbl,MGI:1916824
Cmip<tm1a(EUCOMM)Wtsi>,"c-Maf inducing protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286409,EUCOMM,Cmip,MGI:1921690
Cmpk2<tm1a(KOMP)Wtsi>,"cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840944,KOMP-CSD,Cmpk2,MGI:99830
Cmtm4<tm1a(EUCOMM)Wtsi>,"CKLF-like MARVEL transmembrane domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441855,EUCOMM,Cmtm4,MGI:2142888
Cmtm5<tm1a(KOMP)Wtsi>,"CKLF-like MARVEL transmembrane domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286201,KOMP-CSD,Cmtm5,MGI:2447164
Cmtm6<tm1a(EUCOMM)Wtsi>,"CKLF-like MARVEL transmembrane domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441838,EUCOMM,Cmtm6,MGI:2447165
Cnbd1<tm1a(EUCOMM)Wtsi>,"cyclic nucleotide binding domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434076,EUCOMM,Cnbd1,MGI:3650508
Cnbd1<tm1b(EUCOMM)Wtsi>,"cyclic nucleotide binding domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548907,EUCOMM,Cnbd1,MGI:3650508
Cnih3<tm1a(KOMP)Wtsi>,"cornichon family AMPA receptor auxiliary protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947746,KOMP-CSD,Cnih3,MGI:1920228
Cnot4<tm1a(EUCOMM)Wtsi>,"CCR4-NOT transcription complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842581,EUCOMM,Cnot4,MGI:1859026
Cnot4<tm1b(EUCOMM)Wtsi>,"CCR4-NOT transcription complex, subunit 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636993,EUCOMM,Cnot4,MGI:1859026
Cnot6<tm1a(KOMP)Wtsi>,"CCR4-NOT transcription complex, subunit 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451305,KOMP-CSD,Cnot6,MGI:2144529
Cnot6l<tm1a(EUCOMM)Wtsi>,"CCR4-NOT transcription complex, subunit 6-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014723,EUCOMM,Cnot6l,MGI:2443154
Cnr1<tm1Map>,"cannabinoid receptor 1 (brain); targeted mutation 1, Marc Parmentier",MGI:1857736,0,Cnr1,MGI:104615
Cnr1<tm1Zim>,"cannabinoid receptor 1 (brain); targeted mutation 1, Andreas Zimmer",MGI:1857762,0,Cnr1,MGI:104615
Cnr2<tm1Zim>,"cannabinoid receptor 2 (macrophage); targeted mutation 1, Andreas Zimmer",MGI:2181023,0,Cnr2,MGI:104650
Cntfr<tm1a(EUCOMM)Wtsi>,"ciliary neurotrophic factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433013,EUCOMM,Cntfr,MGI:99605
Cntnap1<tm1a(EUCOMM)Wtsi>,"contactin associated protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431603,EUCOMM,Cntnap1,MGI:1858201
Cog2<tm1a(KOMP)Wtsi>,"component of oligomeric golgi complex 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364810,KOMP-CSD,Cog2,MGI:1923582
Cog3<tm1a(EUCOMM)Hmgu>,"component of oligomeric golgi complex 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5304885,EUCOMM,Cog3,MGI:2450151
Cog3<tm1b(EUCOMM)Hmgu>,"component of oligomeric golgi complex 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548843,EUCOMM,Cog3,MGI:2450151
Cog6<tm1a(EUCOMM)Wtsi>,"component of oligomeric golgi complex 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820323,EUCOMM,Cog6,MGI:1914792
Col11a2<tm1a(KOMP)Wtsi>,"collagen, type XI, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5305616,KOMP-CSD,Col11a2,MGI:88447
Col13a1<tm1Pih>,"collagen, type XIII, alpha 1; targeted mutation 1, Taina Pihlajaniemi",MGI:2386983,0,Col13a1,MGI:1277201
Col13a1<tm2Pih>,"collagen, type XIII, alpha 1; targeted mutation 2, Taina Pihlajaniemi",MGI:4838408,0,Col13a1,MGI:1277201
Col13a1<tm3.1Pih>,"collagen, type XIII, alpha 1; targeted mutation 3.1, Taina Pihlajaniemi",MGI:4838409,0,Col13a1,MGI:1277201
Col15a1<tm1Pih>,"collagen, type XV, alpha 1; targeted mutation 1, Taina Pihlajaniemi",MGI:2386162,0,Col15a1,MGI:88449
Col18a1<tm1Hms>,"collagen, type XVIII, alpha 1; targeted mutation 1, Harvard Medical School",MGI:2179134,0,Col18a1,MGI:88451
Col1a1<Aga2>,"collagen, type I, alpha 1; abnormal gait 2",MGI:3769585,0,Col1a1,MGI:88467
Col1a1<tm1(tetO-Stat1)Biat>,"collagen, type I, alpha 1; targeted mutation 1, Biomodels Austria",MGI:5621001,0,Col1a1,MGI:88467
Col1a2<Mhdakta47>,"collagen, type I, alpha 2; Martin Hrabe de Angelis kinked tail 47",MGI:5620843,0,Col1a2,MGI:88468
Col24a1<tm1a(EUCOMM)Wtsi>,"collagen, type XXIV, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433574,EUCOMM,Col24a1,MGI:1918605
Col24a1<tm1b(EUCOMM)Wtsi>,"collagen, type XXIV, alpha 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637054,EUCOMM,Col24a1,MGI:1918605
Col2a1<Lpk>,"collagen, type II, alpha 1; longpockets",MGI:3847803,Harwell ENU Mutagenesis,Col2a1,MGI:88452
Col3a1<Tsk2>,"collagen, type III, alpha 1; tight skin 2",MGI:1860700,0,Col3a1,MGI:88453
Col4a1<Acso>,"collagen, type IV, alpha 1; anterior capsular and suture opacity",MGI:4822140,0,Col4a1,MGI:88454
Col4a1<Bru>,"collagen, type IV, alpha 1; bruised",MGI:1856689,0,Col4a1,MGI:88454
Col4a1<D456>,"collagen, type IV, alpha 1; radiation induced mutation D456",MGI:4822198,0,Col4a1,MGI:88454
Col4a1<ENU4004>,"collagen, type IV, alpha 1; ENU mutation 4004",MGI:4822148,0,Col4a1,MGI:88454
Col4a1<ENU6005>,"collagen, type IV, alpha 1; ENU mutation 6005",MGI:4822157,0,Col4a1,MGI:88454
Col4a1<ENU6009>,"collagen, type IV, alpha 1; ENU mutation 6009",MGI:4822158,0,Col4a1,MGI:88454
Col4a1<ENU6019>,"collagen, type IV, alpha 1; ENU mutation 6019",MGI:4822161,0,Col4a1,MGI:88454
Col4a1<ENU6024>,"collagen, type IV, alpha 1; ENU mutation 6024",MGI:4822165,0,Col4a1,MGI:88454
Col4a1<ENU911>,"collagen, type IV, alpha 1; ENU mutation 911",MGI:4822141,0,Col4a1,MGI:88454
Col4a1<F247>,"collagen, type IV, alpha 1; radiation induced mutation F247",MGI:4822166,0,Col4a1,MGI:88454
Col4a1<Raw>,"collagen, type IV, alpha 1; retinal arteriolar wiring",MGI:2178446,0,Col4a1,MGI:88454
Col4a1<Svc>,"collagen, type IV, alpha 1; small with vacuolar cataract",MGI:2178448,Harwell ENU Mutagenesis,Col4a1,MGI:88454
Col4a2<ENU4003>,"collagen, type IV, alpha 2; ENU mutation 4003",MGI:4822172,0,Col4a2,MGI:88455
Col4a2<ENU4020>,"collagen, type IV, alpha 2; ENU mutation 4020",MGI:4822173,0,Col4a2,MGI:88455
Col4a2<ENU415>,"collagen, type IV, alpha 2; ENU mutation 415",MGI:4822169,0,Col4a2,MGI:88455
Col4a3<tm1a(EUCOMM)Wtsi>,"collagen, type IV, alpha 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431840,EUCOMM,Col4a3,MGI:104688
Col4a3bp<tm1.1Jsau>,"collagen, type IV, alpha 3 (Goodpasture antigen) binding protein; targeted mutation 1.1, Juan Saus",MGI:5301370,0,Col4a3bp,MGI:1915268
Col4a3bp<tm1Jsau>,"collagen, type IV, alpha 3 (Goodpasture antigen) binding protein; targeted mutation 1, Juan Saus",MGI:5301369,0,Col4a3bp,MGI:1915268
Col4a3bp<tm1a(KOMP)Wtsi>,"collagen, type IV, alpha 3 (Goodpasture antigen) binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5287775,KOMP-CSD,Col4a3bp,MGI:1915268
Col4a5<tm1a(EUCOMM)Wtsi>,"collagen, type IV, alpha 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432414,EUCOMM,Col4a5,MGI:88456
Col5a1<tm1a(EUCOMM)Hmgu>,"collagen, type V, alpha 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435753,EUCOMM,Col5a1,MGI:88457
Col6a1<tm1Yah>,"collagen, type VI, alpha 1; targeted mutation 1, Yann Herault",MGI:4868459,0,Col6a1,MGI:88459
Col8a2<Aca23>,"collagen, type VIII, alpha 2; ACMaster abnormality 23",MGI:4438451,0,Col8a2,MGI:88464
Col9a2<tm1a(EUCOMM)Wtsi>,"collagen, type IX, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4950248,EUCOMM,Col9a2,MGI:88466
Colgalt2<tm1a(KOMP)Wtsi>,"collagen beta(1-O)galactosyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4881956,KOMP-CSD,Colgalt2,MGI:2138232
Colgalt2<tm1b(KOMP)Wtsi>,,MGI:2138232,,,
Commd10<tm1a(EUCOMM)Wtsi>,"COMM domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842273,EUCOMM,Commd10,MGI:1916706
Commd9<tm1a(KOMP)Wtsi>,"COMM domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4365175,KOMP-CSD,Commd9,MGI:1923751
Comt<tm1a(EUCOMM)Wtsi>,"catechol-O-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432657,EUCOMM,Comt,MGI:88470
Copg1<tm1a(EUCOMM)Wtsi>,"coatomer protein complex, subunit gamma 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432009,EUCOMM,Copg1,MGI:1858696
Cops4<tm1a(EUCOMM)Hmgu>,"COP9 signalosome subunit 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435445,EUCOMM,Cops4,MGI:1349414
Coq10b<tm1a(EUCOMM)Wtsi>,"coenzyme Q10B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820231,EUCOMM,Coq10b,MGI:1915126
Coq4<tm1a(EUCOMM)Wtsi>,"coenzyme Q4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441729,EUCOMM,Coq4,MGI:1098826
Coq6<tm1a(EUCOMM)Hmgu>,"coenzyme Q6 monooxygenase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435820,EUCOMM,Coq6,MGI:1924408
Coq9<tm1a(KOMP)Wtsi>,"coenzyme Q9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362815,KOMP-CSD,Coq9,MGI:1915164
Coro1c<tm1a(KOMP)Wtsi>,"coronin, actin binding protein 1C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419168,KOMP-CSD,Coro1c,MGI:1345964
Coro6<tm1e(EUCOMM)Wtsi>,"coronin 6; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:5000412,EUCOMM,Coro6,MGI:2183448
Cotl1<tm1a(EUCOMM)Hmgu>,"coactosin-like 1 (Dictyostelium); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841953,EUCOMM,Cotl1,MGI:1919292
Cotl1<tm1b(EUCOMM)Hmgu>,"coactosin-like 1 (Dictyostelium); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613651,EUCOMM,Cotl1,MGI:1919292
Cox15<m1Mhda>,"cytochrome c oxidase assembly protein 15; mutation 1, Martin Hrabe de Angelis",MGI:5707593,0,Cox15,MGI:1920112
Cox6a1<tm1(KOMP)Wtsi>,"cytochrome c oxidase subunit 6A1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419915,KOMP-CSD,Cox6a1,MGI:103099
Cpa2<tm1a(EUCOMM)Hmgu>,"carboxypeptidase A2, pancreatic; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436075,EUCOMM,Cpa2,MGI:3617840
Cpa2<tm1b(EUCOMM)Hmgu>,"carboxypeptidase A2, pancreatic; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548904,EUCOMM,Cpa2,MGI:3617840
Cpe<tm1a(EUCOMM)Hmgu>,"carboxypeptidase E; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451784,EUCOMM,Cpe,MGI:101932
Cpe<tm1b(EUCOMM)Hmgu>,"carboxypeptidase E; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548328,EUCOMM,Cpe,MGI:101932
Cpeb3<tm1a(EUCOMM)Hmgu>,"cytoplasmic polyadenylation element binding protein 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841750,EUCOMM,Cpeb3,MGI:2443075
Cpeb4<tm1a(EUCOMM)Wtsi>,"cytoplasmic polyadenylation element binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434181,EUCOMM,Cpeb4,MGI:1914829
Cpgi81<tm1.1(NCC)WCS>,,MGI:5665212,,,
Cpsf3<tm1a(EUCOMM)Wtsi>,"cleavage and polyadenylation specificity factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432649,EUCOMM,Cpsf3,MGI:1859328
Cpsf3<tm1b(EUCOMM)Wtsi>,"cleavage and polyadenylation specificity factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548494,EUCOMM,Cpsf3,MGI:1859328
Cpt1a<tm1.2(IMPC)Wtsi>,,MGI:1098296,,,
Cpt2<tm1a(KOMP)Wtsi>,"carnitine palmitoyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362863,KOMP-CSD,Cpt2,MGI:109176
Cpt2<tm1b(KOMP)Wtsi>,"carnitine palmitoyltransferase 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636913,KOMP-CSD,Cpt2,MGI:109176
Crb2<tm1a(KOMP)Wtsi>,"crumbs family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4818586,KOMP-CSD,Crb2,MGI:2679260
Creb1<tm2Gsc>,"cAMP responsive element binding protein 1; targeted mutation 2, Gunther Schutz",MGI:2181382,0,Creb1,MGI:88494
Creb1<tm3Gsc>,"cAMP responsive element binding protein 1; targeted mutation 3, Gunther Schutz",MGI:2181395,0,Creb1,MGI:88494
Creb1<tm4Gsc>,"cAMP responsive element binding protein 1; targeted mutation 4, Gunther Schutz",MGI:2183908,0,Creb1,MGI:88494
Creb3l1<tm1e(EUCOMM)Wtsi>,"cAMP responsive element binding protein 3-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4842311,EUCOMM,Creb3l1,MGI:1347062
Creld2<tm1a(EUCOMM)Hmgu>,"cysteine-rich with EGF-like domains 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435724,EUCOMM,Creld2,MGI:1923987
Crh<m1H>,"corticotropin releasing hormone; mutation 1, Harwell",MGI:5578654,0,Crh,MGI:88496
Crhr1<tm1Wrst>,"corticotropin releasing hormone receptor 1; targeted mutation 1, Wolfgang Wurst",MGI:2178543,0,Crhr1,MGI:88498
Crip2<tm1a(EUCOMM)Wtsi>,"cysteine rich protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849417,EUCOMM,Crip2,MGI:1915587
Crlf3<tm1a(KOMP)Wtsi>,"cytokine receptor-like factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363171,KOMP-CSD,Crlf3,MGI:1860086
Crlf3<tm1b(KOMP)Wtsi>,"cytokine receptor-like factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548496,KOMP-CSD,Crlf3,MGI:1860086
Crlf3<tm1c(KOMP)Wtsi>,,MGI:1860086,,,
Crls1<tm1a(EUCOMM)Wtsi>,"cardiolipin synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432552,EUCOMM,Crls1,MGI:1913836
Crp<tm1Hjf>,"C-reactive protein, pentraxin-related; targeted mutation 1, H J Fehling",MGI:4947397,0,Crp,MGI:88512
Crsl,carousel,MGI:3588652,0,Crsl,MGI:2662567
Cryba2<Aca30>,"crystallin, beta A2; ACMaster abnormality 30",MGI:4950379,0,Cryba2,MGI:104336
Cryge<No3>,"crystallin, gamma E; nuclear opacity 3",MGI:3713105,0,Cryge,MGI:88525
Crygs<Opj>,"crystallin, gamma S; opacity due to poor secondary fiber cell junctions",MGI:1861635,0,Crygs,MGI:1298216
Cs<tm1(KOMP)Wtsi>,"citrate synthase; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4843824,KOMP-CSD,Cs,MGI:88529
Csde1<tm1a(EUCOMM)Wtsi>,"cold shock domain containing E1, RNA binding; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842375,EUCOMM,Csde1,MGI:92356
Csf2rb<tm2a(EUCOMM)Hmgu>,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4460364,EUCOMM,Csf2rb,MGI:1339759
Csf3r<tm1Eur>,"colony stimulating factor 3 receptor (granulocyte); targeted mutation 1, Erasmus University Rotterdam",MGI:2156882,0,Csf3r,MGI:1339755
Csf3r<tm2Eur>,"colony stimulating factor 3 receptor (granulocyte); targeted mutation 2, Erasmus University Rotterdam",MGI:2655452,0,Csf3r,MGI:1339755
Csnk1g2<tm1a(EUCOMM)Wtsi>,"casein kinase 1, gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014700,EUCOMM,Csnk1g2,MGI:1920014
Csnk1g2<tm1b(EUCOMM)Wtsi>,"casein kinase 1, gamma 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613652,EUCOMM,Csnk1g2,MGI:1920014
Csnk1g3<tm1a(EUCOMM)Wtsi>,"casein kinase 1, gamma 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461713,EUCOMM,Csnk1g3,MGI:1917675
Csrp2<tm1Rawe>,"cysteine and glycine-rich protein 2; targeted mutation 1, Ralf Weiskirchen",MGI:3809532,0,Csrp2,MGI:1202907
Cst9<tm1Aw>,"cystatin 9; targeted mutation 1, Anne Wedell",MGI:3581885,0,Cst9,MGI:1340053
Cstb<tm1Yah>,"cystatin B; targeted mutation 1, Yann Herault",MGI:4868410,0,Cstb,MGI:109514
Cstb<tm1a(EUCOMM)Wtsi>,"cystatin B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451968,EUCOMM,Cstb,MGI:109514
Cstb<tm2Yah>,"cystatin B; targeted mutation 2, Yann Herault",MGI:5828767,0,Cstb,MGI:109514
Cstf3<tm2a(EUCOMM)Hmgu>,"cleavage stimulation factor, 3' pre-RNA, subunit 3; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511779,EUCOMM,Cstf3,MGI:1351825
Cstf3<tm2b(EUCOMM)Hmgu>,"cleavage stimulation factor, 3' pre-RNA, subunit 3; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5613641,EUCOMM,Cstf3,MGI:1351825
Ctcf<tm1a(EUCOMM)Wtsi>,"CCCTC-binding factor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431619,EUCOMM,Ctcf,MGI:109447
Ctdsp1<tm1a(EUCOMM)Wtsi>,"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008023,EUCOMM,Ctdsp1,MGI:2654470
Cth<tm1a(EUCOMM)Hmgu>,"cystathionase (cystathionine gamma-lyase); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5435787,EUCOMM,Cth,MGI:1339968
Cth<tm1b(EUCOMM)Hmgu>,"cystathionase (cystathionine gamma-lyase); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5614698,EUCOMM,Cth,MGI:1339968
Ctnnal1<tm1e(EUCOMM)Wtsi>,"catenin (cadherin associated protein), alpha-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4434204,EUCOMM,Ctnnal1,MGI:1859649
Ctnnb1<Bfc>,"catenin (cadherin associated protein), beta 1; batface",MGI:2656734,Harwell ENU Mutagenesis,Ctnnb1,MGI:88276
Ctnnbip1<tm1a(EUCOMM)Wtsi>,"catenin beta interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441623,EUCOMM,Ctnnbip1,MGI:1915756
Ctr9<tm1a(EUCOMM)Wtsi>,"CTR9 homolog, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433989,EUCOMM,Ctr9,MGI:109345
Ctr9<tm1b(EUCOMM)Wtsi>,"CTR9 homolog, Paf1/RNA polymerase II complex component; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548390,EUCOMM,Ctr9,MGI:109345
Ctrc<tm1b(EUCOMM)Hmgu>,,MGI:1923951,,,
Ctsb<tm1Jde>,"cathepsin B; targeted mutation 1, Jan Deussing",MGI:2182129,0,Ctsb,MGI:88561
Ctsd<tm1Cptr>,"cathepsin D; targeted mutation 1, Cristoph Peters",MGI:2182078,0,Ctsd,MGI:88562
Ctsd<tm1a(EUCOMM)Wtsi>,"cathepsin D; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433100,EUCOMM,Ctsd,MGI:88562
Ctse<129S/SvHsd>,cathepsin E; 129S/SvHsd variant,MGI:5435247,0,Ctse,MGI:107361
Ctse<tm1Bchn>,"cathepsin E; targeted mutation 1, Benny Chain",MGI:5435933,0,Ctse,MGI:107361
Ctsg<tm1.1Roes>,"cathepsin G; targeted mutation 1.1, Jurgen Roes",MGI:2182170,0,Ctsg,MGI:88563
Ctsk<tm1Psa>,"cathepsin K; targeted mutation 1, Paul Saftig",MGI:2182131,0,Ctsk,MGI:107823
Ctsl<nkt>,cathepsin L; nackt,MGI:1889860,0,Ctsl,MGI:88564
Ctso<tm2a(KOMP)Wtsi>,"cathepsin O; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841300,KOMP-CSD,Ctso,MGI:2139628
Cttn<tm1a(EUCOMM)Hmgu>,"cortactin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435642,EUCOMM,Cttn,MGI:99695
Cttnbp2<tm1a(KOMP)Wtsi>,"cortactin binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455588,KOMP-CSD,Cttnbp2,MGI:1353467
Cttnbp2<tm1b(KOMP)Wtsi>,"cortactin binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636986,KOMP-CSD,Cttnbp2,MGI:1353467
Cul7<tm1a(EUCOMM)Wtsi>,"cullin 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434069,EUCOMM,Cul7,MGI:1913765
Cutal<tm1a(EUCOMM)Wtsi>,"cutA divalent cation tolerance homolog-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432816,EUCOMM,Cutal,MGI:1925246
Cx3cr1<tm1.1(cre)Jung>,"chemokine (C-X3-C motif) receptor 1; targeted mutation 1.1, Steffen Jung",MGI:5467983,0,Cx3cr1,MGI:1333815
Cx3cr1<tm1Litt>,"chemokine (C-X3-C motif) receptor 1; targeted mutation 1, Dan R Littman",MGI:2670351,0,Cx3cr1,MGI:1333815
Cx3cr1<tm2.1(cre/ERT2)Jung>,"chemokine (C-X3-C motif) receptor 1; targeted mutation 1.1, Steffen Jung",MGI:5467985,0,Cx3cr1,MGI:1333815
Cxcl9<tm1a(EUCOMM)Wtsi>,"chemokine (C-X-C motif) ligand 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944537,EUCOMM,Cxcl9,MGI:1352449
Cxcr1<tm1Dgen>,"chemokine (C-X-C motif) receptor 1; targeted mutation 1, Deltagen",MGI:3604601,Deltagen,Cxcr1,MGI:2448715
Cxcr1<tm1a(EUCOMM)Wtsi>,"chemokine (C-X-C motif) receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5497392,EUCOMM,Cxcr1,MGI:2448715
Cxcr2<tm1a(EUCOMM)Wtsi>,"chemokine (C-X-C motif) receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842593,EUCOMM,Cxcr2,MGI:105303
Cyb561<tm1a(EUCOMM)Wtsi>,"cytochrome b-561; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432734,EUCOMM,Cyb561,MGI:103253
Cyb561a3<tm2a(EUCOMM)Hmgu>,"cytochrome b561 family, member A3; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511778,EUCOMM,Cyb561a3,MGI:2686925
Cyb561a3<tm2b(EUCOMM)Hmgu>,"cytochrome b561 family, member A3; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5588290,EUCOMM,Cyb561a3,MGI:2686925
Cyb5r2<tm1a(EUCOMM)Hmgu>,"cytochrome b5 reductase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455692,EUCOMM,Cyb5r2,MGI:2444415
Cyba<tm1a(EUCOMM)Wtsi>,"cytochrome b-245, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432216,EUCOMM,Cyba,MGI:1316658
Cyba<tm1c(EUCOMM)Wtsi>,,MGI:1316658,,,
Cybb<tm2a(KOMP)Wtsi>,"cytochrome b-245, beta polypeptide; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4847712,KOMP-CSD,Cybb,MGI:88574
Cybc1<tm1a(KOMP)Wtsi>,"cytochrome b 245 chaperone 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363837,KOMP-CSD,Cybc1,MGI:2384959
Cybrd1<tm1a(EUCOMM)Hmgu>,"cytochrome b reductase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435546,EUCOMM,Cybrd1,MGI:2654575
Cycs<tm1Mak>,"cytochrome c, somatic; targeted mutation 1, Tak W Mak",MGI:3581449,0,Cycs,MGI:88578
Cyfip1<tm2a(EUCOMM)Wtsi>,"cytoplasmic FMR1 interacting protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5002986,EUCOMM,Cyfip1,MGI:1338801
Cyfip2<tm1a(EUCOMM)Wtsi>,"cytoplasmic FMR1 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434196,EUCOMM,Cyfip2,MGI:1924134
Cyld<tm1.1Gmos>,"CYLD lysine 63 deubiquitinase; targeted mutation 1.1, George Mosialos",MGI:4819959,0,Cyld,MGI:1921506
Cyp11a1<tm1a(EUCOMM)Hmgu>,"cytochrome P450, family 11, subfamily a, polypeptide 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5565260,EUCOMM,Cyp11a1,MGI:88582
Cyp20a1<tm1a(EUCOMM)Wtsi>,"cytochrome P450, family 20, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842859,EUCOMM,Cyp20a1,MGI:1925201
Cyp2b13<tm1a(KOMP)Wtsi>,"cytochrome P450, family 2, subfamily b, polypeptide 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431428,KOMP-CSD,Cyp2b13,MGI:88599
Cyp2b13<tm1b(KOMP)Wtsi>,"cytochrome P450, family 2, subfamily b, polypeptide 13; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637203,KOMP-CSD,Cyp2b13,MGI:88599
Cyp2e1<tm1a(KOMP)Wtsi>,"cytochrome P450, family 2, subfamily e, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419612,KOMP-CSD,Cyp2e1,MGI:88607
Cyp2r1<tm1a(EUCOMM)Wtsi>,"cytochrome P450, family 2, subfamily r, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456014,EUCOMM,Cyp2r1,MGI:2449771
Cyp2r1<tm1b(EUCOMM)Wtsi>,"cytochrome P450, family 2, subfamily r, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548842,EUCOMM,Cyp2r1,MGI:2449771
Cyp2u1<tm1a(EUCOMM)Wtsi>,"cytochrome P450, family 2, subfamily u, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5141847,EUCOMM,Cyp2u1,MGI:1918769
Cyp3a11<tm1a(KOMP)Wtsi>,"cytochrome P450, family 3, subfamily a, polypeptide 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841233,KOMP-CSD,Cyp3a11,MGI:88609
Cyp4b1<tm1a(KOMP)Wtsi>,"cytochrome P450, family 4, subfamily b, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364022,KOMP-CSD,Cyp4b1,MGI:103225
Cyp4b1<tm1b(KOMP)Wtsi>,"cytochrome P450, family 4, subfamily b, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548340,KOMP-CSD,Cyp4b1,MGI:103225
Cyp4f14<tm1a(EUCOMM)Hmgu>,"cytochrome P450, family 4, subfamily f, polypeptide 14; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5299832,EUCOMM,Cyp4f14,MGI:1927669
Cyp4f14<tm1b(EUCOMM)Hmgu>,"cytochrome P450, family 4, subfamily f, polypeptide 14; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613654,EUCOMM,Cyp4f14,MGI:1927669
Cyp4f16<tm1a(KOMP)Wtsi>,"cytochrome P450, family 4, subfamily f, polypeptide 16; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364137,KOMP-CSD,Cyp4f16,MGI:1917351
Cyp7a1<tm1a(EUCOMM)Wtsi>,"cytochrome P450, family 7, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433062,EUCOMM,Cyp7a1,MGI:106091
Cystm1<tm1a(EUCOMM)Hmgu>,"cysteine-rich transmembrane module containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5299828,EUCOMM,Cystm1,MGI:1913310
Cystm1<tm1b(EUCOMM)Hmgu>,"cysteine-rich transmembrane module containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548508,EUCOMM,Cystm1,MGI:1913310
D16Ertd472e<tm1a(EUCOMM)Wtsi>,"DNA segment, Chr 16, ERATO Doi 472, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842357,EUCOMM,D16Ertd472e,MGI:1196400
D430041D05Rik<tm1a(EUCOMM)Hmgu>,"RIKEN cDNA D430041D05 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435522,EUCOMM,D430041D05Rik,MGI:2181743
D630023F18Rik<tm1a(KOMP)Wtsi>,"RIKEN cDNA D630023F18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4949325,KOMP-CSD,D630023F18Rik,MGI:2138198
D630023F18Rik<tm1b(KOMP)Wtsi>,"RIKEN cDNA D630023F18 gene; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637108,KOMP-CSD,D630023F18Rik,MGI:2138198
D6Wsu163e<tm1a(EUCOMM)Wtsi>,"DNA segment, Chr 6, Wayne State University 163, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4951107,EUCOMM,D6Wsu163e,MGI:107893
D6Wsu163e<tm1b(EUCOMM)Wtsi>,"DNA segment, Chr 6, Wayne State University 163, expressed; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636910,EUCOMM,D6Wsu163e,MGI:107893
D7Ertd443e<tm2a(KOMP)Wtsi>,"DNA segment, Chr 7, ERATO Doi 443, expressed; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4455573,KOMP-CSD,D7Ertd443e,MGI:1196431
D930028M14Rik<tm1a(EUCOMM)Wtsi>,"RIKEN cDNA D930028M14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432198,EUCOMM,D930028M14Rik,MGI:3687343
Daam1<tm1a(EUCOMM)Hmgu>,"dishevelled associated activator of morphogenesis 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5000343,EUCOMM,Daam1,MGI:1914596
Daam2<tm1a(KOMP)Wtsi>,"dishevelled associated activator of morphogenesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841108,KOMP-CSD,Daam2,MGI:1923691
Dach1<tm1Krs>,"dachshund family transcription factor 1; targeted mutation 1, Stefan Krauss",MGI:2448366,0,Dach1,MGI:1277991
Dact3<tm1a(KOMP)Wtsi>,"dishevelled-binding antagonist of beta-catenin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5319818,KOMP-CSD,Dact3,MGI:3654828
Dact3<tm1b(KOMP)Wtsi>,,MGI:3654828,,,
Dap<tm1a(KOMP)Mbp>,"death-associated protein; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4455440,KOMP-CSD,Dap,MGI:1918190
Dapk1<tm1a(EUCOMM)Hmgu>,"death associated protein kinase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435674,EUCOMM,Dapk1,MGI:1916885
Dapk2<tm1a(EUCOMM)Wtsi>,"death-associated protein kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434345,EUCOMM,Dapk2,MGI:1341297
Dapk2<tm1b(EUCOMM)Wtsi>,"death-associated protein kinase 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636971,EUCOMM,Dapk2,MGI:1341297
Dars2<tm1a(KOMP)Wtsi>,"aspartyl-tRNA synthetase 2 (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362200,KOMP-CSD,Dars2,MGI:2442510
Dazl<tm1Hjc>,"deleted in azoospermia-like; targeted mutation 1, Howard J Cooke",MGI:2181904,0,Dazl,MGI:1342328
Dbf,doublefoot,MGI:1857644,0,Dbf,MGI:94863
Dbn1<tm1a(KOMP)Wtsi>,"drebrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363390,KOMP-CSD,Dbn1,MGI:1931838
Dbn1<tm1b(KOMP)Wtsi>,"drebrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5501061,KOMP-CSD,Dbn1,MGI:1931838
Dbnl<tm1a(KOMP)Wtsi>,"drebrin-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451400,KOMP-CSD,Dbnl,MGI:700006
Dbp<tm1Schb>,"D site albumin promoter binding protein; targeted mutation 1, Ueli Schibler",MGI:2183196,0,Dbp,MGI:94866
Dbx1<tm1(DTA)Apie>,"developing brain homeobox 1; targeted mutation 1, Alessandra Pierani",MGI:3757953,0,Dbx1,MGI:94867
Dbx1<tm1Tmj>,"developing brain homeobox 1; targeted mutation 1, Thomas M Jessell",MGI:2182329,0,Dbx1,MGI:94867
Dbx1<tm2(cre)Apie>,"developing brain homeobox 1; targeted mutation 2, Alessandra Pierani",MGI:3757955,0,Dbx1,MGI:94867
Dbx1<tm3Apie>,"developing brain homeobox 1; targeted mutation 3, Alessandra Pierani",MGI:4837336,0,Dbx1,MGI:94867
Dcaf11<tm1a(KOMP)Wtsi>,"DDB1 and CUL4 associated factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841129,KOMP-CSD,Dcaf11,MGI:90168
Dcbld2<tm1a(KOMP)Wtsi>,"discoidin, CUB and LCCL domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363322,KOMP-CSD,Dcbld2,MGI:1920629
Dcdc2b<tm1a(KOMP)Wtsi>,"doublecortin domain containing 2b; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050845,KOMP-CSD,Dcdc2b,MGI:2686212
Dcdc2b<tm1b(KOMP)Wtsi>,"doublecortin domain containing 2b; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637175,KOMP-CSD,Dcdc2b,MGI:2686212
Dcdc2c<tm1a(KOMP)Wtsi>,"doublecortin domain containing 2C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458574,KOMP-CSD,Dcdc2c,MGI:1915761
Dck<memi>,deoxycytidine kinase; memi,MGI:5426400,0,Dck,MGI:102726
Dclk1<tm1a(EUCOMM)Wtsi>,"doublecortin-like kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5543459,EUCOMM,Dclk1,MGI:1330861
Dclre1c<m1Brck>,"DNA cross-link repair 1C; mutation 1, Thomas Brocker",MGI:5562416,0,Dclre1c,MGI:2441769
Dclre1c<tm1.1Jpdv>,"DNA cross-link repair 1C; targeted mutation 1.1, Jean-Pierre de Villartay",MGI:3802969,0,Dclre1c,MGI:2441769
Dclre1c<tm2.1Jpdv>,"DNA cross-link repair 1C; targeted mutation 2.1, Jean-Pierre de Villartay",MGI:4366773,0,Dclre1c,MGI:2441769
Dcn<tm1.2Geno>,"decorin; targeted mutation 1.2, Genoway",MGI:5660397,0,Dcn,MGI:94872
Dcp2<tm1a(KOMP)Wtsi>,"decapping mRNA 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362601,KOMP-CSD,Dcp2,MGI:1917890
Dct<tm1(cre)Bee>,"dopachrome tautomerase; targeted mutation 1, Friedrich Beermann",MGI:2387116,0,Dct,MGI:102563
Dctn1<tm1a(EUCOMM)Wtsi>,"dynactin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432339,EUCOMM,Dctn1,MGI:107745
Dctn5<tm2a(KOMP)Wtsi>,"dynactin 5; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4363526,KOMP-CSD,Dctn5,MGI:1891689
Dcx<tm1.1Ffr>,"doublecortin; targeted mutation 1.1, Fiona Francis",MGI:3624536,0,Dcx,MGI:1277171
Dcx<tm1.2Ffr>,"doublecortin; targeted mutation 1.2, Fiona Francis",MGI:3624537,0,Dcx,MGI:1277171
Dcx<tm1a(EUCOMM)Wtsi>,"doublecortin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441970,EUCOMM,Dcx,MGI:1277171
Ddah1<tm2a(EUCOMM)Wtsi>,"dimethylarginine dimethylaminohydrolase 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527610,EUCOMM,Ddah1,MGI:1916469
Ddhd1<tm1a(KOMP)Wtsi>,"DDHD domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362938,KOMP-CSD,Ddhd1,MGI:2150302
Ddhd2<tm1a(EUCOMM)Wtsi>,"DDHD domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820273,EUCOMM,Ddhd2,MGI:1919358
Ddi2<tm1c(EUCOMM)Hmgu>,,MGI:1917244,,,
Ddn<tm1Ktry>,"dendrin; targeted mutation 1, Karl Tryggvason",MGI:5301891,0,Ddn,MGI:108101
Ddr1<tm1a(EUCOMM)Hmgu>,"discoidin domain receptor family, member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5318761,EUCOMM,Ddr1,MGI:99216
Ddx1<tm1a(EUCOMM)Hmgu>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455792,EUCOMM,Ddx1,MGI:2144727
Ddx1<tm1b(EUCOMM)Hmgu>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5569068,EUCOMM,Ddx1,MGI:2144727
Ddx27<tm1a(KOMP)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 27; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363861,KOMP-CSD,Ddx27,MGI:2385884
Ddx42<tm1a(EUCOMM)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 42; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4948648,EUCOMM,Ddx42,MGI:1919297
Ddx42<tm1b(EUCOMM)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 42; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637061,EUCOMM,Ddx42,MGI:1919297
Ddx43<tm1a(EUCOMM)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 43; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433882,EUCOMM,Ddx43,MGI:3642857
Ddx51<tm1a(KOMP)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 51; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431446,KOMP-CSD,Ddx51,MGI:1916913
Ddx52<tm1a(EUCOMM)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 52; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434081,EUCOMM,Ddx52,MGI:1925644
Ddx55<tm1a(EUCOMM)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 55; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434030,EUCOMM,Ddx55,MGI:1915098
Ddx56<tm1e(EUCOMM)Wtsi>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 56; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4888928,EUCOMM,Ddx56,MGI:1277172
Ddx5<tm1.1Arte>,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 5; targeted mutation 1.1, TaconicArtemis",MGI:5463981,0,Ddx5,MGI:105037
Decr1<tm1Jkh>,"2,4-dienoyl CoA reductase 1, mitochondrial; targeted mutation 1, J Kalervo Hiltunen",MGI:4355415,0,Decr1,MGI:1914710
Decr2<tm1a(EUCOMM)Wtsi>,"2-4-dienoyl-Coenzyme A reductase 2, peroxisomal; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460423,EUCOMM,Decr2,MGI:1347059
Decr2<tm1b(EUCOMM)Wtsi>,"2-4-dienoyl-Coenzyme A reductase 2, peroxisomal; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548465,EUCOMM,Decr2,MGI:1347059
Def6<tm1a(EUCOMM)Wtsi>,"differentially expressed in FDCP 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944563,EUCOMM,Def6,MGI:1346328
Defb14<tm1a(KOMP)Wtsi>,"defensin beta 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362993,KOMP-CSD,Defb14,MGI:2675345
Defb14<tm1b(KOMP)Wtsi>,"defensin beta 14; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637165,KOMP-CSD,Defb14,MGI:2675345
Defb22<tm1a(KOMP)Wtsi>,"defensin beta 22; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013746,KOMP-CSD,Defb22,MGI:3045368
Defb30<tm2a(KOMP)Wtsi>,"defensin beta 30; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4454128,KOMP-CSD,Defb30,MGI:1920920
Defb30<tm2b(KOMP)Wtsi>,"defensin beta 30; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637070,KOMP-CSD,Defb30,MGI:1920920
Del(1)3H,"deletion, Chr 1, Harwell 3",MGI:1856175,0,Del(1)3H,MGI:103583
Del(10Prmt2-Col6a1)1Yah,"deletion, Chr10, Yann Herault 1",MGI:4868462,0,Del(10Prmt2-Col6a1)1Yah,MGI:4868458
Del(10Prmt2-Cstb)4Yah,"deletion, Chr10, Yann Herault 4",MGI:4868385,0,Del(10Prmt2-Cstb)4Yah,MGI:4868387
Del(11Hoxb3-Hoxb4)1Karl,"deletion, Chr 11, Stefan Karlsson 1",MGI:3762002,0,Del(11Hoxb3-Hoxb4)1Karl,MGI:3762001
Del(13)80H,"deletion, Chr 13, Harwell 80",MGI:5304931,0,Del(13)80H,MGI:5304940
Del(16Cldn5-Hira)5Bld,"deletion, Chr 16, Antonio Baldini 5",MGI:3640128,0,Del(16Cldn5-Hira)5Bld,MGI:3640121
Del(16Es2el-Sept5)3Bld,"deletion, Chr 16, Antonio Baldini 3",MGI:3640126,0,Del(16Es2el-Sept5)3Bld,MGI:3640118
Del(16Es2el-T10)2Bld,"deletion, Chr 16, Antonio Baldini 2",MGI:3640125,0,Del(16Es2el-T10)2Bld,MGI:3640117
Del(16Es2el-Ufd1l)217Bld,"deletion, Chr 16, Antonio Baldini 217",MGI:3623881,0,Del(16Es2el-Ufd1l)217Bld,MGI:2677647
Del(16Hspa13-App)3Yah,"deletion, Chr 16, Yann Herault 3",MGI:5519049,0,Del(16Hspa13-App)3Yah,MGI:5519044
Del(16T10-Hira)4Bld,"deletion, Chr 16, Antonio Baldini 4",MGI:3640127,0,Del(16T10-Hira)4Bld,MGI:3640120
Del(17)T<hp>,"deletion, Chr 17, T<hp>, hairpin tail",MGI:1856187,0,Del(17)T<hp>,MGI:5427967
Del(17Abcg1-Cbs)2Yah,"deletion, Chr 17, Yann Herault 2",MGI:4367904,0,Del(17Abcg1-Cbs)2Yah,MGI:4367902
Del(2Hoxd11)33Ddu,"deletion, Chr2, Denis Duboule 33; deletion, Chr 2, Denis Duboule 33",MGI:3776039,0,Del(2Hoxd11)33Ddu,MGI:3774754
Del(2Hoxd11-Hoxd12)34Ddu,"deletion, Chr 2, Denis Duboule 34",MGI:3776040,0,Del(2Hoxd11-Hoxd12)34Ddu,MGI:3774755
Del(2Hoxd11-Hoxd13)27Ddu,"deletion, Chr 2, Denis Duboule 27",MGI:3762143,0,Del(2Hoxd11-Hoxd13)27Ddu,MGI:3762135
Del(2Hoxd11-Hoxd13)29Ddu,"deletion, Chr 2, Denis Duboule 29",MGI:1857661,0,Del(2Hoxd11-Hoxd13)29Ddu,MGI:3762254
Del(2Hoxd11-Hoxd13)2Ddu,"deletion, Chr 2, Denis Duboule 1; deletion, Chr 2, Denis Duboule 2",MGI:2445981,0,Del(2Hoxd11-Hoxd13)2Ddu,MGI:3616074
Del(2Hoxd12-Hoxd13)5Ddu,"deletion, Chr 2, Denis Duboule 5",MGI:2445976,0,Del(2Hoxd12-Hoxd13)5Ddu,MGI:3616102
Del(2Hoxd13)3Ddu,"deletion, Chr 2, Denis Duboule 3",MGI:2445974,0,Del(2Hoxd13)3Ddu,MGI:3616078
Del(2Hoxd4-Hoxd13)28Ddu,"deletion, Chr 2, Denis Duboule 28",MGI:3762137,0,Del(2Hoxd4-Hoxd13)28Ddu,MGI:3762136
Del(7Ifitm5-Ifitm6)1Masu,"deletion, Chr 7, M Azim Surani 1",MGI:3804041,0,Del(7Ifitm5-Ifitm6)1Masu,MGI:3804026
Dennd1b<tm1a(EUCOMM)Hmgu>,"DENN/MADD domain containing 1B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841996,EUCOMM,Dennd1b,MGI:2447812
Dennd1c<tm1a(EUCOMM)Wtsi>,"DENN/MADD domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432505,EUCOMM,Dennd1c,MGI:1918035
Dennd1c<tm1b(EUCOMM)Wtsi>,"DENN/MADD domain containing 1C; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548604,EUCOMM,Dennd1c,MGI:1918035
Dennd3<tm1a(KOMP)Wtsi>,"DENN/MADD domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841067,KOMP-CSD,Dennd3,MGI:2146009
Dennd4c<tm1a(EUCOMM)Wtsi>,"DENN/MADD domain containing 4C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5141837,EUCOMM,Dennd4c,MGI:1914769
Dennd4c<tm1b(EUCOMM)Wtsi>,"DENN/MADD domain containing 4C; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637024,EUCOMM,Dennd4c,MGI:1914769
Dennd5a<tm1a(EUCOMM)Wtsi>,"DENN/MADD domain containing 5A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5051004,EUCOMM,Dennd5a,MGI:1201681
Denr<tm1a(KOMP)Wtsi>,"density-regulated protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451332,KOMP-CSD,Denr,MGI:1915434
Denr<tm1b(KOMP)Wtsi>,"density-regulated protein; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637029,KOMP-CSD,Denr,MGI:1915434
Depdc5<tm1a(EUCOMM)Hmgu>,"DEP domain containing 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5013779,EUCOMM,Depdc5,MGI:2141101
Depdc7<tm1a(EUCOMM)Wtsi>,"DEP domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052484,EUCOMM,Depdc7,MGI:2139258
Deptor<tm1a(EUCOMM)Wtsi>,"DEP domain containing MTOR-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4457558,EUCOMM,Deptor,MGI:2146322
Des<tm1Cba>,"desmin; targeted mutation 1, Charles Babinet",MGI:2159584,0,Des,MGI:94885
Dfp2,dark foot pads 2; dark footpads 2,MGI:1862015,0,Dfp2,MGI:1861991
Dhcr24<tm1a(EUCOMM)Wtsi>,"24-dehydrocholesterol reductase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431942,EUCOMM,Dhcr24,MGI:1922004
Dhdds<tm1a(KOMP)Wtsi>,"dehydrodolichyl diphosphate synthase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362250,KOMP-CSD,Dhdds,MGI:1914672
Dhdds<tm1b(KOMP)Wtsi>,"dehydrodolichyl diphosphate synthase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613645,KOMP-CSD,Dhdds,MGI:1914672
Dhodh<tm1a(EUCOMM)Wtsi>,"dihydroorotate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842671,EUCOMM,Dhodh,MGI:1928378
Dhodh<tm1b(EUCOMM)Wtsi>,"dihydroorotate dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548703,EUCOMM,Dhodh,MGI:1928378
Dhps<tm2a(EUCOMM)Wtsi>,"deoxyhypusine synthase; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4842333,EUCOMM,Dhps,MGI:2683592
Dhrs2<tm1a(KOMP)Wtsi>,"dehydrogenase/reductase member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364555,KOMP-CSD,Dhrs2,MGI:1918662
Dhx33<tm1a(KOMP)Wtsi>,"DEAH (Asp-Glu-Ala-His) box polypeptide 33; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5000320,KOMP-CSD,Dhx33,MGI:2445102
Dhx33<tm1b(KOMP)Wtsi>,"DEAH (Asp-Glu-Ala-His) box polypeptide 33; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637153,KOMP-CSD,Dhx33,MGI:2445102
Dhx35<tm1a(EUCOMM)Wtsi>,"DEAH (Asp-Glu-Ala-His) box polypeptide 35; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453709,EUCOMM,Dhx35,MGI:1918965
Dhx35<tm1b(EUCOMM)Wtsi>,"DEAH (Asp-Glu-Ala-His) box polypeptide 35; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637055,EUCOMM,Dhx35,MGI:1918965
Dhx40<tm1a(KOMP)Wtsi>,"DEAH (Asp-Glu-Ala-His) box polypeptide 40; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419814,KOMP-CSD,Dhx40,MGI:1914737
Diablo<tm1Mak>,"diablo, IAP-binding mitochondrial protein; targeted mutation 1, Tak Mak",MGI:2183277,0,Diablo,MGI:1913843
Diaph2<Gt(A011B06)Wrst>,"diaphanous related formin 2; gene trap A011B06, German Gene Trap Consortium",MGI:4122820,0,Diaph2,MGI:1858500
Dicer1<em3Psv>,"dicer 1, ribonuclease type III; endonuclease-mediated mutation 3, Petr Svoboda",MGI:5566698,0,Dicer1,MGI:2177178
Dicer1<tm1.1Doca>,"dicer 1, ribonuclease type III; targeted mutation 1.1, Donal O'Carroll",MGI:5707512,0,Dicer1,MGI:2177178
Dicer1<tm1a(EUCOMM)Wtsi>,"dicer 1, ribonuclease type III; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461668,EUCOMM,Dicer1,MGI:2177178
Dilp3,dilated pupils 3,MGI:1934629,0,Dilp3,MGI:1934609
Dilp4,dilated pupils 4,MGI:1934630,0,Dilp4,MGI:1934610
Dip2a<tm2a(KOMP)Wtsi>,"disco interacting protein 2 homolog A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841025,KOMP-CSD,Dip2a,MGI:2385920
Dip2a<tm2b(KOMP)Wtsi>,"disco interacting protein 2 homolog A; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548794,KOMP-CSD,Dip2a,MGI:2385920
Dip2b<tm1a(EUCOMM)Wtsi>,"disco interacting protein 2 homolog B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431779,EUCOMM,Dip2b,MGI:2145977
Dis3<tm1e(EUCOMM)Hmgu>,"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH",MGI:4820203,EUCOMM,Dis3,MGI:1919912
Dkk1<tm1.1Svo>,"dickkopf WNT signaling pathway inhibitor 1; targeted mutation 1.1, Seppo Vainio",MGI:5013423,0,Dkk1,MGI:1329040
Dkk3<tm1Cni>,"dickkopf WNT signaling pathway inhibitor 3; targeted mutation 1, Christof Niehrs",MGI:3621929,0,Dkk3,MGI:1354952
Dlec1<tm1a(EUCOMM)Wtsi>,"deleted in lung and esophageal cancer 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432388,EUCOMM,Dlec1,MGI:2443671
Dlec1<tm1b(EUCOMM)Wtsi>,"deleted in lung and esophageal cancer 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548818,EUCOMM,Dlec1,MGI:2443671
Dlg2<tm1a(EUCOMM)Wtsi>,"discs large MAGUK scaffold protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842622,EUCOMM,Dlg2,MGI:1344351
Dlg3<tm1a(EUCOMM)Wtsi>,"discs large MAGUK scaffold protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441739,EUCOMM,Dlg3,MGI:1888986
Dlgap4<tm1a(KOMP)Wtsi>,"DLG associated protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5296545,KOMP-CSD,Dlgap4,MGI:2138865
Dlgap4<tm1b(KOMP)Wtsi>,,MGI:2138865,,,
Dll1<m1Mhda>,"delta like canonical Notch ligand 1; mutation 1, Martin Hrabe de Angelis",MGI:4821259,0,Dll1,MGI:104659
Dll1<tm10.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 10.1, Achim Gossler",MGI:5805257,0,Dll1,MGI:104659
Dll1<tm11.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 11.1, Achim Gossler",MGI:5805263,0,Dll1,MGI:104659
Dll1<tm12.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 12.1, Achim Gossler",MGI:5805265,0,Dll1,MGI:104659
Dll1<tm13.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 13.1, Achim Gossler",MGI:5805267,0,Dll1,MGI:104659
Dll1<tm14.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 14.1, Achim Gossler",MGI:5805291,0,Dll1,MGI:104659
Dll1<tm15.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 15.1, Achim Gossler",MGI:5805295,0,Dll1,MGI:104659
Dll1<tm1Gos>,"delta like canonical Notch ligand 1; targeted mutation 1, Achim Gossler",MGI:1861919,0,Dll1,MGI:104659
Dll1<tm8.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 8.1, Achim Gossler",MGI:5805246,0,Dll1,MGI:104659
Dll1<tm9.1Gos>,"delta like canonical Notch ligand 1; targeted mutation 9.1, Achim Gossler",MGI:5805253,0,Dll1,MGI:104659
Dlx5<tm1Levi>,"distal-less homeobox 5; targeted mutation 1, Giovanni Levi",MGI:2180474,0,Dlx5,MGI:101926
Dmd<mdx>,"dystrophin, muscular dystrophy; X linked muscular dystrophy",MGI:1856328,0,Dmd,MGI:94909
Dmgdh<tm1a(KOMP)Wtsi>,"dimethylglycine dehydrogenase precursor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451237,KOMP-CSD,Dmgdh,MGI:1921379
Dmxl2<tm1a(EUCOMM)Wtsi>,"Dmx-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432280,EUCOMM,Dmxl2,MGI:2444630
Dnah11<iv>,"dynein, axonemal, heavy chain 11; situs inversus viscerum",MGI:1856917,0,Dnah11,MGI:1100864
Dnah17<tm1e(KOMP)Wtsi>,"dynein, axonemal, heavy chain 17; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4940768,KOMP-CSD,Dnah17,MGI:1917176
Dnajb11<tm1a(EUCOMM)Wtsi>,"DnaJ heat shock protein family (Hsp40) member B11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050997,EUCOMM,Dnajb11,MGI:1915088
Dnajb11<tm1b(EUCOMM)Wtsi>,"DnaJ heat shock protein family (Hsp40) member B11; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5614700,EUCOMM,Dnajb11,MGI:1915088
Dnajc10<tm1a(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436651,EUCOMM,Dnajc10,MGI:1914111
Dnajc17<tm1a(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C17; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434811,EUCOMM,Dnajc17,MGI:1916658
Dnajc17<tm1b(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C17; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548585,EUCOMM,Dnajc17,MGI:1916658
Dnajc19<tm1a(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C19; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435205,EUCOMM,Dnajc19,MGI:1914963
Dnajc27<tm1a(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C27; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5444912,EUCOMM,Dnajc27,MGI:2443036
Dnajc27<tm1b(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C27; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5614706,EUCOMM,Dnajc27,MGI:2443036
Dnajc5b<tm1a(EUCOMM)Hmgu>,"DnaJ heat shock protein family (Hsp40) member C5 beta; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434677,EUCOMM,Dnajc5b,MGI:1913576
Dnajc8<tm1a(KOMP)Wtsi>,"DnaJ heat shock protein family (Hsp40) member C8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050155,KOMP-CSD,Dnajc8,MGI:1915848
Dnajc8<tm1b(KOMP)Wtsi>,"DnaJ heat shock protein family (Hsp40) member C8; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637033,KOMP-CSD,Dnajc8,MGI:1915848
Dnal4<tm1a(EUCOMM)Wtsi>,"dynein, axonemal, light chain 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441730,EUCOMM,Dnal4,MGI:1859217
Dnase1l2<tm1(KOMP)Wtsi>,"deoxyribonuclease 1-like 2; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4362265,KOMP-CSD,Dnase1l2,MGI:1913955
Dnase2b<tm1a(EUCOMM)Hmgu>,"deoxyribonuclease II beta; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435602,EUCOMM,Dnase2b,MGI:1913283
Dner<tm3a(EUCOMM)Hmgu>,"delta/notch-like EGF repeat containing; targeted mutation 3a, Helmholtz Zentrum Muenchen GmbH",MGI:4435871,EUCOMM,Dner,MGI:2152889
Dner<tm3b(EUCOMM)Hmgu>,"delta/notch-like EGF repeat containing; targeted mutation 3b, Helmholtz Zentrum Muenchen GmbH",MGI:5637119,EUCOMM,Dner,MGI:2152889
Dnm1l<tm1a(KOMP)Wtsi>,"dynamin 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364147,KOMP-CSD,Dnm1l,MGI:1921256
Dnmt3a<tm1a(KOMP)Wtsi>,"DNA methyltransferase 3A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364077,KOMP-CSD,Dnmt3a,MGI:1261827
Dock10<tm1a(EUCOMM)Hmgu>,"dedicator of cytokinesis 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436497,EUCOMM,Dock10,MGI:2146320
Donson<tm1a(EUCOMM)Wtsi>,"downstream neighbor of SON; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433969,EUCOMM,Donson,MGI:1890621
Dop1b<tm1a(EUCOMM)Wtsi>,"DOP1 leucine zipper like protein B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452820,EUCOMM,Dop1b,MGI:1917278
Dot1l<tm1a(KOMP)Wtsi>,"DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362351,KOMP-CSD,Dot1l,MGI:2143886
Dp(16App-Runx1)5Yah,"duplication, Chr 16, Yann Herault 5",MGI:5789045,0,Dp(16App-Runx1)5Yah,MGI:5789044
Dp(16Dgcr14-Sept5)3Bld,"duplication, Chr 16, Antonio Baldini 3",MGI:3640122,0,Dp(16Dgcr14-Sept5)3Bld,MGI:3640119
Dp(16Dgcr14-Ufd1l)217Bld,"duplication, Chr 16, Antonio Baldini 217",MGI:3640123,0,Dp(16Dgcr14-Ufd1l)217Bld,MGI:3640116
Dp(16Hspa13-App)2Yah,"duplication, Chr 16, Yann Herault 2",MGI:5519056,0,Dp(16Hspa13-App)2Yah,MGI:5519054
Dp(16Lipi-Zbtb21)1TybEmcf,"duplication, Chr 16, Victor Tybulewicz and Elizabeth M C Fisher 1",MGI:5703798,0,Dp(16Lipi-Zbtb21)1TybEmcf,MGI:5703853
Dp(17Abcg1-Cbs)1Yah,"duplication, Chr 17, Yann Herault 1",MGI:4367905,0,Dp(17Abcg1-Cbs)1Yah,MGI:4367903
Dp(17Nfkbil1-Olfr91)1Cogr,"duplication, Chr 17, Cornelius Gross 1",MGI:5451036,0,Dp(17Nfkbil1-Olfr91)1Cogr,MGI:5451039
Dp(2Hoxd11)6Ddu,"duplication, Chr 2, Denis Duboule 6",MGI:5289967,0,Dp(2Hoxd11)6Ddu,MGI:5288507
Dp(2Hoxd11-Hoxd12)5Ddu,,MGI:3774760,,,
Dp(2Hoxd11-Hoxd13)4Ddu,,MGI:3774759,,,
Dp(2Hoxd13)3Ddu,,MGI:3774757,,,
Dpf1<m1Mhda>,"D4, zinc and double PHD fingers family 1; mutation 1, Martin Hrabe de Angelis",MGI:5817503,0,Dpf1,MGI:1352748
Dph2<tm2(EUCOMM)Wtsi>,"DPH2 homolog; targeted mutation 2, Wellcome Trust Sanger Institute",MGI:4840638,EUCOMM,Dph2,MGI:1914978
Dph6<tm1a(KOMP)Wtsi>,"diphthamine biosynthesis 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880925,KOMP-CSD,Dph6,MGI:1913882
Dpm1<tm1a(KOMP)Wtsi>,"dolichol-phosphate (beta-D) mannosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458473,KOMP-CSD,Dpm1,MGI:1330239
Dpm1<tm1b(KOMP)Wtsi>,"dolichol-phosphate (beta-D) mannosyltransferase 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636953,KOMP-CSD,Dpm1,MGI:1330239
Dpm2<tm1a(EUCOMM)Hmgu>,"dolichol-phosphate (beta-D) mannosyltransferase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435371,EUCOMM,Dpm2,MGI:1330238
Dpp4<tm1Nwa>,"dipeptidylpeptidase 4; targeted mutation 1, Nicolai Wagtmann",MGI:2150161,0,Dpp4,MGI:94919
Dpp4<tm1a(EUCOMM)Wtsi>,"dipeptidylpeptidase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433896,EUCOMM,Dpp4,MGI:94919
Dpp9<tm1a(EUCOMM)Hmgu>,"dipeptidylpeptidase 9; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435737,EUCOMM,Dpp9,MGI:2443967
Dpp9<tm1b(EUCOMM)Hmgu>,"dipeptidylpeptidase 9; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548821,EUCOMM,Dpp9,MGI:2443967
Dppa1<tm1a(KOMP)Wtsi>,"developmental pluripotency associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362687,KOMP-CSD,Dppa1,MGI:2157522
Dppa4<tm1.1Hjf>,"developmental pluripotency associated 4; targeted mutation 1.1, H J Felhing",MGI:3848331,0,Dppa4,MGI:2157525
Dpy19l3<tm1a(EUCOMM)Wtsi>,"dpy-19-like 3 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433660,EUCOMM,Dpy19l3,MGI:2443952
Dpy30<tm1a(KOMP)Wtsi>,"dpy-30, histone methyltransferase complex regulatory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887610,KOMP-CSD,Dpy30,MGI:1913560
Dpys<tm1a(EUCOMM)Wtsi>,"dihydropyrimidinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4950254,EUCOMM,Dpys,MGI:1928679
Drg2<tm1a(EUCOMM)Wtsi>,"developmentally regulated GTP binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432942,EUCOMM,Drg2,MGI:1342307
Dsc2<tm1e(KOMP)Wtsi>,"desmocollin 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4455602,KOMP-CSD,Dsc2,MGI:103221
Dscc1<tm1a(KOMP)Wtsi>,"DNA replication and sister chromatid cohesion 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362627,KOMP-CSD,Dscc1,MGI:1919357
Dse<tm1Mmac>,"dermatan sulfate epimerase; targeted mutation 1, Marco Maccarana",MGI:4366965,0,Dse,MGI:2443455
Dsel<tm1Mmac>,"dermatan sulfate epimerase-like; targeted mutation 1, Marco Maccarana",MGI:5583872,0,Dsel,MGI:2442948
Dsg1b<tm1a(KOMP)Wtsi>,"desmoglein 1 beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364614,KOMP-CSD,Dsg1b,MGI:2664357
Dsg3<bal-Pas>,desmoglein 3; balding Institut Pasteur,MGI:1857386,0,Dsg3,MGI:99499
Dsg4<lah>,desmoglein 4; lanceolate hair,MGI:1856929,0,Dsg4,MGI:2661061
Dsn1<tm1a(EUCOMM)Wtsi>,"DSN1 homolog, MIS12 kinetochore complex component; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452782,EUCOMM,Dsn1,MGI:1914184
Duoxa2<tm1a(KOMP)Wtsi>,"dual oxidase maturation factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5305622,KOMP-CSD,Duoxa2,MGI:1914061
Duoxa2<tm1b(KOMP)Wtsi>,"dual oxidase maturation factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637016,KOMP-CSD,Duoxa2,MGI:1914061
Dus2<tm1a(EUCOMM)Wtsi>,"dihydrouridine synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452769,EUCOMM,Dus2,MGI:1913619
Dus2<tm1b(EUCOMM)Wtsi>,,MGI:1913619,,,
Dusp11<tm1a(EUCOMM)Wtsi>,"dual specificity phosphatase 11 (RNA/RNP complex 1-interacting); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434394,EUCOMM,Dusp11,MGI:1919352
Dusp1<tm1(KOMP)Wtsi>,"dual specificity phosphatase 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4364283,KOMP-CSD,Dusp1,MGI:105120
Dusp26<tm1a(KOMP)Wtsi>,"dual specificity phosphatase 26 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363735,KOMP-CSD,Dusp26,MGI:1914209
Dusp3<tm1a(KOMP)Wtsi>,"dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820135,KOMP-CSD,Dusp3,MGI:1919599
Dusp3<tm1b(KOMP)Wtsi>,"dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548619,KOMP-CSD,Dusp3,MGI:1919599
Dusp4<tm1a(EUCOMM)Wtsi>,"dual specificity phosphatase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431999,EUCOMM,Dusp4,MGI:2442191
Dusp5<tm1a(KOMP)Wtsi>,"dual specificity phosphatase 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456654,KOMP-CSD,Dusp5,MGI:2685183
Dusp9<tm1Skey>,"dual specificity phosphatase 9; targeted mutation 1, Stephen M Keyse",MGI:3604672,0,Dusp9,MGI:2387107
Dync1h1<Loa>,dynein cytoplasmic 1 heavy chain 1; legs at odd angles,MGI:2447991,0,Dync1h1,MGI:103147
Dync1h1<Swl>,dynein cytoplasmic 1 heavy chain 1; sprawling,MGI:1861136,0,Dync1h1,MGI:103147
Dync1i2<m1H>,dynein cytoplasmic 1 intermediate chain 2; mutation 1 Harwell,MGI:5440332,Harwell ENU Mutagenesis,Dync1i2,MGI:107750
Dync1i2<tm1a(EUCOMM)Wtsi>,"dynein cytoplasmic 1 intermediate chain 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441864,EUCOMM,Dync1i2,MGI:107750
Dync1li1<m1Emcf>,"dynein cytoplasmic 1 light intermediate chain 1; mutation 1, Elizabeth M C Fisher",MGI:4950685,0,Dync1li1,MGI:2135610
Dynll1<Gt(EUCE0287d04)Hmgu>,"dynein light chain LC8-type 1; gene trap EUCE0287d04, Helmholtz Zentrum Muenchen GmbH",MGI:4368846,0,Dynll1,MGI:1861457
Dynll1<tm1(KOMP)Wtsi>,"dynein light chain LC8-type 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419330,KOMP-CSD,Dynll1,MGI:1861457
Dynlrb1<tm1a(EUCOMM)Wtsi>,"dynein light chain roadblock-type 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432163,EUCOMM,Dynlrb1,MGI:1914318
Dynlrb2<tm1a(KOMP)Wtsi>,"dynein light chain roadblock-type 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052400,KOMP-CSD,Dynlrb2,MGI:1922715
Eaf1<tm1a(EUCOMM)Wtsi>,"ELL associated factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433402,EUCOMM,Eaf1,MGI:1921677
Ears2<tm1a(EUCOMM)Wtsi>,"glutamyl-tRNA synthetase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432622,EUCOMM,Ears2,MGI:1914667
Ebp<Td>,phenylalkylamine Ca2+ antagonist (emopamil) binding protein; tattered,MGI:1857832,0,Ebp,MGI:107822
Ech1<tm1a(EUCOMM)Wtsi>,"enoyl coenzyme A hydratase 1, peroxisomal; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433635,EUCOMM,Ech1,MGI:1858208
Eci2<tm1a(EUCOMM)Hmgu>,"enoyl-Coenzyme A delta isomerase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946719,EUCOMM,Eci2,MGI:1346064
Eci2<tm1b(EUCOMM)Hmgu>,"enoyl-Coenzyme A delta isomerase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588272,EUCOMM,Eci2,MGI:1346064
Eci3<tm1a(EUCOMM)Wtsi>,"enoyl-Coenzyme A delta isomerase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441787,EUCOMM,Eci3,MGI:1916373
Eci3<tm1b(EUCOMM)Wtsi>,"enoyl-Coenzyme A delta isomerase 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548579,EUCOMM,Eci3,MGI:1916373
Ecm1<tm1a(EUCOMM)Hmgu>,"extracellular matrix protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4452742,EUCOMM,Ecm1,MGI:103060
Ect2<tm1a(EUCOMM)Wtsi>,"ect2 oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433090,EUCOMM,Ect2,MGI:95281
Eda<Ta-43H>,ectodysplasin-A; tabby 43 Harwell,MGI:5509473,0,Eda,MGI:1195272
Edc4<tm1a(EUCOMM)Wtsi>,"enhancer of mRNA decapping 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433903,EUCOMM,Edc4,MGI:2446249
Ednra<m1Mhda>,"endothelin receptor type A; mutation 1, Martin Hrabe de Angelis",MGI:5618847,0,Ednra,MGI:105923
Eef2kmt<tm1e(EUCOMM)Wtsi>,"eukaryotic elongation factor 2 lysine methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433018,EUCOMM,Eef2kmt,MGI:1917761
Efcab11<tm1a(EUCOMM)Hmgu>,"EF-hand calcium binding domain 11; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434986,EUCOMM,Efcab11,MGI:1926017
Efna1<tm1a(EUCOMM)Wtsi>,"ephrin A1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433482,EUCOMM,Efna1,MGI:103236
Efna5<tm1a(EUCOMM)Wtsi>,"ephrin A5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441837,EUCOMM,Efna5,MGI:107444
Efna5<tm1b(EUCOMM)Wtsi>,"ephrin A5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548373,EUCOMM,Efna5,MGI:107444
Efnb1<tm1Rha>,"ephrin B1; targeted mutation 1, Ralf H Adams",MGI:3653699,0,Efnb1,MGI:102708
Egfr<Wa5>,epidermal growth factor receptor; waved 5,MGI:2178387,Harwell ENU Mutagenesis,Egfr,MGI:95294
Egfr<tm1a(EUCOMM)Wtsi>,"epidermal growth factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433235,EUCOMM,Egfr,MGI:95294
Egr1<tm1Pch>              ,"early growth response 1; targeted mutation 1, Patrick Charnay",MGI:2181755,0,Egr1,MGI:95295
Egr2<tm1Pch>,"early growth response 2; targeted mutation 1, Patrick Charnay",MGI:1857507,0,Egr2,MGI:95296
Egr2<tm2(cre)Pch>                         ,"early growth response 2; targeted mutation 2, Patrick Charnay",MGI:1931056,0,Egr2,MGI:95296
Egr2<tm3Pch>,"early growth response 2; targeted mutation 3, Patrick Charnay",MGI:2183227,0,Egr2,MGI:95296
Egr2<tm4Pch>,"early growth response 2; targeted mutation 4, Patrick Charney",MGI:3798483,0,Egr2,MGI:95296
Ehbp1l1<tm1a(EUCOMM)Wtsi>,"EH domain binding protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432707,EUCOMM,Ehbp1l1,MGI:3612340
Ehd1<tm1a(EUCOMM)Wtsi>,"EH-domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432418,EUCOMM,Ehd1,MGI:1341878
Ehf<tm1a(EUCOMM)Hmgu>,"ets homologous factor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5520288,EUCOMM,Ehf,MGI:1270840
Ehmt1<tm1a(EUCOMM)Hmgu>,"euchromatic histone methyltransferase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5013778,EUCOMM,Ehmt1,MGI:1924933
Ehmt2<Gt(ES62)Feil>,"euchromatic histone lysine N-methyltransferase 2; gene trap ES62, Robert Feil",MGI:3772197,0,Ehmt2,MGI:2148922
Eif2ak2<tm1Jcbe>,"eukaryotic translation initiation factor 2-alpha kinase 2; targeted mutation 1, John C Bell",MGI:2182590,0,Eif2ak2,MGI:1353449
Eif2ak4<tm1.2Dron>,"eukaryotic translation initiation factor 2 alpha kinase 4; targeted mutation 1.2, David Ron",MGI:3582154,0,Eif2ak4,MGI:1353427
Eif2b1<tm1a(EUCOMM)Hmgu>,"eukaryotic translation initiation factor 2B, subunit 1 (alpha); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436327,EUCOMM,Eif2b1,MGI:2384802
Eif2b2<tm2a(KOMP)Wtsi>,"eukaryotic translation initiation factor 2B, subunit 2 beta; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4364625,KOMP-CSD,Eif2b2,MGI:2145118
Eif2b3<tm1a(EUCOMM)Hmgu>,"eukaryotic translation initiation factor 2B, subunit 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951025,EUCOMM,Eif2b3,MGI:1313286
Eif2b5<tm1a(EUCOMM)Wtsi>,"eukaryotic translation initiation factor 2B, subunit 5 epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432328,EUCOMM,Eif2b5,MGI:2446176
Eif2s3x<tm1.1(IMPC)Wtsi>,,MGI:1349431,,,
Eif3c<Xs>,"eukaryotic translation initiation factor 3, subunit C; extra toes spotting",MGI:1856583,0,Eif3c,MGI:1926966
Eif3h<tm1a(EUCOMM)Hmgu>,"eukaryotic translation initiation factor 3, subunit H; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008832,EUCOMM,Eif3h,MGI:1915385
Eif4e3<tm1a(KOMP)Wtsi>,"eukaryotic translation initiation factor 4E member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364967,KOMP-CSD,Eif4e3,MGI:1914142
Eif4ebp1<tm1Nso>,"eukaryotic translation initiation factor 4E binding protein 1; targeted mutation 1, Nahum Sonenberg",MGI:2177923,0,Eif4ebp1,MGI:103267
Eif4ebp2<tm1Klan>,"eukaryotic translation initiation factor 4E binding protein 2; targeted mutation 1, Eric Klann",MGI:3607258,0,Eif4ebp2,MGI:109198
Eif6<tm1Sbif>,"eukaryotic translation initiation factor 6; targeted mutation 1, Stefano Biffo",MGI:3817934,0,Eif6,MGI:1196288
Elac2<tm1a(EUCOMM)Wtsi>,"elaC ribonuclease Z 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456058,EUCOMM,Elac2,MGI:1890496
Elac2<tm1b(EUCOMM)Wtsi>,"elaC ribonuclease Z 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637003,EUCOMM,Elac2,MGI:1890496
Elane<tm1(cre)Roes>,"elastase, neutrophil expressed; targeted mutation 1, Jurgen Roes",MGI:2182177,0,Elane,MGI:2679229
Elavl1<tm1.2Dkon>,"ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R); targeted mutation 1.2, Dimitris L Kontoyiannis",MGI:3847912,0,Elavl1,MGI:1100851
Elavl1<tm1Dkon>,"ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R); targeted mutation 1, Dimitris L Kontoyiannis",MGI:3847911,0,Elavl1,MGI:1100851
Elk4<tm1a(EUCOMM)Wtsi>,"ELK4, member of ETS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432021,EUCOMM,Elk4,MGI:102853
Ell2<tm1a(EUCOMM)Wtsi>,"elongation factor RNA polymerase II 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441868,EUCOMM,Ell2,MGI:2183438
Ell2<tm1b(EUCOMM)Wtsi>,"elongation factor RNA polymerase II 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548782,EUCOMM,Ell2,MGI:2183438
Elmo1<tm1a(EUCOMM)Wtsi>,"engulfment and cell motility 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939780,EUCOMM,Elmo1,MGI:2153044
Elmod1<tm1a(EUCOMM)Hmgu>,"ELMO/CED-12 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435771,EUCOMM,Elmod1,MGI:3583900
Elmod2<tm1a(EUCOMM)Hmgu>,"ELMO/CED-12 domain containing 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436007,EUCOMM,Elmod2,MGI:2445165
Elovl6<Gt(OST222498)Lex>,"ELOVL family member 6, elongation of long chain fatty acids (yeast); gene trap OST222498 Lexicon Genetics",MGI:3530353,Lexicon,Elovl6,MGI:2156528
Elovl6<tm1a(EUCOMM)Hmgu>,"ELOVL family member 6, elongation of long chain fatty acids (yeast); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008866,EUCOMM,Elovl6,MGI:2156528
Elp1<tm1a(KOMP)Wtsi>,"elongator complex protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362242,KOMP-CSD,Elp1,MGI:1914544
Emc10<tm1a(EUCOMM)Wtsi>,"ER membrane protein complex subunit 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432030,EUCOMM,Emc10,MGI:1916933
Emc3<tm1a(EUCOMM)Wtsi>,"ER membrane protein complex subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453751,EUCOMM,Emc3,MGI:1913337
Emc3<tm1b(EUCOMM)Wtsi>,"ER membrane protein complex subunit 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5629314,EUCOMM,Emc3,MGI:1913337
Emc8<tm1a(EUCOMM)Hmgu>,"ER membrane protein complex subunit 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4942045,EUCOMM,Emc8,MGI:1343095
Emid1<tm1e(EUCOMM)Wtsi>,"EMI domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433762,EUCOMM,Emid1,MGI:2155091
Eml1<heco>,echinoderm microtubule associated protein like 1; heterotopic cortex,MGI:5560734,0,Eml1,MGI:1915769
Emx2<Pdo>,empty spiracles homeobox 2; pardon,MGI:3038078,Harwell ENU Mutagenesis,Emx2,MGI:95388
Emx2<tm1Pgr>,"empty spiracles homeobox 2; targeted mutation 1, Peter Gruss",MGI:2148858,0,Emx2,MGI:95388
En1<tm1(PDGFB)Nist>,"engrailed 1; targeted mutation 1, Monica Nister",MGI:3047856,0,En1,MGI:95389
Enc1<tm1a(EUCOMM)Wtsi>,"ectodermal-neural cortex 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5051006,EUCOMM,Enc1,MGI:109610
Eng<tm1Hma>,"endoglin; targeted mutation 1, Helen M Arthur",MGI:2177822,0,Eng,MGI:95392
Eng<tm2.1Hma>,,MGI:371202,,,
Enpep<tm1a(KOMP)Wtsi>,"glutamyl aminopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363369,KOMP-CSD,Enpep,MGI:106645
Enpp2<tm1.1Vart>,"ectonucleotide pyrophosphatase/phosphodiesterase 2; targeted mutation 1.1, Vassilis Aidinis",MGI:3790757,0,Enpp2,MGI:1321390
Enpp2<tm1.2Vart>,"ectonucleotide pyrophosphatase/phosphodiesterase 2; targeted mutation 1.2, Vassilis Aidinis",MGI:5708147,0,Enpp2,MGI:1321390
Enpp2<tm1Vart>,"ectonucleotide pyrophosphatase/phosphodiesterase 2; targeted mutation 1, Vassilis Aidinis",MGI:3785736,0,Enpp2,MGI:1321390
Entpd1<tm1a(EUCOMM)Wtsi>,"ectonucleoside triphosphate diphosphohydrolase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433342,EUCOMM,Entpd1,MGI:102805
Entpd1<tm1b(EUCOMM)Wtsi>,"ectonucleoside triphosphate diphosphohydrolase 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548332,EUCOMM,Entpd1,MGI:102805
Entpd6<tm1a(KOMP)Wtsi>,"ectonucleoside triphosphate diphosphohydrolase 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363445,KOMP-CSD,Entpd6,MGI:1202295
Eomes<tm1.1Twa>,"eomesodermin; targeted mutation 1.1, Thierry Walzer",MGI:5617491,0,Eomes,MGI:1201683
Eomes<tm1a(EUCOMM)Wtsi>,"eomesodermin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014719,EUCOMM,Eomes,MGI:1201683
Epas1<tm1a(EUCOMM)Hmgu>,"endothelial PAS domain protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951065,EUCOMM,Epas1,MGI:109169
Epb41l5<tm1a(EUCOMM)Hmgu>,"erythrocyte membrane protein band 4.1 like 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436105,EUCOMM,Epb41l5,MGI:103006
Epc2<tm1a(EUCOMM)Wtsi>,"enhancer of polycomb homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431957,EUCOMM,Epc2,MGI:1278321
Epc2<tm1e(EUCOMM)Wtsi>,"enhancer of polycomb homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433594,EUCOMM,Epc2,MGI:1278321
Epha4<tm1Pch>,"Eph receptor A4; targeted mutation 1, Patrick Charnay",MGI:2149729,0,Epha4,MGI:98277
Ephx1<tm1a(EUCOMM)Hmgu>,"epoxide hydrolase 1, microsomal; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434687,EUCOMM,Ephx1,MGI:95405
Epo<Tg(SV40T/Epo)134.3LCPjr>,"erythropoietin; transgene insertion 134.3 LC, Peter J Ratcliffe",MGI:3767166,0,Epo,MGI:95407
Eps15<tm1a(KOMP)Wtsi>,"epidermal growth factor receptor pathway substrate 15; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362352,KOMP-CSD,Eps15,MGI:104583
Epx<tm1a(EUCOMM)Wtsi>,"eosinophil peroxidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842301,EUCOMM,Epx,MGI:107569
Erbb2<tm1Mll>,"erb-b2 receptor tyrosine kinase 2; targeted mutation 1, Ulrich Muller",MGI:2656906,0,Erbb2,MGI:95410
Ercc2<Mhdarco15>,"excision repair cross-complementing rodent repair deficiency, complementation group 2; Martin Hrabe de Angelis reduced coat 15",MGI:5621284,0,Ercc2,MGI:95413
Ercc2<tm1a(EUCOMM)Wtsi>,"excision repair cross-complementing rodent repair deficiency, complementation group 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432864,EUCOMM,Ercc2,MGI:95413
Ergic2<mhdaali32>,ERGIC and golgi 2; Martin Hrabe de Angelis abnormal limbs 32,MGI:5619364,0,Ergic2,MGI:1914706
Erlin2<tm1a(EUCOMM)Wtsi>,"ER lipid raft associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820210,EUCOMM,Erlin2,MGI:2387215
Erp29<tm1a(EUCOMM)Wtsi>,"endoplasmic reticulum protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842664,EUCOMM,Erp29,MGI:1914647
Erp44<tm1a(KOMP)Wtsi>,"endoplasmic reticulum protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052408,KOMP-CSD,Erp44,MGI:1923549
Esco1<tm1(KOMP)Wtsi>,"establishment of sister chromatid cohesion N-acetyltransferase 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419798,KOMP-CSD,Esco1,MGI:1925055
Esco2<tm1a(EUCOMM)Wtsi>,"establishment of sister chromatid cohesion N-acetyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431943,EUCOMM,Esco2,MGI:1919238
Espn<tm1a(EUCOMM)Wtsi>,"espin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431731,EUCOMM,Espn,MGI:1861630
Esr1<tm1.1Gust>,"estrogen receptor 1 (alpha); targeted mutation 1.1, Jan-Ake Gustafsson",MGI:5433576,0,Esr1,MGI:1352467
Esr1<tm1Gust>,"estrogen receptor 1 (alpha); targeted mutation 1, Jan-Ake Gustafsson",MGI:5433575,0,Esr1,MGI:1352467
Esr2<tm1.1Gust>,"estrogen receptor 2 (beta); targeted mutation 1.1, Jan-Ake Gustafsson",MGI:5751115,0,Esr2,MGI:109392
Esr2<tm1Dgen>,"estrogen receptor 2 (beta); targeted mutation 1, Deltagen",MGI:5427668,Deltagen,Esr2,MGI:109392
Esr2<tm1Gust>,"estrogen receptor 2 (beta); targeted mutation 1, Jan-Ake Gustafsson",MGI:5751112,0,Esr2,MGI:109392
Ess2<tm1Bld>,"ess-2 splicing factor; targeted mutation 1, Antonio Baldini",MGI:3640092,0,Ess2,MGI:107854
Esyt3<tm1a(EUCOMM)Wtsi>,"extended synaptotagmin-like protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433605,EUCOMM,Esyt3,MGI:1098699
Etfdh<tm1a(EUCOMM)Hmgu>,"electron transferring flavoprotein, dehydrogenase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451799,EUCOMM,Etfdh,MGI:106100
Ethe1<tm1a(EUCOMM)Wtsi>,"ethylmalonic encephalopathy 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432299,EUCOMM,Ethe1,MGI:1913321
Ets2<m1Mhda>,"E26 avian leukemia oncogene 2, 3' domain; mutation 1, Martin Hrabe de Angelis",MGI:5702953,0,Ets2,MGI:95456
Evi5<tm1a(KOMP)Wtsi>,"ecotropic viral integration site 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458636,KOMP-CSD,Evi5,MGI:104736
Evl<tm1a(KOMP)Wtsi>,"Ena-vasodilator stimulated phosphoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363092,KOMP-CSD,Evl,MGI:1194884
Evta,evita,MGI:3851189,0,Evta,MGI:3851187
Evx2/Hoxd13<tm3.1Ddu>,,MGI:2651625,,,
Evx2/Hoxd13<tm4(cre)Ddu>,"even-skipped homeobox 2; targeted mutation 4, Denis Duboule",MGI:3762124,0,Evx2,MGI:95462
Evx2/Hoxd13<tm5.1(Hoxd11/lacZ)Ddu>,"even-skipped homeobox 2; targeted mutation 5.1, Denis Duboule",MGI:4850026,0,Evx2,MGI:95462
Evx2<tm1Ddu>,"even-skipped homeobox 2; targeted mutation 1, Denis Duboule",MGI:2445967,0,Evx2,MGI:95462
Evx2<tm3Ddu>,"even-skipped homeobox 2; targeted mutation 3, Denis Duboule",MGI:2445968,0,Evx2,MGI:95462
Exd1<tm1Embrp>,"exonuclease 3'-5' domain containing 1; targeted mutation 1, Ramesh Pillai",MGI:5781095,0,Exd1,MGI:3045306
Exoc3l2<tm1a(KOMP)Wtsi>,"exocyst complex component 3-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363569,KOMP-CSD,Exoc3l2,MGI:1921713
Exoc3l2<tm1b(KOMP)Wtsi>,"exocyst complex component 3-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548646,KOMP-CSD,Exoc3l2,MGI:1921713
Exosc9<tm1a(EUCOMM)Wtsi>,"exosome component 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434326,EUCOMM,Exosc9,MGI:1355319
Exosc9<tm1b(EUCOMM)Wtsi>,"exosome component 9; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636988,EUCOMM,Exosc9,MGI:1355319
Extl2<tm1a(KOMP)Wtsi>,"exostoses (multiple)-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5299624,KOMP-CSD,Extl2,MGI:1889574
Eya3<Gt(W096D02)Wrst>,"EYA transcriptional coactivator and phosphatase 3; gene trap W096D02, Wolfgang Wurst",MGI:3834107,0,Eya3,MGI:109339
Ezh2<tm1a(EUCOMM)Wtsi>,"enhancer of zeste 2 polycomb repressive complex 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432638,EUCOMM,Ezh2,MGI:107940
Ezr<tm2a(EUCOMM)Wtsi>,"ezrin; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4431855,EUCOMM,Ezr,MGI:98931
F10<tm1a(EUCOMM)Hmgu>,"coagulation factor X; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435623,EUCOMM,F10,MGI:103107
F2<tm1a(EUCOMM)Hmgu>,"coagulation factor II; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950199,EUCOMM,F2,MGI:88380
F730043M19Rik<tm1b(NCC)WCS>,,MGI:2443237,,,
F7<tm1a(EUCOMM)Hmgu>,"coagulation factor VII; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451755,EUCOMM,F7,MGI:109325
Fabp12<tm1a(EUCOMM)Wtsi>,"fatty acid binding protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433784,EUCOMM,Fabp12,MGI:1922747
Fabp1<tm1a(EUCOMM)Hmgu>,"fatty acid binding protein 1, liver; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435668,EUCOMM,Fabp1,MGI:95479
Fabp3<tm1a(EUCOMM)Wtsi>,"fatty acid binding protein 3, muscle and heart; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431873,EUCOMM,Fabp3,MGI:95476
Fadd<tm1Mak>,"Fas (TNFRSF6)-associated via death domain; targeted mutation 1, Tak W Mak",MGI:2159360,0,Fadd,MGI:109324
Fads3<tm1a(EUCOMM)Hmgu>,"fatty acid desaturase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5568477,EUCOMM,Fads3,MGI:1928740
Fads6<tm1a(EUCOMM)Wtsi>,"fatty acid desaturase domain family, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432828,EUCOMM,Fads6,MGI:3039592
Fads6<tm1b(EUCOMM)Wtsi>,,MGI:3039592,,,
Fah<tm1(NCOM)Mfgc>,"fumarylacetoacetate hydrolase; targeted mutation 1, Mammalian Functional Genomics Centre",MGI:4880346,NorCOMM,Fah,MGI:95482
Fahd2a<tm1a(EUCOMM)Wtsi>,"fumarylacetoacetate hydrolase domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431777,EUCOMM,Fahd2a,MGI:1915376
Fam104a<tm2a(EUCOMM)Wtsi>,"family with sequence similarity 104, member A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4433549,EUCOMM,Fam104a,MGI:106351
Fam107b<tm1a(KOMP)Wtsi>,"family with sequence similarity 107, member B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362853,KOMP-CSD,Fam107b,MGI:1913790
Fam110b<tm1e(EUCOMM)Wtsi>,"family with sequence similarity 110, member B; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4432846,EUCOMM,Fam110b,MGI:1916593
Fam117b<tm1a(EUCOMM)Wtsi>,"family with sequence similarity 117, member B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432848,EUCOMM,Fam117b,MGI:1920000
Fam122c<tm1a(EUCOMM)Wtsi>,"family with sequence similarity 122, member C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432565,EUCOMM,Fam122c,MGI:1921116
Fam122c<tm1b(EUCOMM)Wtsi>,"family with sequence similarity 122, member C; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637072,EUCOMM,Fam122c,MGI:1921116
Fam136a<tm1a(KOMP)Wtsi>,"family with sequence similarity 136, member A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944370,KOMP-CSD,Fam136a,MGI:1913738
Fam136a<tm1b(KOMP)Wtsi>,,MGI:1913738,,,
Fam13b<tm1a(EUCOMM)Wtsi>,"family with sequence similarity 13, member B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842400,EUCOMM,Fam13b,MGI:2447834
Fam151b<tm1a(EUCOMM)Hmgu>,"family with sequence similarity 151, member B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455695,EUCOMM,Fam151b,MGI:1921192
Fam160a1<tm1a(EUCOMM)Wtsi>,"family with sequence similarity 160, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849420,EUCOMM,Fam160a1,MGI:2444746
Fam160a1<tm1b(EUCOMM)Wtsi>,"family with sequence similarity 160, member A1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5638570,EUCOMM,Fam160a1,MGI:2444746
Fam162a<tm1a(EUCOMM)Hmgu>,"family with sequence similarity 162, member A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5289875,EUCOMM,Fam162a,MGI:1917436
Fam162a<tm1b(EUCOMM)Hmgu>,"family with sequence similarity 162, member A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613649,EUCOMM,Fam162a,MGI:1917436
Fam163a<tm2a(KOMP)Wtsi>,"family with sequence similarity 163, member A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5141829,KOMP-CSD,Fam163a,MGI:3618859
Fam163a<tm2b(KOMP)Wtsi>,"family with sequence similarity 163, member A; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637187,KOMP-CSD,Fam163a,MGI:3618859
Fam216a<tm1a(EUCOMM)Hmgu>,"family with sequence similarity 216, member A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841879,EUCOMM,Fam216a,MGI:1916198
Fam216a<tm1b(EUCOMM)Hmgu>,"family with sequence similarity 216, member A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548573,EUCOMM,Fam216a,MGI:1916198
Fam47e<tm1a(EUCOMM)Wtsi>,"family with sequence similarity 47, member E; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4940801,EUCOMM,Fam47e,MGI:2686227
Fam53b<tm1a(EUCOMM)Hmgu>,"family with sequence similarity 53, member B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841848,EUCOMM,Fam53b,MGI:1925188
Fam53b<tm1b(EUCOMM)Hmgu>,"family with sequence similarity 53, member B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548690,EUCOMM,Fam53b,MGI:1925188
Fam69a<tm1a(EUCOMM)Wtsi>,"divergent protein kinase domain 1A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5548321,EUCOMM,Dipk1a,MGI:1914516
Fam71b<tm1a(KOMP)Wtsi>,"family with sequence similarity 71, member B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364165,KOMP-CSD,Fam71b,MGI:3650836
Fam76a<tm1e(EUCOMM)Wtsi>,"family with sequence similarity 76, member A; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4947812,EUCOMM,Fam76a,MGI:2385211
Fam83g<tm1a(EUCOMM)Wtsi>,"family with sequence similarity 83, member G; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431981,EUCOMM,Fam83g,MGI:1916890
Fam92a<tm1a(KOMP)Wtsi>,"family with sequence similarity 92, member A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013734,KOMP-CSD,Fam92a,MGI:1915349
Fam92a<tm1b(KOMP)Wtsi>,"family with sequence similarity 92, member A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637028,KOMP-CSD,Fam92a,MGI:1915349
Fam92b<tm1e(EUCOMM)Wtsi>,"family with sequence similarity 92, member B; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:5296610,EUCOMM,Fam92b,MGI:3588213
Fancd2os<tm2a(EUCOMM)Wtsi>,"Fancd2 opposite strand; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840597,EUCOMM,Fancd2os,MGI:1918229
Fanci<tm1a(EUCOMM)Wtsi>,"Fanconi anemia, complementation group I; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456047,EUCOMM,Fanci,MGI:2384790
Farp1<tm1a(EUCOMM)Hmgu>,"FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841904,EUCOMM,Farp1,MGI:2446173
Farp1<tm1b(EUCOMM)Hmgu>,"FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588287,EUCOMM,Farp1,MGI:2446173
Farp2<tm1a(KOMP)Wtsi>,"FERM, RhoGEF and pleckstrin domain protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363551,KOMP-CSD,Farp2,MGI:2385126
Farsa<tm2a(EUCOMM)Wtsi>,"phenylalanyl-tRNA synthetase, alpha subunit; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4441679,EUCOMM,Farsa,MGI:1913840
Fas<lpr>,Fas (TNF receptor superfamily member 6); lymphoproliferation,MGI:1856334,0,Fas,MGI:95484
Fasl<gld>,"Fas ligand (TNF superfamily, member 6); generalized lymphoproliferative disease",MGI:1856384,0,Fasl,MGI:99255
Fasl<tm1.1Cgm>,"Fas ligand (TNF superfamily, member 6); targeted mutation 1.1, Geert Michel",MGI:4888490,0,Fasl,MGI:99255
Fasl<tm1Lest>,"Fas ligand (TNF superfamily, member 6); targeted mutation 1, Matthieu Levi-Strauss",MGI:3032852,0,Fasl,MGI:99255
Fbf1<tm1a(EUCOMM)Wtsi>,"Fas (TNFRSF6) binding factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432655,EUCOMM,Fbf1,MGI:1922033
Fbh1<tm1a(KOMP)Wtsi>,"F-box DNA helicase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4881960,KOMP-CSD,Fbh1,MGI:1354699
Fbp2<tm2a(EUCOMM)Hmgu>,"fructose bisphosphatase 2; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511594,EUCOMM,Fbp2,MGI:95491
Fbp2<tm2b(EUCOMM)Hmgu>,"fructose bisphosphatase 2; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5637205,EUCOMM,Fbp2,MGI:95491
Fbxl21<tm2a(EUCOMM)Wtsi>,"F-box and leucine-rich repeat protein 21; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5473110,EUCOMM,Fbxl21,MGI:2442921
Fbxl3<Afh>,F-box and leucine-rich repeat protein 3; after hours,MGI:3687377,0,Fbxl3,MGI:1354702
Fbxl7<tm1a(EUCOMM)Wtsi>,"F-box and leucine-rich repeat protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820357,EUCOMM,Fbxl7,MGI:3052506
Fbxo11<Jf>,F-box protein 11; jeff,MGI:1862017,0,Fbxo11,MGI:2147134
Fbxo11<tm2a(EUCOMM)Wtsi>,"F-box protein 11; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4434283,EUCOMM,Fbxo11,MGI:2147134
Fbxo33<tm1a(EUCOMM)Wtsi>,"F-box protein 33; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432600,EUCOMM,Fbxo33,MGI:1917861
Fbxo33<tm1b(EUCOMM)Wtsi>,"F-box protein 33; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548601,EUCOMM,Fbxo33,MGI:1917861
Fbxo47<tm1a(EUCOMM)Wtsi>,"F-box protein 47; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431644,EUCOMM,Fbxo47,MGI:1920223
Fbxo7<tm1a(EUCOMM)Wtsi>,"F-box protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842259,EUCOMM,Fbxo7,MGI:1917004
Fbxo7<tm1b(EUCOMM)Wtsi>,,MGI:1917004,,,
Fbxo7<tm1c(EUCOMM)Wtsi>,,MGI:1917004,,,
Fbxw26<tm1a(KOMP)Wtsi>,"F-box and WD-40 domain protein 26; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947750,KOMP-CSD,Fbxw26,MGI:3646662
Fbxw26<tm1b(KOMP)Wtsi>,"F-box and WD-40 domain protein 26; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548906,KOMP-CSD,Fbxw26,MGI:3646662
Fcamr<tm1Jsv>,"Fc receptor, IgA, IgM, high affinity; targeted mutation 1, J Sjef Verbeek",MGI:5882394,0,Fcamr,MGI:1927803
Fcer1g<tm1Rav>,"Fc receptor, IgE, high affinity I, gamma polypeptide; targeted mutation 1, Jeffrey V Ravetch",MGI:1857165,0,Fcer1g,MGI:95496
Fcgbp<tm1a(EUCOMM)Wtsi>,"Fc fragment of IgG binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432812,EUCOMM,Fcgbp,MGI:2444336
Fcgr1<tm1Jsv>,"Fc receptor, IgG, high affinity I; targeted mutation 1, J Sjef Verbeek",MGI:2664927,0,Fcgr1,MGI:95498
Fcgr2b<tm1.2Jsv>,"Fc receptor, IgG, low affinity IIb; targeted mutation 1.2, J Sjef Verbeek",MGI:5427927,0,Fcgr2b,MGI:95499
Fcgr3<tm1Jsv>,"Fc receptor, IgG, low affinity III; targeted mutation 1, J Sjef Verbeek",MGI:1861924,0,Fcgr3,MGI:95500
Fcgr4<tm1Lex>,"Fc receptor, IgG, low affinity IV; targeted mutation 1, Lexicon Genetics",MGI:4867723,Lexicon,Fcgr4,MGI:2179523
Fcrl6<tm1a(KOMP)Wtsi>,"Fc receptor-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013745,KOMP-CSD,Fcrl6,MGI:3618339
Fdft1<tm1a(KOMP)Wtsi>,"farnesyl diphosphate farnesyl transferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451370,KOMP-CSD,Fdft1,MGI:102706
Fdx1<tm1a(EUCOMM)Wtsi>,"ferredoxin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452014,EUCOMM,Fdx1,MGI:103224
Fdx1<tm1b(EUCOMM)Wtsi>,"ferredoxin 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5588266,EUCOMM,Fdx1,MGI:103224
Fer1l4<m1Mhda>,"fer-1-like 4 (C. elegans); mutation 1, Martin Hrabe de Angelis",MGI:5817678,0,Fer1l4,MGI:1921812
Fermt2<tm1a(EUCOMM)Wtsi>,"fermitin family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433009,EUCOMM,Fermt2,MGI:2385001
Fers,ferris,MGI:1862018,0,Fers,MGI:1861994
Fgd4<tm1a(EUCOMM)Wtsi>,"FYVE, RhoGEF and PH domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849414,EUCOMM,Fgd4,MGI:2183747
Fgf10<Mhdaaey17>,fibroblast growth factor 10; Martin Hrabe de Angelis abnormalities of the eye 17,MGI:4398706,0,Fgf10,MGI:1099809
Fgf10<tm1a(EUCOMM)Wtsi>,"fibroblast growth factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431585,EUCOMM,Fgf10,MGI:1099809
Fgf11<tm1a(EUCOMM)Wtsi>,"fibroblast growth factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432799,EUCOMM,Fgf11,MGI:109167
Fgf22<tm1a(EUCOMM)Hmgu>,"fibroblast growth factor 22; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455942,EUCOMM,Fgf22,MGI:1914362
Fgf2<tm1a(EUCOMM)Wtsi>,"fibroblast growth factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433040,EUCOMM,Fgf2,MGI:95516
Fgf3<tm1Sng>,"fibroblast growth factor 3; targeted mutation 1, Thomas Schimmang",MGI:3027990,0,Fgf3,MGI:95517
Fgf7<tm1e(EUCOMM)Hmgu>,"fibroblast growth factor 7; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH",MGI:4455930,EUCOMM,Fgf7,MGI:95521
Fgf8<tm1a(KOMP)Wtsi>,"fibroblast growth factor 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419458,KOMP-CSD,Fgf8,MGI:99604
Fgf9<Aca12>,fibroblast growth factor 9; ACMaster abnormality 12,MGI:5293829,0,Fgf9,MGI:104723
Fgf9<tm1a(KOMP)Wtsi>,"fibroblast growth factor 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364690,KOMP-CSD,Fgf9,MGI:104723
Fgfr1<Hspy>,fibroblast growth factor receptor 1; hush puppy,MGI:3574787,0,Fgfr1,MGI:95522
Fgfr1op<tm1a(EUCOMM)Hmgu>,"Fgfr1 oncogene partner; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436456,EUCOMM,Fgfr1op,MGI:1922546
Fgfr1op<tm1b(EUCOMM)Hmgu>,"Fgfr1 oncogene partner; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548654,EUCOMM,Fgfr1op,MGI:1922546
Fgfr2<tm4Lni>,"fibroblast growth factor receptor 2; targeted mutation 4, Peter Lonai",MGI:3053095,0,Fgfr2,MGI:95523
Fgfr3<tm1.1Aomw>,"fibroblast growth factor receptor 3; targeted mutation 1.1, Andrew O M Wilkie",MGI:3831364,0,Fgfr3,MGI:95524
Fggy<tm1a(KOMP)Wtsi>,"FGGY carbohydrate kinase domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451404,KOMP-CSD,Fggy,MGI:1922828
Fgl1<tm1a(EUCOMM)Hmgu>,"fibrinogen-like protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436664,EUCOMM,Fgl1,MGI:102795
Fibp<tm1e(EUCOMM)Wtsi>,"fibroblast growth factor (acidic) intracellular binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4820356,EUCOMM,Fibp,MGI:1926233
Ficd<tm1a(EUCOMM)Hmgu>,"FIC domain containing; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4942081,EUCOMM,Ficd,MGI:1098550
Ficd<tm1b(EUCOMM)Hmgu>,,MGI:1098550,,,
Filip1<tm2b(KOMP)Wtsi>,,MGI:1917848,,,
Fip1l1<tm1a(EUCOMM)Wtsi>,"FIP1 like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887691,EUCOMM,Fip1l1,MGI:1914149
Fis1<tm1a(EUCOMM)Hmgu>,"fission, mitochondrial 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5497163,EUCOMM,Fis1,MGI:1913687
Fkbp10<tm2a(EUCOMM)Wtsi>,"FK506 binding protein 10; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5432211,EUCOMM,Fkbp10,MGI:104769
Fkbp3<tm2a(EUCOMM)Wtsi>,"FK506 binding protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5050935,EUCOMM,Fkbp3,MGI:1353460
Fkbp7<tm2a(KOMP)Wtsi>,"FK506 binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4364239,KOMP-CSD,Fkbp7,MGI:1336879
Fkbp9<tm1a(EUCOMM)Hmgu>,"FK506 binding protein 9; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435917,EUCOMM,Fkbp9,MGI:1350921
Fkrp<tm1.1Scbr>,"fukutin related protein; targeted mutation 1.1, S C Brown",MGI:4835412,0,Fkrp,MGI:2447586
Fli1<tm1.1Morl>,"Friend leukemia integration 1; targeted mutation 1.1, Francois Morle",MGI:4878922,0,Fli1,MGI:95554
Fli1<tm1Morl>,"Friend leukemia integration 1; targeted mutation 1,Francois Morle",MGI:4878921,0,Fli1,MGI:95554
Flna<Dilp2>,"filamin, alpha; dilated pupils 2",MGI:1934627,Harwell ENU Mutagenesis,Flna,MGI:95556
Flnb<tm1a(KOMP)Wtsi>,"filamin, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458530,KOMP-CSD,Flnb,MGI:2446089
Flot2<tm1Mak>,"flotillin 2; targeted mutation 1, Tak Mak",MGI:5527543,0,Flot2,MGI:103309
Flot2<tm2e(EUCOMM)Wtsi>,"flotillin 2; targeted mutation 2e, Wellcome Trust Sanger Institute",MGI:4433811,EUCOMM,Flot2,MGI:103309
Flrt2<tm1Rob>,"fibronectin leucine rich transmembrane protein 2; targeted mutation 1, Elizabeth J Robertson",MGI:4950410,0,Flrt2,MGI:3603594
Flrt3<tm1Rob>,"fibronectin leucine rich transmembrane protein 3; targeted mutation 1, Elizabeth J Robertson",MGI:3797077,0,Flrt3,MGI:1918686
Flt4<Chy>,FMS-like tyrosine kinase 4; chylous ascites,MGI:1856694,0,Flt4,MGI:95561
Flt4<tm1Ali>,"FMS-like tyrosine kinase 4; targeted mutation 1, Kari Alitalo",MGI:2181789,0,Flt4,MGI:95561
Flt4<tm2.1Ali>,"FMS-like tyrosine kinase 4; targeted mutation 2.1, Kari Alitalo",MGI:3805195,0,Flt4,MGI:95561
Fn1<tm1Feb>,"fibronectin 1; targeted mutation 1, Francisco E Baralle",MGI:2655527,0,Fn1,MGI:95566
Fn1<tm2Feb>,"fibronectin 1; targeted mutation 2, Francisco E Baralle",MGI:2655542,0,Fn1,MGI:95566
Fnbp4<m1Mhda>,"formin binding protein 4; mutation 1, Martin Hrabe de Angelis",MGI:5818735,0,Fnbp4,MGI:1860513
Fndc1<tm1a(KOMP)Wtsi>,"fibronectin type III domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5000326,KOMP-CSD,Fndc1,MGI:1915905
Fnip2<tm1a(KOMP)Wtsi>,"folliculin interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5303094,KOMP-CSD,Fnip2,MGI:2683054
Fntb<tm1Bbd>,"farnesyltransferase, CAAX box, beta; targeted mutation 1, Mariano Barbacid",MGI:3581447,0,Fntb,MGI:1861305
Foxa2<tm1Jrt>,"forkhead box A2; targeted mutation 1, Janet Rossant",MGI:1857725,0,Foxa2,MGI:1347476
Foxb1<tm1Pgr>,"forkhead box B1; targeted mutation 1, Peter Gruss",MGI:2384086,0,Foxb1,MGI:1927549
Foxe1<tm1Rdl>,"forkhead box E1; targeted mutation 1, Roberto Di Lauro",MGI:2181780,0,Foxe1,MGI:1353500
Foxe3<tm1Pca>,"forkhead box E3; targeted mutation 1, Peter Carlsson",MGI:3707205,0,Foxe3,MGI:1353569
Foxh1<tm1Jlw>,"forkhead box H1; targeted mutation 1, Jeffrey L Wrana",MGI:2179442,0,Foxh1,MGI:1347465
Foxn1<nu>,forkhead box N1; nude,MGI:1856108,0,Foxn1,MGI:102949
Foxp3<sf>,forkhead box P3; scurfy,MGI:1857034,0,Foxp3,MGI:1891436
Foxp3<tm1Mal>,"forkhead box P3; targeted mutation 1, Bernard Malissen",MGI:3773675,0,Foxp3,MGI:1891436
Foxq1<sa>,forkhead box Q1; satin,MGI:1857026,0,Foxq1,MGI:1298228
Fpgs<tm1a(EUCOMM)Hmgu>,"folylpolyglutamyl synthetase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435288,EUCOMM,Fpgs,MGI:95576
Fpr3<tm1a(EUCOMM)Hmgu>,"formyl peptide receptor 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008916,EUCOMM,Fpr3,MGI:1194495
Fra10ac1<tm1a(EUCOMM)Wtsi>,"FRA10AC1 homolog (human); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432196,EUCOMM,Fra10ac1,MGI:1917817
Fras1<bl>,Fraser extracellular matrix complex subunit 1; blebbed,MGI:1856691,0,Fras1,MGI:2385368
Fras1<tm1.1Pjsc>,"Fraser extracellular matrix complex subunit 1; targeted mutation 1.1, Peter J Scambler",MGI:5449386,0,Fras1,MGI:2385368
Fras1<tm1Chpk>,"Fraser extracellular matrix complex subunit 1; targeted mutation 1, George Chalepakis",MGI:2667194,0,Fras1,MGI:2385368
Frat1<tm1Brn>,"frequently rearranged in advanced T cell lymphomas; targeted mutation 1, Anton Berns",MGI:2384128,0,Frat1,MGI:109450
Frat2<tm1Brn>,"frequently rearranged in advanced T cell lymphomas 2; targeted mutation 1, Anton Berns",MGI:3530460,0,Frat2,MGI:2673967
Frat2<tm2Brn>,"frequently rearranged in advanced T cell lymphomas 2; targeted mutation 2, Anton Berns",MGI:3530463,0,Frat2,MGI:2673967
Frg1<tm1a(EUCOMM)Hmgu>,"FSHD region gene 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435564,EUCOMM,Frg1,MGI:893597
Frmd5<tm1a(EUCOMM)Hmgu>,"FERM domain containing 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435944,EUCOMM,Frmd5,MGI:2442557
Frmd5<tm1b(EUCOMM)Hmgu>,"FERM domain containing 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548809,EUCOMM,Frmd5,MGI:2442557
Frmd7<tm1a(KOMP)Wtsi>,"FERM domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455520,KOMP-CSD,Frmd7,MGI:2686379
Frrs1<tm1a(EUCOMM)Wtsi>,"ferric-chelate reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842283,EUCOMM,Frrs1,MGI:108076
Frrs1l<tm1a(EUCOMM)Hmgu>,"ferric-chelate reductase 1 like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4941526,EUCOMM,Frrs1l,MGI:2442704
Frs2<tm1a(EUCOMM)Wtsi>,"fibroblast growth factor receptor substrate 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433393,EUCOMM,Frs2,MGI:1100860
Fryl<tm1a(KOMP)Wtsi>,"FRY like transcription coactivator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4454126,KOMP-CSD,Fryl,MGI:1919563
Fryl<tm1b(KOMP)Wtsi>,,MGI:1919563,,,
Fshr<tm1Mha>,"follicle stimulating hormone receptor; targeted mutation 1, Margaret H Abel",MGI:2384130,0,Fshr,MGI:95583
Fstl1<tm1a(EUCOMM)Hmgu>,"follistatin-like 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458780,EUCOMM,Fstl1,MGI:102793
Fto<tm1a(EUCOMM)Wtsi>,"fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432397,EUCOMM,Fto,MGI:1347093
Fubp1<Gt(A033A08)Wrst>,"far upstream element (FUSE) binding protein 1; gene trap A033A08, German Gene Trap Consortium",MGI:4335984,0,Fubp1,MGI:1196294
Fubp3<tm1a(KOMP)Wtsi>,"far upstream element (FUSE) binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052386,KOMP-CSD,Fubp3,MGI:2443699
Fubp3<tm1b(KOMP)Wtsi>,,MGI:2443699,,,
Fun22,fundus abnormality 22,MGI:5620713,0,Fun22,MGI:5620711
Fun6,fundus abnormality 6,MGI:5699595,0,Fun6,MGI:5699592
Fundc1<tm1a(KOMP)Wtsi>,"FUN14 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363327,KOMP-CSD,Fundc1,MGI:1919268
Fundc1<tm1c(KOMP)Wtsi>,,MGI:1919268,,,
Furin<tm1a(EUCOMM)Wtsi>,"furin (paired basic amino acid cleaving enzyme); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434157,EUCOMM,Furin,MGI:97513
Fus<tm1.1Emcf>,"fused in sarcoma; targeted mutation 1.1, Elizabeth MC Fisher",MGI:6100933,0,Fus,MGI:1353633
Fut1<tm1b(KOMP)Wtsi>,,MGI:109375,,,
Fxyd3<tm1a(KOMP)Wtsi>,"FXYD domain-containing ion transport regulator 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362906,KOMP-CSD,Fxyd3,MGI:107497
Fxyd6<Gt(OST236306)Lex>,"FXYD domain-containing ion transport regulator 6; gene trap OST236306, Lexicon Genetics",MGI:4244813,Lexicon,Fxyd6,MGI:1890226
Fyb<tm1a(EUCOMM)Hmgu>,"FYN binding protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436293,EUCOMM,Fyb,MGI:1346327
Fyb<tm1b(EUCOMM)Hmgu>,"FYN binding protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548460,EUCOMM,Fyb,MGI:1346327
Fyn<tm1a(EUCOMM)Wtsi>,"Fyn proto-oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842482,EUCOMM,Fyn,MGI:95602
Fzd3<tm1a(EUCOMM)Hmgu>,"frizzled class receptor 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842008,EUCOMM,Fzd3,MGI:108476
Fzd6<tm2a(EUCOMM)Wtsi>,"frizzled class receptor 6; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527589,EUCOMM,Fzd6,MGI:108474
Fzr1<tm1Mama>,"fizzy and cell division cycle 20 related 1; targeted mutation 1, Marcos Malumbres",MGI:3800718,0,Fzr1,MGI:1926790
G3bp2<tm1a(EUCOMM)Wtsi>,"GTPase activating protein (SH3 domain) binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461696,EUCOMM,G3bp2,MGI:2442040
G6pdx<a-m1Neu>,"glucose-6-phosphate dehydrogenase X-linked; mutation 1, Neuherberg",MGI:2182739,0,G6pdx,MGI:105979
G6pdx<a-m2Neu>,"glucose-6-phosphate dehydrogenase X-linked; mutation 2, Neuherberg",MGI:2183760,0,G6pdx,MGI:105979
Gabarapl2<tm1a(EUCOMM)Hmgu>,"gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434575,EUCOMM,Gabarapl2,MGI:1890602
Gad2<tm1a(EUCOMM)Wtsi>,"glutamic acid decarboxylase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433273,EUCOMM,Gad2,MGI:95634
Gad2<tm1b(EUCOMM)Wtsi>,"glutamic acid decarboxylase 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548938,EUCOMM,Gad2,MGI:95634
Gal<tm1Wyn>,"galanin; targeted mutation 1, David Wynick",MGI:2183172,0,Gal,MGI:95637
Galk2<tm1a(EUCOMM)Hmgu>,"galactokinase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435970,EUCOMM,Galk2,MGI:1917226
Galk2<tm1b(EUCOMM)Hmgu>,"galactokinase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613648,EUCOMM,Galk2,MGI:1917226
Galnt18<tm1a(KOMP)Wtsi>,"polypeptide N-acetylgalactosaminyltransferase 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5085352,KOMP-CSD,Galnt18,MGI:2446239
Galnt18<tm1b(KOMP)Wtsi>,"polypeptide N-acetylgalactosaminyltransferase 18; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637158,KOMP-CSD,Galnt18,MGI:2446239
Galntl5<tm1a(KOMP)Wtsi>,"UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363889,KOMP-CSD,Galntl5,MGI:1915159
Galntl5<tm1b(KOMP)Wtsi>,"UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5577268,KOMP-CSD,Galntl5,MGI:1915159
Galr2<Gt(OST105469)Lex>,"galanin receptor 2; gene trap OST105469, Lexicon Genetics",MGI:3530476,Lexicon,Galr2,MGI:1337018
Galr2<tm1Dgen>,"galanin receptor 2; targeted mutation 1, Deltagen",MGI:3622325,Deltagen,Galr2,MGI:1337018
Galr3<tm1Lex>,"galanin receptor 3; targeted mutation 1, Lexicon Genetics",MGI:3528737,Lexicon,Galr3,MGI:1329003
Gap43<tm1a(EUCOMM)Wtsi>,"growth associated protein 43; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431861,EUCOMM,Gap43,MGI:95639
Gapdh<M5Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 5, Neuherberg",MGI:3701514,0,Gapdh,MGI:95640
Gapdh<M6Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 6, Neuherberg",MGI:3701515,0,Gapdh,MGI:95640
Gapdh<M7Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 7, Neuherberg",MGI:3701517,0,Gapdh,MGI:95640
Gapdh<M8Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 8, Neuherberg",MGI:3701520,0,Gapdh,MGI:95640
Gapdh<M9Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 9, Neuherberg",MGI:3701521,0,Gapdh,MGI:95640
Gapdh<m1Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 1, Neuherberg",MGI:2183515,0,Gapdh,MGI:95640
Gapdh<m2Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 2, Neuherberg",MGI:2183516,0,Gapdh,MGI:95640
Gapdh<m3Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 3, Neuherberg",MGI:2183517,0,Gapdh,MGI:95640
Gapdh<m4Neu>,"glyceraldehyde-3-phosphate dehydrogenase; mutation 4, Neuherberg",MGI:2183518,0,Gapdh,MGI:95640
Gar1<tm1a(EUCOMM)Wtsi>,"GAR1 ribonucleoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432700,EUCOMM,Gar1,MGI:1930948
Gars<C201R>,glycyl-tRNA synthetase; Cys201Arg,MGI:3760297,Harwell ENU Mutagenesis,Gars,MGI:2449057
Gas2l2<tm1a(KOMP)Wtsi>,"growth arrest-specific 2 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841109,KOMP-CSD,Gas2l2,MGI:3652048
Gatad2b<tm1a(EUCOMM)Hmgu>,"GATA zinc finger domain containing 2B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434913,EUCOMM,Gatad2b,MGI:2443225
Gatc<tm1a(KOMP)Wtsi>,"glutamyl-tRNA(Gln) amidotransferase, subunit C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362453,KOMP-CSD,Gatc,MGI:1923776
Gatm<tm1a(KOMP)Wtsi>,"glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362557,KOMP-CSD,Gatm,MGI:1914342
Gatm<tm1b(KOMP)Wtsi>,"glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548533,KOMP-CSD,Gatm,MGI:1914342
Gba2<tm1a(EUCOMM)Wtsi>,"glucosidase beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433071,EUCOMM,Gba2,MGI:2654325
Gba<tm1Karl>,"glucosidase, beta, acid; targeted mutation 1, Stefan Karlsson",MGI:3687965,0,Gba,MGI:95665
Gba<tm2Karl>,"glucosidase, beta, acid; targeted mutation 2, Stefan Karlsson",MGI:3764510,0,Gba,MGI:95665
Gbe1<tm1a(KOMP)Wtsi>,"glucan (1,4-alpha-), branching enzyme 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364560,KOMP-CSD,Gbe1,MGI:1921435
Gbf1<tm1a(KOMP)Wtsi>,"golgi-specific brefeldin A-resistance factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419544,KOMP-CSD,Gbf1,MGI:1861607
Gbp2<tm1b(KOMP)Wtsi>,"guanylate binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548331,KOMP-CSD,Gbp2,MGI:102772
Gbp3<tm1a(KOMP)Wtsi>,"guanylate binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5426642,KOMP-CSD,Gbp3,MGI:1926263
Gbx1<tm1a(KOMP)Wtsi>,"gastrulation brain homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944338,KOMP-CSD,Gbx1,MGI:95667
Gca<tm1Roes>,"grancalcin; targeted mutation 1, Jurgen Roes",MGI:2450787,0,Gca,MGI:1918521
Gck<Gena348>,"glucokinase; Gena348, Harwell",MGI:3044558,0,Gck,MGI:1270854
Gclc<tm1a(EUCOMM)Wtsi>,"glutamate-cysteine ligase, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432329,EUCOMM,Gclc,MGI:104990
Gda<tm1a(KOMP)Wtsi>,"guanine deaminase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5000323,KOMP-CSD,Gda,MGI:95678
Gde1<tm1a(EUCOMM)Hmgu>,"glycerophosphodiester phosphodiesterase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841688,EUCOMM,Gde1,MGI:1891827
Gde1<tm1b(EUCOMM)Hmgu>,"glycerophosphodiester phosphodiesterase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548506,EUCOMM,Gde1,MGI:1891827
Gdf15<tm1a(KOMP)Wtsi>,"growth differentiation factor 15; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362649,KOMP-CSD,Gdf15,MGI:1346047
Gdf1<tm1Dmus>,"growth differentiation factor 1; targeted mutation 1, Dmitry Usoskin",MGI:3806582,0,Gdf1,MGI:95683
Gdf5<bp-J>,growth differentiation factor 5; brachypodism Jackson,MGI:1855974,0,Gdf5,MGI:95688
Gdi2<tm1a(EUCOMM)Hmgu>,"guanosine diphosphate (GDP) dissociation inhibitor 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286327,EUCOMM,Gdi2,MGI:99845
Gdi2<tm1b(EUCOMM)Hmgu>,"guanosine diphosphate (GDP) dissociation inhibitor 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588293,EUCOMM,Gdi2,MGI:99845
Gdpd2<tm1a(KOMP)Wtsi>,"glycerophosphodiester phosphodiesterase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880967,KOMP-CSD,Gdpd2,MGI:1918834
Gem184,Gem 184 mutant,MGI:5752803,0,Gem184,MGI:5752801
Gena100,"Genetics Harwell, 100",MGI:5490097,Harwell ENU Mutagenesis,Gena100,MGI:3686765
Gena111,"Genetics Harwell, 111",MGI:5490343,Harwell ENU Mutagenesis,Gena111,MGI:5490281
Gena115,"Gena115; Genetics Harwell, 115",MGI:5488925,Harwell ENU Mutagenesis,Gena115,MGI:5488929
Gena127,"Gena127; Genetics Harwell, 127",MGI:5488927,Harwell ENU Mutagenesis,Gena127,MGI:5488933
Gena135,"Genetics Harwell, 135",MGI:5490099,Harwell ENU Mutagenesis,Gena135,MGI:3686763
Gena143,"Genetics Harwell, 143",MGI:5490346,Harwell ENU Mutagenesis,Gena143,MGI:5490324
Gena155,"Genetics Harwell, 155",MGI:5490350,Harwell ENU Mutagenesis,Gena155,MGI:5490287
Gena160,"Genetics Harwell, 160",MGI:5490100,Harwell ENU Mutagenesis,Gena160,MGI:3686761
Gena172,"Genetics Harwell, 172",MGI:5490351,Harwell ENU Mutagenesis,Gena172,MGI:5490330
Gena187,"Genetics Harwell, 187",MGI:5490353,Harwell ENU Mutagenesis,Gena187,MGI:5490279
Gena200,"Genetics Harwell, 200",MGI:5490101,Harwell ENU Mutagenesis,Gena200,MGI:3686759
Gena221,"Genetics Harwell, 221",MGI:5142488,Harwell ENU Mutagenesis,Gena221,MGI:3686755
Gena228,"Genetics Harwell, 228",MGI:5490102,Harwell ENU Mutagenesis,Gena228,MGI:3686753
Gena26,"Genetics Harwell, 26",MGI:5490356,Harwell ENU Mutagenesis,Gena26,MGI:5490318
Gena31,"Genetics Harwell, 31",MGI:5490380,Harwell ENU Mutagenesis,Gena31,MGI:3686741
Gena313,"Genetics Harwell, 313",MGI:5490358,Harwell ENU Mutagenesis,Gena313,MGI:5490328
Gena316,"Genetics Harwell, 316",MGI:5490359,Harwell ENU Mutagenesis,Gena316,MGI:5490310
Gena318,"Genetics Harwell, 318",MGI:5490361,Harwell ENU Mutagenesis,Gena318,MGI:5490316
Gena321,"Genetics Harwell, 321",MGI:5490104,Harwell ENU Mutagenesis,Gena321,MGI:3686739
Gena323,"Genetics Harwell, 323",MGI:5490362,Harwell ENU Mutagenesis,Gena323,MGI:5490308
Gena339,"Genetics Harwell, 339",MGI:5490105,Harwell ENU Mutagenesis,Gena339,MGI:3686735
Gena344,"Genetics Harwell, 344",MGI:5490363,Harwell ENU Mutagenesis,Gena344,MGI:5490306
Gena350,"Genetics Harwell, 350",MGI:5490382,Harwell ENU Mutagenesis,Gena350,MGI:3686731
Gena353,"Genetics Harwell, 353",MGI:5490367,Harwell ENU Mutagenesis,Gena353,MGI:5490304
Gena357,"Genetics Harwell, 357",MGI:5490368,Harwell ENU Mutagenesis,Gena357,MGI:5490302
Gena359,"Genetics Harwell, 359",MGI:5490369,Harwell ENU Mutagenesis,Gena359,MGI:5490312
Gena360,"Genetics Harwell, 360",MGI:5490106,Harwell ENU Mutagenesis,Gena360,MGI:3686729
Gena377,"Genetics Harwell, 377",MGI:5490371,Harwell ENU Mutagenesis,Gena377,MGI:5490298
Gena381,"Genetics Harwell, 381",MGI:5490372,Harwell ENU Mutagenesis,Gena381,MGI:5490334
Gena383,"Genetics Harwell, 383",MGI:4830603,Harwell ENU Mutagenesis,Gena383,MGI:3686727
Gena391,"Genetics Harwell, 391",MGI:5490107,Harwell ENU Mutagenesis,Gena391,MGI:3686725
Gena394,"Genetics Harwell, 394",MGI:5490374,Harwell ENU Mutagenesis,Gena394,MGI:5490336
Gena396,"Genetics Harwell, 396",MGI:5490375,Harwell ENU Mutagenesis,Gena396,MGI:5490296
Gena397,"Genetics Harwell, 397",MGI:5490378,Harwell ENU Mutagenesis,Gena397,MGI:5490295
Gena40,"Genetics Harwell, 40",MGI:5490111,Harwell ENU Mutagenesis,Gena40,MGI:3686723
Gena401,"Genetics Harwell, 401; Genetics, Harwell 401",MGI:2158382,Harwell ENU Mutagenesis,Gena401,MGI:5490283
Gena91,"Genetics Harwell, 91",MGI:5490112,Harwell ENU Mutagenesis,Gena91,MGI:3686721
Gfap<tm1a(EUCOMM)Wtsi>,"glial fibrillary acidic protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947813,EUCOMM,Gfap,MGI:95697
Gfi1<Gen>,growth factor independent 1 transcription repressor; Genista,MGI:4881336,0,Gfi1,MGI:103170
Gfi1b<tm1a(EUCOMM)Hmgu>,"growth factor independent 1B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434882,EUCOMM,Gfi1b,MGI:1276578
Gfm1<tm1a(EUCOMM)Wtsi>,"G elongation factor, mitochondrial 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432285,EUCOMM,Gfm1,MGI:107339
Gfod2<tm1a(EUCOMM)Hmgu>,"glucose-fructose oxidoreductase domain containing 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435083,EUCOMM,Gfod2,MGI:1917825
Gfpt1<tm1a(EUCOMM)Wtsi>,"glutamine fructose-6-phosphate transaminase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431600,EUCOMM,Gfpt1,MGI:95698
Gfpt2<tm1a(EUCOMM)Wtsi>,"glutamine fructose-6-phosphate transaminase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433591,EUCOMM,Gfpt2,MGI:1338883
Gfpt2<tm1b(EUCOMM)Wtsi>,"glutamine fructose-6-phosphate transaminase 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636966,EUCOMM,Gfpt2,MGI:1338883
Ggps1<tm1a(EUCOMM)Wtsi>,"geranylgeranyl diphosphate synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5000392,EUCOMM,Ggps1,MGI:1341724
Ggps1<tm1b(EUCOMM)Wtsi>,"geranylgeranyl diphosphate synthase 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548447,EUCOMM,Ggps1,MGI:1341724
Ggt1<tm1a(EUCOMM)Wtsi>,"gamma-glutamyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432621,EUCOMM,Ggt1,MGI:95706
Gif<tm1a(KOMP)Wtsi>,"cobalamin binding intrinsic factor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363945,KOMP-CSD,Cblif,MGI:1202394
Gimap6<tm1a(KOMP)Wtsi>,"GTPase, IMAP family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364125,KOMP-CSD,Gimap6,MGI:1918876
Git2<Gt(XG510)Byg>,"GIT ArfGAP 2; gene trap XG510, BayGenomics",MGI:3762635,0,Git2,MGI:1347053
Gja10<tm1Kwi>,"gap junction protein, alpha 10; targeted mutation 1, Klaus Willecke",MGI:3043946,0,Gja10,MGI:1339969
Gja10<tm2(HBEGF/EGFP)Kwi>,"gap junction protein, alpha 10; targeted mutation 2, Klaus Willecke",MGI:5433359,0,Gja10,MGI:1339969
Gja1<tm10Kwi>,"gap junction protein, alpha 1; targeted mutation 10, Klaus Willecke",MGI:5476936,0,Gja1,MGI:95713
Gja1<tm11.1Kwi>,"gap junction protein, alpha 1; targeted mutation 11.1, Klaus Willecke",MGI:5707851,0,Gja1,MGI:95713
Gja1<tm1Kwi>,"gap junction protein, alpha 1; targeted mutation 1, Klaus Willecke",MGI:2445468,0,Gja1,MGI:95713
Gja1<tm2(Gjb1)Kwi>,"gap junction protein, alpha 1; targeted mutation 2, Klaus Willecke",MGI:2386240,0,Gja1,MGI:95713
Gja1<tm4Kwi>,"gap junction protein, alpha 1; targeted mutation 4, Klaus Willecke",MGI:3525196,0,Gja1,MGI:95713
Gja1<tm5(cre/ERT)Kwi>,"gap junction protein, alpha 1; targeted mutation 5, Klaus Willecke",MGI:2676327,0,Gja1,MGI:95713
Gja1<tm6.2(Gjb3)Kwi>,"gap junction protein, alpha 1; targeted mutation 6.2, Klaus Willecke",MGI:5004864,0,Gja1,MGI:95713
Gja1<tm7(Gja2)Kwi>,"gap junction protein, alpha 1; targeted mutation 7, Klaus Willecke",MGI:3763136,0,Gja1,MGI:95713
Gja1<tm8Kwi>,"gap junction protein, alpha 1; targeted mutation 8, Klaus Willecke",MGI:3776013,0,Gja1,MGI:95713
Gja1<tm9.1Kwi>,"gap junction protein, alpha 1; targeted mutation 9.1, Klaus Willecke",MGI:5469488,0,Gja1,MGI:95713
Gja5<tm1Kwi>,"gap junction protein, alpha 5; targeted mutation 1, Klaus Willecke",MGI:2445238,0,Gja5,MGI:95716
Gja5<tm2.1Kwi>,"gap junction protein, alpha 5; targeted mutation 2.1, Klaus Willecke",MGI:5544269,0,Gja5,MGI:95716
Gja8<No2>,"gap junction protein, alpha 8; nuclear opacity 2",MGI:1857499,0,Gja8,MGI:99953
Gja8<tm1a(EUCOMM)Hmgu>,"gap junction protein, alpha 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435449,EUCOMM,Gja8,MGI:99953
Gjb1<tm1Kwi>,"gap junction protein, beta 1; targeted mutation 1, Klaus Willecke",MGI:1857927,0,Gjb1,MGI:95719
Gjb2<E119stop>,"gap junction protein, beta 2; Glu119stop",MGI:3056479,0,Gjb2,MGI:95720
Gjb2<I128V>,"gap junction protein, beta 2; Ile128Val",MGI:3056480,0,Gjb2,MGI:95720
Gjb2<tm1Kwi>,"gap junction protein, beta 2; targeted mutation 1, Klaus Willecke",MGI:2155739,0,Gjb2,MGI:95720
Gjb2<tm1Ugds>,"gap junction protein, beta 2; targeted mutation 1, Unite de Genetique des Deficits Sensoriels",MGI:2183509,0,Gjb2,MGI:95720
Gjb2<tm2.1Kwi>,"gap junction protein, beta 2; targeted mutation 2.1, Klaus Willecke",MGI:4867481,0,Gjb2,MGI:95720
Gjb3<tm1Kwi>,"gap junction protein, beta 3; targeted mutation 1, Klaus Willecke",MGI:2155738,0,Gjb3,MGI:95721
Gjb3<tm2.1Kwi>,"gap junction protein, beta 3; targeted mutation 2.1, Klaus Willecke",MGI:3711982,0,Gjb3,MGI:95721
Gjb4<tm1Kwi>,"gap junction protein, beta 4; targeted mutation 1, Klaus Willecke",MGI:3811558,0,Gjb4,MGI:95722
Gjb5<tm1Kwi>,"gap junction protein, beta 5; targeted mutation 1, Klaus Willecke",MGI:3769388,0,Gjb5,MGI:95723
Gjb6<tm1.1Fama>,"gap junction protein, beta 6; targeted mutation 1.1, Fabio Mammano",MGI:4848154,0,Gjb6,MGI:107588
Gjb6<tm1Kwi>,"gap junction protein, beta 6; targeted mutation 1, Klaus Willecke",MGI:2447863,0,Gjb6,MGI:107588
Gjb6<tm2.2Kwi>,"gap junction protein, beta 6; targeted mutation 2.2, Klaus Willecke",MGI:5607781,0,Gjb6,MGI:107588
Gjc1<tm1Kwi>,"gap junction protein, gamma 1; targeted mutation 1, Klaus Willecke",MGI:2386124,0,Gjc1,MGI:95718
Gjc1<tm1Weil>,"gap junction protein, gamma 1; targeted mutation 1, Reto Weiler",MGI:3530292,0,Gjc1,MGI:95718
Gjc2<tm1(EGFP)Kwi>,"gap junction protein, gamma 2; targeted mutation 1, Klaus Willecke",MGI:2664941,0,Gjc2,MGI:2153060
Gjc2<tm2.1Kwi>,"gap junction protein, gamma 2; targeted mutation 2.1, Klaus Willecke",MGI:5140116,0,Gjc2,MGI:2153060
Gjc3<tm1.1Kwi>,"gap junction protein, gamma 3; targeted mutation 1.1, Klaus Willecke",MGI:4420945,0,Gjc3,MGI:2153041
Gjd2<tm1Kwi>,"gap junction protein, delta 2; targeted mutation 1, Klaus Willecke",MGI:2388389,0,Gjd2,MGI:1334209
Gjd2<tm2Kwi>,"gap junction protein, delta 2; targeted mutation 2, Klaus Willecke",MGI:3579104,0,Gjd2,MGI:1334209
Gjd2<tm4Kwi>,"gap junction protein, delta 2; targeted mutation 4, Klaus Willecke",MGI:3835284,0,Gjd2,MGI:1334209
Gjd3<tm1.1Kwi>,"gap junction protein, delta 3; targeted mutation 1.1, Klaus Willecke",MGI:3624628,0,Gjd3,MGI:2384150
Gjd3<tm2.1Kwi>,"gap junction protein, delta 3; targeted mutation 2.1, Klaus Willecke",MGI:5544288,0,Gjd3,MGI:2384150
Gjd4<tm1.1Malt>,"gap junction protein, delta 4; targeted mutation 1.1, Julia von Maltzahn",MGI:5009133,0,Gjd4,MGI:2444990
Gje1<Mhdaaey12>,"gap junction protein, epsilon 1; Martin Hrabe de Angelis abnormal eyes 12",MGI:3529958,0,Gje1,MGI:1923993
Glce<tm1Jpli>,"glucuronyl C5-epimerase; targeted mutation 1, Jin-Ping Li",MGI:2670565,0,Glce,MGI:2136405
Gldc<tm1a(EUCOMM)Wtsi>,"glycine decarboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820272,EUCOMM,Gldc,MGI:1341155
Gle1<tm1a(EUCOMM)Wtsi>,"GLE1 RNA export mediator (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431602,EUCOMM,Gle1,MGI:1921662
Glg1<tm1a(KOMP)Wtsi>,"golgi apparatus protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364575,KOMP-CSD,Glg1,MGI:104967
Gli3<Xt>,GLI-Kruppel family member GLI3; extra toes,MGI:1856275,0,Gli3,MGI:95729
Glo1<tm1a(KOMP)Wtsi>,"glyoxalase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5285714,KOMP-CSD,Glo1,MGI:95742
Glp1r<tm1a(KOMP)Mbp>,"glucagon-like peptide 1 receptor; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4840757,KOMP-CSD,Glp1r,MGI:99571
Glra2<tm1a(KOMP)Wtsi>,"glycine receptor, alpha 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364480,KOMP-CSD,Glra2,MGI:95748
Glra4<tm1a(KOMP)Wtsi>,"glycine receptor, alpha 4 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363311,KOMP-CSD,Glra4,MGI:95750
Glra4<tm1b(KOMP)Wtsi>,,MGI:95750,,,
Glt8d2<tm1a(KOMP)Wtsi>,"glycosyltransferase 8 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364018,KOMP-CSD,Glt8d2,MGI:1922032
Gltp<tm1a(EUCOMM)Hmgu>,"glycolipid transfer protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434874,EUCOMM,Gltp,MGI:1929253
Glul<tm1a(KOMP)Wtsi>,"glutamate-ammonia ligase (glutamine synthetase); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820105,KOMP-CSD,Glul,MGI:95739
Gm12253<tm1a(KOMP)Wtsi>,"predicted gene 12253; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008795,KOMP-CSD,Gm12253,MGI:3651568
Gm12258<tm1a(EUCOMM)Hmgu>,"predicted gene 12258; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436398,EUCOMM,Gm12258,MGI:3651534
Gm13119<tm2a(KOMP)Wtsi>,"predicted gene 13119; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4454060,KOMP-CSD,Gm13119,MGI:3651680
Gm13119<tm2b(KOMP)Wtsi>,"predicted gene 13119; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637189,KOMP-CSD,Gm13119,MGI:3651680
Gm13128<tm1a(KOMP)Wtsi>,"predicted gene 13128; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419287,KOMP-CSD,Gm13128,MGI:3651261
Gm13547<tm1a(KOMP)Wtsi>,"predicted gene 13547; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419244,KOMP-CSD,Gm13547,MGI:3650473
Gm15440<tm1a(KOMP)Wtsi>,"predicted gene 15440; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4462605,KOMP-CSD,Gm15440,MGI:3642353
Gm16379<tm1a(KOMP)Wtsi>,"predicted pseudogene 16379; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364434,KOMP-CSD,Gm16379,MGI:3647120
Gm16432<tm1a(KOMP)Wtsi>,"catsper channel auxiliary subunit epsilon 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841221,KOMP-CSD,Catspere2,MGI:5589632
Gm16432<tm1b(KOMP)Wtsi>,"catsper channel auxiliary subunit epsilon 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5638574,KOMP-CSD,Catspere2,MGI:5589632
Gm5065<tm1a(KOMP)Wtsi>,"predicted gene 5065; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052422,KOMP-CSD,Gm5065,MGI:3643170
Gm5134<tm1a(EUCOMM)Hmgu>,"predicted gene 5134; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435240,EUCOMM,Gm5134,MGI:3646667
Gm5544<tm1a(KOMP)Wtsi>,"predicted gene 5544; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364386,KOMP-CSD,Gm5544,MGI:3648209
Gm648<tm1e(KOMP)Wtsi>,"predicted gene 648; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4364134,KOMP-CSD,Gm648,MGI:2685494
Gm6498<tm1a(KOMP)Wtsi>,"predicted gene 6498; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5299587,KOMP-CSD,Gm6498,MGI:3647773
Gm6578<tm1a(KOMP)Wtsi>,"predicted gene 6578; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455593,KOMP-CSD,Gm6578,MGI:3643037
Gm7489<tm1a(KOMP)Wtsi>,"predicted gene 7489; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841389,KOMP-CSD,Gm7489,MGI:3647008
Gmds<tm1a(KOMP)Wtsi>,"GDP-mannose 4, 6-dehydratase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363597,KOMP-CSD,Gmds,MGI:1891112
Gmfg<tm1a(EUCOMM)Hmgu>,"glia maturation factor, gamma; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434689,EUCOMM,Gmfg,MGI:1927135
Gmnc<tm1a(KOMP)Wtsi>,"geminin coiled-coil domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841069,KOMP-CSD,Gmnc,MGI:2685452
Gmnc<tm1b(KOMP)Wtsi>,"geminin coiled-coil domain containing; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637172,KOMP-CSD,Gmnc,MGI:2685452
Gmnn<tm1a(KOMP)Wtsi>,"geminin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363191,KOMP-CSD,Gmnn,MGI:1927344
Gna11<Mhdadsk7>,"guanine nucleotide binding protein, alpha 11; Martin Hrabe de Angelis dark skin 7",MGI:2682213,0,Gna11,MGI:95766
Gna11<tm1a(EUCOMM)Wtsi>,"guanine nucleotide binding protein, alpha 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432307,EUCOMM,Gna11,MGI:95766
Gnao1<tm1a(EUCOMM)Hmgu>,"guanine nucleotide binding protein, alpha O; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4456727,EUCOMM,Gnao1,MGI:95775
Gnaq<Mhdadsk10>,"guanine nucleotide binding protein, alpha q polypeptide; Martin Hrabe de Angelis dark skin 10",MGI:2681784,0,Gnaq,MGI:95776
Gnaq<Mhdadsk1>,"guanine nucleotide binding protein, alpha q polypeptide; Martin Hrabe de Angelis dark skin 1",MGI:2681766,0,Gnaq,MGI:95776
Gnaq<tm1Soff>,"guanine nucleotide binding protein, alpha q polypeptide; targeted mutation 1, Stefan Offermanns",MGI:2151661,0,Gnaq,MGI:95776
Gnas<tm2Kel>,"GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus; targeted mutation 2, Gavin Kelsey",MGI:3579575,0,Gnas,MGI:95777
Gnb1l<Gt(OST35527)Lex>,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like; gene trap OST35527, Lexicon Genetics",MGI:3530640,Lexicon,Gnb1l,MGI:1338057
Gnb3<tm1a(EUCOMM)Wtsi>,"guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4868086,EUCOMM,Gnb3,MGI:95785
Gnb3<tm1b(EUCOMM)Wtsi>,"guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637208,EUCOMM,Gnb3,MGI:95785
Gnptab<nym>,"N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits; Nymphe",MGI:5616922,0,Gnptab,MGI:3643902
Golga3<tm1a(EUCOMM)Hmgu>,"golgi autoantigen, golgin subfamily a, 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841643,EUCOMM,Golga3,MGI:96958
Golm1<Gt(EUC0047a08)Hmgu>,"golgi membrane protein 1; gene trap EUC0047a08, Helmholtz Zentrum Muenchen GmbH",MGI:5293703,0,Golm1,MGI:1917329
Golt1a<tm1a(KOMP)Wtsi>,"golgi transport 1A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458461,KOMP-CSD,Golt1a,MGI:1915588
Golt1b<tm1a(EUCOMM)Wtsi>,"golgi transport 1B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432110,EUCOMM,Golt1b,MGI:1914214
Gorasp1<tm1a(KOMP)Wtsi>,"golgi reassembly stacking protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014574,KOMP-CSD,Gorasp1,MGI:1921748
Gosr2<tm1a(EUCOMM)Hmgu>,"golgi SNAP receptor complex member 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4849382,EUCOMM,Gosr2,MGI:1927204
Gp1bb<tm1Frla>,"glycoprotein Ib, beta polypeptide; targeted mutation 1, Francois Lanza",MGI:3793296,0,Gp1bb,MGI:107852
Gp1bb<tm2Frla>,"glycoprotein Ib, beta polypeptide; targeted mutation 2, Francois Lanza",MGI:3793297,0,Gp1bb,MGI:107852
Gp5<tm1Cgh>,"glycoprotein 5 (platelet); targeted mutation 1, Shaun R Coughlin",MGI:3623935,0,Gp5,MGI:1096363
Gp6<tm2a(EUCOMM)Hmgu>,"glycoprotein 6 (platelet); targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511640,EUCOMM,Gp6,MGI:1889810
Gpat2<tm2a(KOMP)Wtsi>,"glycerol-3-phosphate acyltransferase 2, mitochondrial; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4881942,KOMP-CSD,Gpat2,MGI:2684962
Gpatch2l<tm1a(KOMP)Wtsi>,"G patch domain containing 2 like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362674,KOMP-CSD,Gpatch2l,MGI:1917623
Gpatch2l<tm1b(KOMP)Wtsi>,"G patch domain containing 2 like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5629318,KOMP-CSD,Gpatch2l,MGI:1917623
Gpatch8<tm1a(EUCOMM)Wtsi>,"G patch domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014717,EUCOMM,Gpatch8,MGI:1918667
Gpbp1<tm1a(EUCOMM)Wtsi>,"GC-rich promoter binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5006774,EUCOMM,Gpbp1,MGI:1920524
Gpbp1l1<tm1a(EUCOMM)Wtsi>,"GC-rich promoter binding protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460432,EUCOMM,Gpbp1l1,MGI:1924360
Gpc5<tm1a(KOMP)Wtsi>,"glypican 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455511,KOMP-CSD,Gpc5,MGI:1194894
Gpc6<tm2a(EUCOMM)Wtsi>,"glypican 6; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4453713,EUCOMM,Gpc6,MGI:1346322
Gphn<tm1Jrs>,"gephyrin; targeted mutation 1, Joshua R Sanes",MGI:2182559,0,Gphn,MGI:109602
Gpi1<a>,glucose phosphate isomerase 1; a variant,MGI:2177271,0,Gpi1,MGI:95797
Gpi1<b-m1Neu>,"glucose phosphate isomerase 1; mutant 1, Neuherberg",MGI:1857497,0,Gpi1,MGI:95797
Gpi1<b-m2Neu>,"glucose phosphate isomerase 1; mutant 2, Neuherberg",MGI:1857274,0,Gpi1,MGI:95797
Gpi1<b>,glucose phosphate isomerase 1; b variant,MGI:2177270,0,Gpi1,MGI:95797
Gpi1<c>,glucose phosphate isomerase 1; c variant,MGI:2177272,0,Gpi1,MGI:95797
Gpn2<tm1a(EUCOMM)Wtsi>,"GPN-loop GTPase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947823,EUCOMM,Gpn2,MGI:2140368
Gpr101<tm1a(KOMP)Mbp>,"G protein-coupled receptor 101; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4843636,KOMP-CSD,Gpr101,MGI:2685211
Gpr107<tm1a(KOMP)Wtsi>,"G protein-coupled receptor 107; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362797,KOMP-CSD,Gpr107,MGI:2139054
Gpr108<tm1a(EUCOMM)Hmgu>,"G protein-coupled receptor 108; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4942099,EUCOMM,Gpr108,MGI:1925558
Gpr137b<tm1a(KOMP)Wtsi>,"G protein-coupled receptor 137B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820052,KOMP-CSD,Gpr137b,MGI:1891463
Gpr143<tm1Inc>,"G protein-coupled receptor 143; targeted mutation 1, Barbara Incerti",MGI:1931862,0,Gpr143,MGI:107193
Gpr149<tm1Yab>,"G protein-coupled receptor 149; targeted mutation 1, Yves-Alain Barde",MGI:5473295,0,Gpr149,MGI:2443628
Gpr152<tm1a(EUCOMM)Wtsi>,"G protein-coupled receptor 152; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008027,EUCOMM,Gpr152,MGI:2685519
Gpr152<tm1b(EUCOMM)Wtsi>,"G protein-coupled receptor 152; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548871,EUCOMM,Gpr152,MGI:2685519
Gpr1<tm1a(EUCOMM)Hmgu>,"G protein-coupled receptor 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434954,EUCOMM,Gpr1,MGI:2385324
Gpr22<tm1a(KOMP)Wtsi>,"G protein-coupled receptor 22; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362775,KOMP-CSD,Gpr22,MGI:1920260
Gpr33<tm1a(EUCOMM)Hmgu>,"G protein-coupled receptor 33; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455795,EUCOMM,Gpr33,MGI:1277106
Gpr35<tm1a(EUCOMM)Hmgu>,"G protein-coupled receptor 35; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5520229,EUCOMM,Gpr35,MGI:1929509
Gpr35<tm1b(EUCOMM)Hmgu>,"G protein-coupled receptor 35; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5638567,EUCOMM,Gpr35,MGI:1929509
Gpr55<tm1Lex>,"G protein-coupled receptor 55; targeted mutation 1, Lexicon Genetics",MGI:3528724,Lexicon,Gpr55,MGI:2685064
Gpr87<tm1Lex>,"G protein-coupled receptor 87; targeted mutation 1, Lexicon Genetics",MGI:5428728,Lexicon,Gpr87,MGI:1934133
Gprc5b<tm1a(EUCOMM)Wtsi>,"G protein-coupled receptor, family C, group 5, member B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452803,EUCOMM,Gprc5b,MGI:1927596
Gpsm2<tm1a(EUCOMM)Wtsi>,"G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441912,EUCOMM,Gpsm2,MGI:1923373
Gpsm2<tm1b(EUCOMM)Wtsi>,"G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548664,EUCOMM,Gpsm2,MGI:1923373
Gpx3<tm1a(KOMP)Wtsi>,"glutathione peroxidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841147,KOMP-CSD,Gpx3,MGI:105102
Gpx4<tm1Marc>,"glutathione peroxidase 4; targeted mutation 1, Marcus Conrad",MGI:3589378,0,Gpx4,MGI:104767
Grb2<tm1a(EUCOMM)Wtsi>,"growth factor receptor bound protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432956,EUCOMM,Grb2,MGI:95805
Grb7<tm1a(EUCOMM)Wtsi>,"growth factor receptor bound protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453768,EUCOMM,Grb7,MGI:102683
Grb7<tm1b(EUCOMM)Wtsi>,"growth factor receptor bound protein 7; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636886,EUCOMM,Grb7,MGI:102683
Grem1<tm1Azun>,"gremlin 1, DAN family BMP antagonist; targeted mutation 1, Aimee Zuniga",MGI:3046937,0,Grem1,MGI:1344337
Grhl3<ct>,grainyhead like transcription factor 3; curly tail,MGI:1856837,0,Grhl3,MGI:2655333
Grhl3<tm1a(EUCOMM)Wtsi>,"grainyhead like transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433681,EUCOMM,Grhl3,MGI:2655333
Gria2<tm2Rsp>,"glutamate receptor, ionotropic, AMPA2 (alpha 2); targeted mutation 2, Rolf Sprengel",MGI:2178121,0,Gria2,MGI:95809
Gria2<tm3Rsp>,"glutamate receptor, ionotropic, AMPA2 (alpha 2); targeted mutation 3, Rolf Sprengel",MGI:3611335,0,Gria2,MGI:95809
Gria3<tm1Rsp>,"glutamate receptor, ionotropic, AMPA3 (alpha 3); targeted mutation 1, Rolf Sprengel",MGI:3611328,0,Gria3,MGI:95810
Grik4<tm1.1(cre)Slab>,"glutamate receptor, ionotropic, kainate 4; targeted mutation 1.1, Ralf Schoepfer",MGI:4398684,0,Grik4,MGI:95817
Grin1<tm1Phs>,"glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1, Peter H Seeburg",MGI:2178081,0,Grin1,MGI:95819
Grin1<tm1Rsp>,"glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1, Rolf Sprengel",MGI:3611337,0,Grin1,MGI:95819
Grin1<tm1Slab>,"glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1, Ralf Schoepfer",MGI:2655224,0,Grin1,MGI:95819
Grin1<tm1a(EUCOMM)Wtsi>,"glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432313,EUCOMM,Grin1,MGI:95819
Grin1<tm2Phs>,"glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 2, Peter H Seeburg",MGI:2178083,0,Grin1,MGI:95819
Grin1<tm2Slab>,"glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 2, Ralf Schoepfer",MGI:2655237,0,Grin1,MGI:95819
Grin2a<tm1Rsp>,"glutamate receptor, ionotropic, NMDA2A (epsilon 1); targeted mutation 1, Rolf Sprengel",MGI:1928287,0,Grin2a,MGI:95820
Grin2b<tm1Rsp>,"glutamate receptor, ionotropic, NMDA2B (epsilon 2); targeted mutation 1, Rolf Sprengel",MGI:1928293,0,Grin2b,MGI:95821
Grin2c<tm1Rsp>,"glutamate receptor, ionotropic, NMDA2C (epsilon 3); targeted mutation 1, Rolf Sprengel",MGI:1928514,0,Grin2c,MGI:95822
Grin2d<tm1a(EUCOMM)Wtsi>,"glutamate receptor, ionotropic, NMDA2D (epsilon 4); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432794,EUCOMM,Grin2d,MGI:95823
Grin3a<tm1a(EUCOMM)Hmgu>,"glutamate receptor ionotropic, NMDA3A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458762,EUCOMM,Grin3a,MGI:1933206
Grm1<tm1Dgen>,"glutamate receptor, metabotropic 1; targeted mutation 1, Deltagen",MGI:3604591,Deltagen,Grm1,MGI:1351338
Grm3<tm1a(KOMP)Wtsi>,"glutamate receptor, metabotropic 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820049,KOMP-CSD,Grm3,MGI:1351340
Grm4<tm1Dgen>,"glutamate receptor, metabotropic 4; targeted mutation 1, Deltagen",MGI:5427673,Deltagen,Grm4,MGI:1351341
Grm5<tm1Dgen>,"glutamate receptor, metabotropic 5; targeted mutation 1, Deltagen",MGI:5427674,Deltagen,Grm5,MGI:1351342
Grm6<tm1a(EUCOMM)Wtsi>,"glutamate receptor, metabotropic 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431613,EUCOMM,Grm6,MGI:1351343
Grm7<Tg(SMN2)89Ahmb>,"glutamate receptor, metabotropic 7; transgene insertion 89, Arthur H M Burghes",MGI:2448989,0,Grm7,MGI:1351344
Grm8<tm1Dgen>,"glutamate receptor, metabotropic 8; targeted mutation 1, Deltagen",MGI:5427675,Deltagen,Grm8,MGI:1351345
Grm8<tm2a(KOMP)Wtsi>,"glutamate receptor, metabotropic 8; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841284,KOMP-CSD,Grm8,MGI:1351345
Grpel2<tm1a(EUCOMM)Hmgu>,"GrpE-like 2, mitochondrial; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842035,EUCOMM,Grpel2,MGI:1334416
Grsf1<tm1a(EUCOMM)Wtsi>,"G-rich RNA sequence binding factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433076,EUCOMM,Grsf1,MGI:106479
Grsf1<tm1b(EUCOMM)Wtsi>,"G-rich RNA sequence binding factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636902,EUCOMM,Grsf1,MGI:106479
Grxcr1<pi-tde>,"glutaredoxin, cysteine rich 1; tasmanian devil",MGI:2681910,0,Grxcr1,MGI:3577767
Gsc<tm1Pgr>,"goosecoid homeobox; targeted mutation 1, Peter Gruss",MGI:1857496,0,Gsc,MGI:95841
Gsdma3<Fgn>,gasdermin A3; finnegan,MGI:2661437,0,Gsdma3,MGI:3044668
Gse1<tm1a(EUCOMM)Wtsi>,"genetic suppressor element 1, coiled-coil protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455973,EUCOMM,Gse1,MGI:1098275
Gsk3a<tm1a(EUCOMM)Hmgu>,"glycogen synthase kinase 3 alpha; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436696,EUCOMM,Gsk3a,MGI:2152453
Gsk3a<tm1a(EUCOMM)Wtsi>,"glycogen synthase kinase 3 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434136,EUCOMM,Gsk3a,MGI:2152453
Gsk3a<tm1b(EUCOMM)Hmgu>,,MGI:2152453,,,
Gsn<tm1Djk>,"gelsolin; targeted mutation 1, David J Kwiatkowski",MGI:2179509,0,Gsn,MGI:95851
Gsr<a1Neu>,"glutathione reductase; glutathione reductase 1, Neuherberg",MGI:1857772,0,Gsr,MGI:95804
Gsta3<tm1a(EUCOMM)Hmgu>,"glutathione S-transferase, alpha 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435234,EUCOMM,Gsta3,MGI:95856
Gsta4<tm1a(EUCOMM)Hmgu>,"glutathione S-transferase, alpha 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5013788,EUCOMM,Gsta4,MGI:1309515
Gsta4<tm1b(EUCOMM)Hmgu>,"glutathione S-transferase, alpha 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5629310,EUCOMM,Gsta4,MGI:1309515
Gstm6<tm1a(EUCOMM)Hmgu>,"glutathione S-transferase, mu 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5287849,EUCOMM,Gstm6,MGI:1309467
Gstm6<tm1b(EUCOMM)Hmgu>,,MGI:1309467,,,
Gsto2<tm2a(KOMP)Wtsi>,"glutathione S-transferase omega 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840928,KOMP-CSD,Gsto2,MGI:1915464
Gstt1<tm1a(EUCOMM)Hmgu>,"glutathione S-transferase, theta 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435247,EUCOMM,Gstt1,MGI:107379
Gstz1<tm1Jmfc>,"glutathione transferase zeta 1 (maleylacetoacetate isomerase); targeted mutation 1, Jose Manuel Fernandez-Canon",MGI:2183286,0,Gstz1,MGI:1341859
"Gt(ROSA)26Sor<tm1(ACTB-cre,-EGFP)Ics>","gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Mouse Clinical Institute",MGI:5285392,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(CAG-ECFP/EYFP*)Phep>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Paul A Heppenstall",MGI:5573198,0,Gt(ROSA)26Sor,MGI:104735
"Gt(ROSA)26Sor<tm1(CAG-Venus/GMNN,Cherry/CDT1)Jkn>","gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Ian Jackson",MGI:5645798,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(CAG-mCherry/GFP)Ganl>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Ian Ganley",MGI:5817670,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(CAG-mCherry/Rpl10a)Sten>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Jan M Stenman",MGI:5569759,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(EYFP)Cos>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Frank Costantini",MGI:2449038,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(FLP1)Dym>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Susan Dymecki",MGI:2429412,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(HBEGF)Awai>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Ari Waisman",MGI:3772576,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(LDLR/avidin)Svo>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Seppo Vainio",MGI:5438799,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(Tva)Dsa>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Dieter Saur",MGI:3814188,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(cre/ERT)Brn>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Anton Berns",MGI:2445311,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1(rtTA*M2)Jae>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Rudolf Jaenisch",MGI:3702294,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1.1(CAG-cre)Jphe>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1.1, Jean-Paul Herman",MGI:3789474,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1.1(Otx2)Daac>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1.1, Dario Acampora",MGI:4887449,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm11(CAG-Braf*/ERT2)Rkuhn>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 11, Ralf Kuhn",MGI:5503124,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1Afst>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, A Francis Stewart",MGI:4367459,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1Coll>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, William Colledge",MGI:5429346,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1Hjf>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Hans Jorg Fehling",MGI:3696099,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm1Sor>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Philippe Soriano",MGI:1861932,0,Gt(ROSA)26Sor,MGI:104735
"Gt(ROSA)26Sor<tm2(CAG-flpo,-EYFP)Ics>","gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Mouse Clinical Institute",MGI:5285396,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm2(ECFP)Cos>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Frank Costantini",MGI:2449039,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm2(SNAPCaaX)Phep>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Paul A Heppenstall",MGI:5645795,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm2(cre/ERT2)Brn>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Anton Berns",MGI:3764519,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm2(icre/ERT2)Jphe>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Jean-Paul Herman",MGI:3793441,0,Gt(ROSA)26Sor,MGI:104735
Gt(ROSA)26Sor<tm9(cre/ESR1)Arte>,"gene trap ROSA 26, Philippe Soriano; targeted mutation 9, TaconicArtemis",MGI:3763211,0,Gt(ROSA)26Sor,MGI:104735
Gtf2a1<tm1a(KOMP)Wtsi>,"general transcription factor II A, 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363802,KOMP-CSD,Gtf2a1,MGI:1933277
Gtf2a2<tm1a(KOMP)Wtsi>,"general transcription factor II A, 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5085353,KOMP-CSD,Gtf2a2,MGI:1933289
Gtf2e2<tm1a(EUCOMM)Wtsi>,"general transcription factor II E, polypeptide 2 (beta subunit); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008024,EUCOMM,Gtf2e2,MGI:1915403
Gtf2h2<tm1a(EUCOMM)Wtsi>,"general transcription factor II H, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432932,EUCOMM,Gtf2h2,MGI:1345669
Gtf2i<tm1Vcam>,"general transcription factor II I; targeted mutation 1, Victoria Campuzano",MGI:5532204,0,Gtf2i,MGI:1202722
Gtf3a<tm1a(KOMP)Wtsi>,"general transcription factor III A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5307107,KOMP-CSD,Gtf3a,MGI:1913846
Gtf3c5<tm2a(KOMP)Wtsi>,"general transcription factor IIIC, polypeptide 5; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4362662,KOMP-CSD,Gtf3c5,MGI:1917489
Gtf3c6<tm1a(EUCOMM)Wtsi>,"general transcription factor IIIC, polypeptide 6, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434292,EUCOMM,Gtf3c6,MGI:1914621
Gtpbp3<tm1a(KOMP)Wtsi>,"GTP binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364401,KOMP-CSD,Gtpbp3,MGI:1917609
Gulo<tm1Mae>,"gulonolactone (L-) oxidase; targeted mutation 1, Nobuyo Maeda",MGI:2158350,0,Gulo,MGI:1353434
Gys2<tm1a(KOMP)Wtsi>,"glycogen synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364592,KOMP-CSD,Gys2,MGI:2385254
Gzmb<tm1Asmv>,"granzyme B; targeted mutation 1, Anne-Marie Schmitt-Verhulst",MGI:5532521,0,Gzmb,MGI:109267
Gzmk<tm1a(KOMP)Wtsi>,"granzyme K; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362377,KOMP-CSD,Gzmk,MGI:1298232
H13<tm1a(KOMP)Wtsi>,"histocompatibility 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5296546,KOMP-CSD,H13,MGI:95886
H19<tm1Lda>,"H19, imprinted maternally expressed transcript; targeted mutation 1, Luisa Dandolo",MGI:1860792,0,H19,MGI:95891
H2-Aa<tm1Blt>,"histocompatibility 2, class II antigen A, alpha; targeted mutation 1, Horst Bluethmann",MGI:2157977,0,H2-Aa,MGI:95895
H2-Ab1<tm1Doi>,"histocompatibility 2, class II antigen A, beta 1; targeted mutation 1, Christophe Benoist and Diane Mathis",MGI:1927483,0,H2-Ab1,MGI:103070
H2-D1<tm1Bpe>,"histocompatibility 2, D region locus 1; targeted mutation 1, Beatrice Perarnau",MGI:1931445,0,H2-D1,MGI:95896
H2-Eb1<tm1a(KOMP)Wtsi>,"histocompatibility 2, class II antigen E beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5297122,KOMP-CSD,H2-Eb1,MGI:95901
H2-K1<tm1Bpe>,"histocompatibility 2, K1, K region; targeted mutation 1, Beatrice Perarnau",MGI:1931444,0,H2-K1,MGI:95904
H2-M5<tm1(KOMP)Wtsi>,"histocompatibility 2, M region locus 5; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4420089,KOMP-CSD,H2-M5,MGI:95917
H2<b>,"histocompatibility-2, MHC; b variant",MGI:3579319,0,H2,MGI:95894
H2<d>,"histocompatibility-2, MHC; d variant",MGI:3579320,0,H2,MGI:95894
H2<k>,"histocompatibility-2, MHC; k variant",MGI:3579322,0,H2,MGI:95894
H2afx<tm1Nus>,"H2A histone family, member X; targeted mutation 1, Andre Nussenzweig",MGI:2156048,0,H2afx,MGI:102688
H6pd<tm1a(EUCOMM)Wtsi>,"hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432827,EUCOMM,H6pd,MGI:2140356
Hace1<tm1a(KOMP)Wtsi>,"HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840984,KOMP-CSD,Hace1,MGI:2446110
Hacl1<tm1a(KOMP)Wtsi>,"2-hydroxyacyl-CoA lyase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362181,KOMP-CSD,Hacl1,MGI:1929657
Hal<his>,histidine ammonia lyase; histidinemia,MGI:1856300,0,Hal,MGI:96010
Has1<tm1a(KOMP)Wtsi>,"hyaluronan synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419868,KOMP-CSD,Has1,MGI:106590
Haus5<tm1a(EUCOMM)Wtsi>,"HAUS augmin-like complex, subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5006767,EUCOMM,Haus5,MGI:1919159
Hbp1<Gt(EUCJ0053g09)Hmgu>,"high mobility group box transcription factor 1; gene trap EUCJ0053g09, Helmholtz Zentrum Muenchen GmbH",MGI:5293702,0,Hbp1,MGI:894659
Hbs1l<tm1a(KOMP)Wtsi>,"Hbs1-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887599,KOMP-CSD,Hbs1l,MGI:1891704
Hc<1>,hemolytic complement; sufficient,MGI:3044820,0,Hc,MGI:96031
Hcn4<tm1a(EUCOMM)Hmgu>,"hyperpolarization-activated, cyclic nucleotide-gated K+ 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435096,EUCOMM,Hcn4,MGI:1298209
Hcrtr2<tm1e(KOMP)Wtsi>,"hypocretin (orexin) receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4456664,KOMP-CSD,Hcrtr2,MGI:2680765
Hdac1<tm1a(EUCOMM)Wtsi>,"histone deacetylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431918,EUCOMM,Hdac1,MGI:108086
Hdac3<tm1a(EUCOMM)Wtsi>,"histone deacetylase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433408,EUCOMM,Hdac3,MGI:1343091
Hdac8<tm1a(EUCOMM)Wtsi>,"histone deacetylase 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432268,EUCOMM,Hdac8,MGI:1917565
Heatr3<tm1a(EUCOMM)Hmgu>,"HEAT repeat containing 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435825,EUCOMM,Heatr3,MGI:2444491
Heatr6<tm1a(KOMP)Wtsi>,"HEAT repeat containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364452,KOMP-CSD,Heatr6,MGI:1919790
Hecw2<tm1a(EUCOMM)Wtsi>,"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441860,EUCOMM,Hecw2,MGI:2685817
Hells<tm1a(EUCOMM)Wtsi>,"helicase, lymphoid specific; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431905,EUCOMM,Hells,MGI:106209
Hells<tm1b(EUCOMM)Wtsi>,"helicase, lymphoid specific; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548365,EUCOMM,Hells,MGI:106209
Heph<Sla>,hephaestin; dominant sex linked anemia,MGI:1862022,0,Heph,MGI:1332240
Herc3<tm1a(EUCOMM)Wtsi>,"hect domain and RLD 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434045,EUCOMM,Herc3,MGI:1921248
Hgd<aku-Yah>,"homogentisate 1, 2-dioxygenase; alkaptonuria Yann Herault",MGI:5829459,0,Hgd,MGI:96078
Hgd<aku>,"homogentisate 1, 2-dioxygenase; alkaptonuria",MGI:1856664,0,Hgd,MGI:96078
Hgs<tm1a(EUCOMM)Wtsi>,"HGF-regulated tyrosine kinase substrate; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431739,EUCOMM,Hgs,MGI:104681
Hgs<tm1b(EUCOMM)Wtsi>,,MGI:104681,,,
Hhipl1<tm1a(KOMP)Wtsi>,"hedgehog interacting protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451243,KOMP-CSD,Hhipl1,MGI:1919265
Hibadh<tm1a(EUCOMM)Wtsi>,"3-hydroxyisobutyrate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014686,EUCOMM,Hibadh,MGI:1889802
Hibadh<tm1b(EUCOMM)Wtsi>,"3-hydroxyisobutyrate dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637002,EUCOMM,Hibadh,MGI:1889802
Hic1<tm1.1Kori>,"hypermethylated in cancer 1; targeted mutation 1.1, Vladimir Korinek",MGI:4946618,0,Hic1,MGI:1338010
Hic1<tm2.1Kori>,"hypermethylated in cancer 1; targeted mutation 2.1, Vladimir Korinek",MGI:4946620,0,Hic1,MGI:1338010
Hint1<tm1Ibw>,"histidine triad nucleotide binding protein 1; targeted mutation 1, I Bernard Weinstein",MGI:2674018,0,Hint1,MGI:1321133
Hint1<tm1a(EUCOMM)Wtsi>,"histidine triad nucleotide binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433692,EUCOMM,Hint1,MGI:1321133
Hipk1<tm1Mak>,"homeodomain interacting protein kinase 1; targeted mutation 1, Tak Wah Mak",MGI:3584135,0,Hipk1,MGI:1314873
Hipk2<tm2a(EUCOMM)Hmgu>,"homeodomain interacting protein kinase 2; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4435696,EUCOMM,Hipk2,MGI:1314872
Hipk3<tm1a(EUCOMM)Hmgu>,"homeodomain interacting protein kinase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5289889,EUCOMM,Hipk3,MGI:1314882
Hipk3<tm1b(EUCOMM)Hmgu>,"homeodomain interacting protein kinase 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588270,EUCOMM,Hipk3,MGI:1314882
Hira<tm1a(EUCOMM)Wtsi>,"histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431679,EUCOMM,Hira,MGI:99430
Hk2<tm1.1Uku>,"hexokinase 2; targeted mutation 1.1, University of Kuopio",MGI:5320615,0,Hk2,MGI:1315197
Hk2<tm1Laak>,"hexokinase 2; targeted mutation 1, Markku Laakso",MGI:3624862,0,Hk2,MGI:1315197
Hlf<tm1Schb>,"hepatic leukemia factor; targeted mutation 1, Ueli Schibler",MGI:3045480,0,Hlf,MGI:96108
Hmgcr<Gt(A005H04)Wrst>,"3-hydroxy-3-methylglutaryl-Coenzyme A reductase; gene trap A005H04, German Gene Trap Consortium",MGI:4122667,0,Hmgcr,MGI:96159
Hmgxb3<tm1a(EUCOMM)Wtsi>,"HMG box domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460446,EUCOMM,Hmgxb3,MGI:2441817
Hmox1<tm1.1Gkl>,"heme oxygenase 1; targeted mutation 1.1, George Kollias",MGI:3526228,0,Hmox1,MGI:96163
Hmox1<tm1.2Gkl>,"heme oxygenase 1; targeted mutation 1.2, George Kollias",MGI:3846093,0,Hmox1,MGI:96163
Hmox2<tm1a(EUCOMM)Hmgu>,"heme oxygenase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434868,EUCOMM,Hmox2,MGI:109373
Hnf1b<tm1Sce>,"HNF1 homeobox B; targeted mutation 1, Silvia Cereghini",MGI:1857856,0,Hnf1b,MGI:98505
Hnf4a<tm1(cre)Sdv>,"hepatic nuclear factor 4, alpha; targeted mutation 1, Stephane D Vincent",MGI:3052820,0,Hnf4a,MGI:109128
Hnf4a<tm1a(EUCOMM)Hmgu>,"hepatic nuclear factor 4, alpha; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455726,EUCOMM,Hnf4a,MGI:109128
Hnf4a<tm1b(EUCOMM)Hmgu>,"hepatic nuclear factor 4, alpha; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613635,EUCOMM,Hnf4a,MGI:109128
Hnrnpll<thdr>,heterogeneous nuclear ribonucleoprotein L-like; thunder,MGI:3707008,APF ENU Mutagenesis,Hnrnpll,MGI:1919942
Hnrnpr<tm1a(EUCOMM)Wtsi>,"heterogeneous nuclear ribonucleoprotein R; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820294,EUCOMM,Hnrnpr,MGI:1891692
Homez<tm1e(KOMP)Wtsi>,"homeodomain leucine zipper-encoding gene; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4944412,KOMP-CSD,Homez,MGI:2678023
Hoxa2<tm1b(EUCOMM)Wtsi>,"homeobox A2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613670,EUCOMM,Hoxa2,MGI:96174
Hoxb1<m1Mhda>,"homeobox B1; mutation 1, Martin Hrabe de Angelis",MGI:5818739,0,Hoxb1,MGI:96182
Hoxb1<tm1.1Mist>,"homeobox B1; targeted mutation 1.1, Michele Studer",MGI:5287678,0,Hoxb1,MGI:96182
Hoxb1<tm1Mist>,"homeobox B1; targeted mutation 1, Michele Studer",MGI:5287653,0,Hoxb1,MGI:96182
Hoxb3<tm1.1Karl>,"homeobox B3; targeted mutation 1.1, Stefan Karlsson",MGI:5320447,0,Hoxb3,MGI:96184
Hoxb4<tm1.1Karl>,"homeobox B4; targeted mutation 1.1, Stefan Karlsson",MGI:3045971,0,Hoxb4,MGI:96185
Hoxb4<tm1Karl>,"homeobox B4; targeted mutation 1, Stefan Karlsson",MGI:3045970,0,Hoxb4,MGI:96185
Hoxb4<tm2.1Karl>,"homeobox B4; targeted mutation 2.1, Stefan Karlsson",MGI:5320448,0,Hoxb4,MGI:96185
Hoxd12<tm2Ddu>,"homeobox D12; targeted mutation 2, Denis Duboule",MGI:2177960,0,Hoxd12,MGI:96204
Hoxd13<Dyc>,homeobox D13; digit in Y-shaped finger and carpe,MGI:4361275,0,Hoxd13,MGI:96205
Hp1bp3<tm1a(EUCOMM)Wtsi>,"heterochromatin protein 1, binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432659,EUCOMM,Hp1bp3,MGI:109369
Hprt<tm1(CMV-cre)Wtsi>,"hypoxanthine guanine phosphoribosyl transferase; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:5496382,0,Hprt,MGI:96217
Hprt<tm1(Cd68-BCL2)Ple>,"hypoxanthine guanine phosphoribosyl transferase; targeted mutation 1, Philippe Lesnik",MGI:5475555,0,Hprt,MGI:96217
Hprt<tm1a(EUCOMM)Hmgu>,"hypoxanthine guanine phosphoribosyl transferase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435169,EUCOMM,Hprt,MGI:96217
Hprt<tm2Brd>,"hypoxanthine guanine phosphoribosyl transferase; targeted mutation 2, Allan Bradley",MGI:3776895,0,Hprt,MGI:96217
Hps3<tm2a(KOMP)Wtsi>,"HPS3, biogenesis of lysosomal organelles complex 2 subunit 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5308292,KOMP-CSD,Hps3,MGI:2153839
Hr<hr-2Pas>,lysine demethylase and nuclear receptor corepressor; hairless 2 Institut Pasteur,MGI:5289957,0,Hr,MGI:96223
Hras<tm2Xbr>,"Harvey rat sarcoma virus oncogene; targeted mutation 2, Xose R Bustelo",MGI:3803587,0,Hras,MGI:96224
Hsd17b12<Gt(A030E06)Wrst>,"hydroxysteroid (17-beta) dehydrogenase 12; gene trap A030E06, German Gene Trap Consortium",MGI:4122956,0,Hsd17b12,MGI:1926967
Hsd17b4<tm1Baes>,"hydroxysteroid (17-beta) dehydrogenase 4; targeted mutation 1, Myriam Baes",MGI:2385822,0,Hsd17b4,MGI:105089
Hsdl1<tm1a(EUCOMM)Wtsi>,"hydroxysteroid dehydrogenase like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5003009,EUCOMM,Hsdl1,MGI:1919802
Hsf2<tm1Mmr>,"heat shock factor 2; targeted mutation 1, Michel Morange",MGI:2182620,0,Hsf2,MGI:96239
Hsf2bp<tm1a(EUCOMM)Hmgu>,"heat shock transcription factor 2 binding protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435082,EUCOMM,Hsf2bp,MGI:1921627
Hsf2bp<tm1b(EUCOMM)Hmgu>,"heat shock transcription factor 2 binding protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548644,EUCOMM,Hsf2bp,MGI:1921627
Hsp90aa1<tm1(KOMP)Wtsi>,"heat shock protein 90, alpha (cytosolic), class A member 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4364475,KOMP-CSD,Hsp90aa1,MGI:96250
Hsp90ab1<Gt(pGT1.8geo)1Pgr>,"heat shock protein 90 alpha (cytosolic), class B member 1; gene trap 1, Peter Gruss",MGI:1857893,0,Hsp90ab1,MGI:96247
Hspa13<tm1Yah>,"heat shock protein 70 family, member 13; targeted mutation 1, Yann Herault",MGI:5648818,0,Hspa13,MGI:1309463
Hspb11<tm1a(EUCOMM)Wtsi>,"heat shock protein family B (small), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432759,EUCOMM,Hspb11,MGI:1920188
Hspg2<Gt(XST097)Byg>,"perlecan (heparan sulfate proteoglycan 2); gene trap XST097, BayGenomics",MGI:4124542,0,Hspg2,MGI:96257
Hspg2<tm1Soin>,"perlecan (heparan sulfate proteoglycan 2); targeted mutation 1, Raija Soininen",MGI:2449915,0,Hspg2,MGI:96257
Hsph1<tm1a(EUCOMM)Wtsi>,"heat shock 105kDa/110kDa protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431540,EUCOMM,Hsph1,MGI:105053
Htr1a<tm2Rhn>,"5-hydroxytryptamine (serotonin) receptor 1A; targeted mutation 2, Rene Hen",MGI:2387416,0,Htr1a,MGI:96273
Htr1b<tm1Rhn>,"5-hydroxytryptamine (serotonin) receptor 1B; targeted mutation 1, Rene Hen",MGI:2653030,0,Htr1b,MGI:96274
Htr2b<tm1Lum>,"5-hydroxytryptamine (serotonin) receptor 2B; targeted mutation 1, Luc Maroteaux",MGI:1888735,0,Htr2b,MGI:109323
Hunk<tm1a(EUCOMM)Wtsi>,"hormonally upregulated Neu-associated kinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050999,EUCOMM,Hunk,MGI:1347352
Hunk<tm1b(EUCOMM)Wtsi>,"hormonally upregulated Neu-associated kinase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613639,EUCOMM,Hunk,MGI:1347352
Iah1<tm1a(EUCOMM)Hmgu>,"isoamyl acetate-hydrolyzing esterase 1 homolog; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435023,EUCOMM,Iah1,MGI:1914982
Iapp<tm1Sgm>,"islet amyloid polypeptide; targeted mutation 1, Samuel Gebre-Medhin",MGI:2656235,0,Iapp,MGI:96382
Ibsp<tm1e(EUCOMM)Wtsi>,"integrin binding sialoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4434523,EUCOMM,Ibsp,MGI:96389
Icos<tm2a(EUCOMM)Wtsi>,"inducible T cell co-stimulator; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5473109,EUCOMM,Icos,MGI:1858745
Idd16<C57BL/6J>,insulin dependent diabetes susceptibility 16; C57BL/6J,MGI:3525333,0,Idd16,MGI:107544
Idd1<C57BL/6>,insulin dependent diabetes susceptibility 1; C57BL/6,MGI:3037294,0,Idd1,MGI:96400
Idd23<C57BL/6J>,insulin dependent diabetes susceptibility 23; C57BL/6J,MGI:3525335,0,Idd23,MGI:3525329
Idd5.1<C57BL/6J>,insulin dependent diabetes susceptibility 5.1; C57BL/6J,MGI:2158432,0,Idd5.1,MGI:2158421
Idd5<C57BL/6>,insulin dependent diabetes susceptibility 5; C57BL/6,MGI:3037292,0,Idd5,MGI:96407
Idd6<C57BL/6>,insulin dependent diabetes susceptibility 6; C57BL/6,MGI:3036668,0,Idd6,MGI:96408
Ide<tm1a(EUCOMM)Wtsi>,"insulin degrading enzyme; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431946,EUCOMM,Ide,MGI:96412
Idnk<tm1Lex>,"idnK gluconokinase homolog (E. coli); targeted mutaion 1, Lexicon Genetics",MGI:5429894,Lexicon,Idnk,MGI:1922981
Ido1<tm1a(EUCOMM)Wtsi>,"indoleamine 2,3-dioxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432044,EUCOMM,Ido1,MGI:96416
Ido2<tm3a(EUCOMM)Wtsi>,"indoleamine 2,3-dioxygenase 2; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:5002991,EUCOMM,Ido2,MGI:2142489
Ifi27<tm1a(EUCOMM)Wtsi>,"interferon, alpha-inducible protein 27; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050993,EUCOMM,Ifi27,MGI:1277180
Ifi27<tm1b(EUCOMM)Wtsi>,"interferon, alpha-inducible protein 27; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636940,EUCOMM,Ifi27,MGI:1277180
Ifitm1<Gt(OST471536)Lex>,"interferon induced transmembrane protein 1; gene trap OST471536, Lexicon Genetics",MGI:4328297,Lexicon,Ifitm1,MGI:1915963
Ifitm1<tm1.1Ieg>,"interferon induced transmembrane protein 1; targeted mutation 1.1, Institute of Experimental Genetics",MGI:5465441,0,Ifitm1,MGI:1915963
Ifitm1<tm1a(EUCOMM)Wtsi>,"interferon induced transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432260,EUCOMM,Ifitm1,MGI:1915963
Ifitm3<tm1Masu>,"interferon induced transmembrane protein 3; targeted mutation 1, M Azim Surani",MGI:3803977,0,Ifitm3,MGI:1913391
Ifitm6<tm1a(EUCOMM)Wtsi>,"interferon induced transmembrane protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433041,EUCOMM,Ifitm6,MGI:2686976
Ifitm6<tm1b(EUCOMM)Wtsi>,"interferon induced transmembrane protein 6; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5638572,EUCOMM,Ifitm6,MGI:2686976
Ifnar1<tm1Agt>,"interferon (alpha and beta) receptor 1; targeted mutation 1, Michel Aguet",MGI:1930950,0,Ifnar1,MGI:107658
Ifnar1<tm2a(EUCOMM)Wtsi>,"interferon (alpha and beta) receptor 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527593,EUCOMM,Ifnar1,MGI:107658
Ifng<tm1Ts>,"interferon gamma; targeted mutation 1, Timothy Stewart",MGI:1857184,0,Ifng,MGI:107656
Ifnlr1<tm1a(EUCOMM)Wtsi>,"interferon lambda receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5527612,EUCOMM,Ifnlr1,MGI:2429859
Ift122<tm1a(EUCOMM)Wtsi>,"intraflagellar transport 122; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432086,EUCOMM,Ift122,MGI:1932386
Ift140<tm1a(KOMP)Wtsi>,"intraflagellar transport 140; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363217,KOMP-CSD,Ift140,MGI:2146906
Ift20<tm1a(EUCOMM)Wtsi>,"intraflagellar transport 20; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431815,EUCOMM,Ift20,MGI:1915585
Ift80<tm1a(KOMP)Wtsi>,"intraflagellar transport 80; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419694,KOMP-CSD,Ift80,MGI:1915509
Ift81<tm1a(EUCOMM)Wtsi>,"intraflagellar transport 81; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433881,EUCOMM,Ift81,MGI:1098597
Ift81<tm1b(EUCOMM)Wtsi>,"intraflagellar transport 81; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636927,EUCOMM,Ift81,MGI:1098597
Igf1r<tm1.2Mhz>,"insulin-like growth factor I receptor; targeted mutation 1.2, Martin Holzenberger",MGI:2386329,0,Igf1r,MGI:96433
Igf1r<tm1Lex>,"insulin-like growth factor I receptor; targeted mutation 1, Lexicon Genetics",MGI:3529204,Lexicon,Igf1r,MGI:96433
Igf2<tm4.1Wrk>,"insulin-like growth factor 2; targeted mutation 4.1, Wolf Reik",MGI:5310741,0,Igf2,MGI:96434
Igf2<tm4Wrk>,"insulin-like growth factor 2; targeted mutation 4, Wolf Reik",MGI:5309176,0,Igf2,MGI:96434
Igf2r<tm2Wag>,"insulin-like growth factor 2 receptor; targeted mutation 2, Erwin F Wagner",MGI:2445841,0,Igf2r,MGI:96435
Igfbp3<tm1a(KOMP)Wtsi>,"insulin-like growth factor binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363852,KOMP-CSD,Igfbp3,MGI:96438
Igfbp3<tm1b(KOMP)Wtsi>,"insulin-like growth factor binding protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548945,KOMP-CSD,Igfbp3,MGI:96438
Igh-8<tm1Aak>,"immunoglobulin heavy chain 8 (heavy chain of IgG3); targeted mutation 1, Ahmed Amine Khamlichi",MGI:3622072,0,Igh-8,MGI:96450
Igh-8<tm2(Ighg1)Aak>,"immunoglobulin heavy chain 8 (heavy chain of IgG3); targeted mutation 2, Ahmed Amine Khamlichi",MGI:3774279,0,Igh-8,MGI:96450
Igh-8<tm2.1Aak>,"immunoglobulin heavy chain 8 (heavy chain of IgG3); targeted mutation 2.1, Ahmed Khamlichi",MGI:4950363,0,Igh-8,MGI:96450
Igh-J<tm1Cgn>,"immunoglobulin heavy chain, joining region; targeted mutation 1, University of Cologne",MGI:1861941,0,Igh-J,MGI:96461
Igh<tm2Cog>,"immunoglobulin heavy chain complex; targeted mutation 2, Michel Cogne",MGI:3045811,0,Igh,MGI:96442
Igh<tm3.1Cog>,"immunoglobulin heavy chain complex; targeted mutation 3.1, Michel Cogne",MGI:3522204,0,Igh,MGI:96442
Igh<tm5.1Cog>,"immunoglobulin heavy chain complex; targeted mutation 5.1, Michel Cogne",MGI:4836663,0,Igh,MGI:96442
Ighm<tm1.1Aak>,"immunoglobulin heavy constant mu; targeted mutation 1.1, Ahmed Khamlichi",MGI:4950361,0,Ighm,MGI:96448
Ighm<tm1Cgn>,"immunoglobulin heavy constant mu; targeted mutation 1, University of Cologne",MGI:1857187,0,Ighm,MGI:96448
Ikbkb<tm1a(EUCOMM)Wtsi>,"inhibitor of kappaB kinase beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432305,EUCOMM,Ikbkb,MGI:1338071
Ikbkb<tm2Cgn>,"inhibitor of kappaB kinase beta; targeted mutation 2, University of Cologne",MGI:2652651,0,Ikbkb,MGI:1338071
Ikbke<tm1b(EUCOMM)Wtsi>,,MGI:1929612,,,
Ikbkg<tm1.1Mpa>,"inhibitor of kappaB kinase gamma; targeted mutation 1.1, Manolis Pasparakis",MGI:2679024,0,Ikbkg,MGI:1338074
Ikbkg<tm1Mak>,"inhibitor of kappaB kinase gamma; targeted mutation 1, Tak Mak",MGI:2386267,0,Ikbkg,MGI:1338074
Ikzf1<plstc>,IKAROS family zinc finger 1; plastic,MGI:2669987,APF ENU Mutagenesis,Ikzf1,MGI:1342540
Il10<tm1Cgn>,"interleukin 10; targeted mutation 1, University of Cologne",MGI:1857199,0,Il10,MGI:96537
Il10<tm1a(EUCOMM)Wtsi>,"interleukin 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432290,EUCOMM,Il10,MGI:96537
Il10ra<tm1a(KOMP)Wtsi>,"interleukin 10 receptor, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5307099,KOMP-CSD,Il10ra,MGI:96538
Il10rb<tm1a(KOMP)Wtsi>,"interleukin 10 receptor, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364200,KOMP-CSD,Il10rb,MGI:109380
Il12a<tm1a(EUCOMM)Hmgu>,"interleukin 12a; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455775,EUCOMM,Il12a,MGI:96539
Il13ra2<tm1a(EUCOMM)Hmgu>,"interleukin 13 receptor, alpha 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4452745,EUCOMM,Il13ra2,MGI:1277954
Il15<tm1a(EUCOMM)Hmgu>,"interleukin 15; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455931,EUCOMM,Il15,MGI:103014
Il17rd<tm1a(EUCOMM)Hmgu>,"interleukin 17 receptor D; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455640,EUCOMM,Il17rd,MGI:2159727
Il17re<tm1b(EUCOMM)Hmgu>,,MGI:1889371,,,
Il18rap<tm1a(KOMP)Wtsi>,"interleukin 18 receptor accessory protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4420007,KOMP-CSD,Il18rap,MGI:1338888
Il19<tm2e(EUCOMM)Hmgu>,"interleukin 19; targeted mutation 2e, Helmholtz Zentrum Muenchen GmbH",MGI:5511440,EUCOMM,Il19,MGI:1890472
Il1r1<tm1Imx>,"interleukin 1 receptor, type I; targeted mutation 1, Immunex Research and Development Corporation",MGI:1861112,0,Il1r1,MGI:96545
Il1r2<tm1a(EUCOMM)Wtsi>,"interleukin 1 receptor, type II; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842437,EUCOMM,Il1r2,MGI:96546
Il1rl1<tm1Brl>,"interleukin 1 receptor-like 1; targeted mutation 1, RCC, Ltd",MGI:3043989,0,Il1rl1,MGI:98427
Il1rn<tm1Nick>,"interleukin 1 receptor antagonist; targeted mutation 1, Martin J H Nicklin",MGI:3038876,0,Il1rn,MGI:96547
Il22ra1<tm1a(EUCOMM)Wtsi>,"interleukin 22 receptor, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431742,EUCOMM,Il22ra1,MGI:2663588
Il23r<tm2a(EUCOMM)Wtsi>,"interleukin 23 receptor; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5085468,EUCOMM,Il23r,MGI:2181693
Il25<tm1Lex>,"interleukin 25; targeted mutation 1, Lexicon Genetics",MGI:3528904,Lexicon,Il25,MGI:2155888
Il27<tm1a(EUCOMM)Wtsi>,"interleukin 27; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5527617,EUCOMM,Il27,MGI:2384409
Il2ra<tm1a(EUCOMM)Wtsi>,"interleukin 2 receptor, alpha chain; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050998,EUCOMM,Il2ra,MGI:96549
Il2rb<tm1Mak>,"interleukin 2 receptor, beta chain; targeted mutation 1, Tak Mak",MGI:1857193,0,Il2rb,MGI:96550
Il2rb<tm1a(EUCOMM)Hmgu>,"interleukin 2 receptor, beta chain; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434929,EUCOMM,Il2rb,MGI:96550
Il2rg<tm1Sug>,"interleukin 2 receptor, gamma chain; targeted mutation 1, Kazuo Sugamura",MGI:2429736,0,Il2rg,MGI:96551
Il31<tm1a(EUCOMM)Wtsi>,"interleukin 31; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842595,EUCOMM,Il31,MGI:1923649
Il31ra<tm1a(EUCOMM)Hmgu>,"interleukin 31 receptor A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841700,EUCOMM,Il31ra,MGI:2180511
Il4i1<tm1a(EUCOMM)Wtsi>,"interleukin 4 induced 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432453,EUCOMM,Il4i1,MGI:109552
Il6<tm1.1Jho>,"interleukin 6; targeted mutation 1.1, Juan Hidalgo",MGI:5577062,0,Il6,MGI:96559
Ildr1<tm1(KOMP)Wtsi>,"immunoglobulin-like domain containing receptor 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419159,KOMP-CSD,Ildr1,MGI:2146574
Ilkap<Gt(OST55141)Lex>,"integrin-linked kinase-associated serine/threonine phosphatase 2C; gene trap OST55141, Lexicon Genetics",MGI:4164011,Lexicon,Ilkap,MGI:1914694
Im1<Bioz:BP1>,Immunoregulatory 1; Bioz:BP1,MGI:2157088,0,Im1,MGI:2148963
Im2<Bioz:BP1>,immunoregulatory 2; Bioz:BP1,MGI:2157092,0,Im2,MGI:2149679
Im3<Bioz:BP1>,immunoregulatory 3; Bioz:BP1,MGI:3033072,0,Im3,MGI:3032849
Im4<Bioz:BP1>,immunoregulatory 4; Bioz:BP1,MGI:3033074,0,Im4,MGI:3032855
Im5<Bioz:BP1>,immunoregulatory 5; Bioz:BP1,MGI:3033076,0,Im5,MGI:3032858
Im7<Bioz:BP1>,immunoregulatory 7; Bioz:BP1,MGI:3033084,0,Im7,MGI:3032863
Impa1<tm1Lex>,"inositol (myo)-1(or 4)-monophosphatase 1; targeted mutation 1, Lexicon Genetics",MGI:3529209,Lexicon,Impa1,MGI:1933158
Impa2<Gt(OST203987)Lex>,"inositol (myo)-1(or 4)-monophosphatase 2; gene trap OST203987, Lexicon Genetics",MGI:3530636,Lexicon,Impa2,MGI:2149728
Impad1<tm1a(KOMP)Wtsi>,"inositol monophosphatase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363750,KOMP-CSD,Impad1,MGI:1915720
In(11Trp53;11Wnt3)8Brd,"inversion, Chr 11, Allan Bradley 8",MGI:2673211,Mutagenesis for Dev. Defects,In(11Trp53;11Wnt3)8Brd,MGI:2673108
Inava<tm2a(EUCOMM)Wtsi>,"innate immunity activator; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527587,EUCOMM,Inava,MGI:1921579
Inca1<tm1Cmt>,"inhibitor of CDK, cyclin A1 interacting protein 1; targeted mutation 1, Carsten Muller-Tidow",MGI:5292392,0,Inca1,MGI:2144284
Ing3<tm1a(EUCOMM)Wtsi>,"inhibitor of growth family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432585,EUCOMM,Ing3,MGI:1919027
Inh17,Inh17 mutant,MGI:5646303,0,Inh17,MGI:5646295
Inh18,Inh18 mutant,MGI:5646306,0,Inh18,MGI:5646297
Inh8,Inh8 mutant,MGI:5646301,0,Inh8,MGI:5646293
Inka2<tm1a(KOMP)Wtsi>,"inka box actin regulator 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013738,KOMP-CSD,Inka2,MGI:1923497
Ino80<tm1a(EUCOMM)Hmgu>,"INO80 complex subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436542,EUCOMM,Ino80,MGI:1915392
Ino80e<tm1a(EUCOMM)Wtsi>,"INO80 complex subunit E; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433084,EUCOMM,Ino80e,MGI:2141881
Inpp1<tm1a(KOMP)Wtsi>,"inositol polyphosphate-1-phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363818,KOMP-CSD,Inpp1,MGI:104848
Inpp1<tm1b(KOMP)Wtsi>,"inositol polyphosphate-1-phosphatase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548354,KOMP-CSD,Inpp1,MGI:104848
Ins1<tm1Jja>,"insulin I; targeted mutation 1, Jacques Jami",MGI:2181877,0,Ins1,MGI:96572
Ins2<tm1Jja>,"insulin II; targeted mutation 1, Jacques Jami",MGI:2181878,0,Ins2,MGI:96573
Ins2<tm2Jja>,"insulin II; targeted mutation 2, Jacques Jami",MGI:2682233,0,Ins2,MGI:96573
Ints12<tm1a(EUCOMM)Wtsi>,"integrator complex subunit 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432308,EUCOMM,Ints12,MGI:1919043
Ints2<tm1a(KOMP)Wtsi>,"integrator complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362455,KOMP-CSD,Ints2,MGI:1917672
Ints9<tm1a(KOMP)Wtsi>,"integrator complex subunit 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5297877,KOMP-CSD,Ints9,MGI:1098533
Ints9<tm1b(KOMP)Wtsi>,,MGI:1098533,,,
Invs<inv>,inversin; inversion of embryonic turning,MGI:1856915,0,Invs,MGI:1335082
Iqce<tm1a(EUCOMM)Hmgu>,"IQ motif containing E; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435267,EUCOMM,Iqce,MGI:1921489
Iqcf4<tm1a(KOMP)Wtsi>,"IQ motif containing F4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050849,KOMP-CSD,Iqcf4,MGI:1914570
Irak1<tm1a(EUCOMM)Hmgu>,"interleukin-1 receptor-associated kinase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5303142,EUCOMM,Irak1,MGI:107420
Irak1<tm1b(EUCOMM)Hmgu>,"interleukin-1 receptor-associated kinase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636906,EUCOMM,Irak1,MGI:107420
Irak2<tm1a(EUCOMM)Wtsi>,"interleukin-1 receptor-associated kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431835,EUCOMM,Irak2,MGI:2429603
Irak4<tm1Yeh>,"interleukin-1 receptor-associated kinase 4; targeted mutation 1, Wen-Chen Yeh",MGI:2676448,0,Irak4,MGI:2182474
Irf1<tm1a(EUCOMM)Wtsi>,"interferon regulatory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431834,EUCOMM,Irf1,MGI:96590
Irf4<tm1Mak>,"interferon regulatory factor 4; targeted mutation 1, Tak Mak",MGI:2387941,0,Irf4,MGI:1096873
Irf5<tm1e(EUCOMM)Wtsi>,"interferon regulatory factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4460527,EUCOMM,Irf5,MGI:1350924
Irf7<tm1(KOMP)Wtsi>,"interferon regulatory factor 7; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419590,KOMP-CSD,Irf7,MGI:1859212
Irf8<tm1Hor>,"interferon regulatory factor 8; targeted mutation 1, Ivan Horak",MGI:1926332,0,Irf8,MGI:96395
Is(17B1)1Yah,"insertion, Chr 17, cytogenetic band B1, Yann Herault 1",MGI:4431358,0,Is(17B1)1Yah,MGI:4431353
Isg20<tm1a(KOMP)Wtsi>,"interferon-stimulated protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820118,KOMP-CSD,Isg20,MGI:1928895
Itch<tm1a(EUCOMM)Hmgu>,"itchy, E3 ubiquitin protein ligase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4888905,EUCOMM,Itch,MGI:1202301
Itga2<tm1a(EUCOMM)Hmgu>,"integrin alpha 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455765,EUCOMM,Itga2,MGI:96600
Itga6<tm1Egl>,"integrin alpha 6; targeted mutation 1, Elisabeth Georges-Labouesse",MGI:1857793,0,Itga6,MGI:96605
Itgae<tm1Cmp>,"integrin alpha E, epithelial-associated; targeted mutation 1, Christina M Parker",MGI:2136817,0,Itgae,MGI:1298377
Itgae<tm1a(EUCOMM)Wtsi>,"integrin alpha E, epithelial-associated; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433992,EUCOMM,Itgae,MGI:1298377
Itgb5<tm1e(EUCOMM)Wtsi>,"integrin beta 5; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433020,EUCOMM,Itgb5,MGI:96614
Itm2c<tm1a(EUCOMM)Wtsi>,"integral membrane protein 2C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431661,EUCOMM,Itm2c,MGI:1927594
Itm2c<tm1b(EUCOMM)Wtsi>,"integral membrane protein 2C; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548700,EUCOMM,Itm2c,MGI:1927594
Itpr3<tf>,"inositol 1,4,5-triphosphate receptor 3; tufted",MGI:1857070,0,Itpr3,MGI:96624
Ivd<tm1a(EUCOMM)Hmgu>,"isovaleryl coenzyme A dehydrogenase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436446,EUCOMM,Ivd,MGI:1929242
Ivd<tm1b(EUCOMM)Hmgu>,"isovaleryl coenzyme A dehydrogenase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548705,EUCOMM,Ivd,MGI:1929242
Izumo1r<tm2a(KOMP)Wtsi>,"IZUMO1 receptor, JUNO; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4363787,KOMP-CSD,Izumo1r,MGI:1929185
Jag1<Mhdahtu>,jagged 1; Martin Hrabe de Angelis headturner,MGI:2386949,0,Jag1,MGI:1095416
Jag1<Slalom>,jagged 1; slalom,MGI:1931798,Harwell ENU Mutagenesis,Jag1,MGI:1095416
Jag1<Yo>,jagged 1; yoyo,MGI:5305601,0,Jag1,MGI:1095416
Jag2<tm1a(KOMP)Wtsi>,"jagged 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880880,KOMP-CSD,Jag2,MGI:1098270
Jak1<M1Mhda>,"Janus kinase 1; mutation 1, Martin Hrabe de Angelis",MGI:5526094,0,Jak1,MGI:96628
Jak1<tm1a(EUCOMM)Hmgu>,"Janus kinase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4456720,EUCOMM,Jak1,MGI:96628
Jarid2<Gt(pGT1.8geo)6Pgr>,"jumonji, AT rich interactive domain 2; gene trap 6, Peter Gruss",MGI:2655460,0,Jarid2,MGI:104813
Jarid2<tm1a(KOMP)Wtsi>,"jumonji, AT rich interactive domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362782,KOMP-CSD,Jarid2,MGI:104813
Jmjd1c<tm1a(EUCOMM)Wtsi>,"jumonji domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842320,EUCOMM,Jmjd1c,MGI:1918614
Jmjd6<tm1.1Gbf>,"jumonji domain containing 6; targeted mutation 1.1, Andreas Lengeling",MGI:3606752,0,Jmjd6,MGI:1858910
Jmjd6<tm1a(EUCOMM)Wtsi>,"jumonji domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432550,EUCOMM,Jmjd6,MGI:1858910
Jmjd6<tm1b(EUCOMM)Wtsi>,"jumonji domain containing 6; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548491,EUCOMM,Jmjd6,MGI:1858910
Kansl1<tm1a(EUCOMM)Hmgu>,"KAT8 regulatory NSL complex subunit 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5296202,EUCOMM,Kansl1,MGI:1923969
Kat14<tm1a(KOMP)Wtsi>,"lysine acetyltransferase 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363521,KOMP-CSD,Kat14,MGI:1917264
Kat2b<tm1Nkt>,"K(lysine) acetyltransferase 2B; targeted mutation 1, Yoshihiro Nakatani",MGI:2386307,0,Kat2b,MGI:1343094
Kat6b<m1Mhda>,"K(lysine) acetyltransferase 6B; mutation 1, Martin Hrabe de Angelis",MGI:5702933,0,Kat6b,MGI:1858746
Katnb1<tm1a(EUCOMM)Hmgu>,"katanin p80 (WD40-containing) subunit B 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436305,EUCOMM,Katnb1,MGI:1921437
Kazn<tm1a(EUCOMM)Wtsi>,"kazrin, periplakin interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432650,EUCOMM,Kazn,MGI:1918779
Kcnab1<tm1Sva>,"potassium voltage-gated channel, shaker-related subfamily, beta member 1; targeted mutation 1, Alcino J Silva",MGI:2181771,0,Kcnab1,MGI:109155
Kcnb1<tm1a(EUCOMM)Hmgu>,"potassium voltage gated channel, Shab-related subfamily, member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5002949,EUCOMM,Kcnb1,MGI:96666
Kcnb2<tm1Lex>,"potassium voltage gated channel, Shab-related subfamily, member 2; targeted mutation 1, Lexicon Genetics",MGI:5429909,Lexicon,Kcnb2,MGI:99632
Kcne1<tm1Sfh>,"potassium voltage-gated channel, Isk-related subfamily, member 1; targeted mutation 1, Stephen F Heinemann",MGI:1857442,0,Kcne1,MGI:96673
Kcne2<tm1a(EUCOMM)Wtsi>,"potassium voltage-gated channel, Isk-related subfamily, gene 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431909,EUCOMM,Kcne2,MGI:1891123
Kcnh1<tm1Lex>,"potassium voltage-gated channel, subfamily H (eag-related), member 1; targeted mutation 1, Lexicon Genetics",MGI:5430765,Lexicon,Kcnh1,MGI:1341721
Kcnh4<tm1a(KOMP)Wtsi>,"potassium voltage-gated channel, subfamily H (eag-related), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460286,KOMP-CSD,Kcnh4,MGI:2156184
Kcnh4<tm1b(KOMP)Wtsi>,"potassium voltage-gated channel, subfamily H (eag-related), member 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637120,KOMP-CSD,Kcnh4,MGI:2156184
Kcnip4<tm1a(KOMP)Wtsi>,"Kv channel interacting protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419266,KOMP-CSD,Kcnip4,MGI:1933131
Kcnj10<tm1a(KOMP)Wtsi>,"potassium inwardly-rectifying channel, subfamily J, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451428,KOMP-CSD,Kcnj10,MGI:1194504
Kcnj11<tm1a(EUCOMM)Wtsi>,"potassium inwardly rectifying channel, subfamily J, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5473147,EUCOMM,Kcnj11,MGI:107501
Kcnj12<tm1a(EUCOMM)Wtsi>,"potassium inwardly-rectifying channel, subfamily J, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432694,EUCOMM,Kcnj12,MGI:108495
Kcnj14<tm2a(EUCOMM)Hmgu>,"potassium inwardly-rectifying channel, subfamily J, member 14; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511630,EUCOMM,Kcnj14,MGI:2384820
Kcnj15<tm1Dgen>,"potassium inwardly-rectifying channel, subfamily J, member 15; targeted mutation 1, Deltagen",MGI:5427676,Deltagen,Kcnj15,MGI:1310000
Kcnj9<tm1a(EUCOMM)Hmgu>,"potassium inwardly-rectifying channel, subfamily J, member 9; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436261,EUCOMM,Kcnj9,MGI:108007
Kcnk1<tm1.1Barh>,"potassium channel, subfamily K, member 1; targeted mutation 1.1, Jacques Barhanin",MGI:5318213,0,Kcnk1,MGI:109322
Kcnk3<tm1Sgb>,"potassium channel, subfamily K, member 3; targeted mutation 1, Stephen G Brickley",MGI:3611768,0,Kcnk3,MGI:1100509
Kcnn1<tm1a(KOMP)Wtsi>,"potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419229,KOMP-CSD,Kcnn1,MGI:1933993
Kcnn3<tm1a(EUCOMM)Wtsi>,"potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433082,EUCOMM,Kcnn3,MGI:2153183
Kcnv2<tm1Wtsi>,"potassium channel, subfamily V, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840969,KOMP-CSD,Kcnv2,MGI:2670981
Kctd10<Gt(RRG305)Byg>,"potassium channel tetramerisation domain containing 10; gene trap RRG305, BayGenomics",MGI:4128950,0,Kctd10,MGI:2141207
Kctd15<tm1a(EUCOMM)Wtsi>,"potassium channel tetramerisation domain containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432583,EUCOMM,Kctd15,MGI:2385276
Kdm4b<tm1a(EUCOMM)Wtsi>,"lysine (K)-specific demethylase 4B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433704,EUCOMM,Kdm4b,MGI:2442355
Kdm4c<tm1a(KOMP)Wtsi>,"lysine (K)-specific demethylase 4C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362199,KOMP-CSD,Kdm4c,MGI:1924054
Kdm4d<tm2a(EUCOMM)Wtsi>,"lysine (K)-specific demethylase 4D; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4460459,EUCOMM,Kdm4d,MGI:3606484
Kdm6a<tm2a(EUCOMM)Wtsi>,"lysine (K)-specific demethylase 6A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4441731,EUCOMM,Kdm6a,MGI:1095419
Kdm6b<tm1b(EUCOMM)Wtsi>,,MGI:2448492,,,
Kdm7a<tm1a(EUCOMM)Wtsi>,"lysine (K)-specific demethylase 7A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432944,EUCOMM,Kdm7a,MGI:2443388
Kdm8<tm1a(EUCOMM)Wtsi>,"lysine (K)-specific demethylase 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431607,EUCOMM,Kdm8,MGI:1924285
Khdrbs1<tm1a(EUCOMM)Hmgu>,"KH domain containing, RNA binding, signal transduction associated 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950200,EUCOMM,Khdrbs1,MGI:893579
Khdrbs3<tm1Dell>,"KH domain containing, RNA binding, signal transduction associated 3; targeted mutation 1, David J Elliott",MGI:5508245,0,Khdrbs3,MGI:1313312
Khdrbs3<tm1a(EUCOMM)Hmgu>,"KH domain containing, RNA binding, signal transduction associated 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4847821,EUCOMM,Khdrbs3,MGI:1313312
Khdrbs3<tm1b(EUCOMM)Hmgu>,"KH domain containing, RNA binding, signal transduction associated 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636948,EUCOMM,Khdrbs3,MGI:1313312
Kif11<tm1Much>,"kinesin family member 11; targeted mutation 1, Muriel Chauviere",MGI:3803280,0,Kif11,MGI:1098231
Kif13b<tm1a(EUCOMM)Wtsi>,"kinesin family member 13B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842489,EUCOMM,Kif13b,MGI:1098265
Kif13b<tm1b(EUCOMM)Wtsi>,"kinesin family member 13B; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636925,EUCOMM,Kif13b,MGI:1098265
Kif18b<tm1a(EUCOMM)Wtsi>,"kinesin family member 18B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944522,EUCOMM,Kif18b,MGI:2446979
Kif1bp<tm1a(KOMP)Wtsi>,"KIF1 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939684,KOMP-CSD,Kif1bp,MGI:1919570
Kif20a<tm1a(EUCOMM)Hmgu>,"kinesin family member 20A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436572,EUCOMM,Kif20a,MGI:1201682
Kif20a<tm1b(EUCOMM)Hmgu>,"kinesin family member 20A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636934,EUCOMM,Kif20a,MGI:1201682
Kif21b<tm1a(KOMP)Wtsi>,"kinesin family member 21B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364527,KOMP-CSD,Kif21b,MGI:109234
Kif24<tm1a(KOMP)Wtsi>,"kinesin family member 24; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841207,KOMP-CSD,Kif24,MGI:1918345
Kif24<tm1b(KOMP)Wtsi>,"kinesin family member 24; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637052,KOMP-CSD,Kif24,MGI:1918345
Kif3b<tm1a(EUCOMM)Wtsi>,"kinesin family member 3B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820245,EUCOMM,Kif3b,MGI:107688
Kif3b<tm1b(EUCOMM)Wtsi>,"kinesin family member 3B; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548376,EUCOMM,Kif3b,MGI:107688
Kifap3<tm1a(KOMP)Wtsi>,"kinesin-associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362297,KOMP-CSD,Kifap3,MGI:107566
Kiss1<tm2(cre/GFP)Coll>,"KiSS-1 metastasis-suppressor; targeted mutation 2, William H Colledge",MGI:6113450,0,Kiss1,MGI:2663985
Kit<Mhdasco1>,KIT proto-oncogene receptor tyrosine kinase; Martin Hrabe de Angelis spotted coat 1,MGI:3530308,0,Kit,MGI:96677
Kit<Mhdasco5>,KIT proto-oncogene receptor tyrosine kinase; Martin Hrabe de Angelis spotted coat 5,MGI:3530315,0,Kit,MGI:96677
Kit<Mhdasow3>,KIT proto-oncogene receptor tyrosine kinase; Martin Hrabe de Angelis sister of W 3,MGI:3530323,0,Kit,MGI:96677
Kit<W-bd>,KIT proto-oncogene receptor tyrosine kinase; banded,MGI:1856258,0,Kit,MGI:96677
Kit<W-e>,KIT proto-oncogene receptor tyrosine kinase; extreme dominant spotting,MGI:1856260,0,Kit,MGI:96677
Kit<W-f>,KIT proto-oncogene receptor tyrosine kinase; fertile dominant spotting,MGI:1856261,0,Kit,MGI:96677
Kit<W>,KIT proto-oncogene receptor tyrosine kinase; dominant spotting,MGI:1856232,0,Kit,MGI:96677
Kit<Whc1>,KIT proto-oncogene receptor tyrosine kinase; white coat,MGI:3760742,0,Kit,MGI:96677
Kit<d18>,KIT proto-oncogene receptor tyrosine kinase; delta 18,MGI:3576614,0,Kit,MGI:96677
Kit<tm1Alf>,"KIT proto-oncogene receptor tyrosine kinase; targeted mutation 1, Jean-Jacques Panthier",MGI:2449782,0,Kit,MGI:96677
Klc2<tm1e(EUCOMM)Wtsi>,"kinesin light chain 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4434042,EUCOMM,Klc2,MGI:107953
Klc4<tm1a(EUCOMM)Wtsi>,"kinesin light chain 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842274,EUCOMM,Klc4,MGI:1922014
Klf13<tm1Coll>,"Kruppel-like factor 13; targeted mutation 1, William Colledge",MGI:4837928,0,Klf13,MGI:1354948
Klf17<tm1a(KOMP)Wtsi>,"Kruppel-like factor 17; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362369,KOMP-CSD,Klf17,MGI:2181068
Klf17<tm1b(KOMP)Wtsi>,"Kruppel-like factor 17; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548777,KOMP-CSD,Klf17,MGI:2181068
Klf7<tm1Rmz>,"Kruppel-like factor 7 (ubiquitous); targeted mutation 1, Francesco Ramirez",MGI:3581890,0,Klf7,MGI:1935151
Klf7<tm1a(EUCOMM)Hmgu>,"Kruppel-like factor 7 (ubiquitous); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434914,EUCOMM,Klf7,MGI:1935151
Klhdc2<tm1a(EUCOMM)Hmgu>,"kelch domain containing 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436518,EUCOMM,Klhdc2,MGI:1916804
Klhl18<tm1a(KOMP)Wtsi>,"kelch-like 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362936,KOMP-CSD,Klhl18,MGI:2143315
Klhl20<tm1a(EUCOMM)Wtsi>,"kelch-like 20; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014725,EUCOMM,Klhl20,MGI:2444855
Klhl21<tm1a(KOMP)Wtsi>,"kelch-like 21; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363013,KOMP-CSD,Klhl21,MGI:1919288
Klhl26<tm1a(EUCOMM)Wtsi>,"kelch-like 26; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842308,EUCOMM,Klhl26,MGI:2443079
Klhl29<tm1a(EUCOMM)Hmgu>,"kelch-like 29; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435268,EUCOMM,Klhl29,MGI:2683857
Klhl30<tm1a(KOMP)Wtsi>,"kelch-like 30; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431509,KOMP-CSD,Klhl30,MGI:1918038
Klhl3<tm1a(KOMP)Wtsi>,"kelch-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4946685,KOMP-CSD,Klhl3,MGI:2445185
Klhl5<tm1a(EUCOMM)Hmgu>,"kelch-like 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286312,EUCOMM,Klhl5,MGI:1919028
Klhl6<tm1Btoci>,"kelch-like 6; targeted mutation 1, Barbara Bertocci",MGI:5882711,0,Klhl6,MGI:2686922
Klk14<tm1(KOMP)Vlcg>,"kallikrein related-peptidase 14; targeted mutation 1, Velocigene",MGI:4843087,KOMP-Regeneron,Klk14,MGI:2447564
Klk5<tm2a(KOMP)Wtsi>,"kallikrein related-peptidase 5; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4364033,KOMP-CSD,Klk5,MGI:1915918
Klk5<tm2b(KOMP)Wtsi>,"kallikrein related-peptidase 5; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5604101,KOMP-CSD,Klk5,MGI:1915918
Klk9<tm1a(KOMP)Wtsi>,"kallikrein related-peptidase 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419836,KOMP-CSD,Klk9,MGI:1921082
Klkb1<tm1a(EUCOMM)Wtsi>,"kallikrein B, plasma 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456034,EUCOMM,Klkb1,MGI:102849
Klkb1<tm1b(EUCOMM)Wtsi>,"kallikrein B, plasma 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548334,EUCOMM,Klkb1,MGI:102849
Klra5<tm1.1Cgbr>,"killer cell lectin-like receptor, subfamily A, member 5; targeted mutation 1.1, Colin G Brooks",MGI:4941892,0,Klra5,MGI:101903
Klrb1<tm1a(EUCOMM)Wtsi>,"killer cell lectin-like receptor subfamily B member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453704,EUCOMM,Klrb1,MGI:96877
Klrb1a<tm1a(KOMP)Wtsi>,"killer cell lectin-like receptor subfamily B member 1A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364549,KOMP-CSD,Klrb1a,MGI:107540
Klrb1c<a>,killer cell lectin-like receptor subfamily B member 1C; antigen Nk-1.1 allele,MGI:2384434,0,Klrb1c,MGI:107538
Kmt2b<tm1.2(IMPC)Wtsi>,,MGI:109565,,,
Kmt2d<tm1.2(IMPC)Wtsi>,,MGI:2682319,,,
Kmt2e<tm1.2(IMPC)Wtsi>,,MGI:1924825,,,
Kmt5b<tm1a(KOMP)Wtsi>,"lysine methyltransferase 5B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363450,KOMP-CSD,Kmt5b,MGI:2444557
Kng2<tm2a(EUCOMM)Wtsi>,"kininogen 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840572,EUCOMM,Kng2,MGI:3027157
Knstrn<tm1a(KOMP)Wtsi>,"kinetochore-localized astrin/SPAG5 binding; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362164,KOMP-CSD,Knstrn,MGI:1289298
Kptn<tm1a(EUCOMM)Wtsi>,"kaptin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433701,EUCOMM,Kptn,MGI:1890380
Kptn<tm1b(EUCOMM)Wtsi>,,MGI:1890380,,,
Kptn<tm1c(EUCOMM)Wtsi>,,MGI:1890380,,,
Kras<tm1Bbd>,"Kirsten rat sarcoma viral oncogene homolog; targeted mutation 1, Mariano Barbacid",MGI:3582830,0,Kras,MGI:96680
Krt10<tm1Tmm>,"keratin 10; targeted mutation 1, Thomas M Magin",MGI:2180882,0,Krt10,MGI:96685
Krt10<tm2Tmm>,"keratin 10; targeted mutation 2,  Thomas M Magin",MGI:3056582,0,Krt10,MGI:96685
Krt18<tm1Tmm>,"keratin 18; targeted mutation 1, Thomas M Magin",MGI:2178045,0,Krt18,MGI:96692
Krt1<Mhdadsk12>,keratin 1; Martin Hrabe de Angelis dark skin 12,MGI:3655853,0,Krt1,MGI:96698
Krt31<tm1e(KOMP)Wtsi>,"keratin 31; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4881940,KOMP-CSD,Krt31,MGI:1309993
Krt5<tm1Tmm>,"keratin 5; targeted mutation 1, Thomas M Magin",MGI:2182612,0,Krt5,MGI:96702
Krt71<Mhdarco12>,keratin 71; Martin Hrabe de Angelis reduced coat 12,MGI:3693873,0,Krt71,MGI:1861586
Krt71<Mhdarco13>,keratin 71; Martin Hrabe de Angelis reduced coat 13,MGI:3693874,0,Krt71,MGI:1861586
Krt74<tm1a(EUCOMM)Wtsi>,"keratin 74; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461649,EUCOMM,Krt74,MGI:3629975
Krt76<tm1a(KOMP)Wtsi>,"keratin 76; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363117,KOMP-CSD,Krt76,MGI:1924305
Krt79<tm2a(KOMP)Wtsi>,"keratin 79; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5297893,KOMP-CSD,Krt79,MGI:2385030
Krt7<tm1a(KOMP)Wtsi>,"keratin 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840979,KOMP-CSD,Krt7,MGI:96704
Krt7<tm1b(KOMP)Wtsi>,"keratin 7; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548947,KOMP-CSD,Krt7,MGI:96704
Krt81<tm1a(KOMP)Wtsi>,"keratin 81; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5299637,KOMP-CSD,Krt81,MGI:1928858
Krt8<tm1a(EUCOMM)Hmgu>,"keratin 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435745,EUCOMM,Krt8,MGI:96705
L3mbtl2<tm2a(EUCOMM)Wtsi>,"L3MBTL2 polycomb repressive complex 1 subunit; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5472695,EUCOMM,L3mbtl2,MGI:2443584
Lacc1<tm1a(KOMP)Wtsi>,"laccase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451304,KOMP-CSD,Lacc1,MGI:2445077
Lactb<tm1(KOMP)Mbp>,"lactamase, beta; targeted mutation 1, Mouse Biology Program, UCDavis",MGI:4819984,KOMP-CSD,Lactb,MGI:1933395
Lama1<tm2a(EUCOMM)Hmgu>,"laminin, alpha 1; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4436547,EUCOMM,Lama1,MGI:99892
Lama1<tm2b(EUCOMM)Hmgu>,"laminin, alpha 1; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5613672,EUCOMM,Lama1,MGI:99892
Lama3<tm1Arte>,"laminin, alpha 3; targeted mutation 1, TaconicArtemis",MGI:6121104,0,Lama3,MGI:99909
Lama4<tm1Ktry>,"laminin, alpha 4; targeted mutation 1, Karl Tryggvason",MGI:2179127,0,Lama4,MGI:109321
Lama5<tm1a(KOMP)Wtsi>,"laminin, alpha 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363608,KOMP-CSD,Lama5,MGI:105382
Lamb3<tm1a(KOMP)Wtsi>,"laminin, beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364410,KOMP-CSD,Lamb3,MGI:99915
Lamc3<tm1a(KOMP)Wtsi>,"laminin gamma 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364864,KOMP-CSD,Lamc3,MGI:1344394
Lamp1<tm1Psa>,"lysosomal-associated membrane protein 1; targeted mutation 1, Paul Saftig",MGI:3053864,0,Lamp1,MGI:96745
Laptm4a<tm1a(EUCOMM)Hmgu>,"lysosomal-associated protein transmembrane 4A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435176,EUCOMM,Laptm4a,MGI:108017
Laptm5<tm1a(EUCOMM)Wtsi>,"lysosomal-associated protein transmembrane 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433224,EUCOMM,Laptm5,MGI:108046
Lars<tm1a(KOMP)Wtsi>,"leucyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052388,KOMP-CSD,Lars,MGI:1913808
Lars<tm1b(KOMP)Wtsi>,"leucyl-tRNA synthetase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637014,KOMP-CSD,Lars,MGI:1913808
Lasp1<m1Mhda>,"LIM and SH3 protein 1; mutation 1, Martin Hrabe de Angelis",MGI:5818740,0,Lasp1,MGI:109656
Lat2<tm1Mal>,"linker for activation of T cells family, member 2; targeted mutation 1, Bernard Malissen",MGI:3510698,0,Lat2,MGI:1926479
Lat<tm5Mal>,"linker for activation of T cells; targeted mutation 5, Bernard Malissen",MGI:4357969,0,Lat,MGI:1342293
Lbp<tm1Jack>,"lipopolysaccharide binding protein; targeted mutation 1, Robert S Jack",MGI:1857976,0,Lbp,MGI:1098776
Lbp<tm1a(EUCOMM)Hmgu>,"lipopolysaccharide binding protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436125,EUCOMM,Lbp,MGI:1098776
Lce1f<tm1a(KOMP)Wtsi>,"late cornified envelope 1F; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841178,KOMP-CSD,Lce1f,MGI:1915078
Lce1h<tm1a(EUCOMM)Wtsi>,"late cornified envelope 1H; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4951095,EUCOMM,Lce1h,MGI:1914968
Lce1m<tm1a(EUCOMM)Wtsi>,"late cornified envelope 1M; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052501,EUCOMM,Lce1m,MGI:1913453
Lce1m<tm1b(EUCOMM)Wtsi>,"late cornified envelope 1M; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637007,EUCOMM,Lce1m,MGI:1913453
Lce3c<tm2a(EUCOMM)Wtsi>,"late cornified envelope 3C; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5472691,EUCOMM,Lce3c,MGI:2135932
Lch,low cholesterol,MGI:2152771,Harwell ENU Mutagenesis,Lch,MGI:2152768
Lch2,low cholesterol 2,MGI:2387761,Harwell ENU Mutagenesis,Lch2,MGI:2387751
Lck<tm3.1Mal>,"lymphocyte protein tyrosine kinase; targeted mutation 3.1, Bernard Malissen",MGI:5706925,0,Lck,MGI:96756
Lcl,lens cloudy,MGI:2178627,0,Lcl,MGI:2149028
Lcn2<tm1Mak>,"lipocalin 2; targeted mutation 1, Tak W Mak",MGI:3620000,0,Lcn2,MGI:96757
Lcp2<tm1a(KOMP)Wtsi>,"lymphocyte cytosolic protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419318,KOMP-CSD,Lcp2,MGI:1321402
Lcp2<twm>,lymphocyte cytosolic protein 2; t-wimp,MGI:3614800,APF ENU Mutagenesis,Lcp2,MGI:1321402
Lct<tm1a(KOMP)Wtsi>,"lactase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841441,KOMP-CSD,Lct,MGI:104576
Ldah<tm1a(EUCOMM)Wtsi>,"lipid droplet associated hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456805,EUCOMM,Ldah,MGI:1916082
Ldah<tm1b(EUCOMM)Wtsi>,"lipid droplet associated hydrolase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637035,EUCOMM,Ldah,MGI:1916082
Ldha<a-m1Neu>,"lactate dehydrogenase A; mutation 1, Neuherberg",MGI:2384559,0,Ldha,MGI:96759
Ldha<tm1a(EUCOMM)Wtsi>,"lactate dehydrogenase A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432392,EUCOMM,Ldha,MGI:96759
Ldhb<tm1a(KOMP)Wtsi>,"lactate dehydrogenase B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5299501,KOMP-CSD,Ldhb,MGI:96763
Ldhb<tm1b(KOMP)Wtsi>,"lactate dehydrogenase B; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637210,KOMP-CSD,Ldhb,MGI:96763
Ldlr<tm1Her>,"low density lipoprotein receptor; targeted mutation 1, Joachim Herz",MGI:1857212,0,Ldlr,MGI:96765
Ldlrad4<tm1a(EUCOMM)Wtsi>,"low density lipoprotein receptor class A domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820334,EUCOMM,Ldlrad4,MGI:1277150
Ldlrad4<tm1b(EUCOMM)Wtsi>,"low density lipoprotein receptor class A domain containing 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636938,EUCOMM,Ldlrad4,MGI:1277150
Leo1<tm1a(EUCOMM)Wtsi>,"Leo1, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4950249,EUCOMM,Leo1,MGI:2685031
Lepr<db-Pas>,leptin receptor; diabetes Institut Pasteur,MGI:1856013,0,Lepr,MGI:104993
Lepr<tm1a(EUCOMM)Wtsi>,"leptin receptor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453725,EUCOMM,Lepr,MGI:104993
Leprot<tm2a(KOMP)Wtsi>,"leptin receptor overlapping transcript; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4364337,KOMP-CSD,Leprot,MGI:2687005
Leprot<tm2b(KOMP)Wtsi>,"leptin receptor overlapping transcript; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548880,KOMP-CSD,Leprot,MGI:2687005
Leprotl1<tm1a(EUCOMM)Hmgu>,"leptin receptor overlapping transcript-like 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434583,EUCOMM,Leprotl1,MGI:1915442
Lgals3<tm1Ftl>,"lectin, galactose binding, soluble 3; targeted mutation 1, Fu-Tong Liu",MGI:2386938,0,Lgals3,MGI:96778
Lgals3<tm1a(EUCOMM)Wtsi>,"lectin, galactose binding, soluble 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432481,EUCOMM,Lgals3,MGI:96778
Lgals7<tm1a(EUCOMM)Wtsi>,"lectin, galactose binding, soluble 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432104,EUCOMM,Lgals7,MGI:1316742
Lgals7<tm1b(EUCOMM)Wtsi>,"lectin, galactose binding, soluble 7; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548425,EUCOMM,Lgals7,MGI:1316742
Lgi1<tm1.1Ics>,"leucine-rich repeat LGI family, member 1; targeted mutation 1.1, Mouse Clinical Institute",MGI:5317113,0,Lgi1,MGI:1861691
Lhcgr<tm1Hht>,"luteinizing hormone/choriogonadotropin receptor; targeted mutation 1, Ilpo Huhtaniemi",MGI:2181999,0,Lhcgr,MGI:96783
Lhfpl2<tm1a(KOMP)Wtsi>,"lipoma HMGIC fusion partner-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4462597,KOMP-CSD,Lhfpl2,MGI:2145236
Lhx1<tm1Bhr>,"LIM homeobox protein 1; targeted mutation 1, Richard R Behringer",MGI:1857848,0,Lhx1,MGI:99783
Lif<tm1Stw>,"leukemia inhibitory factor; targeted mutation 1, Colin L Stewart",MGI:2177780,0,Lif,MGI:96787
Lifr<tm1a(EUCOMM)Hmgu>,"LIF receptor alpha; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841519,EUCOMM,Lifr,MGI:96788
Lig4<tiny>,"ligase IV, DNA, ATP-dependent; tiny",MGI:3714783,APF ENU Mutagenesis,Lig4,MGI:1335098
Lim2<Aca47>,lens intrinsic membrane protein 2; ACMaster abnormality 47,MGI:5304394,0,Lim2,MGI:104698
Lim2<To3>,lens intrinsic membrane protein 2; total opacity 3,MGI:1862040,0,Lim2,MGI:104698
Lime1<tm1Mal>,"Lck interacting transmembrane adaptor 1; targeted mutation 1, Bernard Malissen",MGI:3762394,0,Lime1,MGI:1919949
Limk2<tm1a(EUCOMM)Wtsi>,"LIM motif-containing protein kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431692,EUCOMM,Limk2,MGI:1197517
Lipa<tm1a(EUCOMM)Hmgu>,"lysosomal acid lipase A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5428633,EUCOMM,Lipa,MGI:96789
Lix1l<tm1a(EUCOMM)Wtsi>,"Lix1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432131,EUCOMM,Lix1l,MGI:3036267
Lmna<tm1a(EUCOMM)Wtsi>,"lamin A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433534,EUCOMM,Lmna,MGI:96794
Lmnb1<tm1a(EUCOMM)Wtsi>,"lamin B1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432859,EUCOMM,Lmnb1,MGI:96795
Lmnb2<tm1a(KOMP)Wtsi>,"lamin B2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362469,KOMP-CSD,Lmnb2,MGI:96796
Lmx1a<mtl>,LIM homeobox transcription factor 1 alpha; mutanlallemand,MGI:5423987,0,Lmx1a,MGI:1888519
Lmx1b<Icst>,LIM homeobox transcription factor 1 beta; iris-corneal strands,MGI:2178439,Harwell ENU Mutagenesis,Lmx1b,MGI:1100513
Lnx2<tm1a(EUCOMM)Wtsi>,"ligand of numb-protein X 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433509,EUCOMM,Lnx2,MGI:2155959
Lonp1<tm1a(EUCOMM)Hmgu>,"lon peptidase 1, mitochondrial; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5521859,EUCOMM,Lonp1,MGI:1921392
Lonp2<tm2e(EUCOMM)Hmgu>,"lon peptidase 2, peroxisomal; targeted mutation 2e, Helmholtz Zentrum Muenchen GmbH",MGI:5511246,EUCOMM,Lonp2,MGI:1914137
Lonrf3<tm1a(KOMP)Wtsi>,"LON peptidase N-terminal domain and ring finger 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363930,KOMP-CSD,Lonrf3,MGI:1921615
Lonrf3<tm1b(KOMP)Wtsi>,"LON peptidase N-terminal domain and ring finger 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548642,KOMP-CSD,Lonrf3,MGI:1921615
Lox<tm1Soin>,"lysyl oxidase; targeted mutation 1, Raija Soininen",MGI:3610732,0,Lox,MGI:96817
Lpar1<tm1a(EUCOMM)Wtsi>,"lysophosphatidic acid receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441643,EUCOMM,Lpar1,MGI:108429
Lpar1<tm1b(EUCOMM)Wtsi>,"lysophosphatidic acid receptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5635231,EUCOMM,Lpar1,MGI:108429
Lpar5<tm1a(KOMP)Wtsi>,"lysophosphatidic acid receptor 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4454096,KOMP-CSD,Lpar5,MGI:2685918
Lpo<tm1a(EUCOMM)Wtsi>,"lactoperoxidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432905,EUCOMM,Lpo,MGI:1923363
Lpo<tm1b(EUCOMM)Wtsi>,"lactoperoxidase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548663,EUCOMM,Lpo,MGI:1923363
Lpp<tm1b(KOMP)Wtsi>,,MGI:2441849,,,
Lpxn<tm1a(EUCOMM)Hmgu>,"leupaxin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4843881,EUCOMM,Lpxn,MGI:2147677
Lrig1<tm1a(EUCOMM)Wtsi>,"leucine-rich repeats and immunoglobulin-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431776,EUCOMM,Lrig1,MGI:107935
Lrmp<tm1a(EUCOMM)Wtsi>,"lymphoid-restricted membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432722,EUCOMM,Lrmp,MGI:108424
Lrp1<tm1Ajmr>,"low density lipoprotein receptor-related protein 1; targeted mutation 1, Anton J M Roebroek",MGI:3830336,0,Lrp1,MGI:96828
Lrp1<tm2Ajmr>,"low density lipoprotein receptor-related protein 1; targeted mutation 2, Anton J M Roebroek",MGI:3830330,0,Lrp1,MGI:96828
Lrp1<tm3Ajmr>,"low density lipoprotein receptor-related protein 1; targeted mutation 3, Anton J M Roebroek",MGI:3830332,0,Lrp1,MGI:96828
Lrp1<tm4Ajmr>,"low density lipoprotein receptor-related protein 1; targeted mutation 4, Anton J M Roebroek",MGI:3830333,0,Lrp1,MGI:96828
Lrp1<tm5Ajmr>,"low density lipoprotein receptor-related protein 1; targeted mutation 5, Anton J M Roebroek",MGI:5433527,0,Lrp1,MGI:96828
Lrp1<tm6Ajmr>,"low density lipoprotein receptor-related protein 1; targeted mutation 6, Anton J M Roebroek",MGI:5433528,0,Lrp1,MGI:96828
Lrp4<dan>,low density lipoprotein receptor-related protein 4; digitation anormale,MGI:3580702,0,Lrp4,MGI:2442252
Lrp6<rs>,low density lipoprotein receptor-related protein 6; ringelschwanz,MGI:2673982,0,Lrp6,MGI:1298218
Lrpprc<tm1a(KOMP)Wtsi>,"leucine-rich PPR-motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363281,KOMP-CSD,Lrpprc,MGI:1919666
Lrrc23<tm1a(EUCOMM)Wtsi>,"leucine rich repeat containing 23; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944543,EUCOMM,Lrrc23,MGI:1315192
Lrrc71<tm1a(KOMP)Wtsi>,"leucine rich repeat containing 71; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458520,KOMP-CSD,Lrrc71,MGI:1921735
Lrrc8d<tm1a(EUCOMM)Wtsi>,"leucine rich repeat containing 8D; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849425,EUCOMM,Lrrc8d,MGI:1922368
Lrriq3<tm1a(KOMP)Wtsi>,"leucine-rich repeats and IQ motif containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841185,KOMP-CSD,Lrriq3,MGI:1921685
Lsm10<tm2a(EUCOMM)Wtsi>,"U7 snRNP-specific Sm-like protein LSM10; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840576,EUCOMM,Lsm10,MGI:2151045
Lsm11<tm1a(KOMP)Wtsi>,"U7 snRNP-specific Sm-like protein LSM11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362146,KOMP-CSD,Lsm11,MGI:1919540
Lsm14b<tm1a(KOMP)Mbp>,"LSM family member 14B; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4950120,KOMP-CSD,Lsm14b,MGI:3040677
Lsm1<tm1a(EUCOMM)Hmgu>,"LSM1 homolog, mRNA degradation associated; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4887646,EUCOMM,Lsm1,MGI:1914457
Lsm1<tm1b(EUCOMM)Hmgu>,"LSM1 homolog, mRNA degradation associated; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548536,EUCOMM,Lsm1,MGI:1914457
Lss<tm1a(KOMP)Wtsi>,"lanosterol synthase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362667,KOMP-CSD,Lss,MGI:1336155
Lss<tm1b(KOMP)Wtsi>,"lanosterol synthase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5561557,KOMP-CSD,Lss,MGI:1336155
Lta/Tnf<tm1Fda>,"lymphotoxin A; targeted mutation 1, Francois Dautry",MGI:2447728,0,Lta,MGI:104797
Lta4h<tm1a(KOMP)Wtsi>,"leukotriene A4 hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820073,KOMP-CSD,Lta4h,MGI:96836
Ltbp1<tm1Rawe>,"latent transforming growth factor beta binding protein 1; targeted mutation 1, Ralf Weiskirchen",MGI:3778910,0,Ltbp1,MGI:109151
Ltbp1<tm1a(EUCOMM)Wtsi>,"latent transforming growth factor beta binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433604,EUCOMM,Ltbp1,MGI:109151
Ltbp4<Gt(U3Cre)1Vmel>,"latent transforming growth factor beta binding protein 4; gene trap 1, Harald von Melchner",MGI:2388061,0,Ltbp4,MGI:1321395
Ltn1<tm1a(EUCOMM)Hmgu>,"listerin E3 ubiquitin protein ligase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4462659,EUCOMM,Ltn1,MGI:1926163
Lvrn<tm1a(KOMP)Wtsi>,"laeverin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887593,KOMP-CSD,Lvrn,MGI:1921824
Lyn<tm1a(EUCOMM)Hmgu>,"LYN proto-oncogene, Src family tyrosine kinase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4888900,EUCOMM,Lyn,MGI:96892
Lyrm9<tm1a(KOMP)Mbp>,"LYR motif containing 9; targeted mutation 1a, Mouse Biology Program, University of California, Davis",MGI:5296077,KOMP-CSD,Lyrm9,MGI:1913524
Lyz2<tm1(cre)Ifo>,"lysozyme 2; targeted mutation 1, Irmgard Forster",MGI:1934631,0,Lyz2,MGI:96897
Lztr1<tm1a(EUCOMM)Wtsi>,"leucine-zipper-like transcriptional regulator, 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432946,EUCOMM,Lztr1,MGI:1914113
M1073b,mutant 1073b,MGI:5515456,0,M1073b,MGI:5515454
M1185b,mutant 1185b,MGI:5515459,0,M1185b,MGI:5515457
M1616b,mutant 1616b,MGI:5515462,0,M1616b,MGI:5515460
M1645b,mutant 1645b,MGI:5515465,0,M1645b,MGI:5515463
M241b,mutant 241b,MGI:5515441,0,M241b,MGI:5515439
M369b,mutant 369b,MGI:5515444,0,M369b,MGI:5515442
M412b,mutant 412b,MGI:5515447,0,M412b,MGI:5515445
M54b,mutant 54b,MGI:5515438,0,M54b,MGI:5515436
M624b,mutant 624b,MGI:5515450,0,M624b,MGI:5515448
M6pr<tm1Psa>,"mannose-6-phosphate receptor, cation dependent; targeted mutation 1, Paul Saftig",MGI:2429535,0,M6pr,MGI:96904
M876b,mutant 876b,MGI:5515453,0,M876b,MGI:5515451
Mab21l3<tm1a(KOMP)Wtsi>,"mab-21-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840949,KOMP-CSD,Mab21l3,MGI:2446273
Mad2l2<tm1a(EUCOMM)Wtsi>,"MAD2 mitotic arrest deficient-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432091,EUCOMM,Mad2l2,MGI:1919140
Maea<tm1a(EUCOMM)Wtsi>,"macrophage erythroblast attacher; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842478,EUCOMM,Maea,MGI:1891748
Maea<tm1b(EUCOMM)Wtsi>,"macrophage erythroblast attacher; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5588275,EUCOMM,Maea,MGI:1891748
Maf<Ofl>,avian musculoaponeurotic fibrosarcoma oncogene homolog; opaque flecks in lens,MGI:2654153,0,Maf,MGI:96909
Mafb<kr>,"v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian); kreisler",MGI:1856419,0,Mafb,MGI:104555
Malt1<tm1Mak>,"MALT1 paracaspase; targeted mutation 1, Tak Mak",MGI:3639305,0,Malt1,MGI:2445027
Mamstr<tm1a(EUCOMM)Wtsi>,"MEF2 activating motif and SAP domain containing transcriptional regulator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4942136,EUCOMM,Mamstr,MGI:1921740
Mamstr<tm1b(EUCOMM)Wtsi>,"MEF2 activating motif and SAP domain containing transcriptional regulator; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637079,EUCOMM,Mamstr,MGI:1921740
Man2b2<tm1a(KOMP)Wtsi>,"mannosidase 2, alpha B2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362174,KOMP-CSD,Man2b2,MGI:1195262
Man2b2<tm1b(KOMP)Wtsi>,"mannosidase 2, alpha B2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5513801,KOMP-CSD,Man2b2,MGI:1195262
Maneal<tm1a(KOMP)Wtsi>,"mannosidase, endo-alpha-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362994,KOMP-CSD,Maneal,MGI:2684896
Mansc4<tm1a(KOMP)Wtsi>,"MANSC domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947759,KOMP-CSD,Mansc4,MGI:3645619
Mansc4<tm1b(KOMP)Wtsi>,,MGI:3645619,,,
Maoa<Tg(H2-K1-Ifnb1)8Seif>,"monoamine oxidase A; transgene insertion 8, Isabelle Seif",MGI:2180818,0,Maoa,MGI:96915
Map2k2<tm1a(EUCOMM)Wtsi>,"mitogen-activated protein kinase kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434127,EUCOMM,Map2k2,MGI:1346867
Map2k7<tm1a(EUCOMM)Wtsi>,"mitogen-activated protein kinase kinase 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842504,EUCOMM,Map2k7,MGI:1346871
Map3k10<tm1a(EUCOMM)Hmgu>,"mitogen-activated protein kinase kinase kinase 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435860,EUCOMM,Map3k10,MGI:1346879
Map3k10<tm1b(EUCOMM)Hmgu>,"mitogen-activated protein kinase kinase kinase 10; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548463,EUCOMM,Map3k10,MGI:1346879
Map3k14<aly>,mitogen-activated protein kinase kinase kinase 14; alymphoplasia,MGI:1858522,0,Map3k14,MGI:1858204
Map3k1<tm1a(KOMP)Wtsi>,"mitogen-activated protein kinase kinase kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451248,KOMP-CSD,Map3k1,MGI:1346872
Map3k7<tm1.1Gkl>,"mitogen-activated protein kinase kinase kinase 7; targeted mutation 1.1, George Kollias",MGI:5576979,0,Map3k7,MGI:1346877
Map3k7<tm1.2Gkl>,"mitogen-activated protein kinase kinase kinase 7; targeted mutation 1.2, George Kollias",MGI:5576980,0,Map3k7,MGI:1346877
Map3k7<tm1a(EUCOMM)Wtsi>,"mitogen-activated protein kinase kinase kinase 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947820,EUCOMM,Map3k7,MGI:1346877
Map3k8<tm1.1Gkl>,"mitogen-activated protein kinase kinase kinase 8; targeted mutation 1.1, George Kollias",MGI:5476710,0,Map3k8,MGI:1346878
Map3k8<tm1.2Gkl>,"mitogen-activated protein kinase kinase kinase 8; targeted mutation 1.2, George Kollias",MGI:5476711,0,Map3k8,MGI:1346878
Map4<Gt(pGT1.8geo)2Pgr>,"microtubule-associated protein 4; gene trap 2, Peter Gruss",MGI:2157047,0,Map4,MGI:97178
Map4k5<Gt(OST218153)Lex>,"mitogen-activated protein kinase kinase kinase kinase 5; gene trap OST218153, Lexicon Genetics",MGI:3530833,Lexicon,Map4k5,MGI:1925503
Mapk10<tm1a(EUCOMM)Wtsi>,"mitogen-activated protein kinase 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842613,EUCOMM,Mapk10,MGI:1346863
Mapk11<tm1a(EUCOMM)Hmgu>,"mitogen-activated protein kinase 11; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435746,EUCOMM,Mapk11,MGI:1338024
Mapk14<tm2Nbr>,"mitogen-activated protein kinase 14; targeted mutation 14, Angel R Nebreda",MGI:3715522,0,Mapk14,MGI:1346865
Mapk1<tm1a(EUCOMM)Wtsi>,"mitogen-activated protein kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432537,EUCOMM,Mapk1,MGI:1346858
Mapk3<tm1Gpg>,"mitogen-activated protein kinase 3; targeted mutation 1, Gilles Pages",MGI:2183906,0,Mapk3,MGI:1346859
Mapk8<tm1Wag>,"mitogen-activated protein kinase 8; targeted mutation 1, Erwin F Wagner",MGI:2384141,0,Mapk8,MGI:1346861
Mapk8ip2<tm1a(EUCOMM)Wtsi>,"mitogen-activated protein kinase 8 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433297,EUCOMM,Mapk8ip2,MGI:1926555
Mapk9<tm1Mka>,"mitogen-activated protein kinase 9; targeted mutation 1, Michael Karin",MGI:2183601,0,Mapk9,MGI:1346862
Mapkapk2<tm1a(EUCOMM)Hmgu>,"MAP kinase-activated protein kinase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842229,EUCOMM,Mapkapk2,MGI:109298
Mapkapk2<tm1c(EUCOMM)Hmgu>,"MAP kinase-activated protein kinase 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH",MGI:5822781,EUCOMM,Mapkapk2,MGI:109298
Mapkbp1<tm1a(EUCOMM)Hmgu>,"mitogen-activated protein kinase binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436014,EUCOMM,Mapkbp1,MGI:1347004
Mapre3<tm1a(EUCOMM)Wtsi>,"microtubule-associated protein, RP/EB family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432919,EUCOMM,Mapre3,MGI:2140967
Mapt<tm1a(EUCOMM)Hmgu>,"microtubule-associated protein tau; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008854,EUCOMM,Mapt,MGI:97180
Marc2<tm2a(EUCOMM)Hmgu>,"mitochondrial amidoxime reducing component 2; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4435988,EUCOMM,37316,MGI:1914497
March3<tm1a(EUCOMM)Hmgu>,"membrane-associated ring finger (C3HC4) 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436233,EUCOMM,37681,MGI:2443667
March5<tm1a(EUCOMM)Wtsi>,"membrane-associated ring finger (C3HC4) 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433802,EUCOMM,38412,MGI:1915207
March6<tm1a(EUCOMM)Hmgu>,"membrane-associated ring finger (C3HC4) 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451874,EUCOMM,38777,MGI:2442773
Marco<tm1Ktry>,"macrophage receptor with collagenous structure; targeted mutation 1, Karl Tryggvason",MGI:3690644,0,Marco,MGI:1309998
Marveld2<tm1a(EUCOMM)Wtsi>,"MARVEL (membrane-associating) domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461651,EUCOMM,Marveld2,MGI:2446166
Mast2<tm1a(KOMP)Wtsi>,"microtubule associated serine/threonine kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363089,KOMP-CSD,Mast2,MGI:894676
Mat2a<tm1a(EUCOMM)Hmgu>,"methionine adenosyltransferase II, alpha; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435877,EUCOMM,Mat2a,MGI:2443731
Mau2<tm1a(KOMP)Wtsi>,"MAU2 sister chromatid cohesion factor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419101,KOMP-CSD,Mau2,MGI:1921799
Mau2<tm1b(KOMP)Wtsi>,"MAU2 sister chromatid cohesion factor; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637081,KOMP-CSD,Mau2,MGI:1921799
Mbd3<tm2Blh>,"methyl-CpG binding domain protein 3; targeted mutation 2, Brian Hendrich",MGI:4887391,0,Mbd3,MGI:1333812
Mboat7<tm1a(KOMP)Wtsi>,"membrane bound O-acyltransferase domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363399,KOMP-CSD,Mboat7,MGI:1924832
Mbt1,mutant Mbt1,MGI:5646566,0,Mbt1,MGI:5646417
Mbt2,mutant Mbt2,MGI:5646567,0,Mbt2,MGI:5646419
Mbt3,mutant Mbt3,MGI:5646568,0,Mbt3,MGI:5646421
Mbtd1<tm2a(EUCOMM)Wtsi>,"mbt domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4455993,EUCOMM,Mbtd1,MGI:2143977
Mbtr2,mutant Mbtr2,MGI:5646572,0,Mbtr2,MGI:5646425
Mbtr3,mutant Mbtr3,MGI:5646564,0,Mbtr3,MGI:5646415
Mc2r<tm1Dgen>,"melanocortin 2 receptor; targeted mutation 1, Deltagen",MGI:5427678,Deltagen,Mc2r,MGI:96928
Mc4r<Mhdahwe13>,melanocortin 4 receptor; Martin Hrabe de Angelis heavy weight 13,MGI:5699976,0,Mc4r,MGI:99457
Mcam<tm1Pyu>,"melanoma cell adhesion molecule; targeted mutation 1, Philipp Yu",MGI:5508221,0,Mcam,MGI:1933966
Mcf2l<tm1a(EUCOMM)Hmgu>,"mcf.2 transforming sequence-like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436065,EUCOMM,Mcf2l,MGI:103263
Mchr1<tm1Ohl>,"melanin-concentrating hormone receptor 1; targeted mutation 1, Claes Ohlsson",MGI:3043698,0,Mchr1,MGI:2180756
Mcph1<tm1a(EUCOMM)Wtsi>,"microcephaly, primary autosomal recessive 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431685,EUCOMM,Mcph1,MGI:2443308
Mcu<tm1a(EUCOMM)Hmgu>,"mitochondrial calcium uniporter; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5294185,EUCOMM,Mcu,MGI:3026965
Mcub<tm1a(KOMP)Mbp>,"mitochondrial calcium uniporter dominant negative beta subunit; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4840771,KOMP-CSD,Mcub,MGI:1914065
Mcub<tm1c(KOMP)Mbp>,,MGI:1914065,,,
Mdc1<Gt(OST441263)Lex>,"mediator of DNA damage checkpoint 1; gene trap OST441263, Lexicon Genetics",MGI:3799747,Lexicon,Mdc1,MGI:3525201
Mdh1<m10Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 10, Neuherberg",MGI:4452373,0,Mdh1,MGI:97051
Mdh1<m11Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 11, Neuherberg",MGI:4452374,0,Mdh1,MGI:97051
Mdh1<m1Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 1, Neuherberg",MGI:4452363,0,Mdh1,MGI:97051
Mdh1<m2Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 2, Neuherberg",MGI:4452364,0,Mdh1,MGI:97051
Mdh1<m3Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 3, Neuherberg",MGI:4452365,0,Mdh1,MGI:97051
Mdh1<m4Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 4, Neuherberg",MGI:4452366,0,Mdh1,MGI:97051
Mdh1<m5Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 5, Neuherberg",MGI:4452367,0,Mdh1,MGI:97051
Mdh1<m6Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 6, Neuherberg",MGI:4452368,0,Mdh1,MGI:97051
Mdh1<m7Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 7, Neuherberg",MGI:4452370,0,Mdh1,MGI:97051
Mdh1<m8Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 8, Neuherberg",MGI:4452371,0,Mdh1,MGI:97051
Mdh1<m9Neu>,"malate dehydrogenase 1, NAD (soluble); mutation 9, Neuherberg",MGI:4452372,0,Mdh1,MGI:97051
Mdn1<tm1a(KOMP)Wtsi>,"midasin AAA ATPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363099,KOMP-CSD,Mdn1,MGI:1926159
Me2<m1Mhda>,"malic enzyme 2, NAD(+)-dependent, mitochondrial; mutation 1, Martin Hrabe de Angelis",MGI:5818741,0,Me2,MGI:2147351
Me2<tm1a(EUCOMM)Hmgu>,"malic enzyme 2, NAD(+)-dependent, mitochondrial; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434603,EUCOMM,Me2,MGI:2147351
Me3<tm1a(KOMP)Wtsi>,"malic enzyme 3, NADP(+)-dependent, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362498,KOMP-CSD,Me3,MGI:1916679
Me3<tm1b(KOMP)Wtsi>,"malic enzyme 3, NADP(+)-dependent, mitochondrial; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5629317,KOMP-CSD,Me3,MGI:1916679
Meaf6<tm1a(EUCOMM)Wtsi>,"MYST/Esa1-associated factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433956,EUCOMM,Meaf6,MGI:1917338
Mecom<Jbo>,MDS1 and EVI1 complex locus; Junbo,MGI:2158381,Harwell ENU Mutagenesis,Mecom,MGI:95457
Mecr<tm1a(EUCOMM)Wtsi>,"mitochondrial trans-2-enoyl-CoA reductase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432643,EUCOMM,Mecr,MGI:1349441
Mecr<tm1c(EUCOMM)Wtsi>,"mitochondrial trans-2-enoyl-CoA reductase; targeted mutation 1c, Wellcome Trust Sanger Institute",MGI:6119418,EUCOMM,Mecr,MGI:1349441
Med18<tm1a(EUCOMM)Wtsi>,"mediator complex subunit 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432982,EUCOMM,Med18,MGI:1914469
Med19<tm1a(EUCOMM)Wtsi>,"mediator complex subunit 19; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432772,EUCOMM,Med19,MGI:1914234
Med22<tm1a(EUCOMM)Wtsi>,"mediator complex subunit 22; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008031,EUCOMM,Med22,MGI:98446
Med25<tm1a(KOMP)Wtsi>,"mediator complex subunit 25; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362835,KOMP-CSD,Med25,MGI:1922863
Med31<l11Jus15>,"mediator complex subunit 31; lethal, Chr 11, Justice 15",MGI:2671886,Mutagenesis for Dev. Defects,Med31,MGI:1914529
Medag<tm2a(KOMP)Wtsi>,"mesenteric estrogen dependent adipogenesis; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4431426,KOMP-CSD,Medag,MGI:1917967
Medag<tm2b(KOMP)Wtsi>,"mesenteric estrogen dependent adipogenesis; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548602,KOMP-CSD,Medag,MGI:1917967
Meg3<Gt(pGTi)216Gos>,"maternally expressed 3; gene trap 216, Achim Gossler",MGI:2177961,0,Meg3,MGI:1202886
Meis3<tm1a(EUCOMM)Hmgu>,"Meis homeobox 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5571335,EUCOMM,Meis3,MGI:108519
Melk<tm1a(KOMP)Wtsi>,"maternal embryonic leucine zipper kinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362376,KOMP-CSD,Melk,MGI:106924
Men1<tm1.1Zqw>,"multiple endocrine neoplasia 1; targeted mutation 1.1, Zhao-Qi Wang",MGI:2664873,0,Men1,MGI:1316736
Men1<tm1.2Zqw>,"multiple endocrine neoplasia 1; targeted mutation 1, Zhao-Qi Wang",MGI:2675250,0,Men1,MGI:1316736
Men1<tm1Zqw>,"multiple endocrine neoplasia 1; targeted mutation 1, Zhao-Qi Wang",MGI:2664869,0,Men1,MGI:1316736
Mep1a<tm1a(KOMP)Wtsi>,"meprin 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455495,KOMP-CSD,Mep1a,MGI:96963
Metrnl<tm1a(KOMP)Wtsi>,"meteorin, glial cell differentiation regulator-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362702,KOMP-CSD,Metrnl,MGI:2384806
Metrnl<tm1b(KOMP)Wtsi>,"meteorin, glial cell differentiation regulator-like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637126,KOMP-CSD,Metrnl,MGI:2384806
Mettl24<tm1a(KOMP)Wtsi>,"methyltransferase like 24; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363211,KOMP-CSD,Mettl24,MGI:3045338
Mex3a<tm1(KOMP)Vlcg>,"mex3 RNA binding family member A; targeted mutation 1, Velocigene",MGI:5085513,KOMP-Regeneron,Mex3a,MGI:1919890
Mex3b<tm1a(KOMP)Wtsi>,"mex3 RNA binding family member B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5427179,KOMP-CSD,Mex3b,MGI:1918252
Mfge8<Gt(KST227)Byg>,"milk fat globule-EGF factor 8 protein; gene trap KST227, BayGenomics",MGI:3578644,0,Mfge8,MGI:102768
Mfn2<tm1a(EUCOMM)Wtsi>,"mitofusin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434285,EUCOMM,Mfn2,MGI:2442230
Mfrp<tm1a(KOMP)Wtsi>,"membrane frizzled-related protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456645,KOMP-CSD,Mfrp,MGI:2385957
Mfsd2b<tm1a(KOMP)Wtsi>,"major facilitator superfamily domain containing 2B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362372,KOMP-CSD,Mfsd2b,MGI:3583946
Mfsd8<tm1a(EUCOMM)Hmgu>,"major facilitator superfamily domain containing 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4456699,EUCOMM,Mfsd8,MGI:1919425
Mgat1<tm1a(EUCOMM)Hmgu>,"mannoside acetylglucosaminyltransferase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842039,EUCOMM,Mgat1,MGI:96973
Mgat1<tm1b(EUCOMM)Hmgu>,"mannoside acetylglucosaminyltransferase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613671,EUCOMM,Mgat1,MGI:96973
Mgat4c<tm1a(EUCOMM)Wtsi>,"MGAT4 family, member C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433541,EUCOMM,Mgat4c,MGI:1914819
Mgat5b<tm1Itl>,"mannoside acetylglucosaminyltransferase 5, isoenzyme B; targeted mutation 1, inGenious Targeting Laboratory",MGI:5442814,0,Mgat5b,MGI:3606200
Mgmt<tm1Iz>,"O-6-methylguanine-DNA methyltransferase; targeted mutation 1, Manfred F Rajewsky",MGI:2652462,0,Mgmt,MGI:96977
Mgst3<tm1b(KOMP)Wtsi>,"microsomal glutathione S-transferase 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548521,KOMP-CSD,Mgst3,MGI:1913697
Mhdaabe025,Martin Hrabe de Angelis abnormal behavior mutant 025,MGI:2681160,0,Mhdaabe025,MGI:2681158
Mhdaabe10,Martin Hrabe de Angelis abnormal behavior mutant 10,MGI:2681186,0,Mhdaabe10,MGI:2681180
Mhdaabe12,Martin Hrabe de Angelis abnormal behavior 12,MGI:5618460,0,Mhdaabe12,MGI:5618438
Mhdaabe14,Martin Hrabe de Angelis abnormal behavior 14,MGI:5618475,0,Mhdaabe14,MGI:5618472
Mhdaabe15,Martin Hrabe de Angelis abnormal behavior 15,MGI:5618481,0,Mhdaabe15,MGI:5618479
Mhdaabe16,Martin Hrabe de Angelis abnormal behavior 16,MGI:5618488,0,Mhdaabe16,MGI:5618485
Mhdaabe18,Martin Hrabe de Angelis abnormal behavior mutant 18,MGI:2681199,0,Mhdaabe18,MGI:2681193
Mhdaabe21,Martin Hrabe de Angelis abnormal behavior 21,MGI:5618493,0,Mhdaabe21,MGI:5618490
Mhdaabe26,Martin Hrabe de Angelis abnormal behavior 26,MGI:5618500,0,Mhdaabe26,MGI:5618498
Mhdaabe30,Martin Hrabe de Angelis abnormal behavior 30,MGI:5618504,0,Mhdaabe30,MGI:5618502
Mhdaabe31,Martin Hrabe de Angelis abnormal behavior 31,MGI:5618508,0,Mhdaabe31,MGI:5618506
Mhdaaey15,Martin Hrabe de Angelis abnormal eye 15,MGI:5618903,0,Mhdaaey15,MGI:5618891
Mhdaaey16,Martin Hrabe de Angelis abnormal eye 16,MGI:5618917,0,Mhdaaey16,MGI:5618915
Mhdaaey19,Martin Hrabe de Angelis abnormal eye 19,MGI:5618925,0,Mhdaaey19,MGI:5618923
Mhdaaey43,Martin Hrabe de Angelis abnormal eye 43,MGI:5618929,0,Mhdaaey43,MGI:5618927
Mhdaali026,Martin Hrabe de Angelis abnormal limbs 026,MGI:3530485,0,Mhdaali026,MGI:3530483
Mhdaali028,Martin Hrabe de Angelis limb abnormality 028,MGI:3530493,0,Mhdaali028,MGI:3530489
Mhdaali029,Martin Hrabe de Angelis abnormal limbs 029,MGI:2681266,0,Mhdaali029,MGI:2681245
Mhdaali031,Martin Hrabe de Angelis abnormal limbs 031,MGI:2681240,0,Mhdaali031,MGI:2681219
Mhdaali11,Martin Hrabe de Angelis abnormal limbs 11,MGI:2681241,0,Mhdaali11,MGI:2681221
Mhdaali12,Martin Hrabe de Angelis abnormal limb mutant 12,MGI:5615408,0,Mhdaali12,MGI:5615406
Mhdaali13,Martin Hrabe de Angelis abnormal limbs 13,MGI:2681692,0,Mhdaali13,MGI:2681249
Mhdaali15,Martin Hrabe de Angelis abnormal limbs 15,MGI:2681698,0,Mhdaali15,MGI:2681224
Mhdaali19,Martin Hrabe de Angelis abnormal limbs 19,MGI:3530507,0,Mhdaali19,MGI:3530505
Mhdaali20,Martin Hrabe de Angelis abnormal limbs 20,MGI:3530512,0,Mhdaali20,MGI:3530510
Mhdaali21,Martin Hrabe de Angelis abnormal limbs 21,MGI:5619318,0,Mhdaali21,MGI:5619316
Mhdaali22,Martin Hrabe de Angelis abnormal limb mutant 22,MGI:5615414,0,Mhdaali22,MGI:5615412
Mhdaali23,Martin Hrabe de Angelis abnormal limbs 23,MGI:3530517,0,Mhdaali23,MGI:3530515
Mhdaali24,Martin Hrabe de Angelis abnormal limbs 24,MGI:3530523,0,Mhdaali24,MGI:3530520
Mhdaali25,Martin Hrabe de Angelis abnormal limbs 25,MGI:3530527,0,Mhdaali25,MGI:3530525
Mhdaali33,Martin Hrabe de Angelis abnormal limbs 33,MGI:5619374,0,Mhdaali33,MGI:5619369
Mhdaali36,Martin Hrabe de Angelis abnormal limbs 36,MGI:5619389,0,Mhdaali36,MGI:5619382
Mhdaali38,Martin Hrabe de Angelis abnormal limbs 38,MGI:5619393,0,Mhdaali38,MGI:5619391
Mhdaali39,Martin Hrabe de Angelis abnormal limbs 39,MGI:5619397,0,Mhdaali39,MGI:5619395
Mhdaali4,Martin Hrabe de Angelis abnormal limbs 4,MGI:2681255,0,Mhdaali4,MGI:2681233
Mhdaali40,Martin Hrabe de Angelis abnormal limbs 40,MGI:5619406,0,Mhdaali40,MGI:5619403
Mhdaali41,Martin Hrabe de Angelis abnormal limbs 41,MGI:5619507,0,Mhdaali41,MGI:5619505
Mhdaali42,Martin Hrabe de Angelis abnormal limbs 42,MGI:5619571,0,Mhdaali42,MGI:5619569
Mhdaali44,Martin Hrabe de Angelis abnormal limbs 44,MGI:5619589,0,Mhdaali44,MGI:5619586
Mhdaali45,Martin Hrabe de Angelis abnormal limbs 45,MGI:5619606,0,Mhdaali45,MGI:5619603
Mhdaali7,Martin Hrabe de Angelis abnormal limbs 7,MGI:2681258,0,Mhdaali7,MGI:2681239
Mhdaali9,Martin Hrabe de Angelis abnormal limbs 9,MGI:5618933,0,Mhdaali9,MGI:5618931
Mhdabap001,Martin Hrabe de Angelis bone alkaline phospatase mutant 001,MGI:5424898,0,Mhdabap001,MGI:5425469
Mhdabap003,Martin Hrabe de Angelis bone alkaline phosphatase mutant 003; Martin Hrabe de Angelis bone alkaline phospatase mutant 003,MGI:5424900,0,Mhdabap003,MGI:5425483
Mhdabap009,Martin Hrabe de Angelis bone alkaline phospatase mutant 009,MGI:5424903,0,Mhdabap009,MGI:5425495
Mhdabap16,Martin Hrabe de Angelis bone alkaline phospatase mutant 16,MGI:5424907,0,Mhdabap16,MGI:5425503
Mhdabap17,Martin Hrabe de Angelis bone alkaline phospatase mutant 17,MGI:5424908,0,Mhdabap17,MGI:5425505
Mhdabap18,Martin Hrabe de Angelis bone alkaline phosphatase mutant 18,MGI:5424909,0,Mhdabap18,MGI:5425507
Mhdabap19,Martin Hrabe de Angelis bone alkaline phosphatase mutant 19,MGI:5424910,0,Mhdabap19,MGI:5425509
Mhdabap21,Martin Hrabe de Angelis bone alkaline phosphatase mutant 21,MGI:5424911,0,Mhdabap21,MGI:5425510
Mhdabap22,Martin Hrabe de Angelis bone alkaline phosphatase mutant 22,MGI:5424912,0,Mhdabap22,MGI:5425512
Mhdabcc6,Martin Hrabe de Angelis bright coat color 6,MGI:5619957,0,Mhdabcc6,MGI:5619955
Mhdabcc8,Martin Hrabe de Angelis bright coat color 8,MGI:5619962,0,Mhdabcc8,MGI:5619958
Mhdabch10,Martin Hrabe de Angelis bone screen calcium high 10,MGI:5424977,0,Mhdabch10,MGI:5425931
Mhdabch6,Martin Hrabe de Angelis bone screen calcium high 6,MGI:5424974,0,Mhdabch6,MGI:5425926
Mhdabch8,Martin Hrabe de Angelis bone screen calcium high 8,MGI:5424975,0,Mhdabch8,MGI:5425928
Mhdabch9,Martin Hrabe de Angelis bone screen calcium high 9,MGI:5424976,0,Mhdabch9,MGI:5425930
Mhdacco2,Martin Hrabe de Angelis curly coat 2,MGI:3530531,0,Mhdacco2,MGI:3530529
Mhdacco3,Martin Hrabe de Angelis curly coat 3,MGI:5619972,0,Mhdacco3,MGI:5619969
Mhdacco4,Martin Hrabe de Angelis curly coat 4,MGI:5619976,0,Mhdacco4,MGI:5619974
Mhdacco6,Martin Hrabe de Angelis curly coat 6,MGI:5619983,0,Mhdacco6,MGI:5619981
Mhdacra2,Martin Hrabe de Angelis cramping 2,MGI:5619987,0,Mhdacra2,MGI:5619985
Mhdacra4,Martin Hrabe de Angelis cramping 4,MGI:5620244,0,Mhdacra4,MGI:5620242
Mhdacra7,Martin Hrabe de Angelis cramping 7,MGI:5620388,0,Mhdacra7,MGI:5620386
Mhdacra8,Martin Hrabe de Angelis cramping 8,MGI:5620396,0,Mhdacra8,MGI:5620392
Mhdacta3,Martin Hrabe de Angelis coiled tail 3,MGI:5620400,0,Mhdacta3,MGI:5620398
Mhdadbs1,Martin Hrabe de Angelis DBS1,MGI:5620405,0,Mhdadbs1,MGI:5620403
Mhdadcc2,Martin Hrabe de Angelis dark coat color 2,MGI:2681723,0,Mhdadcc2,MGI:2681719
Mhdadcc3,Martin Hrabe de Angelis dark coat color 3,MGI:5620444,0,Mhdadcc3,MGI:5620441
Mhdadcc8,Martin Hrabe de Angelis dark coat color 8,MGI:5620472,0,Mhdadcc8,MGI:5620470
Mhdadea1,Martin Hrabe de Angelis deafness 1,MGI:5620483,0,Mhdadea1,MGI:5620481
Mhdadea11,Martin Hrabe de Angelis deafness 11,MGI:5620516,0,Mhdadea11,MGI:5620514
Mhdadea13,Martin Hrabe de Angelis deafness 13,MGI:5620643,0,Mhdadea13,MGI:5620641
Mhdadea16,Martin Hrabe de Angelis deafness 16,MGI:5620652,0,Mhdadea16,MGI:5620648
Mhdadsk13,Martin Hrabe de Angelis dark skin 13,MGI:5620656,0,Mhdadsk13,MGI:5620654
Mhdadsk6,Martin Hrabe de Angelis dark skin 6,MGI:2681792,0,Mhdadsk6,MGI:2450687
Mhdadsk8,Martin Hrabe de Angelis dark skin 8,MGI:2682215,0,Mhdadsk8,MGI:2450691
Mhdadxa1,Martin Hrabe de Angelis dual energy X-ray absorptiometry mutant 1,MGI:5620697,0,Mhdadxa1,MGI:5620693
Mhdadxa2,Martin Hrabe de Angelis dual energy X-ray absorptiometry mutant 2,MGI:5620706,0,Mhdadxa2,MGI:5620704
Mhdahwe11,Martin Hrabe de Angelis heavy weight 11,MGI:5620744,0,Mhdahwe11,MGI:5620740
Mhdahwe5,Martin Hrabe de Angelis heavy weight 5,MGI:5620722,0,Mhdahwe5,MGI:5620720
Mhdahwe6,Martin Hrabe de Angelis heavy weight 6,MGI:5620726,0,Mhdahwe6,MGI:5620724
Mhdahwe8,Martin Hrabe de Angelis heavy weight 8,MGI:5620732,0,Mhdahwe8,MGI:5620729
Mhdahwe9,Martin Hrabe de Angelis heavy weight 9,MGI:5620737,0,Mhdahwe9,MGI:5620734
Mhdakta1,Martin Hrabe de Angelis kinked tail 1,MGI:2682717,0,Mhdakta1,MGI:2682669
Mhdakta12,Martin Hrabe de Angelis kinked tail 12,MGI:2682718,0,Mhdakta12,MGI:2682671
Mhdakta18,Martin Hrabe de Angelis kinked tail 18,MGI:2682719,0,Mhdakta18,MGI:2682673
Mhdakta19,Martin Hrabe de Angelis kinked tail 19,MGI:2682720,0,Mhdakta19,MGI:2682675
Mhdakta20,Martin Hrabe de Angelis kinked tail 20,MGI:2682721,0,Mhdakta20,MGI:2682677
Mhdakta21,Martin Hrabe de Angelis kinked tail 21,MGI:2682722,0,Mhdakta21,MGI:2682678
Mhdakta24,Martin Hrabe de Angelis kinked tail 24,MGI:2682723,0,Mhdakta24,MGI:2682679
Mhdakta26,Martin Hrabe de Angelis kinked tail 26,MGI:2682724,0,Mhdakta26,MGI:2682680
Mhdakta27,Martin Hrabe de Angelis kinked tail 27,MGI:5620749,0,Mhdakta27,MGI:5620747
Mhdakta28,Martin Hrabe de Angelis kinked tail 28,MGI:2682725,0,Mhdakta28,MGI:2682681
Mhdakta29,Martin Hrabe de Angelis kinked tail 29,MGI:2682726,0,Mhdakta29,MGI:2682682
Mhdakta30,Martin Hrabe de Angelis kinked tail 30,MGI:2682727,0,Mhdakta30,MGI:2682683
Mhdakta31,Martin Hrabe de Angelis kinked tail 31,MGI:2682728,0,Mhdakta31,MGI:2682684
Mhdakta32,Martin Hrabe de Angelis kinked tail 32,MGI:2682729,0,Mhdakta32,MGI:2682685
Mhdakta33,Martin Hrabe de Angelis kinked tail 33,MGI:2682730,0,Mhdakta33,MGI:2682686
Mhdakta34,Martin Hrabe de Angelis kinked tail 34,MGI:5620753,0,Mhdakta34,MGI:5620751
Mhdakta35,Martin Hrabe de Angelis kinked tail 35,MGI:2682731,0,Mhdakta35,MGI:2682687
Mhdakta36,Martin Hrabe de Angelis kinked tail 36,MGI:2682732,0,Mhdakta36,MGI:2682688
Mhdakta39,Martin Hrabe de Angelis kinked tail 39,MGI:2682734,0,Mhdakta39,MGI:2682690
Mhdakta40,Martin Hrabe de Angelis kinked tail 40,MGI:5620766,0,Mhdakta40,MGI:5620764
Mhdakta42,Martin Hrabe de Angelis kinked tail 42,MGI:5620772,0,Mhdakta42,MGI:5620769
Mhdakta45,Martin Hrabe de Angelis kinked tail 45,MGI:5620788,0,Mhdakta45,MGI:5620786
Mhdakta46,Martin Hrabe de Angelis kinked tail 46,MGI:5620794,0,Mhdakta46,MGI:5620791
Mhdakta49,Martin Hrabe de Angelis kinked tail 49,MGI:5620883,0,Mhdakta49,MGI:5620881
Mhdakta5,Martin Hrabe de Angelis kinked tail 5,MGI:2682735,0,Mhdakta5,MGI:2682691
Mhdakta51,Martin Hrabe de Angelis kinked tail 51,MGI:5620895,0,Mhdakta51,MGI:5620892
Mhdakta52,Martin Hrabe de Angelis kinked tail 52,MGI:5620899,0,Mhdakta52,MGI:5620897
Mhdakta54,Martin Hrabe de Angelis kinked tail 54,MGI:5620903,0,Mhdakta54,MGI:5620901
Mhdarco008,Martin Hrabe de Angelis reduced coat 008,MGI:3530298,0,Mhdarco008,MGI:3530296
Mhdarco17,Martin Hrabe de Angelis reduced  coat 17,MGI:5629246,0,Mhdarco17,MGI:5629244
Mhdarco18,Martin Hrabe de Angelis reduced  coat 18,MGI:5629250,0,Mhdarco18,MGI:5629248
Mhdarco19,Martin Hrabe de Angelis reduced  coat 19,MGI:5629254,0,Mhdarco19,MGI:5629252
Mhdarco4,Martin Hrabe de Angelis reduced  coat 4,MGI:5621044,0,Mhdarco4,MGI:5621041
Mhdarco5,Martin Hrabe de Angelis reduced coat 5,MGI:5621272,0,Mhdarco5,MGI:5621270
Mhdarco6,Martin Hrabe de Angelis reduced coat 6,MGI:5621276,0,Mhdarco6,MGI:5621274
Mhdasca1,Martin Hrabe de Angelis serum calcium mutant 1; Martin Hrabe de Angelis serum calcium mutant 001,MGI:5425010,0,Mhdasca1,MGI:5629256
Mhdasco10,Martin Hrabe de Angelis spotted coat 10,MGI:5629393,0,Mhdasco10,MGI:5629391
Mhdasco11,Martin Hrabe de Angelis spotted  coat 11; Martin Hrabe de Angelis spotted  coat 11q,MGI:5629397,0,Mhdasco11,MGI:5629395
Mhdasco6,Martin Hrabe de Angelis spotted coat 6,MGI:2682768,0,Mhdasco6,MGI:2682764
Mhdasco7,Martin Hrabe de Angelis spotted coat 7,MGI:2682770,0,Mhdasco7,MGI:2682766
Mhdasco8,Martin Hrabe de Angelis spotted  coat 8,MGI:5629380,0,Mhdasco8,MGI:5629374
Mhdasco9,Martin Hrabe de Angelis spotted  coat 9,MGI:5629388,0,Mhdasco9,MGI:5629384
Mhdasma3,Martin Hrabe de Angelis small 3,MGI:5629407,0,Mhdasma3,MGI:5629405
Mhdasma6,Martin Hrabe de Angelis small 6,MGI:5752270,0,Mhdasma6,MGI:5752268
Mhdasta1,Martin Hrabe de Angelis short tail 1,MGI:5629413,0,Mhdasta1,MGI:5629411
Mhdasta2,Martin Hrabe de Angelis short tail 2,MGI:5629418,0,Mhdasta2,MGI:5629416
Mhdawbe5,Martin Hrabe de Angelis waltzing behavior 5,MGI:2682782,0,Mhdawbe5,MGI:2682780
Mhdawbs010,Martin Hrabe de Angelis white belly spot 010,MGI:3530340,0,Mhdawbs010,MGI:3530337
Mhdawbs011,Martin Hrabe de Angelis white belly spot 011,MGI:2682860,0,Mhdawbs011,MGI:2682856
Mhdawbs1,Martin Hrabe de Angelis white belly spot 1,MGI:3530349,0,Mhdawbs1,MGI:3530346
Mhdawbs12,Martin Hrabe de Angelis white belly spot 12,MGI:5629531,0,Mhdawbs12,MGI:5629529
Mhdawbs13,Martin Hrabe de Angelis white belly spot 13,MGI:5629561,0,Mhdawbs13,MGI:5629559
Mhdawbs14,Martin Hrabe de Angelis white belly spot 14,MGI:5629565,0,Mhdawbs14,MGI:5629563
Mhdawbs15,Martin Hrabe de Angelis white belly spot 15,MGI:5629570,0,Mhdawbs15,MGI:5629567
Mhdawbs3,Martin Hrabe de Angelis white belly spot 3,MGI:2682862,0,Mhdawbs3,MGI:2682858
Mhdawbs5,Martin Hrabe de Angelis white belly spot 5,MGI:3530586,0,Mhdawbs5,MGI:3530584
Mhdawbs6,Martin Hrabe de Angelis white belly spot 6,MGI:5629518,0,Mhdawbs6,MGI:5629516
Mhdawbs7,Martin Hrabe de Angelis white belly spot 7,MGI:5629523,0,Mhdawbs7,MGI:5629521
Mhdawbs8,Martin Hrabe de Angelis white belly spot 8,MGI:5629527,0,Mhdawbs8,MGI:5629525
Mhdawbs9,Martin Hrabe de Angelis white belly spot 9,MGI:3530604,0,Mhdawbs9,MGI:3530591
Mib2<tm1a(EUCOMM)Wtsi>,"mindbomb E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431678,EUCOMM,Mib2,MGI:2679684
Micu2<tm1a(EUCOMM)Wtsi>,"mitochondrial calcium uptake 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434182,EUCOMM,Micu2,MGI:1915764
Mier1<tm1a(EUCOMM)Wtsi>,"MEIR1 treanscription regulator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431567,EUCOMM,Mier1,MGI:1918398
Miga2<tm1a(KOMP)Wtsi>,"mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362858,KOMP-CSD,Miga2,MGI:1922035
Minar2<tm1a(KOMP)Wtsi>,"membrane integral NOTCH2 associated receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5000328,KOMP-CSD,Minar2,MGI:2442934
Minar2<tm1b(KOMP)Wtsi>,,MGI:2442934,,,
Mipol1<tm1a(EUCOMM)Hmgu>,"mirror-image polydactyly 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4843891,EUCOMM,Mipol1,MGI:1920740
Mipol1<tm1b(EUCOMM)Hmgu>,"mirror-image polydactyly 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5605791,EUCOMM,Mipol1,MGI:1920740
Mir10a<tm1.1Ahl>,"microRNA 10a; targeted mutation 1.1, Anders Lund",MGI:5567937,0,Mir10a,MGI:3619064
Mir144/Mir451a<tm1.1Doca>,"microRNA 451a; targeted mutation 1.1, Donal O'Carroll",MGI:4829616,0,Mir451a,MGI:3619412
Mir144/Mir451a<tm1.2Doca>,"microRNA 451a; targeted mutation 1.2, Donal O'Carroll",MGI:4829618,0,Mir451a,MGI:3619412
Mir155<tm1.1Brd>,"microRNA 155; targeted mutation 1.1, Allan Bradley",MGI:3709881,0,Mir155,MGI:2676840
Mir210<tm1.1Wtsi>,"microRNA 210; targeted mutation 1.1, Wellcome Trust Sanger Institute",MGI:5555932,0,Mir210,MGI:2676886
Mir451a<tm1.2Doca>,"microRNA 451a; targeted mutation 1.2, Donal O'Carroll",MGI:4829620,0,Mir451a,MGI:3619412
Mir96<Dmdo>,microRNA 96; diminuendo,MGI:4354110,0,Mir96,MGI:3619440
Mir96<tm2.2(IMPC)Wtsi>,,MGI:3619440,,,
Mir96<tm3.2(IMPC)Wtsi>,,MGI:3619440,,,
Mirc12<tm1.1Doca>,"microRNA cluster 12, including Mir144 through Mir451a; targeted mutation 1.1, Donal O'Carroll",MGI:5296851,0,Mirc12,MGI:5296816
Mirc36<tm1.1Jcav>,"microRNA cluster 36, including Mir379 through Mir3072; targeted mutation 1.1,  Jerome Cavaille",MGI:5614047,0,Mirc36,MGI:5614031
Mis18bp1<tm1a(EUCOMM)Wtsi>,"MIS18 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432385,EUCOMM,Mis18bp1,MGI:2145099
Mitf<Mi>,melanogenesis associated transcription factor; microphthalmia,MGI:1856085,0,Mitf,MGI:104554
Mitf<Rorp>,melanogenesis associated transcription factor; retinal orange patches,MGI:2178357,0,Mitf,MGI:104554
Mitf<mi-Mhdabcc2>,melanogenesis associated transcription factor; microphthalmia Martin Hrabe de Angelis bright coat color 2,MGI:3040390,0,Mitf,MGI:104554
Mkrn1<tm1a(EUCOMM)Hmgu>,"makorin, ring finger protein, 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5430125,EUCOMM,Mkrn1,MGI:1859353
Mkrn2<tm1a(KOMP)Wtsi>,"makorin, ring finger protein, 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944368,KOMP-CSD,Mkrn2,MGI:1914277
Mkrn2<tm1b(KOMP)Wtsi>,"makorin, ring finger protein, 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548531,KOMP-CSD,Mkrn2,MGI:1914277
Mks1<tm1a(EUCOMM)Wtsi>,"Meckel syndrome, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433029,EUCOMM,Mks1,MGI:3584243
Mlana<tm1.1Bee>,"melan-A; targeted mutation 1.1, Friedrich Beermann",MGI:5476658,0,Mlana,MGI:108454
Mlana<tm1.2Bee>,"melan-A; targeted mutation 1.2, Friedrich Beermann",MGI:5476663,0,Mlana,MGI:108454
Mlec<tm1a(EUCOMM)Wtsi>,"malectin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461689,EUCOMM,Mlec,MGI:1924015
Mlh1<tm1a(EUCOMM)Hmgu>,"mutL homolog 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435839,EUCOMM,Mlh1,MGI:101938
Mllt3<tm1a(EUCOMM)Hmgu>,"myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434535,EUCOMM,Mllt3,MGI:1917372
Mmp11<tm1a(EUCOMM)Hmgu>,"matrix metallopeptidase 11; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436340,EUCOMM,Mmp11,MGI:97008
Mmp12<tm1a(EUCOMM)Hmgu>,"matrix metallopeptidase 12; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455797,EUCOMM,Mmp12,MGI:97005
Mmp16<tm1a(EUCOMM)Wtsi>,"matrix metallopeptidase 16; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014693,EUCOMM,Mmp16,MGI:1276107
Mmp19<tm1Rase>,"matrix metallopeptidase 19; targeted mutation 1, Radislav Sedlacek",MGI:5509300,0,Mmp19,MGI:1927899
Mmp20<m1Mhda>,"matrix metallopeptidase 20 (enamelysin); mutation 1, Martin Hrabe de Angelis",MGI:5619597,0,Mmp20,MGI:1353466
Mmp27<m1Mhda>,"matrix metallopeptidase 27; mutation 1, Martin Hrabe de Angelis",MGI:5818742,0,Mmp27,MGI:3039232
Mmp28<tm1Mani>,"matrix metallopeptidase 28 (epilysin); targeted mutation 1, Anne M Manicone",MGI:3836773,0,Mmp28,MGI:2153062
Mmp9<tm1a(EUCOMM)Wtsi>,"matrix metallopeptidase 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286404,EUCOMM,Mmp9,MGI:97011
Mmrn1<tm1a(EUCOMM)Hmgu>,"multimerin 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451813,EUCOMM,Mmrn1,MGI:1918195
Mms22l<tm1a(EUCOMM)Wtsi>,"MMS22-like, DNA repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433323,EUCOMM,Mms22l,MGI:2684980
Mob2<tm1a(KOMP)Wtsi>,"MOB kinase activator 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286243,KOMP-CSD,Mob2,MGI:1919891
Mob3b<tm1a(KOMP)Wtsi>,"MOB kinase activator 3B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052418,KOMP-CSD,Mob3b,MGI:2664539
Mocs2<tm1a(EUCOMM)Wtsi>,"molybdenum cofactor synthesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456059,EUCOMM,Mocs2,MGI:1336894
Mocs2<tm1b(EUCOMM)Wtsi>,"molybdenum cofactor synthesis 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548433,EUCOMM,Mocs2,MGI:1336894
Mok<tm1a(EUCOMM)Hmgu>,"MOK protein kinase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841489,EUCOMM,Mok,MGI:1336881
Mospd1<tm1a(KOMP)Wtsi>,"motile sperm domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362521,KOMP-CSD,Mospd1,MGI:1917630
Mpg<tm1a(EUCOMM)Wtsi>,"N-methylpurine-DNA glycosylase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432493,EUCOMM,Mpg,MGI:97073
Mpi<tm1a(EUCOMM)Wtsi>,"mannose phosphate isomerase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432151,EUCOMM,Mpi,MGI:97075
Mpo<tm1a(KOMP)Wtsi>,"myeloperoxidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362976,KOMP-CSD,Mpo,MGI:97137
Mpst<tm1a(EUCOMM)Hmgu>,"mercaptopyruvate sulfurtransferase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841819,EUCOMM,Mpst,MGI:2179733
Mr1<tm1Gfn>,"major histocompatibility complex, class I-related; targeted mutation 1, Susan Gilfillan",MGI:3664578,0,Mr1,MGI:1195463
Mrap2<tm1a(EUCOMM)Wtsi>,"melanocortin 2 receptor accessory protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434054,EUCOMM,Mrap2,MGI:3609239
Mras<Gt(OST108223)Lex>,"muscle and microspikes RAS; gene trap OST108223, Lexicon Genetics",MGI:3530902,Lexicon,Mras,MGI:1100856
Mrc2<tm1Cmi>,"mannose receptor, C type 2; targeted mutation 1, Clare M Isacke",MGI:3722867,0,Mrc2,MGI:107818
Mrm1<tm2a(EUCOMM)Wtsi>,"mitochondrial rRNA methyltransferase 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5472694,EUCOMM,Mrm1,MGI:2443470
Mroh1<tm1a(KOMP)Wtsi>,"maestro heat-like repeat family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050151,KOMP-CSD,Mroh1,MGI:2442558
Mroh4<tm1a(KOMP)Wtsi>,"maestro heat-like repeat family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363764,KOMP-CSD,Mroh4,MGI:1916689
Mroh4<tm1b(KOMP)Wtsi>,"maestro heat-like repeat family member 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637041,KOMP-CSD,Mroh4,MGI:1916689
Mroh7<tm1a(EUCOMM)Wtsi>,"maestro heat-like repeat family member 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434135,EUCOMM,Mroh7,MGI:2685873
Mroh9<tm1a(EUCOMM)Wtsi>,"maestro heat-like repeat family member 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5302347,EUCOMM,Mroh9,MGI:1925508
Mrpl10<tm1a(EUCOMM)Hmgu>,"mitochondrial ribosomal protein L10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435617,EUCOMM,Mrpl10,MGI:1333801
Mrpl23<tm2a(EUCOMM)Wtsi>,"mitochondrial ribosomal protein L23; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840687,EUCOMM,Mrpl23,MGI:1196612
Mrpl54<tm1a(EUCOMM)Wtsi>,"mitochondrial ribosomal protein L54; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432901,EUCOMM,Mrpl54,MGI:1913297
Mrps21<tm1e(EUCOMM)Wtsi>,"mitochondrial ribosomal protein S21; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433908,EUCOMM,Mrps21,MGI:1913542
Mrps35<tm1a(EUCOMM)Wtsi>,"mitochondrial ribosomal protein S35; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433487,EUCOMM,Mrps35,MGI:2385255
Mrps5<tm1a(EUCOMM)Wtsi>,"mitochondrial ribosomal protein S5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432560,EUCOMM,Mrps5,MGI:1924971
Mrps5<tm1b(EUCOMM)Wtsi>,"mitochondrial ribosomal protein S5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548689,EUCOMM,Mrps5,MGI:1924971
Msh5<tm1Rak>,"mutS homolog 5; targeted mutation 1, Raju Kucherlapati",MGI:1858057,0,Msh5,MGI:1329021
Msh5<tm1a(EUCOMM)Wtsi>,"mutS homolog 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842260,EUCOMM,Msh5,MGI:1329021
Msh5<tm1b(EUCOMM)Wtsi>,"mutS homolog 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5629311,EUCOMM,Msh5,MGI:1329021
Msmo1<tm1a(EUCOMM)Wtsi>,"methylsterol monoxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432850,EUCOMM,Msmo1,MGI:1913484
Mst1<tm1(KOMP)Wtsi>,"macrophage stimulating 1 (hepatocyte growth factor-like); targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4431447,KOMP-CSD,Mst1,MGI:96080
Msx1<tm1Bero>,"msh homeobox 1; targeted mutation 1, Benoit Robert",MGI:1933766,0,Msx1,MGI:97168
Msx1<tm2.1(cre/ERT2)Bero>,"msh homeobox 1; targeted mutation 2.1, Benoit Robert",MGI:5049923,0,Msx1,MGI:97168
Msx2<tm1.1Yvla>,"msh homeobox 2; targeted mutation 1.1, Yves Lallemand",MGI:3795775,0,Msx2,MGI:97169
Msx2<tm1Bero>,"msh homeobox 2; targeted mutation 1, Benoit Robert",MGI:2676049,0,Msx2,MGI:97169
Mta1<tm1a(EUCOMM)Wtsi>,"metastasis associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842891,EUCOMM,Mta1,MGI:2150037
Mta3<tm3a(KOMP)Wtsi>,"metastasis associated 3; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:4419906,KOMP-CSD,Mta3,MGI:2151172
Mtch2<tm1a(EUCOMM)Hmgu>,"mitochondrial carrier 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436614,EUCOMM,Mtch2,MGI:1929260
Mtf2<Gt(U3Betageo)1Ruiz>,"metal response element binding transcription factor 2; gene trap 1, Patricia Ruiz",MGI:2678466,0,Mtf2,MGI:105050
Mtfmt<tm1e(KOMP)Wtsi>,"mitochondrial methionyl-tRNA formyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362485,KOMP-CSD,Mtfmt,MGI:1916856
Mthfd1l<tm1a(EUCOMM)Wtsi>,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434021,EUCOMM,Mthfd1l,MGI:1924836
Mthfd2l<tm1a(EUCOMM)Wtsi>,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431820,EUCOMM,Mthfd2l,MGI:1915871
Mthfsl<tm1a(EUCOMM)Hmgu>,"5, 10-methenyltetrahydrofolate synthetase-like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434563,EUCOMM,Mthfsl,MGI:3780550
Mthfsl<tm1b(EUCOMM)Hmgu>,"5, 10-methenyltetrahydrofolate synthetase-like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548911,EUCOMM,Mthfsl,MGI:3780550
Mtif3<tm1a(EUCOMM)Wtsi>,"mitochondrial translational initiation factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4457571,EUCOMM,Mtif3,MGI:1923616
Mtif3<tm1b(EUCOMM)Wtsi>,"mitochondrial translational initiation factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613653,EUCOMM,Mtif3,MGI:1923616
Mtmr12<tm1a(KOMP)Wtsi>,"myotubularin related protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5427201,KOMP-CSD,Mtmr12,MGI:2443034
Mtmr14<tm1a(KOMP)Wtsi>,"myotubularin related protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362891,KOMP-CSD,Mtmr14,MGI:1916075
Mtmr1<tm2a(KOMP)Wtsi>,"myotubularin related protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4455465,KOMP-CSD,Mtmr1,MGI:1858271
Mtmr4<tm1a(EUCOMM)Wtsi>,"myotubularin related protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433302,EUCOMM,Mtmr4,MGI:2180699
Mto1<tm1a(EUCOMM)Wtsi>,"mitochondrial tRNA translation optimization 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432793,EUCOMM,Mto1,MGI:1915541
Mtor<tm1.1Gcon>,"mechanistic target of rapamycin kinase; targeted mutation 1.1, Gianluigi Condorelli",MGI:5707218,0,Mtor,MGI:1928394
Mtor<tm1a(EUCOMM)Wtsi>,"mechanistic target of rapamycin kinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432158,EUCOMM,Mtor,MGI:1928394
Mtpn<tm1a(KOMP)Wtsi>,"myotrophin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451557,KOMP-CSD,Mtpn,MGI:99445
Mtrf1<tm1a(EUCOMM)Hmgu>,"mitochondrial translational release factor 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434932,EUCOMM,Mtrf1,MGI:2384815
Mtss1l<tm1a(KOMP)Wtsi>,"MTSS I-BAR domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840989,KOMP-CSD,Mtss2,MGI:3039591
Mtv2<a>,"mammary tumor virus locus 2; mammary tumor virus locus 2, present",MGI:3579297,0,Mtv2,MGI:97188
Muc16<m1Mhda>,"mucin 16; mutation 1, Martin Hrabe de Angelis",MGI:5818745,0,Muc16,MGI:1920982
Mut1154,Mut1154,MGI:5427409,0,Mut1154,MGI:5427407
Mut1231,Mut1231,MGI:5439981,0,Mut1231,MGI:5439979
Mut1264,Mut1264,MGI:5427414,Harwell ENU Mutagenesis,Mut1264,MGI:5427412
Mut1293,Mut1293,MGI:5427423,Harwell ENU Mutagenesis,Mut1293,MGI:5427421
Mut1305,Mut1305,MGI:5429756,Harwell ENU Mutagenesis,Mut1305,MGI:5429751
Mut1397,Mut1397,MGI:5428963,0,Mut1397,MGI:5428961
Mut1488,Mut1488,MGI:5470112,0,Mut1488,MGI:5470110
Mut1544,Mut1544,MGI:5442354,Harwell ENU Mutagenesis,Mut1544,MGI:5442350
Mut1602,Mut1602,MGI:5470123,Harwell ENU Mutagenesis,Mut1602,MGI:5470121
Mut921,Mut921,MGI:5430732,0,Mut921,MGI:5430735
Muts1/14,mutation Muts1/14,MGI:5646384,0,Muts1/14,MGI:5646381
Mx1<tm1a(EUCOMM)Wtsi>,"MX dynamin-like GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431734,EUCOMM,Mx1,MGI:97243
Mxra7<tm1a(EUCOMM)Wtsi>,"matrix-remodelling associated 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433751,EUCOMM,Mxra7,MGI:1914872
Mybbp1a<tm1a(EUCOMM)Hmgu>,"MYB binding protein (P160) 1a; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435114,EUCOMM,Mybbp1a,MGI:106181
Mybbp1a<tm1b(EUCOMM)Hmgu>,"MYB binding protein (P160) 1a; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548364,EUCOMM,Mybbp1a,MGI:106181
Mybpc3<tm1a(EUCOMM)Hmgu>,"myosin binding protein C, cardiac; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435924,EUCOMM,Mybpc3,MGI:102844
Mybphl<tm1a(KOMP)Wtsi>,"myosin binding protein H-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364468,KOMP-CSD,Mybphl,MGI:1916003
Mybphl<tm1b(KOMP)Wtsi>,"myosin binding protein H-like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548569,KOMP-CSD,Mybphl,MGI:1916003
Myc<tm1.1(MYC)Gwbk>,"myelocytomatosis oncogene; targeted mutation 1.1, Georg W Bornkamm",MGI:5447463,0,Myc,MGI:97250
Myd88<tm1a(EUCOMM)Wtsi>,"myeloid differentiation primary response gene 88; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434029,EUCOMM,Myd88,MGI:108005
Myh14<tm1a(EUCOMM)Wtsi>,"myosin, heavy polypeptide 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431529,EUCOMM,Myh14,MGI:1919210
Myh7b<tm1a(KOMP)Wtsi>,"myosin, heavy chain 7B, cardiac muscle, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013737,KOMP-CSD,Myh7b,MGI:3710243
Myh9<tm1.1Gac>,"myosin, heavy polypeptide 9, non-muscle; targeted mutation 1.1, Christian Gachet",MGI:3843980,0,Myh9,MGI:107717
Myh9<tm1a(EUCOMM)Wtsi>,"myosin, heavy polypeptide 9, non-muscle; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432815,EUCOMM,Myh9,MGI:107717
Myl12b<tm1a(EUCOMM)Wtsi>,"myosin, light chain 12B, regulatory; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433200,EUCOMM,Myl12b,MGI:107494
Myl2<tm1a(EUCOMM)Hmgu>,"myosin, light polypeptide 2, regulatory, cardiac, slow; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5425876,EUCOMM,Myl2,MGI:97272
Myl2<tm1b(EUCOMM)Hmgu>,"myosin, light polypeptide 2, regulatory, cardiac, slow; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5629324,EUCOMM,Myl2,MGI:97272
Myl4<tm1a(EUCOMM)Wtsi>,"myosin, light polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431641,EUCOMM,Myl4,MGI:97267
Myo10<tm2(KOMP)Wtsi>,"myosin X; targeted mutation 2, Wellcome Trust Sanger Institute",MGI:4362966,KOMP-CSD,Myo10,MGI:107716
Myo15<tm1a(EUCOMM)Wtsi>,"myosin XV; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431637,EUCOMM,Myo15,MGI:1261811
Myo19<tm1a(EUCOMM)Hmgu>,"myosin XIX; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434919,EUCOMM,Myo19,MGI:1913446
Myo6<Mhdatlc>,myosin VI; Martin Hrabe de Angelis tailchaser,MGI:1913078,0,Myo6,MGI:104785
Myo7a<26SB>,myosin VIIA; shaker 26SB,MGI:2155417,0,Myo7a,MGI:104510
Myo7a<3336SB>,myosin VIIA; shaker 3336SB,MGI:2155420,0,Myo7a,MGI:104510
Myo7a<4494SB>,myosin VIIA; shaker 4494SB,MGI:2155421,0,Myo7a,MGI:104510
Myo7a<4626SB>,myosin VIIA; shaker 4626SB,MGI:2155422,0,Myo7a,MGI:104510
Myo7a<816SB>,myosin VIIA; shaker 816SB,MGI:2155423,0,Myo7a,MGI:104510
Myo7a<Hdb>,myosin VIIA; headbanger,MGI:3511858,0,Myo7a,MGI:104510
Myo7a<sh1-6J>,"myosin VIIA; shaker 1, 6 Jackson",MGI:1860092,0,Myo7a,MGI:104510
Myo7a<sh1>,myosin VIIA; shaker 1,MGI:1856716,0,Myo7a,MGI:104510
Myo7a<tm1a(EUCOMM)Wtsi>,"myosin VIIA; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431921,EUCOMM,Myo7a,MGI:104510
Myo9a<tm1a(EUCOMM)Wtsi>,"myosin IXa; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433267,EUCOMM,Myo9a,MGI:107735
Myo9a<tm1b(EUCOMM)Wtsi>,"myosin IXa; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636908,EUCOMM,Myo9a,MGI:107735
Myoz1<tm1a(EUCOMM)Hmgu>,"myozenin 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436678,EUCOMM,Myoz1,MGI:1929471
Myoz1<tm1b(EUCOMM)Hmgu>,"myozenin 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548708,EUCOMM,Myoz1,MGI:1929471
Myrfl<tm1a(EUCOMM)Wtsi>,"myelin regulatory factor-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441747,EUCOMM,Myrfl,MGI:2685085
Mysm1<tm1a(KOMP)Wtsi>,"myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362924,KOMP-CSD,Mysm1,MGI:2444584
Myt1l<tm1a(EUCOMM)Wtsi>,"myelin transcription factor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842524,EUCOMM,Myt1l,MGI:1100511
Naaa<tm1a(KOMP)Wtsi>,"N-acylethanolamine acid amidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419604,KOMP-CSD,Naaa,MGI:1914361
Nab2<tm1a(EUCOMM)Hmgu>,"Ngfi-A binding protein 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435541,EUCOMM,Nab2,MGI:107563
Nacad<tm1(KOMP)Wtsi>,"NAC alpha domain containing; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4362585,KOMP-CSD,Nacad,MGI:3603030
Nacc2<tm2a(EUCOMM)Wtsi>,"nucleus accumbens associated 2, BEN and BTB (POZ) domain containing; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4441947,EUCOMM,Nacc2,MGI:1915241
Nacc2<tm2b(EUCOMM)Wtsi>,"nucleus accumbens associated 2, BEN and BTB (POZ) domain containing; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637027,EUCOMM,Nacc2,MGI:1915241
Nadk2<tm1a(EUCOMM)Wtsi>,"NAD kinase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842252,EUCOMM,Nadk2,MGI:1915896
Nadk2<tm1b(EUCOMM)Wtsi>,"NAD kinase 2, mitochondrial; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637034,EUCOMM,Nadk2,MGI:1915896
Nae1<tm1a(EUCOMM)Wtsi>,"NEDD8 activating enzyme E1 subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434194,EUCOMM,Nae1,MGI:2384561
Naga<tm1a(EUCOMM)Wtsi>,"N-acetyl galactosaminidase, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820246,EUCOMM,Naga,MGI:1261422
Nagk<tm1a(EUCOMM)Hmgu>,"N-acetylglucosamine kinase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455634,EUCOMM,Nagk,MGI:1860418
Nano,nanomouse,MGI:1862023,Harwell ENU Mutagenesis,Nano,MGI:1861998
Nap1l2<tm2.1Ucr>,"nucleosome assembly protein 1-like 2; targeted mutation 2.1, Ute Christine Rogner",MGI:5569260,0,Nap1l2,MGI:106654
Napb<tm1a(EUCOMM)Hmgu>,"N-ethylmaleimide sensitive fusion protein attachment protein beta; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434916,EUCOMM,Napb,MGI:104562
Nat10<tm1a(KOMP)Wtsi>,"N-acetyltransferase 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050156,KOMP-CSD,Nat10,MGI:2138939
Nat2<tm1Esim>,"N-acetyltransferase 2 (arylamine N-acetyltransferase); targeted mutation 1, Edith Sim",MGI:2675637,0,Nat2,MGI:109201
Natd1<tm1a(EUCOMM)Wtsi>,"N-acetyltransferase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432892,EUCOMM,Natd1,MGI:1344388
Natd1<tm1b(EUCOMM)Wtsi>,"N-acetyltransferase domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548455,EUCOMM,Natd1,MGI:1344388
Nbas<tm1b(EUCOMM)Hmgu>,"neuroblastoma amplified sequence; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548607,EUCOMM,Nbas,MGI:1918419
Nbeal2<tm1a(EUCOMM)Wtsi>,"neurobeachin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461705,EUCOMM,Nbeal2,MGI:2448554
Nbr1<tm1a(KOMP)Wtsi>,"NBR1, autophagy cargo receptor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362162,KOMP-CSD,Nbr1,MGI:108498
Ncaph2<tm1a(EUCOMM)Wtsi>,"non-SMC condensin II complex, subunit H2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433039,EUCOMM,Ncaph2,MGI:1289164
Ncaph<tm1a(EUCOMM)Wtsi>,"non-SMC condensin I complex, subunit H; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431609,EUCOMM,Ncaph,MGI:2444777
Ncf1<m1J>,"neutrophil cytosolic factor 1; mutation 1, Jackson",MGI:2661962,0,Ncf1,MGI:97283
Ncf1<tm1Hbd>,"neutrophil cytosolic factor 1; targeted mutation 1, Marcus Harbord",MGI:3576788,0,Ncf1,MGI:97283
Ncf2<tm1a(EUCOMM)Wtsi>,"neutrophil cytosolic factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432766,EUCOMM,Ncf2,MGI:97284
Ncf2<tm1c(EUCOMM)Wtsi>,,MGI:97284,,,
Ncf4<tm1a(KOMP)Wtsi>,"neutrophil cytosolic factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841143,KOMP-CSD,Ncf4,MGI:109186
Ncoa3<tm1a(EUCOMM)Wtsi>,"nuclear receptor coactivator 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008021,EUCOMM,Ncoa3,MGI:1276535
Ncoa6<tm1Pera>,"nuclear receptor coactivator 6; targeted mutation 1, Per Antonson",MGI:2450859,0,Ncoa6,MGI:1929915
Ncr1<tm1.1(icre)Viv>,"natural cytotoxicity triggering receptor 1; targeted mutation 1.1, Eric Vivier",MGI:5308410,0,Ncr1,MGI:1336212
Ncr1<tm2.1Viv>,"natural cytotoxicity triggering receptor 1; targeted mutation 2.1, Eric Vivier",MGI:5430925,0,Ncr1,MGI:1336212
Ncs1<tm1a(EUCOMM)Hmgu>,"neuronal calcium sensor 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436379,EUCOMM,Ncs1,MGI:109166
Ndfip2<tm1a(EUCOMM)Hmgu>,"Nedd4 family interacting protein 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436082,EUCOMM,Ndfip2,MGI:1923523
Ndfip2<tm1b(EUCOMM)Hmgu>,"Nedd4 family interacting protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548666,EUCOMM,Ndfip2,MGI:1923523
Ndnf<tm1(NCOM)Mfgc>,"neuron-derived neurotrophic factor; targeted mutation 1, Mammalian Functional Genomics Centre",MGI:4880569,NorCOMM,Ndnf,MGI:1915419
Ndrg1<str>,N-myc downstream regulated gene 1; stretcher,MGI:5009138,0,Ndrg1,MGI:1341799
Ndrg4<tm1a(KOMP)Wtsi>,"N-myc downstream regulated gene 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362496,KOMP-CSD,Ndrg4,MGI:2384590
Ndufa8<tm1a(EUCOMM)Hmgu>,"NADH:ubiquinone oxidoreductase subunit A8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436517,EUCOMM,Ndufa8,MGI:1915625
Ndufa8<tm1b(EUCOMM)Hmgu>,"NADH:ubiquinone oxidoreductase subunit A8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548563,EUCOMM,Ndufa8,MGI:1915625
Ndufaf6<tm1a(EUCOMM)Wtsi>,"NADH:ubiquinone oxidoreductase complex assembly factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433125,EUCOMM,Ndufaf6,MGI:1924197
Ndufb4<tm1a(KOMP)Wtsi>,"NADH:ubiquinone oxidoreductase subunit B4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451549,KOMP-CSD,Ndufb4,MGI:1915444
Ndufb4<tm1b(KOMP)Wtsi>,,MGI:1915444,,,
Ndufb8<tm1a(EUCOMM)Wtsi>,"NADH:ubiquinone oxidoreductase subunit B8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432457,EUCOMM,Ndufb8,MGI:1914514
Ndufb9<tm1a(EUCOMM)Hmgu>,"NADH:ubiquinone oxidoreductase subunit B9; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841556,EUCOMM,Ndufb9,MGI:1913468
Ndufb9<tm1b(EUCOMM)Hmgu>,"NADH:ubiquinone oxidoreductase subunit B9; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5637008,EUCOMM,Ndufb9,MGI:1913468
Ndufs1<tm1a(EUCOMM)Hmgu>,"NADH:ubiquinone oxidoreductase core subunit S1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4843861,EUCOMM,Ndufs1,MGI:2443241
Ndufs1<tm1b(EUCOMM)Hmgu>,"NADH:ubiquinone oxidoreductase core subunit S1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548814,EUCOMM,Ndufs1,MGI:2443241
Ndufs3<tm1a(EUCOMM)Wtsi>,"NADH:ubiquinone oxidoreductase core subunit S3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433795,EUCOMM,Ndufs3,MGI:1915599
Ndufs3<tm1c(EUCOMM)Wtsi>,"NADH:ubiquinone oxidoreductase core subunit S3; targeted mutation 1c, Wellcome Trust Sanger Institute",MGI:6119407,EUCOMM,Ndufs3,MGI:1915599
Neb<tm1(cre)Chen>,"nebulin; targeted mutation 1, Ju Chen",MGI:3664092,0,Neb,MGI:97292
Neb<tm2.1Chen>,"nebulin; targeted mutation 2.1, Ju Chen",MGI:5618471,0,Neb,MGI:97292
Nebl<tm1a(EUCOMM)Wtsi>,"nebulette; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5603346,EUCOMM,Nebl,MGI:1921353
Necab2<tm1a(KOMP)Wtsi>,"N-terminal EF-hand calcium binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363790,KOMP-CSD,Necab2,MGI:2152211
Nedd4<tm2a(EUCOMM)Hmgu>,"neural precursor cell expressed, developmentally down-regulated 4; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511569,EUCOMM,Nedd4,MGI:97297
Nedd4l<tm1a(KOMP)Wtsi>,"neural precursor cell expressed, developmentally down-regulated gene 4-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363447,KOMP-CSD,Nedd4l,MGI:1933754
Nek10<tm1a(KOMP)Wtsi>,"NIMA (never in mitosis gene a)- related kinase 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363663,KOMP-CSD,Nek10,MGI:2685128
Nek3<tm1a(EUCOMM)Wtsi>,"NIMA (never in mitosis gene a)-related expressed kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432332,EUCOMM,Nek3,MGI:1344371
Nek3<tm1b(EUCOMM)Wtsi>,"NIMA (never in mitosis gene a)-related expressed kinase 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636976,EUCOMM,Nek3,MGI:1344371
Nek6<tm1Dgen>,"NIMA (never in mitosis gene a)-related expressed kinase 6; targeted mutation 1, Deltagen",MGI:5427679,Deltagen,Nek6,MGI:1891638
Nek9<tm1a(EUCOMM)Wtsi>,"NIMA (never in mitosis gene a)-related expressed kinase 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433670,EUCOMM,Nek9,MGI:2387995
Nelfa<m1Mhda>,"negative elongation factor complex member A, Whsc2; mutation 1, Martin Hrabe de Angelis",MGI:5818776,0,Nelfa,MGI:1346098
Nelfe<tm1a(EUCOMM)Wtsi>,"negative elongation factor complex member E, Rdbp; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842623,EUCOMM,Nelfe,MGI:102744
Nf1<Mhdadsk9>,neurofibromin 1; Martin Hrabe de Angelis dark skin 9,MGI:2682223,0,Nf1,MGI:97306
Nf1<tm1a(KOMP)Wtsi>,"neurofibromin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364806,KOMP-CSD,Nf1,MGI:97306
Nf2<tm2Gth>,"neurofibromin 2; targeted mutation 2, Gilles Thomas",MGI:1926955,0,Nf2,MGI:97307
Nfasc<tm1a(EUCOMM)Hmgu>,"neurofascin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435919,EUCOMM,Nfasc,MGI:104753
Nfatc3<tm1a(EUCOMM)Hmgu>,"nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5000351,EUCOMM,Nfatc3,MGI:103296
Nfatc3<tm1b(EUCOMM)Hmgu>,"nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548344,EUCOMM,Nfatc3,MGI:103296
Nfkb1<tm1.1Dkam>,"nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105; targeted mutation 1.1, Derek A Mann",MGI:5643936,0,Nfkb1,MGI:97312
Nfkb1<tm1a(KOMP)Wtsi>,"nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363738,KOMP-CSD,Nfkb1,MGI:97312
Nfkbia<tm1.1Kbp>,"nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha; targeted mutation 1, Klaus Pfeffer",MGI:3577710,0,Nfkbia,MGI:104741
Nfkbia<tm1Kbp>,"nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha; targeted mutation 1, Klaus Pfeffer",MGI:3577709,0,Nfkbia,MGI:104741
Nfkbid<tm1a(EUCOMM)Wtsi>,"nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432464,EUCOMM,Nfkbid,MGI:3041243
Nfkbil1<tm1a(KOMP)Wtsi>,"nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286210,KOMP-CSD,Nfkbil1,MGI:1340031
Nfu1<tm1a(KOMP)Wtsi>,"NFU1 iron-sulfur cluster scaffold; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840988,KOMP-CSD,Nfu1,MGI:1913290
Nfxl1<tm1a(EUCOMM)Wtsi>,"nuclear transcription factor, X-box binding-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432670,EUCOMM,Nfxl1,MGI:1923646
Nfya<Gt(EUCJ0004f10)Hmgu>,"nuclear transcription factor-Y alpha; gene trap EUCJ0004f10, Helmholtz Zentrum Muenchen GmbH",MGI:4872253,0,Nfya,MGI:97316
Ngfr<tm1a(EUCOMM)Wtsi>,"nerve growth factor receptor (TNFR superfamily, member 16); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432054,EUCOMM,Ngfr,MGI:97323
Ngrn<tm1a(KOMP)Wtsi>,"neugrin, neurite outgrowth associated; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4940742,KOMP-CSD,Ngrn,MGI:1933212
Nhlrc2<tm1a(KOMP)Wtsi>,"NHL repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419640,KOMP-CSD,Nhlrc2,MGI:1914116
Nhp2<tm1a(KOMP)Wtsi>,"NHP2 ribonucleoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362251,KOMP-CSD,Nhp2,MGI:1098547
Ninj2<tm1a(KOMP)Wtsi>,"ninjurin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451377,KOMP-CSD,Ninj2,MGI:1352751
Ninl<tm2a(EUCOMM)Wtsi>,"ninein-like; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4433740,EUCOMM,Ninl,MGI:1925427
Nipa1<tm1a(KOMP)Wtsi>,"non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363744,KOMP-CSD,Nipa1,MGI:2442058
Nipsnap1<tm1a(EUCOMM)Wtsi>,"nipsnap homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431806,EUCOMM,Nipsnap1,MGI:1278344
Nipsnap3a<tm1a(KOMP)Wtsi>,"nipsnap homolog 3A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944344,KOMP-CSD,Nipsnap3a,MGI:1920648
Nipsnap3a<tm1b(KOMP)Wtsi>,"nipsnap homolog 3A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637068,KOMP-CSD,Nipsnap3a,MGI:1920648
Nisch<tm1a(EUCOMM)Hmgu>,"nischarin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5319353,EUCOMM,Nisch,MGI:1928323
Nkain4<Gt(M076C04)Vmel>,"Na+/K+ transporting ATPase interacting 4; gene trap M076C04, Harald von Melchner",MGI:4413343,0,Nkain4,MGI:1915372
Nkiras2<tm1a(EUCOMM)Wtsi>,"NFKB inhibitor interacting Ras-like protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432279,EUCOMM,Nkiras2,MGI:1919216
Nkx6-1<m1Mhda>,"NK6 homeobox 1; mutation 1, Martin Hrabe de Angelis",MGI:5818754,0,Nkx6-1,MGI:1206039
Nkx6-2<tm1Ercs>,"NK6 homeobox 2; targeted mutation 1, Johan Ericson",MGI:2651850,0,Nkx6-2,MGI:1352738
Nkx6-2<tm2(cre)Ercs>,"NK6 homeobox 2; targeted mutation 2, Johan Ericson",MGI:4440471,0,Nkx6-2,MGI:1352738
Nlk<tm2a(KOMP)Wtsi>,"nemo like kinase; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4454071,KOMP-CSD,Nlk,MGI:1201387
Nlrc5<m1Mhda>,"NLR family, CARD domain containing 5; mutation 1, Martin Hrabe de Angelis",MGI:5818757,0,Nlrc5,MGI:3612191
Nlrp9b<tm1a(KOMP)Wtsi>,"NLR family, pyrin domain containing 9B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841142,KOMP-CSD,Nlrp9b,MGI:2675377
Nme4<tm1a(EUCOMM)Wtsi>,"NME/NM23 nucleoside diphosphate kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441641,EUCOMM,Nme4,MGI:1931148
Nmnat1<tm1a(EUCOMM)Wtsi>,"nicotinamide nucleotide adenylyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431754,EUCOMM,Nmnat1,MGI:1913704
Nmrk1<tm1a(KOMP)Wtsi>,"nicotinamide riboside kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419121,KOMP-CSD,Nmrk1,MGI:2147434
Nmt2<tm2a(EUCOMM)Hmgu>,"N-myristoyltransferase 2; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4436550,EUCOMM,Nmt2,MGI:1202298
Nodal<tm1Rob>,"nodal; targeted mutation 1, Elizabeth J Robertson",MGI:2180793,0,Nodal,MGI:97359
Nog<tm1Amc>,"noggin; targeted mutation 1, Andrew P McMahon",MGI:1862000,0,Nog,MGI:104327
Nol8<tm1a(EUCOMM)Hmgu>,"nucleolar protein 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436496,EUCOMM,Nol8,MGI:1918180
Nolc1<tm1a(EUCOMM)Wtsi>,"nucleolar and coiled-body phosphoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432873,EUCOMM,Nolc1,MGI:1918019
Nom1<tm1a(KOMP)Wtsi>,"nucleolar protein with MIF4G domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841092,KOMP-CSD,Nom1,MGI:1861749
Nos2<tm1Lau>,"nitric oxide synthase 2, inducible; targeted mutation 1, Victor E Laubach",MGI:1857228,0,Nos2,MGI:97361
Notch1<tm1a(EUCOMM)Hmgu>,"notch 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455755,EUCOMM,Notch1,MGI:97363
Noto<tm1Gos>,"notochord homeobox; targeted mutation 1, Achim Gossler",MGI:3053092,0,Noto,MGI:3053002
Noto<tm2.1(Foxj1)Gos>,"notochord homeobox; targeted mutation 2.1, Achim Gossler",MGI:5317920,0,Noto,MGI:3053002
Nox4<tm1.1Hwsc>,"NADPH oxidase 4; targeted mutation 1.1, Harald H H W Schmidt",MGI:4881785,0,Nox4,MGI:1354184
Nox4<tm1.2Hwsc>,"NADPH oxidase 4; targeted mutation 1.2, Harald H H W Schmidt",MGI:5896730,0,Nox4,MGI:1354184
Npat<tm1a(EUCOMM)Wtsi>,"nuclear protein in the AT region; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433158,EUCOMM,Npat,MGI:107605
Npat<tm1b(EUCOMM)Wtsi>,"nuclear protein in the AT region; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636907,EUCOMM,Npat,MGI:107605
Npc1<tm1a(EUCOMM)Hmgu>,"NPC intracellular cholesterol transporter 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436617,EUCOMM,Npc1,MGI:1097712
Npdc1<tm1Ce>,"neural proliferation, differentiation and control 1; targeted mutation 1, C Evrard",MGI:3512311,0,Npdc1,MGI:1099802
Nploc4<tm1a(EUCOMM)Wtsi>,"NPL4 homolog, ubiquitin recognition factor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432939,EUCOMM,Nploc4,MGI:2679787
Nptn<tm1a(EUCOMM)Hmgu>,"neuroplastin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455733,EUCOMM,Nptn,MGI:108077
Npy1r<tm1.1Ceva>,"neuropeptide Y receptor Y1; targeted mutation 1.1, Carola Eva",MGI:5307897,0,Npy1r,MGI:104963
Npy6r<tm1Dgen>,"neuropeptide Y receptor Y6; targeted mutation 1, Deltagen",MGI:5427680,Deltagen,Npy6r,MGI:1098590
Nr1d1<tm1Schb>,"nuclear receptor subfamily 1, group D, member 1; targeted mutation 1, Ueli Schibler",MGI:2671157,0,Nr1d1,MGI:2444210
Nr1d2<tm1Dgen>,"nuclear receptor subfamily 1, group D, member 2; targeted mutation 1, Deltagen",MGI:5427681,Deltagen,Nr1d2,MGI:2449205
Nr1i2<tm1.1Ics>,"nuclear receptor subfamily 1, group I, member 2; targeted mutation 1.1, Mouse Clinical Institute",MGI:5433121,0,Nr1i2,MGI:1337040
Nr1i2<tm1Sakl>,"nuclear receptor subfamily 1, group I, member 2; targeted mutation 1, Steven A Kliewer",MGI:3609633,0,Nr1i2,MGI:1337040
Nr2f1<tm1Mist>,"nuclear receptor subfamily 2, group F, member 1; targeted mutation 1, Michele Studer",MGI:3521756,0,Nr2f1,MGI:1352451
Nr2f1<tm2Mist>,"nuclear receptor subfamily 2, group F, member 1; targeted mutation 2, Michele Studer",MGI:4834594,0,Nr2f1,MGI:1352451
Nr3c1<tm2.1Gsc>,"nuclear receptor subfamily 3, group C, member 1; targeted mutation 2.1, Gunther Schutz",MGI:1931328,0,Nr3c1,MGI:95824
Nr3c1<tm2Gsc>,"nuclear receptor subfamily 3, group C, member 1; targeted mutation 2, Gunther Schutz",MGI:1931327,0,Nr3c1,MGI:95824
Nr3c1<tm3Gsc>,"nuclear receptor subfamily 3, group C, member 1; targeted mutation 3, Gunther Schutz",MGI:1931329,0,Nr3c1,MGI:95824
Nr3c2<tm2.1Gsc>,"nuclear receptor subfamily 3, group C, member 2; targeted mutation 2.1, Gunther Schutz",MGI:3613035,0,Nr3c2,MGI:99459
Nr4a1<tm1Jmi>,"nuclear receptor subfamily 4, group A, member 1; targeted mutation 1, Jeffrey Milbrandt",MGI:2182325,0,Nr4a1,MGI:1352454
Nr4a1<tm1a(EUCOMM)Wtsi>,"nuclear receptor subfamily 4, group A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432935,EUCOMM,Nr4a1,MGI:1352454
Nras<tm1a(EUCOMM)Hmgu>,"neuroblastoma ras oncogene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5002952,EUCOMM,Nras,MGI:97376
Nrbp1<tm3a(EUCOMM)Wtsi>,"nuclear receptor binding protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:5511930,EUCOMM,Nrbp1,MGI:2183436
Nrbp1<tm3b(EUCOMM)Wtsi>,"nuclear receptor binding protein 1; targeted mutation 3b, Wellcome Trust Sanger Institute",MGI:5637124,EUCOMM,Nrbp1,MGI:2183436
Nrcam<tm1Fgr>,"neuronal cell adhesion molecule; targeted mutation 1, Fritz G Rathjen",MGI:2179756,0,Nrcam,MGI:104750
Nrde2<tm2a(KOMP)Wtsi>,"nrde-2 necessary for RNA interference, domain containing; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4843855,KOMP-CSD,Nrde2,MGI:2670969
Nrxn1<tm1a(KOMP)Wtsi>,"neurexin I; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008771,KOMP-CSD,Nrxn1,MGI:1096391
Nrxn2<tm1Sud>,"neurexin II; targeted mutation 1, Thomas C Sudhof",MGI:3042719,0,Nrxn2,MGI:1096362
Nsdhl<Bpa-8H>,NAD(P) dependent steroid dehydrogenase-like; bare patches 8 Harwell,MGI:1862021,Harwell ENU Mutagenesis,Nsdhl,MGI:1099438
Nsdhl<Str-1H>,NAD(P) dependent steroid dehydrogenase-like; striated 1 Harwell,MGI:1857780,0,Nsdhl,MGI:1099438
Nsmf<tm1a(KOMP)Wtsi>,"NMDA receptor synaptonuclear signaling and neuronal migration factor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363881,KOMP-CSD,Nsmf,MGI:1861755
Nsun2<tm1a(EUCOMM)Wtsi>,"NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432654,EUCOMM,Nsun2,MGI:107252
Nsun2<tm1c(EUCOMM)Wtsi>,,MGI:107252,,,
Ntf5<tm1a(EUCOMM)Hmgu>,"neurotrophin 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436129,EUCOMM,Ntf5,MGI:97381
Ntn1<Gt(IRESBetageo)1Pgr>,"netrin 1; gene trap 1, Peter Gruss",MGI:2137018,0,Ntn1,MGI:105088
Ntn4<tm1a(KOMP)Wtsi>,"netrin 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4840942,KOMP-CSD,Ntn4,MGI:1888978
Ntrk1<tm1a(EUCOMM)Wtsi>,"neurotrophic tyrosine kinase, receptor, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887687,EUCOMM,Ntrk1,MGI:97383
Ntrk2<tm1a(EUCOMM)Wtsi>,"neurotrophic tyrosine kinase, receptor, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460486,EUCOMM,Ntrk2,MGI:97384
Nub1<tm1a(EUCOMM)Hmgu>,"negative regulator of ubiquitin-like proteins 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841553,EUCOMM,Nub1,MGI:1889001
Nubp2<tm1a(EUCOMM)Hmgu>,"nucleotide binding protein 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4460379,EUCOMM,Nubp2,MGI:1347072
Nubp2<tm1b(EUCOMM)Hmgu>,"nucleotide binding protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613638,EUCOMM,Nubp2,MGI:1347072
Nubpl<tm1a(KOMP)Wtsi>,"nucleotide binding protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363128,KOMP-CSD,Nubpl,MGI:1924076
Nubpl<tm1b(KOMP)Wtsi>,"nucleotide binding protein-like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548675,KOMP-CSD,Nubpl,MGI:1924076
Nudt12<tm1a(KOMP)Wtsi>,"nudix (nucleoside diphosphate linked moiety X)-type motif 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451360,KOMP-CSD,Nudt12,MGI:1915243
Nup35<tm1b(EUCOMM)Wtsi>,,MGI:1916732,,,
Nup85<tm1a(KOMP)Wtsi>,"nucleoporin 85; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944384,KOMP-CSD,Nup85,MGI:3046173
Nup88<tm1a(EUCOMM)Wtsi>,"nucleoporin 88; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431752,EUCOMM,Nup88,MGI:104900
Nutm1<tm1a(KOMP)Wtsi>,"NUT midline carcinoma, family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363742,KOMP-CSD,Nutm1,MGI:2661384
Nutm1<tm1b(KOMP)Wtsi>,,MGI:2661384,,,
Nutm2<tm2a(EUCOMM)Wtsi>,"NUT family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840651,EUCOMM,Nutm2,MGI:2685652
Nutm2<tm2b(EUCOMM)Wtsi>,"NUT family member 2; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637173,EUCOMM,Nutm2,MGI:2685652
Nxn<tm1a(EUCOMM)Wtsi>,"nucleoredoxin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432925,EUCOMM,Nxn,MGI:109331
Nxn<tm1b(EUCOMM)Wtsi>,"nucleoredoxin; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548389,EUCOMM,Nxn,MGI:109331
Nxpe5<tm1a(EUCOMM)Wtsi>,"neurexophilin and PC-esterase domain family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433447,EUCOMM,Nxpe5,MGI:3584036
Oaf<tm1a(EUCOMM)Wtsi>,"out at first homolog; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5284928,EUCOMM,Oaf,MGI:94852
Oas1g<tm3e(KOMP)Wtsi>,"2'-5' oligoadenylate synthetase 1G; targeted mutation 3e, Wellcome Trust Sanger Institute",MGI:4455595,KOMP-CSD,Oas1g,MGI:97429
Oasl2<tm1a(EUCOMM)Wtsi>,"2'-5' oligoadenylate synthetase-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431962,EUCOMM,Oasl2,MGI:1344390
Oaz1<tm2e(EUCOMM)Wtsi>,"ornithine decarboxylase antizyme 1; targeted mutation 2e, Wellcome Trust Sanger Institute",MGI:4840706,EUCOMM,Oaz1,MGI:109433
Obp2a<tm1a(EUCOMM)Wtsi>,"odorant binding protein 2A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4949352,EUCOMM,Obp2a,MGI:2387617
Obscn<m1Mhda>,"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF; mutation 1, Martin Hrabe de Angelis",MGI:5818758,0,Obscn,MGI:2681862
Ociad2<m1Mhda>,"OCIA domain containing 2; mutation 1, Martin Hrabe de Angelis",MGI:5818760,0,Ociad2,MGI:1916377
Ocm<tm1e(EUCOMM)Wtsi>,"oncomodulin; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4432497,EUCOMM,Ocm,MGI:97401
Ogdh<tm1e(KOMP)Wtsi>,"oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide); targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4939737,KOMP-CSD,Ogdh,MGI:1098267
Ogfod1<tm1a(KOMP)Wtsi>,"2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362420,KOMP-CSD,Ogfod1,MGI:2442978
Ogfod3<tm1a(KOMP)Wtsi>,"2-oxoglutarate and iron-dependent oxygenase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364925,KOMP-CSD,Ogfod3,MGI:1913429
Ogfr<tm1a(EUCOMM)Hmgu>,"opioid growth factor receptor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451743,EUCOMM,Ogfr,MGI:1919325
Oog2<tm1a(EUCOMM)Wtsi>,"oogenesin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460430,EUCOMM,Oog2,MGI:2684035
Ophn1<tm1Bill>,"oligophrenin 1; targeted mutation 1, Pierre Billuart",MGI:3757609,0,Ophn1,MGI:2151070
Ophn1<tm2Bill>,"oligophrenin 1; targeted mutation 2, Pierre Billuart",MGI:3757642,0,Ophn1,MGI:2151070
Oplah<tm1a(KOMP)Wtsi>,"5-oxoprolinase (ATP-hydrolysing); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363400,KOMP-CSD,Oplah,MGI:1922725
Oplah<tm1b(KOMP)Wtsi>,"5-oxoprolinase (ATP-hydrolysing); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548658,KOMP-CSD,Oplah,MGI:1922725
Optn<tm1a(EUCOMM)Wtsi>,"optineurin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432769,EUCOMM,Optn,MGI:1918898
Orc1<tm1a(KOMP)Wtsi>,"origin recognition complex, subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4847686,KOMP-CSD,Orc1,MGI:1328337
Orc3<tm1a(EUCOMM)Wtsi>,"origin recognition complex, subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433411,EUCOMM,Orc3,MGI:1354944
Orc4<tm1a(EUCOMM)Wtsi>,"origin recognition complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433141,EUCOMM,Orc4,MGI:1347043
Orc5<tm1a(EUCOMM)Wtsi>,"origin recognition complex, subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433614,EUCOMM,Orc5,MGI:1347044
Os9<tm1a(EUCOMM)Wtsi>,"amplified in osteosarcoma; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939774,EUCOMM,Os9,MGI:1924301
Osbpl3<tm1a(EUCOMM)Wtsi>,"oxysterol binding protein-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842360,EUCOMM,Osbpl3,MGI:1918970
Osbpl9<tm1a(KOMP)Wtsi>,"oxysterol binding protein-like 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364325,KOMP-CSD,Osbpl9,MGI:1923784
Oscp1<tm1a(EUCOMM)Hmgu>,"organic solute carrier partner 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4881057,EUCOMM,Oscp1,MGI:1916308
Ossc1<102/El>,osteosarcoma susceptibility 1; 102/El,MGI:3577303,0,Ossc1,MGI:3577289
Ossc2<102/El>,osteosarcoma susceptibility 2; 102/El,MGI:3577305,0,Ossc2,MGI:3577290
Ostes,ostes,MGI:3689329,0,Ostes,MGI:3688249
Ostf1<tm1a(EUCOMM)Hmgu>,"osteoclast stimulating factor 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5052480,EUCOMM,Ostf1,MGI:700012
Ostm1<om>,osteopetrosis associated transmembrane protein 1; omi,MGI:5512861,0,Ostm1,MGI:2655574
Otoa<tm1Gpr>,"otoancorin; targeted mutation 1, Guy P Richardson",MGI:5469411,0,Otoa,MGI:2149209
Otog<tm1Prs>,"otogelin; targeted mutation 1, Marie-Christine Simmler",MGI:2181633,0,Otog,MGI:1202064
Otop1<ied>,otopetrin 1; inner ear defect,MGI:4881519,0,Otop1,MGI:2388363
Otop3<tm1a(EUCOMM)Wtsi>,"otopetrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431640,EUCOMM,Otop3,MGI:1916852
Otp<tm1Asim>,"orthopedia homeobox; targeted mutation 1, Antonio Simeone",MGI:2180541,0,Otp,MGI:99835
Otub1<tm1a(EUCOMM)Hmgu>,"OTU domain, ubiquitin aldehyde binding 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434587,EUCOMM,Otub1,MGI:2147616
Otub2<tm1a(EUCOMM)Wtsi>,"OTU domain, ubiquitin aldehyde binding 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433067,EUCOMM,Otub2,MGI:1915399
Otud6b<tm1a(EUCOMM)Wtsi>,"OTU domain containing 6B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431669,EUCOMM,Otud6b,MGI:1919451
Otud7b<tm1a(EUCOMM)Wtsi>,"OTU domain containing 7B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008026,EUCOMM,Otud7b,MGI:2654703
Otud7b<tm1b(EUCOMM)Wtsi>,"OTU domain containing 7B; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637162,EUCOMM,Otud7b,MGI:2654703
Otx1<tm1Asim>,"orthodenticle homeobox 1; targeted mutation 1, Antonio Simeone",MGI:2136272,0,Otx1,MGI:97450
Otx1<tm2(otd)Asim>,"orthodenticle homeobox 1; targeted mutation 2, Antonio Simeone",MGI:2153199,0,Otx1,MGI:97450
Otx1<tm4(cre)Asim>,"orthodenticle homeobox 1; targeted mutation 4, Antonio Simeone",MGI:2661060,0,Otx1,MGI:97450
Otx2<tm1(OTX1)Asim>,"orthodenticle homeobox 2; targeted mutation 1, Antonio Simeone",MGI:2153202,0,Otx2,MGI:97451
Otx2<tm1.1(cre/ERT2)Mgoe>,"orthodenticle homeobox 2; targeted mutation 1.1, Magdalena Goetz",MGI:5473314,0,Otx2,MGI:97451
Otx2<tm10Asim>,"orthodenticle homeobox 2; targeted mutation 10, Antonio Simeone",MGI:4365829,0,Otx2,MGI:97451
Otx2<tm11Asim>,"orthodenticle homeobox 2; targeted mutation 11, Antonio Simeone",MGI:4365830,0,Otx2,MGI:97451
Otx2<tm1Pas>,"orthodenticle homeobox 2; targeted mutation 1, Institut Pasteur",MGI:1857510,0,Otx2,MGI:97451
Otx2<tm2Asim>,"orthodenticle homeobox 2; targeted mutation 2, Antonio Simeone",MGI:2150146,0,Otx2,MGI:97451
Otx2<tm3(otd)Asim>,"orthodenticle homeobox 2; targeted mutation 3, Antonio Simeone",MGI:2157778,0,Otx2,MGI:97451
Otx2<tm4(otd)Asim>,"orthodenticle homeobox 2; targeted mutation 4, Antonio Simeone",MGI:2157779,0,Otx2,MGI:97451
Otx2<tm6Asim>,"orthodenticle homeobox 2; targeted mutation 6, Antonio Simeone",MGI:2661065,0,Otx2,MGI:97451
Otx2<tm9Asim>,"orthodenticle homeobox 2; targeted mutation 9, Antonio Simeone",MGI:4365828,0,Otx2,MGI:97451
Ovgp1<tm1a(KOMP)Wtsi>,"oviductal glycoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362777,KOMP-CSD,Ovgp1,MGI:106661
Oxr1<tm1a(EUCOMM)Wtsi>,"oxidation resistance 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461745,EUCOMM,Oxr1,MGI:2179326
P2rx4<tm1a(EUCOMM)Wtsi>,"purinergic receptor P2X, ligand-gated ion channel 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944573,EUCOMM,P2rx4,MGI:1338859
P2rx4<tm1b(EUCOMM)Wtsi>,"purinergic receptor P2X, ligand-gated ion channel 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548440,EUCOMM,P2rx4,MGI:1338859
P2rx5<tm1Lex>,"purinergic receptor P2X, ligand-gated ion channel, 5; targeted mutation 1, Lexicon Genetics",MGI:5430769,Lexicon,P2rx5,MGI:2137026
P2rx5<tm1a(EUCOMM)Hmgu>,"purinergic receptor P2X, ligand-gated ion channel, 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841555,EUCOMM,P2rx5,MGI:2137026
P2rx6<tm1Dgen>,"purinergic receptor P2X, ligand-gated ion channel, 6; targeted mutation 1, Deltagen",MGI:5427682,Deltagen,P2rx6,MGI:1337113
P2rx6<tm2a(EUCOMM)Wtsi>,"purinergic receptor P2X, ligand-gated ion channel, 6; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5050912,EUCOMM,P2rx6,MGI:1337113
P2rx7<tm1a(EUCOMM)Wtsi>,"purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432150,EUCOMM,P2rx7,MGI:1339957
P2rx7<tm1b(EUCOMM)Wtsi>,"purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548444,EUCOMM,P2rx7,MGI:1339957
P2ry12<tm1Dgen>,"purinergic receptor P2Y, G-protein coupled 12; targeted mutation 1, Deltagen",MGI:5427683,Deltagen,P2ry12,MGI:1918089
P2ry14<tm1.1Gac>,"purinergic receptor P2Y, G-protein coupled, 14; targeted mutation 1.1, Christian Gachet",MGI:5475514,0,P2ry14,MGI:2155705
P2ry1<tm1Gac>,"purinergic receptor P2Y, G-protein coupled 1; targeted mutation 1, Christian Gachet",MGI:2181709,0,P2ry1,MGI:105049
P4ha1<tm1Jomy>,"procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide; targeted mutation 1, Johanna Myllyharju",MGI:3706369,0,P4ha1,MGI:97463
P4ha2<tm1Jomy>,"procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide; targeted mutation 1, Johanna Myllyharju",MGI:5645507,0,P4ha2,MGI:894286
Pa2g4<tm1a(EUCOMM)Wtsi>,"proliferation-associated 2G4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433339,EUCOMM,Pa2g4,MGI:894684
Pabpc1l<tm1a(EUCOMM)Wtsi>,"poly(A) binding protein, cytoplasmic 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431852,EUCOMM,Pabpc1l,MGI:1922908
Pabpc4<tm1a(KOMP)Wtsi>,"poly(A) binding protein, cytoplasmic 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364054,KOMP-CSD,Pabpc4,MGI:2385206
Pabpc4<tm1e(KOMP)Wtsi>,"poly(A) binding protein, cytoplasmic 4; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4364130,KOMP-CSD,Pabpc4,MGI:2385206
Pabpn1l<tm1a(EUCOMM)Wtsi>,"poly(A)binding protein nuclear 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842589,EUCOMM,Pabpn1l,MGI:2685954
Pacs2<tm1a(EUCOMM)Hmgu>,"phosphofurin acidic cluster sorting protein 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435377,EUCOMM,Pacs2,MGI:1924399
Pacsin3<tm1a(EUCOMM)Wtsi>,"protein kinase C and casein kinase substrate in neurons 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431643,EUCOMM,Pacsin3,MGI:1891410
Padi3<tm1a(KOMP)Wtsi>,"peptidyl arginine deiminase, type III; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362791,KOMP-CSD,Padi3,MGI:1338891
Pak1<tm1a(EUCOMM)Hmgu>,"p21 (RAC1) activated kinase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842016,EUCOMM,Pak1,MGI:1339975
Pak2<tm1Dgen>,"p21 (RAC1) activated kinase 2; targeted mutation 1, Deltagen",MGI:5427684,Deltagen,Pak2,MGI:1339984
Palm3<tm1a(EUCOMM)Wtsi>,"paralemmin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434121,EUCOMM,Palm3,MGI:1921587
Pam16<tm1a(EUCOMM)Wtsi>,"presequence translocase-asssociated motor 16 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5000409,EUCOMM,Pam16,MGI:1913699
Pam16<tm1b(EUCOMM)Wtsi>,"presequence translocase-asssociated motor 16 homolog (S. cerevisiae); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637011,EUCOMM,Pam16,MGI:1913699
Panx1<tm1.1Fama>,"pannexin 1; targeted mutation 1.1, Fabio Mammano",MGI:5297171,0,Panx1,MGI:1860055
Paox<tm1.1(KOMP)Wtsi>,"polyamine oxidase (exo-N4-amino); targeted mutation 1.1, Wellcome Trust Sanger Institute",MGI:5548591,KOMP-CSD,Paox,MGI:1916983
Pard3<tm1a(KOMP)Wtsi>,"par-3 family cell polarity regulator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364353,KOMP-CSD,Pard3,MGI:2135608
Pard3b<tm1a(EUCOMM)Wtsi>,"par-3 family cell polarity regulator beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441664,EUCOMM,Pard3b,MGI:1919301
Pard3b<tm1b(EUCOMM)Wtsi>,"par-3 family cell polarity regulator beta; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5588280,EUCOMM,Pard3b,MGI:1919301
Park7<tm1Dsp>,"Parkinson disease (autosomal recessive, early onset) 7; targeted mutation 1, David S Park",MGI:3576227,0,Park7,MGI:2135637
Parl<tm1.1Bdes>,"presenilin associated, rhomboid-like; targeted mutation 1.1, Bart De Strooper",MGI:3693645,0,Parl,MGI:1277152
Parl<tm1Bdes>,"presenilin associated, rhomboid-like; targeted mutation 1, Bart De Strooper",MGI:3526574,0,Parl,MGI:1277152
Parl<tm1a(EUCOMM)Hmgu>,"presenilin associated, rhomboid-like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435986,EUCOMM,Parl,MGI:1277152
Parp1<tm1Jmdm>,"poly (ADP-ribose) polymerase family, member 1; targeted mutation 1, Josiane Menissier de Murcia",MGI:1857861,0,Parp1,MGI:1340806
Parp1<tm1Zqw>,"poly (ADP-ribose) polymerase family, member 1; targeted mutation 1, Zhao-Qi Wang",MGI:1857862,0,Parp1,MGI:1340806
Parp1<tm1a(EUCOMM)Hmgu>,"poly (ADP-ribose) polymerase family, member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435467,EUCOMM,Parp1,MGI:1340806
Parp2<tm1Jmdm>,"poly (ADP-ribose) polymerase family, member 2; targeted mutation 1, Josiane Menissier de Murcia",MGI:2663016,0,Parp2,MGI:1341112
Parvb<tm1a(EUCOMM)Wtsi>,"parvin, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431642,EUCOMM,Parvb,MGI:2153063
Patl2<tm1a(EUCOMM)Hmgu>,"protein associated with topoisomerase II homolog 2 (yeast); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435914,EUCOMM,Patl2,MGI:1914828
Pawr<tm1Jmos>,"PRKC, apoptosis, WT1, regulator; targeted mutation 1, Jorge Moscat",MGI:2678021,0,Pawr,MGI:2149961
Pawr<tm1a(EUCOMM)Wtsi>,"PRKC, apoptosis, WT1, regulator; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4888921,EUCOMM,Pawr,MGI:2149961
Pax1<tm2Neu>,"paired box 1; targeted mutation 2, Neuherberg",MGI:1857741,0,Pax1,MGI:97485
Pax2<1Neu>,paired box 2; Neuherberg 1,MGI:1857114,0,Pax2,MGI:97486
Pax2<Opdc>,paired box 2; optic disc coloboma,MGI:1934620,0,Pax2,MGI:97486
Pax2<tm1Pgr>,"paired box 2; targeted mutation 1, Peter Gruss",MGI:1857673,0,Pax2,MGI:97486
Pax3<Sp-2H>,paired box 3; splotch 2 Harwell,MGI:1856293,0,Pax3,MGI:97487
Pax3<tm1Buck>,"paired box 3; targeted mutation 1, Margaret E Buckingham",MGI:2687297,0,Pax3,MGI:97487
Pax3<tm2(PAX3/FOXO1A)Buck>,"paired box 3; targeted mutation 2, Margaret E Buckingham",MGI:2687304,0,Pax3,MGI:97487
Pax3<tm3.1(Pax7)Buck>,"paired box 3; targeted mutation 3.1, Margaret Buckingham",MGI:3047632,0,Pax3,MGI:97487
Pax3<tm5Buck>,"paired box 3; targeted mutation 5, Margaret E Buckingham",MGI:3687384,0,Pax3,MGI:97487
Pax3<tm6.2Buck>,"paired box 3; targeted mutation 6.2, Margaret E Buckingham",MGI:5291823,0,Pax3,MGI:97487
Pax4<tm1a(EUCOMM)Hmgu>,"paired box 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841624,EUCOMM,Pax4,MGI:97488
Pax6<10Neu>,"paired box 6; 10, Neuherberg",MGI:2156820,0,Pax6,MGI:97490
Pax6<2Neu>,"paired box 6; 2, Neuherberg",MGI:2156812,0,Pax6,MGI:97490
Pax6<3Neu>,"paired box 6; 3, Neuherberg",MGI:2156742,0,Pax6,MGI:97490
Pax6<4Neu>,"paired box 6; 4, Neuherberg",MGI:2156741,0,Pax6,MGI:97490
Pax6<5Neu>,"paired box 6; 5, Neuherberg",MGI:2156817,0,Pax6,MGI:97490
Pax6<6Neu>,"paired box 6; 6, Neuherberg",MGI:2156818,0,Pax6,MGI:97490
Pax6<7Neu>,"paired box 6; 7, Neuherberg",MGI:2156738,0,Pax6,MGI:97490
Pax6<8Neu>,"paired box 6; 8, Neuherberg",MGI:2156819,0,Pax6,MGI:97490
Pax6<9Neu>,"paired box 6; 9, Neuherberg",MGI:2156821,0,Pax6,MGI:97490
Pax6<Aey80>,paired box 6; abnormality of the eye 80,MGI:5511011,0,Pax6,MGI:97490
Pax6<Leca1>,paired box 6; lens corneal adhesion 1,MGI:1934622,0,Pax6,MGI:97490
Pax6<Leca2>,paired box 6; lens corneal adhesion 2,MGI:1934621,0,Pax6,MGI:97490
Pax6<Leca3>,paired box 6; lens corneal adhesion 3,MGI:1934632,0,Pax6,MGI:97490
Pax6<Leca4>,paired box 6; lens corneal adhesion 4,MGI:1934618,0,Pax6,MGI:97490
Pax6<Mhdaaey11>,paired box 6; Martin Hrabe de Angelis abnormal eyes 11,MGI:3529954,0,Pax6,MGI:97490
Pax6<Mhdaaey18>,paired box 6; Martin Hrabe de Angelis abnormal eyes 18,MGI:3521718,0,Pax6,MGI:97490
Pax6<Sey-H>,"paired box 6; small eye, Harwell",MGI:1856156,0,Pax6,MGI:97490
Pax6<Sey-Neu>,"paired box 6; small eye, Neuherberg",MGI:1856158,0,Pax6,MGI:97490
Pax6<Sey>,paired box 6; small eye,MGI:1856155,0,Pax6,MGI:97490
Pax6<tm1Pgr>,"paired box 6; targeted mutation 1, Peter Gruss",MGI:1934347,0,Pax6,MGI:97490
Pax7<tm1(cre)Mrc>,"paired box 7; targeted mutation 1, Mario R Capecchi",MGI:3497712,0,Pax7,MGI:97491
Pax7<tm2Pgr>,"paired box 7; targeted mutation 2, Peter Gruss",MGI:3047633,0,Pax7,MGI:97491
Pax8<tm1Pgr>,"paired box 8; targeted mutation 1, Peter Gruss",MGI:2156985,0,Pax8,MGI:97492
Pbdc1<tm2a(KOMP)Wtsi>,"polysaccharide biosynthesis domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4451656,KOMP-CSD,Pbdc1,MGI:1914933
Pbrm1<tm1a(EUCOMM)Wtsi>,"polybromo 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432389,EUCOMM,Pbrm1,MGI:1923998
Pbrm1<tm1b(EUCOMM)Wtsi>,"polybromo 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548674,EUCOMM,Pbrm1,MGI:1923998
Pbx3<tm1a(EUCOMM)Wtsi>,"pre B cell leukemia homeobox 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433160,EUCOMM,Pbx3,MGI:97496
Pced1a<tm1a(EUCOMM)Wtsi>,"PC-esterase domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842567,EUCOMM,Pced1a,MGI:2442177
Pced1a<tm1b(EUCOMM)Wtsi>,"PC-esterase domain containing 1A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548804,EUCOMM,Pced1a,MGI:2442177
Pcp4l1<tm1b(KOMP)Wtsi>,,MGI:1913675,,,
Pcsk1<tm1a(EUCOMM)Wtsi>,"proprotein convertase subtilisin/kexin type 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441678,EUCOMM,Pcsk1,MGI:97511
Pcsk9<tm2a(EUCOMM)Hmgu>,"proprotein convertase subtilisin/kexin type 9; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511776,EUCOMM,Pcsk9,MGI:2140260
Pcsk9<tm2b(EUCOMM)Hmgu>,"proprotein convertase subtilisin/kexin type 9; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5637110,EUCOMM,Pcsk9,MGI:2140260
Pcx<tm1a(EUCOMM)Wtsi>,"pyruvate carboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432994,EUCOMM,Pcx,MGI:97520
Pcx<tm1b(EUCOMM)Wtsi>,"pyruvate carboxylase; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548959,EUCOMM,Pcx,MGI:97520
Pdcd2<tm1a(EUCOMM)Wtsi>,"programmed cell death 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432528,EUCOMM,Pdcd2,MGI:104643
Pdcd2<tm1b(EUCOMM)Wtsi>,"programmed cell death 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636894,EUCOMM,Pdcd2,MGI:104643
Pdcd5<tm1(KOMP)Vlcg>,"programmed cell death 5; targeted mutation 1, Velocigene",MGI:4951313,KOMP-Regeneron,Pdcd5,MGI:1913538
Pde12<tm1a(KOMP)Wtsi>,"phosphodiesterase 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451347,KOMP-CSD,Pde12,MGI:2443226
Pde2a<tm1Dgen>,"phosphodiesterase 2A, cGMP-stimulated; targeted mutation 1, Deltagen",MGI:5427685,Deltagen,Pde2a,MGI:2446107
Pde3a<tm1Dgen>,"phosphodiesterase 3A, cGMP inhibited; targeted mutation 1, Deltagen",MGI:5427686,Deltagen,Pde3a,MGI:1860764
Pde4b<tm1Dgen>,"phosphodiesterase 4B, cAMP specific; targeted mutation 1, Deltagen",MGI:5427687,Deltagen,Pde4b,MGI:99557
Pde4d<tm1Dgen>,"phosphodiesterase 4D, cAMP specific; targeted mutation 1, Deltagen",MGI:5427688,Deltagen,Pde4d,MGI:99555
Pde6b<atrd1>,"phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; atypical retinal degeneration 1",MGI:2178311,0,Pde6b,MGI:97525
Pde6b<atrd2>,"phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; atypical retinal degeneration 2",MGI:2178315,0,Pde6b,MGI:97525
Pde6b<atrd3>,"phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; atypical retinal degeneration 3",MGI:2178316,0,Pde6b,MGI:97525
Pde6b<rd1-2H>,"phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; retinal degeneration 1, 2 Harwell",MGI:2178318,0,Pde6b,MGI:97525
Pde6b<rd1-3H>,"phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; retinal degeneration 1, 3 Harwell",MGI:2178319,0,Pde6b,MGI:97525
Pde6b<rd1-4H>,"phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; retinal degeneration 1, 4 Harwell",MGI:2178320,0,Pde6b,MGI:97525
Pde8a<tm1Dgen>,"phosphodiesterase 8A; targeted mutation 1, Deltagen",MGI:3699271,Deltagen,Pde8a,MGI:1277116
Pdgfa<tm2Cbet>,"platelet derived growth factor, alpha; targeted mutation 2, Christer Betsholtz",MGI:5548172,0,Pdgfa,MGI:97527
Pdgfc<tm1b(EUCOMM)Hmgu>,,MGI:1859631,,,
Pdgfrb<tm1Rheu>,"platelet derived growth factor receptor, beta polypeptide; targeted mutation 1, Rainer Heuchel",MGI:3511432,0,Pdgfrb,MGI:97531
Pdgfrb<tm1a(EUCOMM)Hmgu>,"platelet derived growth factor receptor, beta polypeptide; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841570,EUCOMM,Pdgfrb,MGI:97531
Pdgfrb<tm3Sor>,"platelet derived growth factor receptor, beta polypeptide; targeted mutation 3, Philippe Soriano",MGI:2135532,0,Pdgfrb,MGI:97531
Pdhx<tm1a(EUCOMM)Hmgu>,"pyruvate dehydrogenase complex, component X; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435592,EUCOMM,Pdhx,MGI:1351627
Pdhx<tm1b(EUCOMM)Hmgu>,"pyruvate dehydrogenase complex, component X; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613640,EUCOMM,Pdhx,MGI:1351627
Pdia4<tm1a(EUCOMM)Wtsi>,"protein disulfide isomerase associated 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842358,EUCOMM,Pdia4,MGI:104864
Pdia4<tm1b(EUCOMM)Wtsi>,"protein disulfide isomerase associated 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636896,EUCOMM,Pdia4,MGI:104864
Pdia6<tm1a(EUCOMM)Hmgu>,"protein disulfide isomerase associated 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435366,EUCOMM,Pdia6,MGI:1919103
Pdia6<tm1b(EUCOMM)Hmgu>,"protein disulfide isomerase associated 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5605786,EUCOMM,Pdia6,MGI:1919103
Pdk3<tm2a(KOMP)Wtsi>,"pyruvate dehydrogenase kinase, isoenzyme 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4458498,KOMP-CSD,Pdk3,MGI:2384308
Pdpn<tm1a(EUCOMM)Wtsi>,"podoplanin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842558,EUCOMM,Pdpn,MGI:103098
Pds5b<tm1a(EUCOMM)Wtsi>,"PDS5 cohesin associated factor B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432978,EUCOMM,Pds5b,MGI:2140945
Pdss2<tm1a(EUCOMM)Hmgu>,"prenyl (solanesyl) diphosphate synthase, subunit 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946711,EUCOMM,Pdss2,MGI:1918615
Pdxk<tm1a(EUCOMM)Wtsi>,"pyridoxal (pyridoxine, vitamin B6) kinase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441874,EUCOMM,Pdxk,MGI:1351869
Pdyn<tm1Zim>,"prodynorphin; targeted mutation 1, Andreas Zimmer",MGI:3719377,0,Pdyn,MGI:97535
Pdzd3<tm1a(KOMP)Wtsi>,"PDZ domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419952,KOMP-CSD,Pdzd3,MGI:2429554
Pdzd8<tm1a(EUCOMM)Wtsi>,"PDZ domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431887,EUCOMM,Pdzd8,MGI:2677270
Pdzk1<tm2a(EUCOMM)Wtsi>,"PDZ domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5497391,EUCOMM,Pdzk1,MGI:1928901
Pear1<tm1a(KOMP)Wtsi>,"platelet endothelial aggregation receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363617,KOMP-CSD,Pear1,MGI:1920432
Pebp4<tm1a(EUCOMM)Hmgu>,"phosphatidylethanolamine binding protein 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436202,EUCOMM,Pebp4,MGI:1920773
Pecam1<tm1Mak>,"platelet/endothelial cell adhesion molecule 1; targeted mutation 1, Tak W Mak",MGI:2677448,0,Pecam1,MGI:97537
Pedm14,"Pedm14, Harwell; Pedm/14, Harwell",MGI:5499202,Harwell ENU Mutagenesis,Pedm14,MGI:5499185
Pedm15,"Pedm15, Harwell; Pedm/15, Harwell",MGI:5499197,Harwell ENU Mutagenesis,Pedm15,MGI:5499180
Pedm25,"Pedm25, Harwell; Pedm/25, Harwell",MGI:5499198,Harwell ENU Mutagenesis,Pedm25,MGI:5499181
Pedm29,"Pedm29, Harwell; Pedm/29, Harwell",MGI:5499200,Harwell ENU Mutagenesis,Pedm29,MGI:5499183
Pedm36,"Pedm36, Harwell; Pedm/36, Harwell",MGI:5499199,Harwell ENU Mutagenesis,Pedm36,MGI:5499182
Pedm41,"Pedm41, Harwell; Pedm/41, Harwell",MGI:5499201,Harwell ENU Mutagenesis,Pedm41,MGI:5499184
Pedm42,"Pedm42, Harwell; Pedm/42, Harwell",MGI:5499203,Harwell ENU Mutagenesis,Pedm42,MGI:5499186
Pef1<tm1a(EUCOMM)Hmgu>,"penta-EF hand domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434599,EUCOMM,Pef1,MGI:1915148
Pef1<tm1b(EUCOMM)Hmgu>,"penta-EF hand domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5614701,EUCOMM,Pef1,MGI:1915148
Peg12<tm1Brn>,"paternally expressed 12; targeted mutation 1, Anton Berns",MGI:3530465,0,Peg12,MGI:1351637
Penk-rs<tm1Pig>,"preproenkephalin, related sequence; targeted mutation 1, Pain Investigation Group",MGI:2136456,0,Penk-rs,MGI:104628
Pepc<b>,peptidase C; b variant,MGI:4819861,0,Pepc,MGI:97541
Per2<tm1a(EUCOMM)Hmgu>,"period circadian clock 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436072,EUCOMM,Per2,MGI:1195265
Pex10<tm1a(EUCOMM)Wtsi>,"peroxisomal biogenesis factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432787,EUCOMM,Pex10,MGI:2684988
Pex16<tm1a(EUCOMM)Hmgu>,"peroxisomal biogenesis factor 16; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434961,EUCOMM,Pex16,MGI:1338829
Pex1<tm1e(EUCOMM)Hmgu>,"peroxisomal biogenesis factor 1; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH",MGI:4458786,EUCOMM,Pex1,MGI:1918632
Pex1<tm1e.1(EUCOMM)Hmgu>,,MGI:1918632,,,
Pex3<tm1a(EUCOMM)Wtsi>,"peroxisomal biogenesis factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431895,EUCOMM,Pex3,MGI:1929646
Pfkfb1<tm1a(KOMP)Wtsi>,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944400,KOMP-CSD,Pfkfb1,MGI:107816
Pfkfb3<tm1a(EUCOMM)Wtsi>,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441922,EUCOMM,Pfkfb3,MGI:2181202
Pfkfb4<tm1a(KOMP)Wtsi>,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362852,KOMP-CSD,Pfkfb4,MGI:2687284
Pfkl<tm1a(EUCOMM)Wtsi>,"phosphofructokinase, liver, B-type; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432814,EUCOMM,Pfkl,MGI:97547
Pfn1<tm1a(EUCOMM)Wtsi>,"profilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433191,EUCOMM,Pfn1,MGI:97549
Pgam5<tm1a(EUCOMM)Wtsi>,"phosphoglycerate mutase family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432458,EUCOMM,Pgam5,MGI:1919792
Pgap2<tm1a(EUCOMM)Wtsi>,"post-GPI attachment to proteins 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453763,EUCOMM,Pgap2,MGI:2385286
Pgap2<tm1b(EUCOMM)Wtsi>,"post-GPI attachment to proteins 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637131,EUCOMM,Pgap2,MGI:2385286
Pgd<tm1a(EUCOMM)Wtsi>,"phosphogluconate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431737,EUCOMM,Pgd,MGI:97553
Pgs1<tm1a(EUCOMM)Hmgu>,"phosphatidylglycerophosphate synthase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451871,EUCOMM,Pgs1,MGI:1921701
Pgs1<tm1b(EUCOMM)Hmgu>,"phosphatidylglycerophosphate synthase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5637078,EUCOMM,Pgs1,MGI:1921701
Phex<Hpr>,"phosphate regulating endopeptidase homolog, X-linked; hypophosphatemic rickets",MGI:5435304,0,Phex,MGI:107489
Phex<Mhdabap012>,"phosphate regulating endopeptidase homolog, X-linked; Martin Hrabe de Angelis bone alkaline phospatase mutant 012",MGI:5424918,0,Phex,MGI:107489
Phex<Mhdabap024>,"phosphate regulating endopeptidase homolog, X-linked; Martin Hrabe de Angelis bone alkaline phospatase mutant 024",MGI:5424921,0,Phex,MGI:107489
Phf10<tm1a(EUCOMM)Hmgu>,"PHD finger protein 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5497157,EUCOMM,Phf10,MGI:1919307
Phf20<tm1a(EUCOMM)Wtsi>,"PHD finger protein 20; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432264,EUCOMM,Phf20,MGI:2444148
Phf6<tm1a(EUCOMM)Wtsi>,"PHD finger protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432234,EUCOMM,Phf6,MGI:1918248
Phox2a<tm1(Phox2b)Mist>,"paired-like homeobox 2a; targeted mutation 1, Michele Studer",MGI:3521825,0,Phox2a,MGI:106633
Phox2a<tm2Jbr>,"paired-like homeobox 2a; targeted mutation 2.1, Jean-Francois Brunet",MGI:4438118,0,Phox2a,MGI:106633
Phox2b<m1Mhda>,"paired-like homeobox 2b; mutation 1, Martin Hrabe de Angelis",MGI:5818761,0,Phox2b,MGI:1100882
Phox2b<tm1(Phox2a)Mist>,"paired-like homeobox 2b; targeted mutation 1, Michele Studer",MGI:3521828,0,Phox2b,MGI:1100882
Phox2b<tm4Jbr>,"paired-like homeobox 2b; targeted mutation 4, Jean-Francois Brunet",MGI:4418298,0,Phox2b,MGI:1100882
Phtf2<tm1a(EUCOMM)Wtsi>,"putative homeodomain transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432782,EUCOMM,Phtf2,MGI:1916020
Phyhipl<tm1a(EUCOMM)Wtsi>,"phytanoyl-CoA hydroxylase interacting protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460503,EUCOMM,Phyhipl,MGI:1918161
Phykpl<tm1a(EUCOMM)Wtsi>,"5-phosphohydroxy-L-lysine phospholyase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431628,EUCOMM,Phykpl,MGI:1920197
Pi4k2a<Gt(AK0094)Wtsi>,"phosphatidylinositol 4-kinase type 2 alpha; gene trap AK0094, Wellcome Trust Sanger Institute",MGI:4345401,Sanger Inst. Gene Trap Res.,Pi4k2a,MGI:1934031
Pias2<tm1a(KOMP)Wtsi>,"protein inhibitor of activated STAT 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419892,KOMP-CSD,Pias2,MGI:1096566
Pigf<tm1a(KOMP)Wtsi>,"phosphatidylinositol glycan anchor biosynthesis, class F; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5013736,KOMP-CSD,Pigf,MGI:99462
Pigl<tm1a(KOMP)Wtsi>,"phosphatidylinositol glycan anchor biosynthesis, class L; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820087,KOMP-CSD,Pigl,MGI:2681271
Pigl<tm1b(KOMP)Wtsi>,"phosphatidylinositol glycan anchor biosynthesis, class L; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637168,KOMP-CSD,Pigl,MGI:2681271
Pigu<tm1a(EUCOMM)Hmgu>,"phosphatidylinositol glycan anchor biosynthesis, class U; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435661,EUCOMM,Pigu,MGI:3039607
Pik3ap1<tm1a(KOMP)Wtsi>,"phosphoinositide-3-kinase adaptor protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419954,KOMP-CSD,Pik3ap1,MGI:1933177
Pik3c3<tm1a(EUCOMM)Wtsi>,"phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433098,EUCOMM,Pik3c3,MGI:2445019
Pik3ca<tm1Bvan>,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; targeted mutation 1, Bart Vanhaesebroeck",MGI:3628805,0,Pik3ca,MGI:1206581
Pik3ca<tm3Bvan>,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; targeted mutation 3, Bart Vanhaesebroeck",MGI:3795787,0,Pik3ca,MGI:1206581
Pik3cb<tm1a(EUCOMM)Wtsi>,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434375,EUCOMM,Pik3cb,MGI:1922019
Pik3cd<tm1.1Bvan>,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta; targeted mutation 1.1, Bart Vanhaesebroeck",MGI:2385596,0,Pik3cd,MGI:1098211
Pik3cg<tm1a(EUCOMM)Wtsi>,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432229,EUCOMM,Pik3cg,MGI:1353576
Pik3cg<tm1c(EUCOMM)Wtsi>,,MGI:1353576,,,
Pik3r2<tm1e(KOMP)Wtsi>,"phosphoinositide-3-kinase regulatory subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4363631,KOMP-CSD,Pik3r2,MGI:1098772
Pink1<tm1a(EUCOMM)Wtsi>,"PTEN induced putative kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008020,EUCOMM,Pink1,MGI:1916193
Pip5k1c<tm1a(KOMP)Wtsi>,"phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362880,KOMP-CSD,Pip5k1c,MGI:1298224
Pitpnm1<tm1a(EUCOMM)Wtsi>,"phosphatidylinositol transfer protein, membrane-associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431584,EUCOMM,Pitpnm1,MGI:1197524
Pitrm1<tm1a(KOMP)Wtsi>,"pitrilysin metallepetidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5085349,KOMP-CSD,Pitrm1,MGI:1916867
Pitx3<eyl>,paired-like homeodomain transcription factor 3; eyeless,MGI:4429408,0,Pitx3,MGI:1100498
Piwil1<tm1.1Embrp>,"piwi-like RNA-mediated gene silencing 1; targeted mutation 1.1, Ramesh Pillai",MGI:5316870,0,Piwil1,MGI:1928897
Piwil1<tm1.2Embrp>,"piwi-like RNA-mediated gene silencing 1; targeted mutation 1.2, Ramesh Pillai",MGI:5316871,0,Piwil1,MGI:1928897
Piwil2<tm1.1Doca>,"piwi-like RNA-mediated gene silencing 2; targeted mutation 1.1, Donal O'Carroll",MGI:5320635,0,Piwil2,MGI:1930036
Piwil2<tm2.1Doca>,"piwi-like RNA-mediated gene silencing 2; targeted mutation 2.1, Donal O'Carroll",MGI:5521292,0,Piwil2,MGI:1930036
Piwil2<tm2.2Doca>,"piwi-like RNA-mediated gene silencing 2; targeted mutation 2.2, Donal O'Carroll",MGI:5521293,0,Piwil2,MGI:1930036
Piwil4<tm1.1Doca>,"piwi-like RNA-mediated gene silencing 4; targeted mutation 1.1, Donal O'Carroll",MGI:5320636,0,Piwil4,MGI:3041167
Piwil4<tm2.1Doca>,"piwi-like RNA-mediated gene silencing 4; targeted mutation 2.1, Donal O'Carroll",MGI:5320638,0,Piwil4,MGI:3041167
Pja1<m1Yah>,"praja ring finger ubiquitin ligase 1; mutation 1, Yann Herault",MGI:5762626,0,Pja1,MGI:1101765
Pk27053,pyruvate kinase activity mutant 27053,MGI:5752521,0,Pk27053,MGI:5752518
Pkd1l2<tm1a(KOMP)Mbp>,"polycystic kidney disease 1 like 2; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4455437,KOMP-CSD,Pkd1l2,MGI:2664668
Pkd2<tm1Dwo>,"polycystin 2, transient receptor potential cation channel; targeted mutation 1, Bernd Dworniczak",MGI:2676373,0,Pkd2,MGI:1099818
Pkd2l2<tm1a(EUCOMM)Wtsi>,"polycystic kidney disease 2-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432894,EUCOMM,Pkd2l2,MGI:1858231
Pkig<tm1a(EUCOMM)Hmgu>,"protein kinase inhibitor, gamma; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5014672,EUCOMM,Pkig,MGI:1343086
Pkig<tm1b(EUCOMM)Hmgu>,"protein kinase inhibitor, gamma; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636975,EUCOMM,Pkig,MGI:1343086
Pklr<M1Neu>,"pyruvate kinase liver and red blood cell; mutation 1, Neuherberg",MGI:4820881,0,Pklr,MGI:97604
Pkn1<tm1a(KOMP)Wtsi>,"protein kinase N1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4365010,KOMP-CSD,Pkn1,MGI:108022
Pkn2<tm1a(KOMP)Wtsi>,"protein kinase N2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363870,KOMP-CSD,Pkn2,MGI:109211
Pkn2<tm1b(KOMP)Wtsi>,"protein kinase N2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613636,KOMP-CSD,Pkn2,MGI:109211
Pknox1<Gt(EUCJ0079d10)Hmgu>,"Pbx/knotted 1 homeobox; gene trap EUCJ0079d10, Helmholtz Zentrum Muenchen GmbH",MGI:4876037,0,Pknox1,MGI:1201409
Pla2g10<tm1a(EUCOMM)Hmgu>,"phospholipase A2, group X; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435080,EUCOMM,Pla2g10,MGI:1347522
Pla2g10<tm1b(EUCOMM)Hmgu>,"phospholipase A2, group X; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548469,EUCOMM,Pla2g10,MGI:1347522
Pla2g2c<tm1a(EUCOMM)Wtsi>,"phospholipase A2, group IIC; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455976,EUCOMM,Pla2g2c,MGI:106638
Pla2g2e<tm1a(EUCOMM)Wtsi>,"phospholipase A2, group IIE; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432002,EUCOMM,Pla2g2e,MGI:1349660
Pla2g2e<tm1b(EUCOMM)Wtsi>,"phospholipase A2, group IIE; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636980,EUCOMM,Pla2g2e,MGI:1349660
Pla2g4f<tm1a(EUCOMM)Hmgu>,"phospholipase A2, group IVF; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435081,EUCOMM,Pla2g4f,MGI:2685493
Plac8<tm1a(EUCOMM)Hmgu>,"placenta-specific 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841670,EUCOMM,Plac8,MGI:2445289
Plac8<tm1b(EUCOMM)Hmgu>,"placenta-specific 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5637155,EUCOMM,Plac8,MGI:2445289
Plac9a<tm1a(EUCOMM)Hmgu>,"placenta specific 9a; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946775,EUCOMM,Plac9a,MGI:2663998
Plat<tm1Mlg>,"plasminogen activator, tissue; targeted mutation 1, Richard C Mulligan",MGI:1857288,0,Plat,MGI:97610
Play1,Play1,MGI:5496403,Harwell ENU Mutagenesis,Play1,MGI:5495797
Play16,Play16,MGI:5496404,Harwell ENU Mutagenesis,Play16,MGI:5495799
Play19,Play19,MGI:5496405,Harwell ENU Mutagenesis,Play19,MGI:5495800
Play22,play 22; Play22,MGI:3606337,0,Play22,MGI:3606324
Play31,Play31,MGI:5496406,Harwell ENU Mutagenesis,Play31,MGI:5495801
Play32,Play32,MGI:5496407,Harwell ENU Mutagenesis,Play32,MGI:5495802
Play36,play 36; Play36,MGI:3606335,0,Play36,MGI:3606322
Play40,Play40,MGI:5496408,Harwell ENU Mutagenesis,Play40,MGI:5495803
Play41,play 41; Play41,MGI:3606329,0,Play41,MGI:3606312
Play42,Play42,MGI:5496409,Harwell ENU Mutagenesis,Play42,MGI:5495804
Play44,Play44,MGI:5496410,Harwell ENU Mutagenesis,Play44,MGI:5495805
Play46,play 46; Play46,MGI:3606334,0,Play46,MGI:3606320
Play47,Play47,MGI:5496412,Harwell ENU Mutagenesis,Play47,MGI:5495806
Play50,play 50; Play50,MGI:3606338,0,Play50,MGI:3606326
Play57,play 57; Play57,MGI:3606332,0,Play57,MGI:3606316
Play63,play 63,MGI:5141718,Harwell ENU Mutagenesis,Play63,MGI:5141714
Play65,Play65,MGI:5495814,Harwell ENU Mutagenesis,Play65,MGI:5495791
Play72,Play72,MGI:5495815,Harwell ENU Mutagenesis,Play72,MGI:5495792
Play78,Play78,MGI:5495933,Harwell ENU Mutagenesis,Play78,MGI:5495793
Play79,Play79,MGI:5496397,Harwell ENU Mutagenesis,Play79,MGI:5495794
Play81,,MGI:5495795,,,
Play82,Play82,MGI:5496401,Harwell ENU Mutagenesis,Play82,MGI:5495796
Plbd1<tm1a(KOMP)Wtsi>,"phospholipase B domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362953,KOMP-CSD,Plbd1,MGI:1914107
Plcg2<tm1Jni>,"phospholipase C, gamma 2; targeted mutation 1, James N Ihle",MGI:2386100,0,Plcg2,MGI:97616
Pld3<tm1e(EUCOMM)Wtsi>,"phospholipase D family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4842606,EUCOMM,Pld3,MGI:1333782
Pld5<tm1a(KOMP)Wtsi>,"phospholipase D family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363433,KOMP-CSD,Pld5,MGI:2442056
Pld5<tm1b(KOMP)Wtsi>,"phospholipase D family, member 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548802,KOMP-CSD,Pld5,MGI:2442056
Plekha1<Gt(EUCE0158g11)Hmgu>,"pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1; gene trap EUCE0158g11, Helmholtz Zentrum Muenchen GmbH",MGI:4395634,0,Plekha1,MGI:2442213
Plekha1<tm1a(EUCOMM)Hmgu>,"pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5501548,EUCOMM,Plekha1,MGI:2442213
Plekha5<Tg(AMH-cre)1Flor>,"pleckstrin homology domain containing, family A member 5; transgene insertion 1, Florian Guillou",MGI:2450300,0,Plekha5,MGI:1923802
Plekhg1<tm1a(EUCOMM)Wtsi>,"pleckstrin homology domain containing, family G (with RhoGef domain) member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431598,EUCOMM,Plekhg1,MGI:2676551
Plekhg3<tm1a(EUCOMM)Hmgu>,"pleckstrin homology domain containing, family G (with RhoGef domain) member 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435115,EUCOMM,Plekhg3,MGI:2388284
Plekhm1<Gt(OST201689)Lex>,"pleckstrin homology domain containing, family M (with RUN domain) member 1; gene trap OST201689, Lexicon Genetics",MGI:3529341,Lexicon,Plekhm1,MGI:2443207
Plekhm2<tm1a(EUCOMM)Wtsi>,"pleckstrin homology domain containing, family M (with RUN domain) member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432896,EUCOMM,Plekhm2,MGI:1916832
Plg<tm1Jld>,"plasminogen; targeted mutation 1, Jay L Degen",MGI:1857291,0,Plg,MGI:97620
Plin2<tm1a(EUCOMM)Wtsi>,"perilipin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432810,EUCOMM,Plin2,MGI:87920
Plod1<Gt(RST531)Byg>,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1; gene trap RST531, BayGenomics",MGI:3712145,0,Plod1,MGI:99907
Plod1<tm1Soin>,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1; targeted mutation 1, Raija Soininen",MGI:3712146,0,Plod1,MGI:99907
Plod3<tm1Rmyl>,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3; targeted mutation 1, Raili Myllyla",MGI:3620600,0,Plod3,MGI:1347008
Plod3<tm1Soin>,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3; targeted mutation 1, Raija Soininen",MGI:3497741,0,Plod3,MGI:1347008
Plod3<tm2.1Rmyl>,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3; targeted mutation 2.1, Raili Myllyla",MGI:3620603,0,Plod3,MGI:1347008
Plod3<tm2Rmyl>,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3; targeted mutation 2, Raili Myllyla",MGI:3620601,0,Plod3,MGI:1347008
Pls1<tm1Fri>,"plastin 1 (I-isoform); targeted mutation 1, Francisco Rivero",MGI:5609592,0,Pls1,MGI:104809
Pls3<tm1a(EUCOMM)Wtsi>,"plastin 3 (T-isoform); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451991,EUCOMM,Pls3,MGI:104807
Plscr1<tm1Lex>,"phospholipid scramblase 1; targeted mutation 1, Lexicon Genetics",MGI:2180949,Lexicon,Plscr1,MGI:893575
Plscr1<tm1a(EUCOMM)Hmgu>,"phospholipid scramblase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435862,EUCOMM,Plscr1,MGI:893575
Plscr2<tm1a(KOMP)Wtsi>,"phospholipid scramblase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363158,KOMP-CSD,Plscr2,MGI:1270860
Plscr2<tm1b(KOMP)Wtsi>,"phospholipid scramblase 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636936,KOMP-CSD,Plscr2,MGI:1270860
Plxna2<tm1a(EUCOMM)Wtsi>,"plexin A2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432861,EUCOMM,Plxna2,MGI:107684
Plxnb1<tm1Matl>,"plexin B1; targeted mutation 1, Marc Tessier-Lavigne",MGI:3765917,0,Plxnb1,MGI:2154238
Plxnb2<tm1Matl>,"plexin B2; targeted mutation 1, Marc Tessier-Lavigne",MGI:3620317,0,Plxnb2,MGI:2154239
Plxnb2<tm1a(EUCOMM)Wtsi>,"plexin B2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433461,EUCOMM,Plxnb2,MGI:2154239
Plxnb3<tm1a(KOMP)Wtsi>,"plexin B3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419514,KOMP-CSD,Plxnb3,MGI:2154240
Pmel<tm1.1Sson>,"premelanosome protein; targeted mutation 1.1, Leif Andersson",MGI:5294792,0,Pmel,MGI:98301
Pmel<tm1a(EUCOMM)Wtsi>,"premelanosome protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441778,EUCOMM,Pmel,MGI:98301
Pmel<tm1b(EUCOMM)Wtsi>,"premelanosome protein; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637220,EUCOMM,Pmel,MGI:98301
Pml<Gt(EUCJ0019c12)Hmgu>,"promyelocytic leukemia; gene trap EUCJ0019c12, Helmholtz Zentrum Muenchen GmbH",MGI:4871089,0,Pml,MGI:104662
Pmp22<Tr-1H>,peripheral myelin protein 22; trembler 1 Harwell,MGI:1862010,0,Pmp22,MGI:97631
Pmp22<Tr-2H>,peripheral myelin protein 22; trembler 2 Harwell,MGI:1862011,Harwell ENU Mutagenesis,Pmp22,MGI:97631
Pmp22<Tr-3H>,peripheral myelin protein 22; trembler 3 Harwell,MGI:2388488,Harwell ENU Mutagenesis,Pmp22,MGI:97631
Pnpla1<tm1a(KOMP)Wtsi>,"patatin-like phospholipase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5085354,KOMP-CSD,Pnpla1,MGI:3617850
Pnpo<tm1a(KOMP)Wtsi>,"pyridoxine 5'-phosphate oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363478,KOMP-CSD,Pnpo,MGI:2144151
Pnpt1<tm1a(KOMP)Wtsi>,"polyribonucleotide nucleotidyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364657,KOMP-CSD,Pnpt1,MGI:1918951
Pof1b<tm1Toni>,"premature ovarian failure 1B; targeted mutation 1, Daniela Toniolo",MGI:5008640,0,Pof1b,MGI:1916943
Polb<tm1a(KOMP)Wtsi>,"polymerase (DNA directed), beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4950969,KOMP-CSD,Polb,MGI:97740
Pold3<tm1a(EUCOMM)Wtsi>,"polymerase (DNA-directed), delta 3, accessory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441785,EUCOMM,Pold3,MGI:1915217
Pold3<tm1b(EUCOMM)Wtsi>,"polymerase (DNA-directed), delta 3, accessory subunit; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637026,EUCOMM,Pold3,MGI:1915217
Polg2<tm1a(EUCOMM)Wtsi>,"polymerase (DNA directed), gamma 2, accessory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432134,EUCOMM,Polg2,MGI:1354947
Polh<tm1Crey>,"polymerase (DNA directed), eta (RAD 30 related); targeted mutation 1, Claude-Agnes Reynaud",MGI:3577345,0,Polh,MGI:1891457
Poli<Gt(S15-7G1)Sor>,"polymerase (DNA directed), iota; gene trap S15-7G1, Philippe Soriano",MGI:4974011,0,Poli,MGI:1347081
Polk<tm1.1Rsky>,"polymerase (DNA directed), kappa; targeted mutation 1.1, Klaus Rajewsky",MGI:2445458,0,Polk,MGI:1349767
Poll<tm1Crey>,"polymerase (DNA directed), lambda; targeted mutation 1, Claude-Agnes Reynaud",MGI:2179232,0,Poll,MGI:1889000
Polm<tm1Crey>,"polymerase (DNA directed), mu; targeted mutation 1, Claude-Agnes Reynaud",MGI:2179233,0,Polm,MGI:1860191
Poln<tm1a(EUCOMM)Hmgu>,"DNA polymerase N; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435830,EUCOMM,Poln,MGI:2675617
Polr1e<tm1a(KOMP)Wtsi>,"polymerase (RNA) I polypeptide E; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362193,KOMP-CSD,Polr1e,MGI:1929022
Polr2a<tm1(cre/ERT2)Bbd>,"polymerase (RNA) II (DNA directed) polypeptide A; targeted mutation 1, Mariano Barbacid",MGI:3772332,0,Polr2a,MGI:98086
Polr2d<tm1a(KOMP)Wtsi>,"polymerase (RNA) II (DNA directed) polypeptide D; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4942026,KOMP-CSD,Polr2d,MGI:1916491
Polr3f<tm1a(EUCOMM)Wtsi>,"polymerase (RNA) III (DNA directed) polypeptide F; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431549,EUCOMM,Polr3f,MGI:1924086
Polr3g<tm1a(EUCOMM)Wtsi>,"polymerase (RNA) III (DNA directed) polypeptide G; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441807,EUCOMM,Polr3g,MGI:1914736
Pomt1<tm1Jec>,"protein-O-mannosyltransferase 1; targeted mutation 1, Jesus Cruces",MGI:3497739,0,Pomt1,MGI:2138994
Pomt1<tm1c(EUCOMM)Hmgu>,"protein-O-mannosyltransferase 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH",MGI:6197751,0,Pomt1,MGI:2138994
Pon2<tm1a(EUCOMM)Hmgu>,"paraoxonase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4847743,EUCOMM,Pon2,MGI:106687
Pop4<tm1a(EUCOMM)Wtsi>,"processing of precursor 4, ribonuclease P/MRP family, (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944520,EUCOMM,Pop4,MGI:1913411
Ppard<tm1(PPARD)Bsls>,"peroxisome proliferator activator receptor delta; targeted mutation 1, Bart Staels",MGI:5576390,0,Ppard,MGI:101884
Pparg<tm1Avp>,"peroxisome proliferator activated receptor gamma; targeted mutation 1, Antonio Vidal-Puig",MGI:3694813,0,Pparg,MGI:97747
Pparg<tm1a(KOMP)Wtsi>,"peroxisome proliferator activated receptor gamma; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419888,KOMP-CSD,Pparg,MGI:97747
Ppargc1b<tm1.1Avp>,"peroxisome proliferative activated receptor, gamma, coactivator 1 beta; targeted mutation 1.1, Antonio Vidal-Pulg",MGI:3757705,0,Ppargc1b,MGI:2444934
Ppfia2<tm1a(EUCOMM)Hmgu>,"protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458715,EUCOMM,Ppfia2,MGI:2443834
Ppil3<tm1a(EUCOMM)Wtsi>,"peptidylprolyl isomerase (cyclophilin)-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460482,EUCOMM,Ppil3,MGI:1917475
Ppil3<tm1b(EUCOMM)Wtsi>,"peptidylprolyl isomerase (cyclophilin)-like 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637044,EUCOMM,Ppil3,MGI:1917475
Ppm1a<tm1a(EUCOMM)Hmgu>,"protein phosphatase 1A, magnesium dependent, alpha isoform; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458753,EUCOMM,Ppm1a,MGI:99878
Ppp1r42<tm1a(KOMP)Wtsi>,"protein phosphatase 1, regulatory subunit 42; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364817,KOMP-CSD,Ppp1r42,MGI:1921138
Ppp2r2b<tm1a(KOMP)Wtsi>,"protein phosphatase 2, regulatory subunit B, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364039,KOMP-CSD,Ppp2r2b,MGI:1920180
Ppp3ca<tm2e(EUCOMM)Wtsi>,"protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 2e, Wellcome Trust Sanger Institute",MGI:4432193,EUCOMM,Ppp3ca,MGI:107164
Ppp3cc<tm1a(EUCOMM)Hmgu>,"protein phosphatase 3, catalytic subunit, gamma isoform; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434809,EUCOMM,Ppp3cc,MGI:107162
Ppp5c<tm1a(EUCOMM)Wtsi>,"protein phosphatase 5, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431812,EUCOMM,Ppp5c,MGI:102666
Ppp6c<tm1a(EUCOMM)Hmgu>,"protein phosphatase 6, catalytic subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435995,EUCOMM,Ppp6c,MGI:1915107
Ppt2<tm2a(KOMP)Wtsi>,"palmitoyl-protein thioesterase 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841007,KOMP-CSD,Ppt2,MGI:1860075
Ppy<tm1a(KOMP)Wtsi>,"pancreatic polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362546,KOMP-CSD,Ppy,MGI:97753
Pqlc3<tm1a(KOMP)Wtsi>,"PQ loop repeat containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820031,KOMP-CSD,Pqlc3,MGI:2444067
Praf2<tm1e(EUCOMM)Wtsi>,"PRA1 domain family 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4457557,EUCOMM,Praf2,MGI:1859607
Pram1<tm1a(EUCOMM)Wtsi>,"PML-RAR alpha-regulated adaptor molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461665,EUCOMM,Pram1,MGI:3576625
Prame<tm1a(KOMP)Wtsi>,"preferentially expressed antigen in melanoma; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880903,KOMP-CSD,Prame,MGI:1923079
Pramef20<tm1b(KOMP)Wtsi>,,MGI:3712553,,,
Prc1<tm1a(EUCOMM)Hmgu>,"protein regulator of cytokinesis 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5294171,EUCOMM,Prc1,MGI:1858961
Prc1<tm1b(EUCOMM)Hmgu>,"protein regulator of cytokinesis 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613643,EUCOMM,Prc1,MGI:1858961
Prdm10<tm1a(EUCOMM)Hmgu>,"PR domain containing 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434635,EUCOMM,Prdm10,MGI:2682952
Prdm11<tm1Ahl>,"PR domain containing 11; targeted mutation 1, Anders Henrik Lund",MGI:5708065,0,Prdm11,MGI:2685553
Prdm1<tm1.1Liz>,"PR domain containing 1, with ZNF domain; targeted mutation 1.1, Elizabeth K Bikoff",MGI:4366868,0,Prdm1,MGI:99655
Prdm1<tm2.1Liz>,"PR domain containing 1, with ZNF domain; targeted mutation 2.1, Elizabeth K Bikoff",MGI:4366869,0,Prdm1,MGI:99655
Prdm4<tm1a(EUCOMM)Hmgu>,"PR domain containing 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435837,EUCOMM,Prdm4,MGI:1920093
Prdm4<tm2.1Liz>,"PR domain containing 4; targeted mutation 2.1, Elizabeth K Bikoff",MGI:5547614,0,Prdm4,MGI:1920093
Prdm5<Gt(AV0702)Wtsi>,"PR domain containing 5; gene trap AV0702, Wellcome Trust Sanger Institute",MGI:3853086,Sanger Inst. Gene Trap Res.,Prdm5,MGI:1918029
Prdm6<tm1.1Jrld>,"PR domain containing 6; targeted mutation 1.1, Jurgen Ruland",MGI:5576799,0,Prdm6,MGI:2684938
Prdx6<tm1a(EUCOMM)Wtsi>,"peroxiredoxin 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431891,EUCOMM,Prdx6,MGI:894320
Prelid2<tm1a(EUCOMM)Wtsi>,"PRELI domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842294,EUCOMM,Prelid2,MGI:1924869
Prep<tm1Dgen>,"prolyl endopeptidase; targeted mutation 1, Deltagen",MGI:5427690,Deltagen,Prep,MGI:1270863
Prf1<tm1Sdz>,"perforin 1 (pore forming protein); targeted mutation 1, Sandoz Pharmaceuticals",MGI:1857235,0,Prf1,MGI:97551
Primpol<tm1a(EUCOMM)Wtsi>,"primase and polymerase (DNA-directed); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432243,EUCOMM,Primpol,MGI:3603756
Prkaa1<tm1Sbj>,"protein kinase, AMP-activated, alpha 1 catalytic subunit; targeted mutation 1, Sebastian B Jorgensen",MGI:3029359,0,Prkaa1,MGI:2145955
Prkaa2<tm1.1Vio>,"protein kinase, AMP-activated, alpha 2 catalytic subunit; targeted mutation 1.1, Benoit Viollet",MGI:2448467,0,Prkaa2,MGI:1336173
Prkaa2<tm1Vio>,"protein kinase, AMP-activated, alpha 2 catalytic subunit; targeted mutation 1, Benoit Viollet",MGI:2448466,0,Prkaa2,MGI:1336173
Prkaa2<tm1a(EUCOMM)Hmgu>,"protein kinase, AMP-activated, alpha 2 catalytic subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5318770,EUCOMM,Prkaa2,MGI:1336173
Prkab1<Gt(RRR454)Byg>,"protein kinase, AMP-activated, beta 1 non-catalytic subunit; gene trap RRR454, BayGenomics",MGI:3838355,0,Prkab1,MGI:1336167
Prkab1<tm1a(KOMP)Wtsi>,"protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362414,KOMP-CSD,Prkab1,MGI:1336167
Prkab1<tm1b(KOMP)Wtsi>,"protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5501071,KOMP-CSD,Prkab1,MGI:1336167
Prkab2<tm1a(EUCOMM)Hmgu>,"protein kinase, AMP-activated, beta 2 non-catalytic subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946773,EUCOMM,Prkab2,MGI:1336185
Prkcz<tm1a(EUCOMM)Wtsi>,"protein kinase C, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433718,EUCOMM,Prkcz,MGI:97602
Prkd3<tm1a(EUCOMM)Wtsi>,"protein kinase D3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432250,EUCOMM,Prkd3,MGI:1922542
Prkg1<tm1a(KOMP)Wtsi>,"protein kinase, cGMP-dependent, type I; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4454120,KOMP-CSD,Prkg1,MGI:108174
Prkra<rep>,"protein kinase, interferon inducible double stranded RNA dependent activator; reduced pinna",MGI:5430998,0,Prkra,MGI:1344375
Prmt1<tm1a(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432476,EUCOMM,Prmt1,MGI:107846
Prmt2<tm1Yah>,"protein arginine N-methyltransferase 2; targeted mutation 1, Yann Herault",MGI:4868409,0,Prmt2,MGI:1316652
Prmt2<tm1a(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433170,EUCOMM,Prmt2,MGI:1316652
Prmt3<tm1a(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433008,EUCOMM,Prmt3,MGI:1919224
Prmt5<tm2a(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4432368,EUCOMM,Prmt5,MGI:1351645
Prmt5<tm2b(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 5; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5636983,EUCOMM,Prmt5,MGI:1351645
Prmt5<tm2c(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute",MGI:5546597,EUCOMM,Prmt5,MGI:1351645
Prmt7<tm1a(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431677,EUCOMM,Prmt7,MGI:2384879
Prmt8<tm1a(EUCOMM)Wtsi>,"protein arginine N-methyltransferase 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434085,EUCOMM,Prmt8,MGI:3043083
Prnd<tm1Aag>,"prion like protein doppel; targeted mutation 1, Adriano Aguzzi",MGI:3047561,0,Prnd,MGI:1346999
Prnp/Prnd<tm1Aag>,"prion like protein doppel; targeted mutation 1, Adriano Aguzzi",MGI:3047634,0,Prnd,MGI:1346999
Prnp<tm1Cwe>,"prion protein; targeted mutation 1, Charles Weissmann",MGI:1888773,0,Prnp,MGI:97769
Prnp<tm2Edin>,"prion protein; targeted mutation 2, Edinburgh University",MGI:2387688,0,Prnp,MGI:97769
Prph2<tm1a(EUCOMM)Hmgu>,"peripherin 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435174,EUCOMM,Prph2,MGI:102791
Prps1<tm1a(EUCOMM)Wtsi>,"phosphoribosyl pyrophosphate synthetase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434300,EUCOMM,Prps1,MGI:97775
Prpsap2<tm1a(EUCOMM)Wtsi>,"phosphoribosyl pyrophosphate synthetase-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432556,EUCOMM,Prpsap2,MGI:2384838
Prrc2b<tm1a(EUCOMM)Wtsi>,"proline-rich coiled-coil 2B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461729,EUCOMM,Prrc2b,MGI:1923304
Prrg2<tm1a(EUCOMM)Wtsi>,"proline-rich Gla (G-carboxyglutamic acid) polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441650,EUCOMM,Prrg2,MGI:1929596
Prrg2<tm1b(EUCOMM)Wtsi>,"proline-rich Gla (G-carboxyglutamic acid) polypeptide 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548709,EUCOMM,Prrg2,MGI:1929596
Prrt2<tm1a(KOMP)Wtsi>,"proline-rich transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362325,KOMP-CSD,Prrt2,MGI:1916267
Prss16<tm1Mal>,"protease, serine 16 (thymus); targeted mutation 1, Bernard Malissen",MGI:3843929,0,Prss16,MGI:1859181
Prss38<tm1a(KOMP)Wtsi>,"protease, serine 38; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4947730,KOMP-CSD,Prss38,MGI:2685095
Prss50<tm1a(EUCOMM)Hmgu>,"protease, serine 50; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455807,EUCOMM,Prss50,MGI:2447303
Prss52<tm2a(KOMP)Wtsi>,"protease, serine 52; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5299581,KOMP-CSD,Prss52,MGI:1920632
Prss8<tm1Hum>,"protease, serine 8 (prostasin); targeted mutation 1, Edith Hummler",MGI:2384519,0,Prss8,MGI:1923810
Prune2<tm1e(KOMP)Wtsi>,"prune homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4841026,KOMP-CSD,Prune2,MGI:1925004
Psat1<tm1a(KOMP)Wtsi>,"phosphoserine aminotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363603,KOMP-CSD,Psat1,MGI:2183441
Psat1<tm1b(KOMP)Wtsi>,,MGI:2183441,,,
Psen1<tm1Bdes>,"presenilin 1; targeted mutation 1, Bart de Strooper",MGI:2149116,0,Psen1,MGI:1202717
Psen2<tm1Bdes>,"presenilin 2; targeted mutation 1, Bart de Strooper",MGI:2149117,0,Psen2,MGI:109284
Psip1<Gt(betageo)1Hgs>,"PC4 and SFRS1 interacting protein 1; gene trap 1, Heidi Sutherland",MGI:3664569,0,Psip1,MGI:2142116
Psmc2<tm1a(EUCOMM)Hmgu>,"proteasome (prosome, macropain) 26S subunit, ATPase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841895,EUCOMM,Psmc2,MGI:109555
Psph<tm1a(EUCOMM)Hmgu>,"phosphoserine phosphatase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950198,EUCOMM,Psph,MGI:97788
Ptafr<tm1a(KOMP)Wtsi>,"platelet-activating factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460278,KOMP-CSD,Ptafr,MGI:106066
Ptch1<tm1Zim>,"patched 1; targeted mutation 1, Andreas Zimmer",MGI:1857935,0,Ptch1,MGI:105373
Ptch1<tm1a(EUCOMM)Hmgu>,"patched 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435107,EUCOMM,Ptch1,MGI:105373
Ptcra<tm1(icre)Hjf>,"pre T cell antigen receptor alpha; targeted mutation 1, Hans Jorg Fehling",MGI:3696089,0,Ptcra,MGI:104857
Ptdss1<tm1a(EUCOMM)Hmgu>,"phosphatidylserine synthase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434934,EUCOMM,Ptdss1,MGI:1276575
Pten<tm1Mro>,"phosphatase and tensin homolog; targeted mutation 1, Silvia Marino",MGI:2183284,0,Pten,MGI:109583
Ptgdr2<tm1(KOMP)Vlcg>,"prostaglandin D2 receptor 2; targeted mutation 1, Velocigene",MGI:4843032,KOMP-Regeneron,Ptgdr2,MGI:1330275
Ptges2<tm1a(EUCOMM)Wtsi>,"prostaglandin E synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432215,EUCOMM,Ptges2,MGI:1917592
Ptgfrn<Gt(OST437383)Lex>,"prostaglandin F2 receptor negative regulator; gene trap OST437383, Lexicon Genetics",MGI:4316955,Lexicon,Ptgfrn,MGI:1277114
Ptgr1<tm1a(EUCOMM)Wtsi>,"prostaglandin reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432266,EUCOMM,Ptgr1,MGI:1914353
Pth1r<tm1a(EUCOMM)Hmgu>,"parathyroid hormone 1 receptor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5014612,EUCOMM,Pth1r,MGI:97801
Pth2r<tm2a(KOMP)Wtsi>,"parathyroid hormone 2 receptor; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4364506,KOMP-CSD,Pth2r,MGI:2180917
Pth<tm1a(EUCOMM)Wtsi>,"parathyroid hormone; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849407,EUCOMM,Pth,MGI:97799
Pthlh<tm1a(KOMP)Wtsi>,"parathyroid hormone-like peptide; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880897,KOMP-CSD,Pthlh,MGI:97800
Ptpn22<tm1e(EUCOMM)Wtsi>,,MGI:4434299,,,
Ptpn23<tm1a(EUCOMM)Hmgu>,"protein tyrosine phosphatase, non-receptor type 23; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434698,EUCOMM,Ptpn23,MGI:2144837
Ptpn23<tm1b(EUCOMM)Hmgu>,"protein tyrosine phosphatase, non-receptor type 23; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5567111,EUCOMM,Ptpn23,MGI:2144837
Ptpn2<tm1a(EUCOMM)Wtsi>,"protein tyrosine phosphatase, non-receptor type 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441737,EUCOMM,Ptpn2,MGI:97806
Ptpra<tm1a(EUCOMM)Hmgu>,"protein tyrosine phosphatase, receptor type, A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434690,EUCOMM,Ptpra,MGI:97808
Ptprc<a>,"protein tyrosine phosphatase, receptor type, C; a variant",MGI:4819849,0,Ptprc,MGI:97810
Ptprc<b>,"protein tyrosine phosphatase, receptor type, C; b variant",MGI:4819850,0,Ptprc,MGI:97810
Ptprc<loc>,"protein tyrosine phosphatase, receptor type, C; lochy",MGI:3611894,APF ENU Mutagenesis,Ptprc,MGI:97810
Ptprc<tm1Holm>,"protein tyrosine phosphatase, receptor type, C; targeted mutation 1, Nick Holmes",MGI:1857277,0,Ptprc,MGI:97810
Ptprd<tm2a(KOMP)Wtsi>,"protein tyrosine phosphatase, receptor type, D; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4458607,KOMP-CSD,Ptprd,MGI:97812
Pus10<tm1a(EUCOMM)Hmgu>,"pseudouridylate synthase 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434872,EUCOMM,Pus10,MGI:1921717
Pus7l<tm2a(KOMP)Wtsi>,"pseudouridylate synthase 7-like; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4451717,KOMP-CSD,Pus7l,MGI:1926145
Pwp1<tm1a(EUCOMM)Wtsi>,"PWP1 homolog, endonuclein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441688,EUCOMM,Pwp1,MGI:1914735
Pwp2<tm1a(KOMP)Wtsi>,"PWP2 periodic tryptophan protein homolog (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5299574,KOMP-CSD,Pwp2,MGI:1341200
Pxdn<mhdakta048>,peroxidasin; Martin Hrabe de Angelis kinked tail 048,MGI:5584201,0,Pxdn,MGI:1916925
Pxmp2<tm1Jkh>,"peroxisomal membrane protein 2; targeted mutation 1, J Kalervo Hiltunen",MGI:3844254,0,Pxmp2,MGI:107487
Pxylp1<tm1a(KOMP)Wtsi>,"2-phosphoxylose phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362699,KOMP-CSD,Pxylp1,MGI:2442444
Pycr2<tm1a(EUCOMM)Wtsi>,"pyrroline-5-carboxylate reductase family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842705,EUCOMM,Pycr2,MGI:1277956
Rab15<tm1a(KOMP)Wtsi>,"RAB15, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363640,KOMP-CSD,Rab15,MGI:1916865
Rab17<tm1a(KOMP)Wtsi>,"RAB17, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4948606,KOMP-CSD,Rab17,MGI:104640
Rab18<Gt(EUCE0233a03)Hmgu>,"RAB18, member RAS oncogene family; gene trap EUCE0233a03, Helmholtz Zentrum Muenchen GmbH",MGI:4369232,0,Rab18,MGI:102790
Rab19<tm1a(EUCOMM)Hmgu>,"RAB19, member RAS oncogene family; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434870,EUCOMM,Rab19,MGI:103292
Rab1b<Gt(OST191074)Lex>,"RAB1B, member RAS oncogene family; gene trap OST191074, Lexicon Genetics",MGI:3530156,Lexicon,Rab1b,MGI:1923558
Rab21<tm1a(KOMP)Wtsi>,"RAB21, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458569,KOMP-CSD,Rab21,MGI:894308
Rab21<tm1b(KOMP)Wtsi>,"RAB21, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5638577,KOMP-CSD,Rab21,MGI:894308
Rab23<tm1a(EUCOMM)Wtsi>,"RAB23, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460477,EUCOMM,Rab23,MGI:99833
Rab27a<ash>,"RAB27A, member RAS oncogene family; ashen",MGI:1856656,0,Rab27a,MGI:1861441
Rab27b<tm1.2Seab>,"RAB27B, member RAS oncogene family; targeted mutation 1.2, Miguel C Seabra",MGI:3706986,0,Rab27b,MGI:1931295
Rab29<tm1a(EUCOMM)Wtsi>,"RAB29, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432353,EUCOMM,Rab29,MGI:2385107
Rab35<tm1a(EUCOMM)Hmgu>,"RAB35, member RAS oncogene family; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436336,EUCOMM,Rab35,MGI:1924657
Rab35<tm1b(EUCOMM)Hmgu>,"RAB35, member RAS oncogene family; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548685,EUCOMM,Rab35,MGI:1924657
Rab5c<tm1a(EUCOMM)Wtsi>,"RAB5C, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432624,EUCOMM,Rab5c,MGI:105306
Rab6b<m1Mhda>,"RAB6B, member RAS oncogene family; mutation 1, Martin Hrabe de Angelis",MGI:5818763,0,Rab6b,MGI:107283
Rabgap1<tm1a(EUCOMM)Hmgu>,"RAB GTPase activating protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434702,EUCOMM,Rabgap1,MGI:2385139
Rack1<tm1Sbif>,"receptor for activated C kinase 1; targeted mutation 1, Stefano Biffo",MGI:5660834,0,Rack1,MGI:101849
Rad18<tm1a(EUCOMM)Wtsi>,"RAD18 E3 ubiquitin protein ligase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433190,EUCOMM,Rad18,MGI:1890476
Rad52<tm1Aps>,"RAD52 homolog, DNA repair protein; targeted mutation 1, Albert Pastink",MGI:2383953,0,Rad52,MGI:101949
Raet1c<tm1a(EUCOMM)Hmgu>,"retinoic acid early transcript gamma; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008842,EUCOMM,Raet1c,MGI:109431
Raet1c<tm1b(EUCOMM)Hmgu>,"retinoic acid early transcript gamma; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548391,EUCOMM,Raet1c,MGI:109431
Raf1<tm1a(EUCOMM)Wtsi>,"v-raf-leukemia viral oncogene 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433410,EUCOMM,Raf1,MGI:97847
Rag1<tm1Bal>,"recombination activating 1; targeted mutation 1, David Baltimore",MGI:2448994,0,Rag1,MGI:97848
Rag1<tm1Mom>,"recombination activating 1; targeted mutation 1, Peter Mombaerts",MGI:1857241,0,Rag1,MGI:97848
Rag2<tm1Fwa>,"recombination activating gene 2; targeted mutation 1, Frederick W Alt",MGI:1858556,0,Rag2,MGI:97849
Rala<tm1.2Cjm>,"v-ral simian leukemia viral oncogene A (ras related); targeted mutation 1.2, Christopher J Marshall",MGI:5505279,0,Rala,MGI:1927243
Rala<tm1a(EUCOMM)Wtsi>,"v-ral simian leukemia viral oncogene A (ras related); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451975,EUCOMM,Rala,MGI:1927243
Ralb<tm1.2Cjm>,"v-ral simian leukemia viral oncogene B; targeted mutation 1.2, Christopher J Marshall",MGI:5505280,0,Ralb,MGI:1927244
Ralb<tm1a(EUCOMM)Wtsi>,"v-ral simian leukemia viral oncogene B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433898,EUCOMM,Ralb,MGI:1927244
Ralbp1<Gt(OST359995)Lex>,"ralA binding protein 1; gene trap OST359995, Lexicon Genetics",MGI:3530809,Lexicon,Ralbp1,MGI:108466
Ralgapb<tm1a(KOMP)Wtsi>,"Ral GTPase activating protein, beta subunit (non-catalytic); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363602,KOMP-CSD,Ralgapb,MGI:2444531
Ralgps2<tm1a(EUCOMM)Wtsi>,"Ral GEF with PH domain and SH3 binding motif 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460462,EUCOMM,Ralgps2,MGI:1925505
Ramp1<tm1a(EUCOMM)Wtsi>,"receptor (calcitonin) activity modifying protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286381,EUCOMM,Ramp1,MGI:1858418
Rapgefl1<tm1a(KOMP)Wtsi>,"Rap guanine nucleotide exchange factor (GEF)-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362680,KOMP-CSD,Rapgefl1,MGI:3611446
Raph1<tm1.1Makr>,"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1; targeted mutation 1.1, Matthias Krause",MGI:5575553,0,Raph1,MGI:1924550
Raph1<tm1a(EUCOMM)Wtsi>,"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842387,EUCOMM,Raph1,MGI:1924550
Raph1<tm1b(EUCOMM)Wtsi>,"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637089,EUCOMM,Raph1,MGI:1924550
Rapsn<tm1a(EUCOMM)Wtsi>,"receptor-associated protein of the synapse; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433819,EUCOMM,Rapsn,MGI:99422
Rars2<tm1a(EUCOMM)Wtsi>,"arginyl-tRNA synthetase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432770,EUCOMM,Rars2,MGI:1923596
Rars<tm1a(EUCOMM)Wtsi>,"arginyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432394,EUCOMM,Rars,MGI:1914297
Rasa1<tm1Wid>,"RAS p21 protein activator 1; targeted mutation 1, Christian Widmann",MGI:5446031,0,Rasa1,MGI:97860
Rasal2<tm1a(EUCOMM)Wtsi>,"RAS protein activator like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939768,EUCOMM,Rasal2,MGI:2443881
Rasal3<tm1a(EUCOMM)Hmgu>,"RAS protein activator like 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436426,EUCOMM,Rasal3,MGI:2444128
Rasd2<tm1Rdl>,"RASD family, member 2; targeted mutation 1, Roberto Di Lauro",MGI:3050759,0,Rasd2,MGI:1922391
Rasgrf1<enu1H>,RAS protein-specific guanine nucleotide-releasing factor 1; enu 1 Harwell,MGI:2670335,0,Rasgrf1,MGI:99694
Rasgrf1<enu2H>,RAS protein-specific guanine nucleotide-releasing factor 1; enu 2 Harwell,MGI:2670337,0,Rasgrf1,MGI:99694
Rasgrf1<tm1Kln>,"RAS protein-specific guanine nucleotide-releasing factor 1; targeted mutation 1, Rudiger Klein",MGI:2157015,0,Rasgrf1,MGI:99694
Rasgrf1<tm2Pds>,"RAS protein-specific guanine nucleotide-releasing factor 1; targeted mutation 2, Paul D Soloway",MGI:3611766,0,Rasgrf1,MGI:99694
Rasgrp4<tm2a(KOMP)Wtsi>,"RAS guanyl releasing protein 4; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841072,KOMP-CSD,Rasgrp4,MGI:2386851
Raz,"replicated anterior zeugopod, inversion",MGI:2683726,0,Raz,MGI:2683724
Rb1<tm1Brn>,"RB transcriptional corepressor 1; targeted mutation 1, Anton Berns",MGI:1931015,0,Rb1,MGI:97874
Rb1<tm2Brn>,"RB transcriptional corepressor 1; targeted mutation 2, Anton Berns",MGI:1931018,0,Rb1,MGI:97874
Rbak<tm1a(KOMP)Wtsi>,"RB-associated KRAB zinc finger; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364920,KOMP-CSD,Rbak,MGI:1927369
Rbak<tm1b(KOMP)Wtsi>,"RB-associated KRAB zinc finger; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637097,KOMP-CSD,Rbak,MGI:1927369
Rbbp7<tm1a(EUCOMM)Wtsi>,"retinoblastoma binding protein 7, chromatin remodeling factor; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455962,EUCOMM,Rbbp7,MGI:1194910
Rbck1<tm1a(EUCOMM)Hmgu>,"RanBP-type and C3HC4-type zinc finger containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5294210,EUCOMM,Rbck1,MGI:1344372
Rbfox1<tm1a(KOMP)Wtsi>,"RNA binding protein, fox-1 homolog (C. elegans) 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5428536,KOMP-CSD,Rbfox1,MGI:1926224
Rbfox3<tm1a(EUCOMM)Hmgu>,"RNA binding protein, fox-1 homolog (C. elegans) 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434907,EUCOMM,Rbfox3,MGI:106368
Rbl1<tm1a(EUCOMM)Hmgu>,"RB transcriptional corepressor like 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5497361,EUCOMM,Rbl1,MGI:103300
Rbm14<tm1a(KOMP)Wtsi>,"RNA binding motif protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362139,KOMP-CSD,Rbm14,MGI:1929092
Rbm33<tm1a(EUCOMM)Wtsi>,"RNA binding motif protein 33; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887695,EUCOMM,Rbm33,MGI:1919670
Rbm33<tm1b(EUCOMM)Wtsi>,"RNA binding motif protein 33; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637065,EUCOMM,Rbm33,MGI:1919670
Rbm39<Gt(U3Betageo)1Ruiz>,"RNA binding motif protein 39; gene trap 1, Patricia Ruiz",MGI:2679203,0,Rbm39,MGI:2157953
Rbm47<tm1a(EUCOMM)Wtsi>,"RNA binding motif protein 47; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432904,EUCOMM,Rbm47,MGI:2384294
Rbm4<tm1a(EUCOMM)Hmgu>,"RNA binding motif protein 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435180,EUCOMM,Rbm4,MGI:1100865
Rbms1<tm1a(EUCOMM)Wtsi>,"RNA binding motif, single stranded interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433622,EUCOMM,Rbms1,MGI:1861774
Rbmx<tm2a(KOMP)Wtsi>,"RNA binding motif protein, X chromosome; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4363716,KOMP-CSD,Rbmx,MGI:1343044
Rbmx<tm2b(KOMP)Wtsi>,"RNA binding motif protein, X chromosome; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5558151,KOMP-CSD,Rbmx,MGI:1343044
Rbpjl<tm1a(KOMP)Wtsi>,"recombination signal binding protein for immunoglobulin kappa J region-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364029,KOMP-CSD,Rbpjl,MGI:1196616
Rbsn<tm1a(EUCOMM)Wtsi>,"rabenosyn, RAB effector; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441653,EUCOMM,Rbsn,MGI:1925537
Rc3h1<san>,RING CCCH (C3H) domains 1; sanroque,MGI:3581675,APF ENU Mutagenesis,Rc3h1,MGI:2685397
Rc3h1<tm1a(EUCOMM)Hmgu>,"RING CCCH (C3H) domains 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434899,EUCOMM,Rc3h1,MGI:2685397
Rc3h2<tm1a(KOMP)Wtsi>,"ring finger and CCCH-type zinc finger domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364357,KOMP-CSD,Rc3h2,MGI:2442789
Rcan1<tm1a(KOMP)Wtsi>,"regulator of calcineurin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286172,KOMP-CSD,Rcan1,MGI:1890564
Rcc2<tm1a(EUCOMM)Wtsi>,"regulator of chromosome condensation 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453694,EUCOMM,Rcc2,MGI:1919784
Rcn1<tm1a(EUCOMM)Hmgu>,"reticulocalbin 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841832,EUCOMM,Rcn1,MGI:104559
Rcn1<tm1b(EUCOMM)Hmgu>,"reticulocalbin 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613634,EUCOMM,Rcn1,MGI:104559
Rcor2<tm1a(EUCOMM)Wtsi>,"REST corepressor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431639,EUCOMM,Rcor2,MGI:1859854
Rdh16<tm1a(KOMP)Wtsi>,"retinol dehydrogenase 16; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362960,KOMP-CSD,Rdh16,MGI:1201375
Rdh16f2<tm1a(KOMP)Wtsi>,"RDH16 family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363554,KOMP-CSD,Rdh16f2,MGI:3583955
Rec9,mutant Rec9,MGI:5646527,0,Rec9,MGI:5646404
Recb13,mutant Recb13,MGI:5646525,0,Recb13,MGI:5646402
Reep5<Gt(OST296938)Lex>,"receptor accessory protein 5; gene trap OST296938, Lexicon Genetics",MGI:4269334,Lexicon,Reep5,MGI:1270152
Reg2<tm1Lchr>,"regenerating islet-derived 2; targeted mutation 1, Laurence Christa",MGI:3812476,0,Reg2,MGI:97896
Reg3d<tm1a(EUCOMM)Wtsi>,"regenerating islet-derived 3 delta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849409,EUCOMM,Reg3d,MGI:1353426
Reg3d<tm1b(EUCOMM)Wtsi>,"regenerating islet-derived 3 delta; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636985,EUCOMM,Reg3d,MGI:1353426
Reg3g<tm1a(KOMP)Wtsi>,"regenerating islet-derived 3 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363444,KOMP-CSD,Reg3g,MGI:109406
Rel<tm1a(EUCOMM)Wtsi>,"reticuloendotheliosis oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441649,EUCOMM,Rel,MGI:97897
Rell2<tm1a(EUCOMM)Wtsi>,"RELT-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5140486,EUCOMM,Rell2,MGI:1918044
Rem1<tm1a(KOMP)Wtsi>,"rad and gem related GTP binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052412,KOMP-CSD,Rem1,MGI:1097696
Repin1<tm1a(EUCOMM)Wtsi>,"replication initiator 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008938,EUCOMM,Repin1,MGI:1889817
Rest<tm2a(EUCOMM)Wtsi>,"RE1-silencing transcription factor; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4431796,EUCOMM,Rest,MGI:104897
Ret<tm1.1Pern>,"ret proto-oncogene; targeted mutation 1.1, Patrik Ernfors",MGI:4440475,0,Ret,MGI:97902
Ret<tm1Cos>,"ret proto-oncogene; targeted mutation 1, Frank Costantini",MGI:2136894,0,Ret,MGI:97902
Ret<tm1Kln>,"ret proto-oncogene; targeted mutation 1, Rudiger Klein",MGI:3662623,0,Ret,MGI:97902
Rexo2<tm1a(EUCOMM)Wtsi>,"RNA exonuclease 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433994,EUCOMM,Rexo2,MGI:1888981
Rffl<tm1Cota>,"ring finger and FYVE like domain containing protein; targeted mutation 1, Michel Cohen-Tannoudji",MGI:3846097,0,Rffl,MGI:1914588
Rftn2<tm1e(EUCOMM)Wtsi>,"raftlin family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433645,EUCOMM,Rftn2,MGI:1921263
Rfx7<tm2a(EUCOMM)Hmgu>,"regulatory factor X, 7; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511570,EUCOMM,Rfx7,MGI:2442675
Rfxank<tm1a(EUCOMM)Hmgu>,"regulatory factor X-associated ankyrin-containing protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008000,EUCOMM,Rfxank,MGI:1333865
Rfxank<tm1b(EUCOMM)Hmgu>,"regulatory factor X-associated ankyrin-containing protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5614696,EUCOMM,Rfxank,MGI:1333865
Rgcc<tm1(KOMP)Wtsi>,"regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4362711,KOMP-CSD,Rgcc,MGI:1913464
Rgs18<m1H>,"regulator of G-protein signaling 18; mutation 1, Harwell",MGI:5307901,Harwell ENU Mutagenesis,Rgs18,MGI:1927498
Rgs4<tm1.1Jbr>,"regulator of G-protein signaling 4; targeted mutation 1, Jean-Francois Brunet",MGI:3580388,0,Rgs4,MGI:108409
Rgs4<tm1Jbr>,"regulator of G-protein signaling 4; targeted mutation 1, Jean-Francois Brunet",MGI:4834882,0,Rgs4,MGI:108409
Rgs5<tm1Dgen>,"regulator of G-protein signaling 5; targeted mutation 1, Deltagen",MGI:3604464,Deltagen,Rgs5,MGI:1098434
Rgs5<tm1a(EUCOMM)Wtsi>,"regulator of G-protein signaling 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432511,EUCOMM,Rgs5,MGI:1098434
Rhag<tm1Goo>,"Rhesus blood group-associated A glycoprotein; targeted mutation 1, Dominique Goossens",MGI:5318589,0,Rhag,MGI:1202713
Rhbdl3<tm1a(EUCOMM)Wtsi>,"rhomboid like 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433810,EUCOMM,Rhbdl3,MGI:2179276
Rhd<tm1Goo>,"Rh blood group, D antigen; targeted mutation 1, Dominique Goossens",MGI:5318588,0,Rhd,MGI:1202882
Rhd<tm1a(EUCOMM)Wtsi>,"Rh blood group, D antigen; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431572,EUCOMM,Rhd,MGI:1202882
Rhd<tm1e(EUCOMM)Wtsi>,"Rh blood group, D antigen; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433877,EUCOMM,Rhd,MGI:1202882
Rhobtb3<tm1a(KOMP)Wtsi>,"Rho-related BTB domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362349,KOMP-CSD,Rhobtb3,MGI:1920546
Rhoc<tm1Mak>,"ras homolog family member C; targeted mutation 1, Tak W Mak",MGI:3589206,0,Rhoc,MGI:106028
Rhog<tm1Tnr>,"ras homolog family member G; targeted mutation 1, Martin Turner",MGI:3029009,0,Rhog,MGI:1928370
Rhot1<tm1a(EUCOMM)Wtsi>,"ras homolog family member T1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432006,EUCOMM,Rhot1,MGI:1926078
Rhot2<tm1(KOMP)Wtsi>,"ras homolog family member T2; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419477,KOMP-CSD,Rhot2,MGI:2384892
Rhou<tm1a(KOMP)Wtsi>,"ras homolog family member U; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363423,KOMP-CSD,Rhou,MGI:1916831
Rhox13<tm1a(KOMP)Wtsi>,"reproductive homeobox 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820151,KOMP-CSD,Rhox13,MGI:1920864
Rhox13<tm1b(KOMP)Wtsi>,"reproductive homeobox 13; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548634,KOMP-CSD,Rhox13,MGI:1920864
Ric1<tm1a(EUCOMM)Hmgu>,"RAB6A GEF complex partner 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435468,EUCOMM,Ric1,MGI:1924893
Ric8b<tm1a(EUCOMM)Hmgu>,"RIC8 guanine nucleotide exchange factor B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434606,EUCOMM,Ric8b,MGI:2682307
Rilpl1<tm1a(EUCOMM)Hmgu>,"Rab interacting lysosomal protein-like 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946743,EUCOMM,Rilpl1,MGI:1922945
Rilpl1<tm1b(EUCOMM)Hmgu>,"Rab interacting lysosomal protein-like 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548660,EUCOMM,Rilpl1,MGI:1922945
Ripk4<tm1a(EUCOMM)Wtsi>,"receptor-interacting serine-threonine kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4442055,EUCOMM,Ripk4,MGI:1919638
Ripply3<tm1a(EUCOMM)Wtsi>,"ripply transcriptional repressor 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433779,EUCOMM,Ripply3,MGI:2181192
Rky,rocky,MGI:3662926,Harwell ENU Mutagenesis,Rky,MGI:3662924
Rlbp1<tm1a(EUCOMM)Hmgu>,"retinaldehyde binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4462637,EUCOMM,Rlbp1,MGI:97930
Rnase10<tm1a(EUCOMM)Hmgu>,"ribonuclease, RNase A family, 10 (non-active); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435923,EUCOMM,Rnase10,MGI:1922269
Rnaseh2b<tm1a(EUCOMM)Wtsi>,"ribonuclease H2, subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432164,EUCOMM,Rnaseh2b,MGI:1914403
Rnaseh2c<tm1(KOMP)Wtsi>,"ribonuclease H2, subunit C; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4364620,KOMP-CSD,Rnaseh2c,MGI:1915459
Rnasek<tm1a(EUCOMM)Wtsi>,"ribonuclease, RNase K; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849411,EUCOMM,Rnasek,MGI:106369
Rnasek<tm1b(EUCOMM)Wtsi>,"ribonuclease, RNase K; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636901,EUCOMM,Rnasek,MGI:106369
Rnaset2b<tm1a(EUCOMM)Hmgu>,"ribonuclease T2B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5497319,EUCOMM,Rnaset2b,MGI:3702087
Rnd3<tm1a(EUCOMM)Hmgu>,"Rho family GTPase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434854,EUCOMM,Rnd3,MGI:1921444
Rnf10<tm1a(KOMP)Wtsi>,"ring finger protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362564,KOMP-CSD,Rnf10,MGI:1859162
Rnf10<tm1b(KOMP)Wtsi>,"ring finger protein 10; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548492,KOMP-CSD,Rnf10,MGI:1859162
Rnf121<tm1a(EUCOMM)Hmgu>,"ring finger protein 121; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950215,EUCOMM,Rnf121,MGI:1922462
Rnf125<tm1a(EUCOMM)Hmgu>,"ring finger protein 125; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4881004,EUCOMM,Rnf125,MGI:1914914
Rnf128<tm1(KOMP)Vlcg>,"ring finger protein 128; targeted mutation 1, Velocigene",MGI:4399514,KOMP-Regeneron,Rnf128,MGI:1914139
Rnf138<tm1a(EUCOMM)Hmgu>,"ring finger protein 138; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4944446,EUCOMM,Rnf138,MGI:1929211
Rnf144b<tm1a(EUCOMM)Hmgu>,"ring finger protein 144B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435770,EUCOMM,Rnf144b,MGI:2384986
Rnf157<tm1a(EUCOMM)Wtsi>,"ring finger protein 157; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432623,EUCOMM,Rnf157,MGI:2442484
Rnf157<tm1b(EUCOMM)Wtsi>,"ring finger protein 157; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637139,EUCOMM,Rnf157,MGI:2442484
Rnf169<tm1a(EUCOMM)Hmgu>,"ring finger protein 169; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4452734,EUCOMM,Rnf169,MGI:1920257
Rnf183<tm1a(KOMP)Wtsi>,"ring finger protein 183; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419200,KOMP-CSD,Rnf183,MGI:1923322
Rnf186<tm1(KOMP)Vlcg>,"ring finger protein 186; targeted mutation 1, Velocigene",MGI:3808437,KOMP-Regeneron,Rnf186,MGI:1914075
Rnf5<tm1(KOMP)Vlcg>,"ring finger protein 5; targeted mutation 1, Velocigene",MGI:4951194,KOMP-Regeneron,Rnf5,MGI:1860076
Rnf7<tm1a(EUCOMM)Wtsi>,"ring finger protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432053,EUCOMM,Rnf7,MGI:1337096
Rnls<tm1a(EUCOMM)Wtsi>,"renalase, FAD-dependent amine oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4847877,EUCOMM,Rnls,MGI:1915045
Ropn1l<tm1a(EUCOMM)Wtsi>,"ropporin 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842420,EUCOMM,Ropn1l,MGI:2182357
Ropn1l<tm1b(EUCOMM)Wtsi>,"ropporin 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548780,EUCOMM,Ropn1l,MGI:2182357
Rora<tm1a(EUCOMM)Wtsi>,"RAR-related orphan receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432489,EUCOMM,Rora,MGI:104661
Rora<tm1b(EUCOMM)Wtsi>,"RAR-related orphan receptor alpha; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548347,EUCOMM,Rora,MGI:104661
Rpap2<tm1a(KOMP)Wtsi>,"RNA polymerase II associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362158,KOMP-CSD,Rpap2,MGI:2141142
Rpe65<tm1a(EUCOMM)Hmgu>,"retinal pigment epithelium 65; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436481,EUCOMM,Rpe65,MGI:98001
Rpgrip1l<tm1a(EUCOMM)Wtsi>,"Rpgrip1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432510,EUCOMM,Rpgrip1l,MGI:1920563
Rph3a<tm1a(EUCOMM)Hmgu>,"rabphilin 3A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4946758,EUCOMM,Rph3a,MGI:102788
Rph3a<tm1b(EUCOMM)Hmgu>,"rabphilin 3A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588265,EUCOMM,Rph3a,MGI:102788
Rpia<tm1a(KOMP)Wtsi>,"ribose 5-phosphate isomerase A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364474,KOMP-CSD,Rpia,MGI:103254
Rpn2<tm1a(EUCOMM)Wtsi>,"ribophorin II; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432779,EUCOMM,Rpn2,MGI:98085
Rprd1b<tm1a(EUCOMM)Hmgu>,"regulation of nuclear pre-mRNA domain containing 1B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435125,EUCOMM,Rprd1b,MGI:1917720
Rps19<tm1Dahl>,"ribosomal protein S19; targeted mutation 1, Niklas Dahl",MGI:3043595,0,Rps19,MGI:1333780
Rps20<Mhdadsk4>,ribosomal protein S20; Martin Hrabe de Angelis dark skin 4,MGI:2681787,0,Rps20,MGI:1914677
Rps7<Mtu>,ribosomal protein S7; montu,MGI:3043039,0,Rps7,MGI:1333818
Rptor<tm2a(EUCOMM)Wtsi>,"regulatory associated protein of MTOR, complex 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4441657,EUCOMM,Rptor,MGI:1921620
Rr27<tm2Wrk>,"regulatory region 27; targeted mutation 2, Wolf Reik",MGI:3051218,0,Rr27,MGI:5489785
Rr4<tm1Hgc>,"regulatory region 4; targeted mutation 1, Edward M Rubin",MGI:4421037,0,Rr4,MGI:4421017
Rras2<Gt(OST47398)Lex>,"related RAS viral (r-ras) oncogene 2; gene trap OST47398, Lexicon Genetics",MGI:4160490,Lexicon,Rras2,MGI:1914172
Rras<Gt(OST24882)Lex>,"related RAS viral (r-ras) oncogene; gene trap OST24882, Lexicon Genetics",MGI:3530792,Lexicon,Rras,MGI:98179
Rrm2<tm1a(KOMP)Wtsi>,"ribonucleotide reductase M2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841063,KOMP-CSD,Rrm2,MGI:98181
Rsbn1<tm1a(EUCOMM)Wtsi>,"rosbin, round spermatid basic protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433850,EUCOMM,Rsbn1,MGI:2444993
Rspo4<tm1a(KOMP)Wtsi>,"R-spondin 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364711,KOMP-CSD,Rspo4,MGI:1924467
Rtbdn<tm1a(EUCOMM)Wtsi>,"retbindin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433926,EUCOMM,Rtbdn,MGI:2443686
Rtf1<tm1a(KOMP)Wtsi>,"RTF1, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363925,KOMP-CSD,Rtf1,MGI:1309480
Rtn1<tm1a(KOMP)Wtsi>,"reticulon 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880888,KOMP-CSD,Rtn1,MGI:1933947
Rttn<Gt(pGT1.8geo)7Pgr>,"rotatin; gene trap 7, Peter Gruss",MGI:2674124,0,Rttn,MGI:2179288
Rufy2<tm1a(EUCOMM)Wtsi>,"RUN and FYVE domain-containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434385,EUCOMM,Rufy2,MGI:1917682
Rundc1<tm1a(EUCOMM)Wtsi>,"RUN domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441618,EUCOMM,Rundc1,MGI:2144506
Rundc1<tm1b(EUCOMM)Wtsi>,"RUN domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548750,EUCOMM,Rundc1,MGI:2144506
Runx1<tm1Yg>,"runt related transcription factor 1; targeted mutation 1, Yoram Groner",MGI:3760788,0,Runx1,MGI:99852
Ruvbl1<tm1a(EUCOMM)Wtsi>,"RuvB-like protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432034,EUCOMM,Ruvbl1,MGI:1928760
Rvm,retinal vascular mass,MGI:1934625,0,Rvm,MGI:1934624
Rw,"rump white, inversion; rump white",MGI:1857317,0,Rw,MGI:98213
Rwdd1<tm1a(KOMP)Wtsi>,"RWD domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362724,KOMP-CSD,Rwdd1,MGI:1913771
Rwdd1<tm1b(KOMP)Wtsi>,"RWD domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637013,KOMP-CSD,Rwdd1,MGI:1913771
Rwdd2b<tm1a(EUCOMM)Wtsi>,"RWD domain containing 2B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433511,EUCOMM,Rwdd2b,MGI:1858215
Rwdd3<tm1a(KOMP)Wtsi>,"RWD domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419570,KOMP-CSD,Rwdd3,MGI:1920420
Rwhs,retinal white spots,MGI:2178433,Harwell ENU Mutagenesis,Rwhs,MGI:1890529
Rxfp2<tm1a(EUCOMM)Wtsi>,"relaxin/insulin-like family peptide receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433327,EUCOMM,Rxfp2,MGI:2153463
Rxfp2<tm1b(EUCOMM)Wtsi>,"relaxin/insulin-like family peptide receptor 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548762,EUCOMM,Rxfp2,MGI:2153463
Ryr1<tm1a(EUCOMM)Hmgu>,"ryanodine receptor 1, skeletal muscle; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951021,EUCOMM,Ryr1,MGI:99659
Ryr2<tm1a(KOMP)Wtsi>,"ryanodine receptor 2, cardiac; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458493,KOMP-CSD,Ryr2,MGI:99685
Ryr3<tm1Vso>,"ryanodine receptor 3; targeted mutation 1, Vincenzo Sorrentino",MGI:2181794,0,Ryr3,MGI:99684
S100a10<tm1Jnw>,"S100 calcium binding protein A10 (calpactin); targeted mutation 1, John N Wood",MGI:3665443,0,S100a10,MGI:1339468
S100b<tm1a(EUCOMM)Wtsi>,"S100 protein, beta polypeptide, neural; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432844,EUCOMM,S100b,MGI:98217
SB2/1,mutant SB2/1; mutation SB2/1,MGI:5646532,0,SB2/1,MGI:5646408
Sag<tm1a(EUCOMM)Wtsi>,"S-antigen, retina and pineal gland (arrestin); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433619,EUCOMM,Sag,MGI:98227
Sagg,saggy,MGI:1862016,0,Sagg,MGI:1861992
Samd8<tm1.1Kwi>,"sterile alpha motif domain containing 8; targeted mutation 1.1, Klaus Willecke",MGI:5707954,0,Samd8,MGI:1914880
Samd8<tm2.2Kwi>,"sterile alpha motif domain containing 8; targeted mutation 2.2, Klaus Willecke",MGI:5707965,0,Samd8,MGI:1914880
Sap130<tm1a(KOMP)Mbp>,"Sin3A associated protein; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:5141821,KOMP-CSD,Sap130,MGI:1919782
Sar1b<tm1a(EUCOMM)Wtsi>,"secretion associated Ras related GTPase 1B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432515,EUCOMM,Sar1b,MGI:1913647
Sarnp<tm1a(EUCOMM)Hmgu>,"SAP domain containing ribonucleoprotein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434696,EUCOMM,Sarnp,MGI:1913368
Sarnp<tm1b(EUCOMM)Hmgu>,"SAP domain containing ribonucleoprotein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548511,EUCOMM,Sarnp,MGI:1913368
Sat1<tm1Alh>,"spermidine/spermine N1-acetyl transferase 1; targeted mutation 1, Leena Alhonen",MGI:3521903,0,Sat1,MGI:98233
Satb1<tm1a(EUCOMM)Hmgu>,"special AT-rich sequence binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436287,EUCOMM,Satb1,MGI:105084
Sbc,setback,MGI:2679584,0,Sbc,MGI:2679582
Sbno1<tm1a(EUCOMM)Hmgu>,"strawberry notch 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5294216,EUCOMM,Sbno1,MGI:2384298
Sbsn<m1Mhda>,"suprabasin; mutation 1, Martin Hrabe de Angelis",MGI:5818764,0,Sbsn,MGI:2446326
Scara5<tm1Ktry>,"scavenger receptor class A, member 5; targeted mutation 1, Karl Tryggvason",MGI:5510759,0,Scara5,MGI:1918395
Scg3<m1Mhda>,"secretogranin III; mutation 1, Martin Hrabe de Angelis",MGI:5702924,0,Scg3,MGI:103032
Scimp<tm1a(KOMP)Wtsi>,"SLP adaptor and CSK interacting membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362812,KOMP-CSD,Scimp,MGI:3610314
Scmh1<tm1e.1(EUCOMM)Hmgu>,,MGI:1352762,,,
Scn10a<tm1Jnw>,"sodium channel, voltage-gated, type X, alpha; targeted mutation 1, John N Wood",MGI:2180183,0,Scn10a,MGI:108029
Scn10a<tm2(cre)Jnw>,"sodium channel, voltage-gated, type X, alpha; targeted mutation 2, John N Wood",MGI:3053096,0,Scn10a,MGI:108029
Scn10a<tm3(cre/ERT2)Jnw>,"sodium channel, voltage-gated, type X, alpha; targeted mutation 3, John N Wood",MGI:3689893,0,Scn10a,MGI:108029
Scn3a<tm1Jwo>,"sodium channel, voltage-gated, type III, alpha; targeted mutation 1, John N Wood",MGI:5505504,0,Scn3a,MGI:98249
Scn3b<tm1a(KOMP)Wtsi>,"sodium channel, voltage-gated, type III, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363292,KOMP-CSD,Scn3b,MGI:1918882
Scn4a<tm2a(KOMP)Wtsi>,"sodium channel, voltage-gated, type IV, alpha; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5284906,KOMP-CSD,Scn4a,MGI:98250
Scn5a<tm2.1Care>,"sodium channel, voltage-gated, type V, alpha; targated mutation 2.1, Carol Ann Remme",MGI:5705587,0,Scn5a,MGI:98251
Scn8a<Clth>,"sodium channel, voltage-gated, type VIII, alpha; cloth-ears",MGI:3827095,Harwell ENU Mutagenesis,Scn8a,MGI:103169
Scnn1a<tm1.1Hum>,"sodium channel, nonvoltage-gated 1 alpha; targeted mutation 1.1, Edith Hummler",MGI:2384527,0,Scnn1a,MGI:101782
Scnn1a<tm1Rss>,"sodium channel, nonvoltage-gated 1 alpha; targeted mutation 1, Bernard C Rossier",MGI:2158700,0,Scnn1a,MGI:101782
Scnn1b<tm1.1Hum>,"sodium channel, nonvoltage-gated 1 beta; targeted mutation 1.1, Edith Hummler",MGI:3832670,0,Scnn1b,MGI:104696
Scnn1b<tm1.1Ipt>,"sodium channel, nonvoltage-gated 1 beta; targeted mutation 1.1, Edith Hummler",MGI:2448620,0,Scnn1b,MGI:104696
Scnn1b<tm1Ipt>,"sodium channel, nonvoltage-gated 1 beta; targeted mutation 1, Edith Hummler",MGI:2179831,0,Scnn1b,MGI:104696
Scnn1b<tm1Wsh>,"sodium channel, nonvoltage-gated 1 beta; targeted mutation 1, Michael J Welsh",MGI:2179819,0,Scnn1b,MGI:104696
Scnn1b<tm1a(EUCOMM)Hmgu>,"sodium channel, nonvoltage-gated 1 beta; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435286,EUCOMM,Scnn1b,MGI:104696
Scnn1g<tm1.1Hum>,"sodium channel, nonvoltage-gated 1 gamma; targeted mutation 1.1, Edith Hummer",MGI:3832674,0,Scnn1g,MGI:104695
Sco1<tm1a(KOMP)Wtsi>,"SCO1 cytochrome c oxidase assembly protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363778,KOMP-CSD,Sco1,MGI:106362
Scube3<tm1Dgen>,"signal peptide, CUB domain, EGF-like 3; targeted mutation 1, Deltagen",MGI:4939493,Deltagen,Scube3,MGI:3045253
Sdc2<tm1a(KOMP)Wtsi>,"syndecan 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364777,KOMP-CSD,Sdc2,MGI:1349165
Sdc2<tm1b(KOMP)Wtsi>,"syndecan 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548470,KOMP-CSD,Sdc2,MGI:1349165
Sdc4<tm2a(KOMP)Wtsi>,"syndecan 4; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4451381,KOMP-CSD,Sdc4,MGI:1349164
Sdhb<tm1Dost>,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip); targeted mutation 1, Douglas Strathdee",MGI:5702640,0,Sdhb,MGI:1914930
Sdhb<tm1a(EUCOMM)Hmgu>,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5085385,EUCOMM,Sdhb,MGI:1914930
Sdhb<tm1b(EUCOMM)Hmgu>,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548548,EUCOMM,Sdhb,MGI:1914930
Sdhc<tm1a(EUCOMM)Wtsi>,"succinate dehydrogenase complex, subunit C, integral membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433079,EUCOMM,Sdhc,MGI:1913302
Sdsl<tm1a(EUCOMM)Hmgu>,"serine dehydratase-like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436390,EUCOMM,Sdsl,MGI:2182607
Sec11c<tm1a(EUCOMM)Wtsi>,"SEC11 homolog C, signal peptidase complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456039,EUCOMM,Sec11c,MGI:1913536
Sec14l4<tm1a(EUCOMM)Wtsi>,"SEC14-like lipid binding 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433028,EUCOMM,Sec14l4,MGI:2144095
Sec14l4<tm1b(EUCOMM)Wtsi>,"SEC14-like lipid binding 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613659,EUCOMM,Sec14l4,MGI:2144095
Sec16b<tm1a(KOMP)Wtsi>,"SEC16 homolog B (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4365061,KOMP-CSD,Sec16b,MGI:2148802
Sec1<tm1a(EUCOMM)Wtsi>,"secretory blood group 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842255,EUCOMM,Sec1,MGI:1928893
Sec22b<tm1a(EUCOMM)Wtsi>,"SEC22 homolog B, vesicle trafficking protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433526,EUCOMM,Sec22b,MGI:1338759
Sec23a<tm1a(KOMP)Wtsi>,"SEC23 homolog A, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362215,KOMP-CSD,Sec23a,MGI:1349635
Sec24a<tm1a(KOMP)Wtsi>,"Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362779,KOMP-CSD,Sec24a,MGI:1924621
Secisbp2<tm1a(EUCOMM)Wtsi>,"SECIS binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433050,EUCOMM,Secisbp2,MGI:1922670
Seh1l<tm1a(EUCOMM)Wtsi>,"SEH1-like (S. cerevisiae; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453708,EUCOMM,Seh1l,MGI:1919374
Selenon<tm1.2Mred>,"selenoprotein N; targeted mutation 1.2, Mathieu Rederstorff",MGI:4946396,0,Selenon,MGI:2151208
Selenon<tm1a(KOMP)Wtsi>,"selenoprotein N; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363081,KOMP-CSD,Selenon,MGI:2151208
Selenow<tm1b(EUCOMM)Wtsi>,,MGI:1100878,,,
Selk<tm1b(EUCOMM)Wtsi>,"selenoprotein K; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548722,EUCOMM,Selenok,MGI:1931466
Sell<tm1a(EUCOMM)Hmgu>,"selectin, lymphocyte; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434581,EUCOMM,Sell,MGI:98279
Sema3e<Gt(RST629)Byg>,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E; gene trap RST629, BayGenomics",MGI:4128247,0,Sema3e,MGI:1340034
Sema3e<tm1Ddg>,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E; targeted mutation 1, David D Ginty",MGI:3527995,0,Sema3e,MGI:1340034
Sema3f<tm1a(EUCOMM)Hmgu>,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435144,EUCOMM,Sema3f,MGI:1096347
Sema4b<Gt(RST235)Byg>,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; gene trap RST235, BayGenomics",MGI:4125445,0,Sema4b,MGI:107559
Sema4d<tm1a(EUCOMM)Wtsi>,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433529,EUCOMM,Sema4d,MGI:109244
Sema5b<tm1a(EUCOMM)Wtsi>,"sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432860,EUCOMM,Sema5b,MGI:107555
Sema6a<Gt(KST069)Byg>,"sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A; gene trap KST069, BayGenomics",MGI:2156202,0,Sema6a,MGI:1203727
Senp1<Gt(OST215108)Lex>,"SUMO1/sentrin specific peptidase 1; gene trap OST215108, Lexicon Genetics",MGI:4235933,Lexicon,Senp1,MGI:2445054
Senp2<Gt(OST66117)Lex>,"SUMO/sentrin specific peptidase 2; gene trap OST66117, Lexicon Genetics",MGI:3531129,Lexicon,Senp2,MGI:1923076
Senp6<Gt(OST66115)Lex>,"SUMO/sentrin specific peptidase 6; gene trap OST66115, Lexicon Genetics",MGI:3531135,Lexicon,Senp6,MGI:1922075
Sept10<tm1a(KOMP)Wtsi>,"septin 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014599,KOMP-CSD,40422,MGI:1918110
Sept1<m1Mhda>,"septin 1; mutation 1, Martin Hrabe de Angelis",MGI:5818769,0,37135,MGI:1858916
Sept3<tm1a(KOMP)Wtsi>,"septin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363384,KOMP-CSD,37865,MGI:1345148
Sept5<tm1Bld>,"septin 5; targeted mutation 1, Antonio Baldini",MGI:3640090,0,38596,MGI:1195461
Sept8<tm1a(EUCOMM)Wtsi>,"septin 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433986,EUCOMM,39692,MGI:894310
Serinc3<tm1a(KOMP)Wtsi>,"serine incorporator 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363849,KOMP-CSD,Serinc3,MGI:1349457
Serpina3c<tm1a(KOMP)Wtsi>,"serine (or cysteine) peptidase inhibitor, clade A, member 3C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363850,KOMP-CSD,Serpina3c,MGI:102848
Serpinb12<tm1a(KOMP)Wtsi>,"serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362859,KOMP-CSD,Serpinb12,MGI:1919119
Serpine1<tm1Mlg>,"serine (or cysteine) peptidase inhibitor, clade E, member 1; targeted mutation 1, Richard C Mulligan",MGI:1857287,0,Serpine1,MGI:97608
Sertad1<tm1Srn>,"SERTA domain containing 1; targeted mutation 1, Manuel Serrano",MGI:4437094,0,Sertad1,MGI:1913438
Sesn3<tm1a(EUCOMM)Wtsi>,"sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432370,EUCOMM,Sesn3,MGI:1922997
Setbp1<tm1a(EUCOMM)Wtsi>,"SET binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4442011,EUCOMM,Setbp1,MGI:1933199
Setd1a<tm1.2(IMPC)Wtsi>,,MGI:2446244,,,
Setd1a<tm1a(EUCOMM)Wtsi>,"SET domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432882,EUCOMM,Setd1a,MGI:2446244
Setd1a<tm1b(EUCOMM)Wtsi>,,MGI:2446244,,,
Setd4<tm1a(KOMP)Wtsi>,"SET domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364212,KOMP-CSD,Setd4,MGI:2136890
Setd5<tm1a(EUCOMM)Wtsi>,"SET domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432631,EUCOMM,Setd5,MGI:1920145
Setd7<tm1.1Ital>,"SET domain containing (lysine methyltransferase) 7; targeted mutation 1.1, Iannis Talianidis",MGI:5828599,0,Setd7,MGI:1920501
Setdb1<tm1a(EUCOMM)Wtsi>,"SET domain, bifurcated 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432424,EUCOMM,Setdb1,MGI:1934229
Setdb2<tm1Desr>,"SET domain, bifurcated 2; targeted mutation 1, David E Symer",MGI:5751798,0,Setdb2,MGI:2685139
Setdb2<tm1a(KOMP)Wtsi>,"SET domain, bifurcated 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364322,KOMP-CSD,Setdb2,MGI:2685139
Setmar<tm1a(EUCOMM)Wtsi>,"SET domain without mariner transposase fusion; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432061,EUCOMM,Setmar,MGI:1921979
Setx<tm1a(EUCOMM)Wtsi>,"senataxin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014716,EUCOMM,Setx,MGI:2443480
Sez6l2<tm1a(EUCOMM)Hmgu>,"seizure related 6 homolog like 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5285738,EUCOMM,Sez6l2,MGI:2385295
Sez6l<tm1a(EUCOMM)Hmgu>,"seizure related 6 homolog like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4942074,EUCOMM,Sez6l,MGI:1935121
Sfl,shiftless,MGI:2679580,0,Sfl,MGI:2679578
Sfpq<tm1a(EUCOMM)Wtsi>,"splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4847863,EUCOMM,Sfpq,MGI:1918764
Sfxn3<tm1a(KOMP)Wtsi>,"sideroflexin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431412,KOMP-CSD,Sfxn3,MGI:2137679
Sfxn3<tm1b(KOMP)Wtsi>,"sideroflexin 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548735,KOMP-CSD,Sfxn3,MGI:2137679
Sgca<tm1Kcam>,"sarcoglycan, alpha (dystrophin-associated glycoprotein); targeted mutation 1, Kevin P Campbell",MGI:1934922,0,Sgca,MGI:894698
Sgce<tm1Vinni>,"sarcoglycan, epsilon; targeted mutation 1, Vincenzo Nigro",MGI:5296936,0,Sgce,MGI:1329042
Sgh,sluggish,MGI:2679588,0,Sgh,MGI:2679586
Sgip1<tm1a(EUCOMM)Hmgu>,"SH3-domain GRB2-like (endophilin) interacting protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841887,EUCOMM,Sgip1,MGI:1920344
Sgip1<tm1b(EUCOMM)Hmgu>,"SH3-domain GRB2-like (endophilin) interacting protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548629,EUCOMM,Sgip1,MGI:1920344
Sgms1<tm1a(EUCOMM)Wtsi>,"sphingomyelin synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4950245,EUCOMM,Sgms1,MGI:2444110
Sgsm1<tm1a(EUCOMM)Wtsi>,"small G protein signaling modulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4949373,EUCOMM,Sgsm1,MGI:107320
Sgsm1<tm1b(EUCOMM)Wtsi>,"small G protein signaling modulator 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636905,EUCOMM,Sgsm1,MGI:107320
Sh2d5<tm1a(EUCOMM)Wtsi>,"SH2 domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432348,EUCOMM,Sh2d5,MGI:2446215
Sh3bgrl3<tm2a(EUCOMM)Wtsi>,"SH3 domain binding glutamic acid-rich protein-like 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840634,EUCOMM,Sh3bgrl3,MGI:1920973
Sh3bgrl3<tm2b(EUCOMM)Wtsi>,"SH3 domain binding glutamic acid-rich protein-like 3; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637071,EUCOMM,Sh3bgrl3,MGI:1920973
Sh3bp4<tm1a(EUCOMM)Wtsi>,"SH3-domain binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433523,EUCOMM,Sh3bp4,MGI:2138297
Sh3pxd2a<tm1a(EUCOMM)Wtsi>,"SH3 and PX domains 2A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842409,EUCOMM,Sh3pxd2a,MGI:1298393
Sh3pxd2a<tm1b(EUCOMM)Wtsi>,"SH3 and PX domains 2A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636944,EUCOMM,Sh3pxd2a,MGI:1298393
Shb<tm1a(EUCOMM)Hmgu>,"src homology 2 domain-containing transforming protein B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451783,EUCOMM,Shb,MGI:98294
Shby<2H>,shabby; shabby 2 Harwell,MGI:5440312,Harwell ENU Mutagenesis,Shby,MGI:1891134
Shh<tm1a(EUCOMM)Wtsi>,"sonic hedgehog; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433366,EUCOMM,Shh,MGI:98297
Shmt1<tm1a(KOMP)Wtsi>,"serine hydroxymethyltransferase 1 (soluble); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4454114,KOMP-CSD,Shmt1,MGI:98299
Sho2,shorthead 2,MGI:4367837,Harwell ENU Mutagenesis,Sho2,MGI:4367793
Sic,sickly,MGI:1862005,0,Sic,MGI:1861984
Sigmar1<tm1Lmon>,"sigma non-opioid intracellular receptor 1; targeted mutation 1, Lluis Montoliu",MGI:3044771,0,Sigmar1,MGI:1195268
Sik3<tm1a(EUCOMM)Hmgu>,"SIK family kinase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5085429,EUCOMM,Sik3,MGI:2446296
Sipa1<tm1a(EUCOMM)Hmgu>,"signal-induced proliferation associated gene 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4847818,EUCOMM,Sipa1,MGI:107576
Sipa1l2<tm1a(KOMP)Wtsi>,"signal-induced proliferation-associated 1 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419620,KOMP-CSD,Sipa1l2,MGI:2676970
Sirt1<tm1a(EUCOMM)Wtsi>,"sirtuin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432175,EUCOMM,Sirt1,MGI:2135607
Sirt2<tm1a(EUCOMM)Wtsi>,"sirtuin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431586,EUCOMM,Sirt2,MGI:1927664
Sirt3<tm1a(EUCOMM)Wtsi>,"sirtuin 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441628,EUCOMM,Sirt3,MGI:1927665
Sirt4<tm1a(EUCOMM)Hmgu>,"sirtuin 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4457551,EUCOMM,Sirt4,MGI:1922637
Sirt5<tm2a(EUCOMM)Hmgu>,"sirtuin 5; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511642,EUCOMM,Sirt5,MGI:1915596
Sirt6<tm1a(EUCOMM)Wtsi>,"sirtuin 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432093,EUCOMM,Sirt6,MGI:1354161
Siva1<tm1a(EUCOMM)Hmgu>,"SIVA1, apoptosis-inducing factor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455701,EUCOMM,Siva1,MGI:1353606
Siva1<tm1b(EUCOMM)Hmgu>,"SIVA1, apoptosis-inducing factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5605765,EUCOMM,Siva1,MGI:1353606
Six1<Cwe>,sine oculis-related homeobox 1; Catweasel,MGI:3849082,0,Six1,MGI:102780
Skida1<tm1(KOMP)Wtsi>,"SKI/DACH domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4841167,KOMP-CSD,Skida1,MGI:1919918
Slamf9<tm1a(EUCOMM)Wtsi>,"SLAM family member 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433560,EUCOMM,Slamf9,MGI:1923692
Slc13a5<tm1a(EUCOMM)Hmgu>,"solute carrier family 13 (sodium-dependent citrate transporter), member 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841523,EUCOMM,Slc13a5,MGI:3037150
Slc13a5<tm1b(EUCOMM)Hmgu>,"solute carrier family 13 (sodium-dependent citrate transporter), member 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5614709,EUCOMM,Slc13a5,MGI:3037150
Slc15a3<tm1a(KOMP)Wtsi>,"solute carrier family 15, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363498,KOMP-CSD,Slc15a3,MGI:1929691
Slc16a2<tm1a(KOMP)Wtsi>,"solute carrier family 16 (monocarboxylic acid transporters), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364794,KOMP-CSD,Slc16a2,MGI:1203732
Slc16a2<tm1c(KOMP)Wtsi>,,MGI:1203732,,,
Slc16a3<tm1a(EUCOMM)Wtsi>,"solute carrier family 16 (monocarboxylic acid transporters), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453792,EUCOMM,Slc16a3,MGI:1933438
Slc16a4<tm2e(EUCOMM)Wtsi>,"solute carrier family 16 (monocarboxylic acid transporters), member 4; targeted mutation 2e, Wellcome Trust Sanger Institute",MGI:4840599,EUCOMM,Slc16a4,MGI:2385183
Slc16a6<tm1a(EUCOMM)Wtsi>,"solute carrier family 16 (monocarboxylic acid transporters), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431916,EUCOMM,Slc16a6,MGI:2144585
Slc17a3<tm2a(KOMP)Wtsi>,"solute carrier family 17 (sodium phosphate), member 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4362759,KOMP-CSD,Slc17a3,MGI:2389216
Slc17a6<tm1Kldr>,"solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6; targeted mutation 1, Klas Kullander",MGI:3693864,0,Slc17a6,MGI:2156052
Slc17a6<tm1a(EUCOMM)Hmgu>,"solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455898,EUCOMM,Slc17a6,MGI:2156052
Slc17a8<tm2Selm>,"solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8; targeted mutation 2, Salah El Mestikawy",MGI:5645786,0,Slc17a8,MGI:3039629
Slc1a7<tm1a(EUCOMM)Hmgu>,"solute carrier family 1 (glutamate transporter), member 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436714,EUCOMM,Slc1a7,MGI:2444087
Slc20a2<tm1a(EUCOMM)Wtsi>,"solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431725,EUCOMM,Slc20a2,MGI:97851
Slc20a2<tm1b(EUCOMM)Wtsi>,"solute carrier family 20, member 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548966,EUCOMM,Slc20a2,MGI:97851
Slc22a21<tm1a(KOMP)Wtsi>,"solute carrier family 22 (organic cation transporter), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364715,KOMP-CSD,Slc22a21,MGI:1929481
Slc22a6<tm1.1(cre/ERT2)Amat>,"solute carrier family 22 (organic anion transporter), member 6; targeted mutation 1.1, Athena Matakidou",MGI:5911847,0,Slc22a6,MGI:892001
Slc22a8<tm1a(KOMP)Wtsi>,"solute carrier family 22 (organic anion transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419220,KOMP-CSD,Slc22a8,MGI:1336187
Slc23a4<tm1a(KOMP)Wtsi>,"solute carrier family 23 member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363429,KOMP-CSD,Slc23a4,MGI:1917272
Slc24a4<tm1a(KOMP)Wtsi>,"solute carrier family 24 (sodium/potassium/calcium exchanger), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944392,KOMP-CSD,Slc24a4,MGI:2447362
Slc25a10<tm1b(EUCOMM)Wtsi>,,MGI:1353497,,,
Slc25a15<tm1a(EUCOMM)Hmgu>,"solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5085374,EUCOMM,Slc25a15,MGI:1342274
Slc25a15<tm1b(EUCOMM)Hmgu>,"solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5636973,EUCOMM,Slc25a15,MGI:1342274
Slc25a20<tm1a(EUCOMM)Wtsi>,"solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431570,EUCOMM,Slc25a20,MGI:1928738
Slc25a21<tm1a(KOMP)Wtsi>,"solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364913,KOMP-CSD,Slc25a21,MGI:2445059
Slc25a21<tm1b(KOMP)Wtsi>,"solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548834,KOMP-CSD,Slc25a21,MGI:2445059
Slc25a21<tm1c(KOMP)Wtsi>,,MGI:2445059,,,
Slc25a21<tm1d(KOMP)Wtsi>,,MGI:2445059,,,
Slc25a28<tm1a(EUCOMM)Wtsi>,"solute carrier family 25, member 28; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452777,EUCOMM,Slc25a28,MGI:2180509
Slc25a28<tm1b(EUCOMM)Wtsi>,"solute carrier family 25, member 28; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637123,EUCOMM,Slc25a28,MGI:2180509
Slc25a29<tm1a(KOMP)Wtsi>,"solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362397,KOMP-CSD,Slc25a29,MGI:2444911
Slc25a30<tm1a(EUCOMM)Wtsi>,"solute carrier family 25, member 30; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842343,EUCOMM,Slc25a30,MGI:1914804
Slc25a38<tm1a(EUCOMM)Wtsi>,"solute carrier family 25, member 38; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431760,EUCOMM,Slc25a38,MGI:2384782
Slc25a43<tm1a(EUCOMM)Wtsi>,"solute carrier family 25, member 43; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431833,EUCOMM,Slc25a43,MGI:2684854
Slc25a4<tm1a(EUCOMM)Wtsi>,"solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432177,EUCOMM,Slc25a4,MGI:1353495
Slc2a2<m1Mhda>,"solute carrier family 2 (facilitated glucose transporter), member 2; mutation 1, Martin Hrabe de Angelis",MGI:5818770,0,Slc2a2,MGI:1095438
Slc2a5<tm1a(EUCOMM)Wtsi>,"solute carrier family 2 (facilitated glucose transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842480,EUCOMM,Slc2a5,MGI:1928369
Slc2a5<tm1b(EUCOMM)Wtsi>,"solute carrier family 2 (facilitated glucose transporter), member 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613655,EUCOMM,Slc2a5,MGI:1928369
Slc2a9<tm1.2Thor>,"solute carrier family 2 (facilitated glucose transporter), member 9; targeted mutation 1.2, Bernard Thorens",MGI:4361278,0,Slc2a9,MGI:2152844
Slc30a8<tm1a(KOMP)Wtsi>,"solute carrier family 30 (zinc transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363904,KOMP-CSD,Slc30a8,MGI:2442682
Slc31a2<tm1a(EUCOMM)Wtsi>,"solute carrier family 31, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432041,EUCOMM,Slc31a2,MGI:1333844
Slc34a3<tm1.1Nhch>,"solute carrier family 34 (sodium phosphate), member 3; targeted mutation 1.1, Nati Hernando",MGI:5609132,0,Slc34a3,MGI:2159410
Slc35b1<tm2a(EUCOMM)Wtsi>,"solute carrier family 35, member B1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5306495,EUCOMM,Slc35b1,MGI:1343133
Slc35f1<tm1a(KOMP)Wtsi>,"solute carrier family 35, member F1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363454,KOMP-CSD,Slc35f1,MGI:2139810
Slc35f6<tm1a(EUCOMM)Wtsi>,"solute carrier family 35, member F6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432047,EUCOMM,Slc35f6,MGI:1922169
Slc38a10<tm1a(EUCOMM)Wtsi>,"solute carrier family 38, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431702,EUCOMM,Slc38a10,MGI:1919305
Slc38a10<tm2a(EUCOMM)Wtsi>,"solute carrier family 38, member 10; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4441779,EUCOMM,Slc38a10,MGI:1919305
Slc38a2<tm1a(KOMP)Wtsi>,"solute carrier family 38, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5293947,KOMP-CSD,Slc38a2,MGI:1915010
Slc38a3<m1Ingm>,"solute carrier family 38, member 3; mutation 1, Ingenium Pharmaceuticals AG",MGI:5790979,0,Slc38a3,MGI:1923507
Slc38a4<tm1a(EUCOMM)Wtsi>,"solute carrier family 38, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431996,EUCOMM,Slc38a4,MGI:1916604
Slc39a8<tm1a(EUCOMM)Wtsi>,"solute carrier family 39 (metal ion transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432011,EUCOMM,Slc39a8,MGI:1914797
Slc40a1<Pcm>,"solute carrier family 40 (iron-regulated transporter), member 1; polycythaemia",MGI:1889622,0,Slc40a1,MGI:1315204
Slc40a1<tm1a(EUCOMM)Hmgu>,"solute carrier family 40 (iron-regulated transporter), member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435780,EUCOMM,Slc40a1,MGI:1315204
Slc41a3<tm1a(KOMP)Wtsi>,"solute carrier family 41, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4365235,KOMP-CSD,Slc41a3,MGI:1918949
Slc44a3<tm1a(EUCOMM)Wtsi>,"solute carrier family 44, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434043,EUCOMM,Slc44a3,MGI:2384860
Slc44a3<tm1b(EUCOMM)Wtsi>,"solute carrier family 44, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613661,EUCOMM,Slc44a3,MGI:2384860
Slc44a4<tm1a(EUCOMM)Hmgu>,"solute carrier family 44, member 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841742,EUCOMM,Slc44a4,MGI:1917379
Slc44a5<tm1a(KOMP)Wtsi>,"solute carrier family 44, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364041,KOMP-CSD,Slc44a5,MGI:3035141
Slc47a1<tm1a(EUCOMM)Wtsi>,"solute carrier family 47, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432174,EUCOMM,Slc47a1,MGI:1914723
Slc47a1<tm1b(EUCOMM)Wtsi>,"solute carrier family 47, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548541,EUCOMM,Slc47a1,MGI:1914723
Slc4a10<tm1a(KOMP)Wtsi>,"solute carrier family 4, sodium bicarbonate cotransporter-like, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451535,KOMP-CSD,Slc4a10,MGI:2150150
Slc52a3<tm2a(KOMP)Wtsi>,"solute carrier protein family 52, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4363008,KOMP-CSD,Slc52a3,MGI:1916948
Slc5a2<tm1a(KOMP)Wtsi>,"solute carrier family 5 (sodium/glucose cotransporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363573,KOMP-CSD,Slc5a2,MGI:2181411
Slc5a6<tm1a(EUCOMM)Wtsi>,"solute carrier family 5 (sodium-dependent vitamin transporter), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432225,EUCOMM,Slc5a6,MGI:2660847
Slc5a7<tm1a(KOMP)Wtsi>,"solute carrier family 5 (choline transporter), member 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4942035,KOMP-CSD,Slc5a7,MGI:1927126
Slc6a20a<tm1a(KOMP)Wtsi>,"solute carrier family 6 (neurotransmitter transporter), member 20A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362653,KOMP-CSD,Slc6a20a,MGI:2143217
Slc6a20a<tm1b(KOMP)Wtsi>,"solute carrier family 6 (neurotransmitter transporter), member 20A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5613657,KOMP-CSD,Slc6a20a,MGI:2143217
Slc6a2<tm1a(EUCOMM)Hmgu>,"solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4461511,EUCOMM,Slc6a2,MGI:1270850
Slc6a2<tm1b(EUCOMM)Hmgu>,"solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588269,EUCOMM,Slc6a2,MGI:1270850
Slc6a3<tm1(cre)Xz>,"solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; targeted mutation 1, Xiaoxi Zhuang",MGI:3691571,0,Slc6a3,MGI:94862
Slc6a4<tm1(cre)Xz>,"solute carrier family 6 (neurotransmitter transporter, serotonin), member 4; targeted mutation 1, Xiaoxi Zhuang",MGI:3691577,0,Slc6a4,MGI:96285
Slc6a4<tm1(tTA)Cogr>,"solute carrier family 6 (neurotransmitter transporter, serotonin), member 4; targeted mutation 1, Cornelius Gross",MGI:3800924,0,Slc6a4,MGI:96285
Slc6a4<tm1Kpl>,"solute carrier family 6 (neurotransmitter transporter, serotonin), member 4; targeted mutation 1, Klaus-Peter Lesch",MGI:2178613,0,Slc6a4,MGI:96285
Slc7a10<tm1Dgen>,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 10; targeted mutation 1, Deltagen",MGI:3716074,Deltagen,Slc7a10,MGI:1858261
Slc7a11<tm1a(EUCOMM)Wtsi>,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441748,EUCOMM,Slc7a11,MGI:1347355
Slc9a3r2<tm2a(EUCOMM)Hmgu>,"solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511797,EUCOMM,Slc9a3r2,MGI:1890662
Slc9a4<tm1a(EUCOMM)Wtsi>,"solute carrier family 9 (sodium/hydrogen exchanger), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842748,EUCOMM,Slc9a4,MGI:105074
Slc9a8<tm1a(KOMP)Wtsi>,"solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363224,KOMP-CSD,Slc9a8,MGI:1924281
Slco2b1<tm1a(KOMP)Wtsi>,"solute carrier organic anion transporter family, member 2b1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363700,KOMP-CSD,Slco2b1,MGI:1351872
Slfn4<tm1a(EUCOMM)Wtsi>,"schlafen 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944570,EUCOMM,Slfn4,MGI:1329010
Slfn9<tm1a(EUCOMM)Wtsi>,"schlafen 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286383,EUCOMM,Slfn9,MGI:2445121
Slfnl1<tm1a(EUCOMM)Wtsi>,"schlafen like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453731,EUCOMM,Slfnl1,MGI:3045330
Slfnl1<tm1b(EUCOMM)Wtsi>,,MGI:3045330,,,
Slit1<tm1a(KOMP)Wtsi>,"slit guidance ligand 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363887,KOMP-CSD,Slit1,MGI:1315203
Slitrk4<tm1a(KOMP)Wtsi>,"SLIT and NTRK-like family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460289,KOMP-CSD,Slitrk4,MGI:2442509
Slitrk4<tm1b(KOMP)Wtsi>,"SLIT and NTRK-like family, member 4; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548808,KOMP-CSD,Slitrk4,MGI:2442509
Slu7<tm1a(KOMP)Wtsi>,"SLU7 splicing factor homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363740,KOMP-CSD,Slu7,MGI:2385598
Slx4<tm1a(EUCOMM)Wtsi>,"SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432843,EUCOMM,Slx4,MGI:106299
Slx4ip<tm1a(EUCOMM)Wtsi>,"SLX4 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433347,EUCOMM,Slx4ip,MGI:1921493
Smad2<tm3Rob>,"SMAD family member 2; targeted mutation 3, Elizabeth J Robertson",MGI:3527155,0,Smad2,MGI:108051
Smad2<tm4(SMADH3)Rob>,"SMAD family member 2; targeted mutation 4, Elizabeth J Robertson",MGI:3527156,0,Smad2,MGI:108051
Smad9<tm1Rob>,"SMAD family member 9; targeted mutation 1, Elizabeth J Robertson",MGI:3701868,0,Smad9,MGI:1859993
Smad9<tm2Rob>,"SMAD family member 9; targeted mutation 2, Elizabeth J Robertson",MGI:5514164,0,Smad9,MGI:1859993
Smarca5<tm2.1Ais>,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5; targeted mutation 2.1, Art I Skoultchi",MGI:5706633,0,Smarca5,MGI:1935129
Smarcal1<tm1a(EUCOMM)Wtsi>,"SWI/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433467,EUCOMM,Smarcal1,MGI:1859183
Smc3<tm1a(EUCOMM)Wtsi>,"structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434007,EUCOMM,Smc3,MGI:1339795
Smc5<tm1a(KOMP)Wtsi>,"structural maintenance of chromosomes 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419231,KOMP-CSD,Smc5,MGI:2385088
Smc6<tm1a(EUCOMM)Hmgu>,"structural maintenance of chromosomes 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435686,EUCOMM,Smc6,MGI:1914491
Smc6<tm1b(EUCOMM)Hmgu>,"structural maintenance of chromosomes 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613644,EUCOMM,Smc6,MGI:1914491
Smco4<tm1a(EUCOMM)Wtsi>,"single-pass membrane protein with coiled-coil domains 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433435,EUCOMM,Smco4,MGI:3039636
Smcr8<tm1(KOMP)Vlcg>,"Smith-Magenis syndrome chromosome region, candidate 8 homolog (human); targeted mutation 1, Velocigene",MGI:4452950,KOMP-Regeneron,Smcr8,MGI:2444720
Smg1<Gt(RRT449)Byg>,"SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans); gene trap RRT449, BayGenomics",MGI:4338581,0,Smg1,MGI:1919742
Smg1<tm1a(EUCOMM)Hmgu>,"SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5497170,EUCOMM,Smg1,MGI:1919742
Smg6<Tg(SMN1*delta5)1Pks>,"Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans); transgene insertion 1, Nick Parkinson",MGI:5493450,0,Smg6,MGI:2144117
Smg9<tm1a(EUCOMM)Wtsi>,"smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433646,EUCOMM,Smg9,MGI:1919247
Smn1<tm1Msd>,"survival motor neuron 1; targeted mutation 1, Michael Sendtner",MGI:2183946,0,Smn1,MGI:109257
Smoc1<tm1a(EUCOMM)Wtsi>,"SPARC related  modular calcium binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431709,EUCOMM,Smoc1,MGI:1929878
Smpd3<fro>,"sphingomyelin phosphodiesterase 3, neutral; fragilitas ossium",MGI:1856877,0,Smpd3,MGI:1927578
Smpd4<tm2a(KOMP)Wtsi>,"sphingomyelin phosphodiesterase 4; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841172,KOMP-CSD,Smpd4,MGI:1924876
Smpd4<tm2b(KOMP)Wtsi>,"sphingomyelin phosphodiesterase 4; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548688,KOMP-CSD,Smpd4,MGI:1924876
Smpdl3b<tm1a(EUCOMM)Wtsi>,"sphingomyelin phosphodiesterase, acid-like 3B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433288,EUCOMM,Smpdl3b,MGI:1916022
Sms<tm1a(EUCOMM)Wtsi>,"spermine synthase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431547,EUCOMM,Sms,MGI:109490
Smurf1<tm1a(EUCOMM)Wtsi>,"SMAD specific E3 ubiquitin protein ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433314,EUCOMM,Smurf1,MGI:1923038
Smurf2<tm1a(EUCOMM)Wtsi>,"SMAD specific E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431726,EUCOMM,Smurf2,MGI:1913563
Smyd2<tm1a(KOMP)Wtsi>,"SET and MYND domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362468,KOMP-CSD,Smyd2,MGI:1915889
Smyd3<Gt(AS0527)Wtsi>,"SET and MYND domain containing 3; gene trap AS0527, Wellcome Trust Sanger Institute",MGI:4346714,Sanger Inst. Gene Trap Res.,Smyd3,MGI:1916976
Smyd3<tm1a(KOMP)Wtsi>,"SET and MYND domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362710,KOMP-CSD,Smyd3,MGI:1916976
Smyd4<tm1a(EUCOMM)Wtsi>,"SET and MYND domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432884,EUCOMM,Smyd4,MGI:2442796
Smyd5<tm1a(EUCOMM)Wtsi>,"SET and MYND domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431696,EUCOMM,Smyd5,MGI:108048
Smyd5<tm1e(EUCOMM)Wtsi>,"SET and MYND domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433561,EUCOMM,Smyd5,MGI:108048
Snap23<tm1a(EUCOMM)Wtsi>,"synaptosomal-associated protein 23; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460454,EUCOMM,Snap23,MGI:109356
Snap25<Bdr>,synaptosomal-associated protein 25; blind drunk,MGI:1862014,Harwell ENU Mutagenesis,Snap25,MGI:98331
Snap25<tm1Bark>,"synaptosomal-associated protein 25; targeted mutation 1, Christina Bark",MGI:3821973,0,Snap25,MGI:98331
Snap29<tm1a(EUCOMM)Wtsi>,"synaptosomal-associated protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433565,EUCOMM,Snap29,MGI:1914724
Snap47<tm1a(EUCOMM)Wtsi>,"synaptosomal-associated protein, 47; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433792,EUCOMM,Snap47,MGI:1915076
Snapc1<tm1a(KOMP)Mbp>,"small nuclear RNA activating complex, polypeptide 1; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4867920,KOMP-CSD,Snapc1,MGI:1922877
Snapc4<tm1a(KOMP)Wtsi>,"small nuclear RNA activating complex, polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362491,KOMP-CSD,Snapc4,MGI:2443935
Sncaip<tm1a(EUCOMM)Wtsi>,"synuclein, alpha interacting protein (synphilin); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4938575,EUCOMM,Sncaip,MGI:1915097
Sncaip<tm1b(EUCOMM)Wtsi>,"synuclein, alpha interacting protein (synphilin); targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5569950,EUCOMM,Sncaip,MGI:1915097
Sncb<tm1a(EUCOMM)Hmgu>,"synuclein, beta; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455731,EUCOMM,Sncb,MGI:1889011
Snf8<tm1a(EUCOMM)Wtsi>,"SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433763,EUCOMM,Snf8,MGI:1343161
Snip1<tm1a(EUCOMM)Wtsi>,"Smad nuclear interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431749,EUCOMM,Snip1,MGI:2156003
Snorc<tm1a(EUCOMM)Hmgu>,"secondary ossification center associated regulator of chondrocyte maturation; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436063,EUCOMM,Snorc,MGI:1920484
Snorc<tm1b(EUCOMM)Hmgu>,"secondary ossification center associated regulator of chondrocyte maturation; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5637067,EUCOMM,Snorc,MGI:1920484
Snrnp200<tm1a(KOMP)Mbp>,"small nuclear ribonucleoprotein 200 (U5); targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4840806,KOMP-CSD,Snrnp200,MGI:2444401
Snrnp27<tm1a(EUCOMM)Wtsi>,"small nuclear ribonucleoprotein 27 (U4/U6.U5); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842426,EUCOMM,Snrnp27,MGI:1913868
Snx29<tm1a(EUCOMM)Hmgu>,"sorting nexin 29; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434822,EUCOMM,Snx29,MGI:1921728
Snx31<tm1a(KOMP)Wtsi>,"sorting nexin 31; targeted mutation 1a, Mouse Biology Program, University of California, Davis",MGI:5497029,KOMP-CSD,Snx31,MGI:1913946
Snx5<tm1a(KOMP)Wtsi>,"sorting nexin 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362512,KOMP-CSD,Snx5,MGI:1916428
Snx8<tm2a(EUCOMM)Hmgu>,"sorting nexin 8; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5546671,EUCOMM,Snx8,MGI:2443816
Socs7<tm1a(EUCOMM)Wtsi>,"suppressor of cytokine signaling 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432554,EUCOMM,Socs7,MGI:2651588
Sorl1<tm1a(EUCOMM)Wtsi>,"sortilin-related receptor, LDLR class A repeats-containing; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451976,EUCOMM,Sorl1,MGI:1202296
Sorl1<tm1b(EUCOMM)Wtsi>,"sortilin-related receptor, LDLR class A repeats-containing; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5569945,EUCOMM,Sorl1,MGI:1202296
Sort1<tm1a(EUCOMM)Wtsi>,"sortilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842306,EUCOMM,Sort1,MGI:1338015
Sox13<tm1a(EUCOMM)Wtsi>,"SRY (sex determining region Y)-box 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433017,EUCOMM,Sox13,MGI:98361
Sox2<lcc>,SRY (sex determining region Y)-box 2; light coat and circling,MGI:2447995,0,Sox2,MGI:98364
Sox2<tm2Skn>,"SRY (sex determining region Y)-box 2; targeted mutation 2, Silvia K Nicolis",MGI:2181440,0,Sox2,MGI:98364
Sox2<tm3Skn>,"SRY (sex determining region Y)-box 2; targeted mutation 3, Silvia K Nicolis",MGI:3052123,0,Sox2,MGI:98364
Sox2<tm4.1Skn>,"SRY (sex determining region Y)-box 2; targeted mutation 4.1, Silvia K Nicolis",MGI:4397705,0,Sox2,MGI:98364
Sox2<ysb>,SRY (sex determining region Y)-box 2; yellow submarine,MGI:2447996,0,Sox2,MGI:98364
Sox4<M91Ark>,"SRY (sex determining region Y)-box 4; mutation 91, Ruth M Arkell",MGI:3819793,0,Sox4,MGI:98366
Sox9<tm1Gsr>,"SRY (sex determining region Y)-box 9; targeted mutation 1, Gerd Scherer",MGI:2385468,0,Sox9,MGI:98371
Sox9<tm2Gsr>,"SRY (sex determining region Y)-box 9; targeted mutation 2, Gerd Scherer",MGI:3817218,0,Sox9,MGI:98371
Sp1<tm1Phi>,"trans-acting transcription factor 1; targeted mutation 1, Sjaak Philipsen",MGI:2181866,0,Sp1,MGI:98372
Sp2<Gt(EUCJ0012h08)Hmgu>,"Sp2 transcription factor; gene trap EUCJ0012h08, Helmholtz Zentrum Muenchen GmbH",MGI:4870800,0,Sp2,MGI:1926162
Sp3<tm1Sus>,"trans-acting transcription factor 3; targeted mutation 1, Guntram Suske",MGI:2182438,0,Sp3,MGI:1277166
Sp4<tm1Sus>,"trans-acting transcription factor 4; targeted mutation 1, Guntram Suske",MGI:2183651,0,Sp4,MGI:107595
Sp6<tm1.1Ibmm>,"trans-acting transcription factor 6; targeted mutation 1.1, Claude Szpirer",MGI:3778294,0,Sp6,MGI:1932575
Sp6<tm1Ibmm>,"trans-acting transcription factor 6; targeted mutation 1, Claude Szpirer",MGI:3778292,0,Sp6,MGI:1932575
Sparc<tm1a(EUCOMM)Wtsi>,"secreted acidic cysteine rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432869,EUCOMM,Sparc,MGI:98373
Spata25<tm1(KOMP)Wtsi>,"spermatogenesis associated 25; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4451280,KOMP-CSD,Spata25,MGI:1922892
Spats1<tm1a(EUCOMM)Hmgu>,"spermatogenesis associated, serine-rich 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5436890,EUCOMM,Spats1,MGI:1918270
Spg20<tm2a(EUCOMM)Hmgu>,"spastic paraplegia 20, spartin (Troyer syndrome) homolog (human); targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4436639,EUCOMM,Spg20,MGI:2139806
Spg20<tm2b(EUCOMM)Hmgu>,"spastic paraplegia 20, spartin (Troyer syndrome) homolog (human); targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5548741,EUCOMM,Spg20,MGI:2139806
Spgl,spag luxate,MGI:3576619,Harwell ENU Mutagenesis,Spgl,MGI:1890620
Spice1<tm1a(EUCOMM)Hmgu>,"spindle and centriole associated protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286323,EUCOMM,Spice1,MGI:1196252
Spink10<tm1a(KOMP)Wtsi>,"serine peptidase inhibitor, Kazal type 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841128,KOMP-CSD,Spink10,MGI:3584533
Spink14<tm1e(KOMP)Wtsi>,"serine peptidase inhibitor, Kazal type 14; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4841420,KOMP-CSD,Spink14,MGI:3646952
Spns1<tm1e(EUCOMM)Wtsi>,"spinster homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4434332,EUCOMM,Spns1,MGI:1920908
Spns2<tm1a(KOMP)Wtsi>,"spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460276,KOMP-CSD,Spns2,MGI:2384936
Spns2<tm1b(KOMP)Wtsi>,"spinster homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5442804,KOMP-CSD,Spns2,MGI:2384936
Spns2<tm1c(KOMP)Wtsi>,,MGI:2384936,,,
Spo11<tm1Mjn>,"SPO11 meiotic protein covalently bound to DSB; targeted mutation 1, Maria Jasin",MGI:2178805,0,Spo11,MGI:1349669
Spopl<tm1a(EUCOMM)Wtsi>,"speckle-type POZ protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455963,EUCOMM,Spopl,MGI:1924107
Spp1<tm1Rit>,"secreted phosphoprotein 1; targeted mutation 1, Susan R Rittling",MGI:1932084,0,Spp1,MGI:98389
Spryd3<tm1a(EUCOMM)Hmgu>,"SPRY domain containing 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434532,EUCOMM,Spryd3,MGI:2446175
Sptbn1<tm1a(EUCOMM)Wtsi>,"spectrin beta, non-erythrocytic 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432393,EUCOMM,Sptbn1,MGI:98388
Sptbn2<tm1a(EUCOMM)Hmgu>,"spectrin beta, non-erythrocytic 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841660,EUCOMM,Sptbn2,MGI:1313261
Sqle<tm1a(EUCOMM)Wtsi>,"squalene epoxidase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431854,EUCOMM,Sqle,MGI:109296
Sqstm1<tm1a(KOMP)Wtsi>,"sequestosome 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364926,KOMP-CSD,Sqstm1,MGI:107931
Src<tm2a(EUCOMM)Wtsi>,"Rous sarcoma oncogene; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4431843,EUCOMM,Src,MGI:98397
Srebf2<tm1b(KOMP)Wtsi>,,MGI:107585,,,
Srrm4<bv>,serine/arginine repetitive matrix 4; Bronx waltzer,MGI:1856676,0,Srrm4,MGI:1916205
Srrm4<tm1e(EUCOMM)Wtsi>,"serine/arginine repetitive matrix 4; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4451952,EUCOMM,Srrm4,MGI:1916205
Srsf4<tm1a(EUCOMM)Wtsi>,"serine/arginine-rich splicing factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431961,EUCOMM,Srsf4,MGI:1890577
Srsf7<tm1a(EUCOMM)Wtsi>,"serine/arginine-rich splicing factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433826,EUCOMM,Srsf7,MGI:1926232
Ssbp1<tm1a(KOMP)Wtsi>,"single-stranded DNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4938520,KOMP-CSD,Ssbp1,MGI:1920040
Sspn<tm1a(EUCOMM)Hmgu>,"sarcospan; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436581,EUCOMM,Sspn,MGI:1353511
Sspn<tm1b(EUCOMM)Hmgu>,"sarcospan; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613642,EUCOMM,Sspn,MGI:1353511
Ssr2<tm1a(EUCOMM)Wtsi>,"signal sequence receptor, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842268,EUCOMM,Ssr2,MGI:1913506
Ssr2<tm1b(EUCOMM)Wtsi>,"signal sequence receptor, beta; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637009,EUCOMM,Ssr2,MGI:1913506
Sst<tm1Ute>,"somatostatin; targeted mutation 1, Ute Hochgeschwender",MGI:1888381,0,Sst,MGI:98326
Sstr1<tm1Dric>,"somatostatin receptor 1; targeted mutation 1, Dietmar Richter",MGI:3055541,0,Sstr1,MGI:98327
Sstr2<tm1Rgs>,"somatostatin receptor 2; targeted mutation 1, Roy G Smith",MGI:2388099,0,Sstr2,MGI:98328
St18<tm1a(KOMP)Wtsi>,"suppression of tumorigenicity 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363363,KOMP-CSD,St18,MGI:2446700
Stap1<tm1a(KOMP)Wtsi>,"signal transducing adaptor family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458470,KOMP-CSD,Stap1,MGI:1926193
Stard10<tm1a(KOMP)Wtsi>,"START domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419294,KOMP-CSD,Stard10,MGI:1860093
Stard13<tm1a(KOMP)Wtsi>,"StAR-related lipid transfer (START) domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363733,KOMP-CSD,Stard13,MGI:2385331
Stard5<tm1a(KOMP)Wtsi>,"StAR-related lipid transfer (START) domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363550,KOMP-CSD,Stard5,MGI:2156765
Stard6<tm1a(KOMP)Wtsi>,"StAR-related lipid transfer (START) domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362248,KOMP-CSD,Stard6,MGI:2156774
Stard7<tm1a(EUCOMM)Wtsi>,"START domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433666,EUCOMM,Stard7,MGI:2139090
Stard7<tm1b(EUCOMM)Wtsi>,,MGI:2139090,,,
Stard8<tm1a(EUCOMM)Wtsi>,"START domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434109,EUCOMM,Stard8,MGI:2448556
Stard8<tm1b(EUCOMM)Wtsi>,"START domain containing 8; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548840,EUCOMM,Stard8,MGI:2448556
Stat1<tm1.1Bstr>,"signal transducer and activator of transcription 1; targeted mutation 1.1, Birgit Strobl",MGI:5705230,0,Stat1,MGI:103063
Stat1<tm1.1Mmul>,"signal transducer and activator of transcription 1; targeted mutation 1.1, Mathias Muller",MGI:5319173,0,Stat1,MGI:103063
Stat1<tm1Dlv>,"signal transducer and activator of transcription 1; targeted mutation 1, David E Levy",MGI:1930947,0,Stat1,MGI:103063
Stat1<tm2.1Bstr>,"signal transducer and activator of transcription 1; targeted mutation 2.1, Birgit Strobl",MGI:5705232,0,Stat1,MGI:103063
Stat1<tm2a(EUCOMM)Wtsi>,"signal transducer and activator of transcription 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4820224,EUCOMM,Stat1,MGI:103063
Stau2<tm1a(EUCOMM)Wtsi>,"staufen double-stranded RNA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431690,EUCOMM,Stau2,MGI:1352508
Steap3<fred>,STEAP family member 3; fragile-red,MGI:3758911,APF ENU Mutagenesis,Steap3,MGI:1915678
Stk26<tm1b(EUCOMM)Hmgu>,,MGI:1917665,,,
Stk31<tm2a(KOMP)Wtsi>,"serine threonine kinase 31; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4841276,KOMP-CSD,Stk31,MGI:1924735
Stk32a<tm1a(EUCOMM)Wtsi>,"serine/threonine kinase 32A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433325,EUCOMM,Stk32a,MGI:2442403
Stk39<tm1a(EUCOMM)Wtsi>,"serine/threonine kinase 39; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433935,EUCOMM,Stk39,MGI:1858416
Stk4<m1Mhda>,"serine/threonine kinase 4; mutation 1, Martin Hrabe de Angelis",MGI:5702919,0,Stk4,MGI:1929004
Strn4<tm1b(EUCOMM)Hmgu>,,MGI:2142346,,,
Stx5a<tm1a(EUCOMM)Hmgu>,"syntaxin 5A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5284918,EUCOMM,Stx5a,MGI:1928483
Stx8<tm2a(EUCOMM)Wtsi>,"syntaxin 8; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4432376,EUCOMM,Stx8,MGI:1890156
Stxbp4<tm1a(EUCOMM)Wtsi>,"syntaxin binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441932,EUCOMM,Stxbp4,MGI:1342296
Sufu<tm1Rto>,"SUFU negative regulator of hedgehog signaling; targeted mutation 1, Rune Toftgard",MGI:3619046,0,Sufu,MGI:1345643
Sulf1<tm1b(KOMP)Mbp>,,MGI:2138563,,,
Sult1c1<tm1a(KOMP)Wtsi>,"sulfotransferase family, cytosolic, 1C, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841111,KOMP-CSD,Sult1c1,MGI:102928
Sult1c1<tm1b(KOMP)Wtsi>,"sulfotransferase family, cytosolic, 1C, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636889,KOMP-CSD,Sult1c1,MGI:102928
Sumf1<tm1.1Clear>,"sulfatase modifying factor 1; targeted mutation 1.1, Andrea Ballabio",MGI:5796638,0,Sumf1,MGI:1889844
Sun1<tm1a(EUCOMM)Wtsi>,"Sad1 and UNC84 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433047,EUCOMM,Sun1,MGI:1924303
Supt3<tm1a(EUCOMM)Hmgu>,"suppressor of Ty 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435781,EUCOMM,Supt3,MGI:1923723
Supt5<tm2a(KOMP)Wtsi>,"suppressor of Ty 5; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840996,KOMP-CSD,Supt5,MGI:1202400
Supt7l<tm1a(EUCOMM)Wtsi>,"suppressor of Ty 7-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432224,EUCOMM,Supt7l,MGI:1919445
Supv3l1<tm1a(EUCOMM)Wtsi>,"suppressor of var1, 3-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434293,EUCOMM,Supv3l1,MGI:2441711
Sv2c<tm1a(EUCOMM)Wtsi>,"synaptic vesicle glycoprotein 2c; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441757,EUCOMM,Sv2c,MGI:1922459
Sv2c<tm1b(EUCOMM)Wtsi>,,MGI:1922459,,,
Syap1<tm1a(EUCOMM)Hmgu>,"synapse associated protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841544,EUCOMM,Syap1,MGI:1914293
Syce1<tm1Hgu>,"synaptonemal complex central element protein 1; targeted mutation 1, MRC Human Genetics Unit",MGI:3840564,0,Syce1,MGI:1921325
Syce2<Gt(FHCRC-GT-S8-7E1)Sor>,"synaptonemal complex central element protein 2; gene trap FHCRC-GT-S8-7E1, Philippe Soriano",MGI:3708176,0,Syce2,MGI:1919096
Sycn<tm1Rja>,"syncollin; targeted mutation 1, Reinhard Jahn",MGI:3046204,0,Sycn,MGI:1915666
Syk<tm1a(EUCOMM)Hmgu>,"spleen tyrosine kinase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4950230,EUCOMM,Syk,MGI:99515
Syk<tm1b(EUCOMM)Hmgu>,"spleen tyrosine kinase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588292,EUCOMM,Syk,MGI:99515
Sympk<tm1a(EUCOMM)Wtsi>,"symplekin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434309,EUCOMM,Sympk,MGI:1915438
Syna<tm1Ics>,"syncytin a; targeted mutation 1, Mouse Clinical Institute",MGI:3852415,0,Syna,MGI:2684898
Synb<tm1.1Ics>,"syncytin b; targeted mutation 1.1, Mouse Clinical Institute",MGI:5308858,0,Synb,MGI:3045308
Sync<tm1.1Ked>,"syncoilin; targeted mutation 1.1, Kay E Davies",MGI:3813569,0,Sync,MGI:1916078
Syndig1l<tm1Embr>,"synapse differentiation inducing 1 like; targeted mutation 1, Emmanuel Brouillet",MGI:5440443,0,Syndig1l,MGI:2685107
Synj1<tm1a(EUCOMM)Wtsi>,"synaptojanin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432121,EUCOMM,Synj1,MGI:1354961
Synj2<tm1a(EUCOMM)Wtsi>,"synaptojanin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432435,EUCOMM,Synj2,MGI:1201671
Synpo2<tm1a(EUCOMM)Wtsi>,"synaptopodin 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441661,EUCOMM,Synpo2,MGI:2153070
Syt16<tm1a(EUCOMM)Wtsi>,"synaptotagmin XVI; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842316,EUCOMM,Syt16,MGI:2673872
Syt1<tm1.2(IMPC)Wtsi>,,MGI:99667,,,
Syt1<tm1a(EUCOMM)Wtsi>,"synaptotagmin I; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433781,EUCOMM,Syt1,MGI:99667
Sytl1<tm1a(KOMP)Wtsi>,"synaptotagmin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363391,KOMP-CSD,Sytl1,MGI:1933365
T,"brachyury, T-box transcription factor T; brachyury",MGI:1856184,0,T,MGI:98472
T(7;19)145H,"reciprocal translocation, Chr 7 and 19, Harwell 145",MGI:5316040,0,T(7;19)145H,MGI:103979
T(X;11)38H ,,MGI:104275,,,
T<21H>,"brachyury, T-box transcription factor T; brachyury 21 Harwell",MGI:1859667,0,T,MGI:98472
T<c>,"brachyury, T-box transcription factor T; curtailed",MGI:1856185,0,T,MGI:98472
Ta33Hl,tabby 33 Harwell-like,MGI:5288362,Harwell ENU Mutagenesis,Ta33Hl,MGI:5288350
Tac1<tm1Pig>,"tachykinin 1; targeted mutation 1, Pain Investigation Group",MGI:2136279,0,Tac1,MGI:98474
Tacr1<tm1Sph>,"tachykinin receptor 1; targeted mutation 1, Stephen P Hunt",MGI:2182395,0,Tacr1,MGI:98475
Tacr1<tm1a(EUCOMM)Wtsi>,"tachykinin receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008936,EUCOMM,Tacr1,MGI:98475
Tacr1<tm1b(EUCOMM)Wtsi>,"tachykinin receptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5569967,EUCOMM,Tacr1,MGI:98475
Taf11<tm1a(EUCOMM)Wtsi>,"TATA-box binding protein associated factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842481,EUCOMM,Taf11,MGI:1916026
Tango6<tm1a(EUCOMM)Hmgu>,"transport and golgi organization 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455865,EUCOMM,Tango6,MGI:2142786
Tap1<tm1Arp>,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); targeted mutation 1, Philip Ashton-Rickardt",MGI:1857253,0,Tap1,MGI:98483
Tap1<tm2a(EUCOMM)Hmgu>,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:4868062,EUCOMM,Tap1,MGI:98483
Tardbp<tm1a(EUCOMM)Wtsi>,"TAR DNA binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5140493,EUCOMM,Tardbp,MGI:2387629
Tas16,,MGI:5646388,,,
Tas2,Tas2,MGI:5496842,Harwell ENU Mutagenesis,Tas2,MGI:5496844
Tas4,Tas4,MGI:5496923,Harwell ENU Mutagenesis,Tas4,MGI:5496920
Tas6,mutant Tas6,MGI:5646497,0,Tas6,MGI:5646398
Tatdn3<tm1a(EUCOMM)Wtsi>,"TatD DNase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431994,EUCOMM,Tatdn3,MGI:1916222
Tatdn3<tm1b(EUCOMM)Wtsi>,"TatD DNase domain containing 3; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548575,EUCOMM,Tatdn3,MGI:1916222
Tax1bp3<tm1a(EUCOMM)Hmgu>,"Tax1 (human T cell leukemia virus type I) binding protein 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436221,EUCOMM,Tax1bp3,MGI:1923531
Tbc1d10a<tm2a(EUCOMM)Wtsi>,"TBC1 domain family, member 10a; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4432519,EUCOMM,Tbc1d10a,MGI:2144164
Tbc1d10c<tm1.1Psou>,"TBC1 domain family, member 10c; targeted mutation 1.1, Pauline Soulas-Sprauel",MGI:5578033,0,Tbc1d10c,MGI:1922072
Tbc1d10c<tm1.2Psou>,"TBC1 domain family, member 10c; targeted mutation 1.2, Pauline Soulas-Sprauel",MGI:5578034,0,Tbc1d10c,MGI:1922072
Tbc1d22a<tm1a(KOMP)Wtsi>,"TBC1 domain family, member 22a; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014583,KOMP-CSD,Tbc1d22a,MGI:1289265
Tbc1d22a<tm1b(KOMP)Wtsi>,"TBC1 domain family, member 22a; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636942,KOMP-CSD,Tbc1d22a,MGI:1289265
Tbc1d2b<tm1a(EUCOMM)Hmgu>,"TBC1 domain family, member 2B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434639,EUCOMM,Tbc1d2b,MGI:1914266
Tbce<pmn>,tubulin-specific chaperone E; progressive motor neuronopathy,MGI:1856997,0,Tbce,MGI:1917680
Tbce<tm2a(EUCOMM)Hmgu>,"tubulin-specific chaperone E; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5297130,EUCOMM,Tbce,MGI:1917680
Tbce<tm2b(EUCOMM)Hmgu>,"tubulin-specific chaperone E; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH",MGI:5588279,EUCOMM,Tbce,MGI:1917680
Tbk1<tm1Yeh>,"TANK-binding kinase 1; targeted mutation 1, Wen-Chen Yeh",MGI:3050522,0,Tbk1,MGI:1929658
Tbkbp1<tm1a(EUCOMM)Wtsi>,"TBK1 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842322,EUCOMM,Tbkbp1,MGI:1920424
Tbl1xr1<tm1b(EUCOMM)Hmgu>,,MGI:2441730,,,
Tbx1<m1H>,"T-box 1; mutation 1, Harwell",MGI:5829802,0,Tbx1,MGI:98493
Tbx1<tm1(Fgf8)Vite>,"T-box 1; targeted mutation 1, Francesca Vitelli",MGI:3641283,0,Tbx1,MGI:98493
Tbx1<tm1Bld>,"T-box 1; targeted mutation 1, Antonio Baldini",MGI:2179136,0,Tbx1,MGI:98493
Tbx1<tm2Bld>,"T-box 1; targeted mutation 2, Antonio Baldini",MGI:3046792,0,Tbx1,MGI:98493
Tbx1<tm3.1Bld>,"T-box 1; targeted mutation 3.1, Antonio Baldini",MGI:4453450,0,Tbx1,MGI:98493
Tbx1<tm3Bld>,"T-box 1; targeted mutation 3, Antonio Baldini",MGI:3046793,0,Tbx1,MGI:98493
Tbx1<tm4(cre/Esr1*)Bld>,"T-box 1; targeted mutation 4, Antonio Baldini",MGI:3046795,0,Tbx1,MGI:98493
Tbx1<tm5Bld>,"T-box 1; targeted mutation 5, Antonio Baldini",MGI:3664784,0,Tbx1,MGI:98493
Tbx1<tm6(cre)Bld>,"T-box 1; targeted mutation 6, Antonio Baldini",MGI:3757964,0,Tbx1,MGI:98493
Tbx22<tm1Sta>,"T-box 22; targeted mutation 1, Philip Stanier",MGI:4361266,0,Tbx22,MGI:2389465
Tc(HSA21)1TybEmcf,"transchromosomal, human 21, line 1, Victor Tybulewicz and Elizabeth M C Fisher",MGI:3814712,0,Tc(HSA21)1TybEmcf,MGI:3814702
Tcaim<tm1a(EUCOMM)Wtsi>,"T cell activation inhibitor, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433698,EUCOMM,Tcaim,MGI:1196217
Tcam1<tm2a(EUCOMM)Wtsi>,"testicular cell adhesion molecule 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4441899,EUCOMM,Tcam1,MGI:1923120
Tceal5<tm1a(KOMP)Wtsi>,"transcription elongation factor A (SII)-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451413,KOMP-CSD,Tceal5,MGI:3036236
Tceal5<tm1b(KOMP)Wtsi>,"transcription elongation factor A (SII)-like 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548883,KOMP-CSD,Tceal5,MGI:3036236
Tcerg1l<tm1a(KOMP)Wtsi>,"transcription elongation regulator 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820071,KOMP-CSD,Tcerg1l,MGI:1917821
Tcf4<tm1a(EUCOMM)Wtsi>,"transcription factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432303,EUCOMM,Tcf4,MGI:98506
Tcf7<tm1a(EUCOMM)Wtsi>,"transcription factor 7, T cell specific; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441645,EUCOMM,Tcf7,MGI:98507
Tcf7l1<tm1a(EUCOMM)Wtsi>,"transcription factor 7 like 1 (T cell specific, HMG box); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432867,EUCOMM,Tcf7l1,MGI:1202876
Tcf7l2<tm1a(EUCOMM)Wtsi>,"transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431951,EUCOMM,Tcf7l2,MGI:1202879
Tchp<tm1a(EUCOMM)Wtsi>,"trichoplein, keratin filament binding; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433203,EUCOMM,Tchp,MGI:1925082
Tcl1<tm1Rso>,"T cell lymphoma breakpoint 1; targeted mutation 1, Giandomenico Russo",MGI:2387964,0,Tcl1,MGI:1097166
Tcp11<tm1a(EUCOMM)Wtsi>,"t-complex protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842472,EUCOMM,Tcp11,MGI:98544
Tcra<tm1Mjo>,"T cell receptor alpha chain; targeted mutation 1, Michael J Owen",MGI:2180883,0,Tcra,MGI:98553
Tcrb<tm1Mom>,"T cell receptor beta chain; targeted mutation 1, Peter Mombaerts",MGI:1857256,0,Tcrb,MGI:98578
Tcrd<tm1Mom>,"T cell receptor delta chain; targeted mutation 1, Peter Mombaerts",MGI:1857257,0,Tcrd,MGI:98611
Tcte1<tm1a(KOMP)Wtsi>,"t-complex-associated testis expressed 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820083,KOMP-CSD,Tcte1,MGI:98640
Tctex1d2<tm1e(EUCOMM)Wtsi>,"Tctex1 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4431764,EUCOMM,Tctex1d2,MGI:1913311
Tctex1d2<tm2a(EUCOMM)Wtsi>,"Tctex1 domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5472698,EUCOMM,Tctex1d2,MGI:1913311
Tctex1d4<tm1e(EUCOMM)Wtsi>,"Tctex1 domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4457572,EUCOMM,Tctex1d4,MGI:3045358
Tdgf1<tm1.1Gmin>,"teratocarcinoma-derived growth factor 1; targeted mutation 1.1, Gabriella Minchiotti",MGI:5433707,0,Tdgf1,MGI:98658
Tdrkh<tm1a(KOMP)Wtsi>,"tudor and KH domain containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849959,KOMP-CSD,Tdrkh,MGI:1919884
Tead3<tm1a(EUCOMM)Wtsi>,"TEA domain family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431809,EUCOMM,Tead3,MGI:109241
Tecta<tm1Gpr>,"tectorin alpha; targeted mutation 1, Guy P Richardson",MGI:2183148,0,Tecta,MGI:109575
Tecta<tm2Gpr>,"tectorin alpha; targeted mutation 2, Guy P Richardson",MGI:3605485,0,Tecta,MGI:109575
Tecta<tm3.1Gpr>,"tectorin alpha; targeted mutation 3.1, Guy P Richardson",MGI:5527094,0,Tecta,MGI:109575
Tecta<tm4.1Gpr>,"tectorin alpha; targeted mutation 4.1, Guy P Richardson",MGI:5527095,0,Tecta,MGI:109575
Tecta<tm5.1Gpr>,"tectorin alpha; targeted mutation 5.1, Guy P Richardson",MGI:5527096,0,Tecta,MGI:109575
Tectb<tm1Gpr>,"tectorin beta; targeted mutation 1, Guy P Richardson",MGI:3711698,0,Tectb,MGI:109574
Tef<tm1Schb>,"thyrotroph embryonic factor; targeted mutation 1, Ueli Schibler",MGI:3045494,0,Tef,MGI:98663
Tent4a<tm1a(EUCOMM)Hmgu>,"terminal nucleotidyltransferase 4A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451868,EUCOMM,Tent4a,MGI:2682295
Tent4a<tm1b(EUCOMM)Hmgu>,,MGI:2682295,,,
Tent5a<m1Mhda>,"terminal nucleotidyltransferase 5A; mutation 1, Martin Hrabe de Angelis",MGI:5424906,0,Tent5a,MGI:2670964
Tent5c<tm1a(KOMP)Wtsi>,"terminal nucleotidyltransferase 5C; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5085347,KOMP-CSD,Tent5c,MGI:1921895
Tent5c<tm1b(KOMP)Wtsi>,,MGI:1921895,,,
Tepsin<tm1b(KOMP)Wtsi>,,MGI:1926027,,,
Tesa,"tail, ear and spinning abnormalities",MGI:3044472,0,Tesa,MGI:3044430
Tet1<tm1a(KOMP)Wtsi>,"tet methylcytosine dioxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286193,KOMP-CSD,Tet1,MGI:1098693
Tex261<tm1a(EUCOMM)Wtsi>,"testis expressed gene 261; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441776,EUCOMM,Tex261,MGI:1096575
Tex38<tm1a(KOMP)Wtsi>,"testis expressed 38; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363110,KOMP-CSD,Tex38,MGI:1922423
Tfap2a<Mhdador>,"transcription factor AP-2, alpha; Martin Hrabe de Angelis doarad",MGI:3045427,0,Tfap2a,MGI:104671
Tfap2b<tm1a(EUCOMM)Wtsi>,"transcription factor AP-2 beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4948640,EUCOMM,Tfap2b,MGI:104672
Tfap2b<tm1b(EUCOMM)Wtsi>,"transcription factor AP-2 beta; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5635165,EUCOMM,Tfap2b,MGI:104672
Tfdp2<tm1a(EUCOMM)Wtsi>,"transcription factor Dp 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5014714,EUCOMM,Tfdp2,MGI:107167
Tff1<tm1a(EUCOMM)Wtsi>,"trefoil factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433486,EUCOMM,Tff1,MGI:88135
Tg(ACTA1-Utrn)3Ked,"transgene insertion 3, Kay E Davies",MGI:5566891,0,Tg(ACTA1-Utrn)3Ked,MGI:5566890
Tg(ACTA2-TFPI/CD4/SELP)#aAdor,"transgene insertion #a, Anthony Dorling",MGI:5578126,0,Tg(ACTA2-TFPI/CD4/SELP)#aAdor,MGI:5578154
Tg(ACTB-At5g20990)17Betz,"transgene insertion 17, Heinrich Betz",MGI:3696419,0,Tg(ACTB-At5g20990)17Betz,MGI:3696418
Tg(ACTB-Neurog3)1Bzal,"transgene insertion 1, Bernard Zalc",MGI:5750091,0,Tg(ACTB-Neurog3)1Bzal,MGI:5750088
"Tg(ACTB-Tbx1,-GFP)1Bald","transgene insertion 1, Antonio Baldini",MGI:5567088,0,"Tg(ACTB-Tbx1,-GFP)1Bald",MGI:5567087
Tg(ACTB-cre)3Mrt,"transgene insertion 3, Gail R Martin",MGI:5316983,0,Tg(ACTB-cre)3Mrt,MGI:5316982
Tg(ACTB-gag/THRA1)AVen,"transgene insertion A, Bjorn Vennstrom",MGI:3044356,0,Tg(ACTB-gag/THRA1)AVen,MGI:3044355
Tg(ACTB-tTS)1Mllo,"transgene insertion 1, Moises Mallo",MGI:3717162,0,Tg(ACTB-tTS)1Mllo,MGI:3717161
Tg(ACTFLPe)9205Dym,"transgene insertion 9205, Susan Dymecki",MGI:2448985,0,Tg(ACTFLPe)9205Dym,MGI:2450978
Tg(ADCYAP1R1)1Sshe,"transgene insertion 1, Sanbing Shen",MGI:5645747,0,Tg(ADCYAP1R1)1Sshe,MGI:5645743
Tg(ADCYAP1R1)2Sshe,"transgene insertion 2, Sanbing Shen",MGI:5645748,0,Tg(ADCYAP1R1)2Sshe,MGI:5645744
Tg(ADCYAP1R1)3Sshe,"transgene insertion 3, Sanbing Shen",MGI:5645749,0,Tg(ADCYAP1R1)3Sshe,MGI:5645745
Tg(ADCYAP1R1)4Sshe,"transgene insertion 4, Sanbing Shen",MGI:5645751,0,Tg(ADCYAP1R1)4Sshe,MGI:5645746
Tg(ANPEP)270Mmul,"transgene insertion 270, Mathias Muller",MGI:5645778,0,Tg(ANPEP)270Mmul,MGI:5645776
Tg(ANPEP)861Mmul,"transgene insertion 861, Mathias Muller",MGI:5645779,0,Tg(ANPEP)861Mmul,MGI:5645777
Tg(APOA4)8018Feb,"transgene insertion 8018, Francisco E Baralle",MGI:2652473,0,Tg(APOA4)8018Feb,MGI:2652469
Tg(APOA4)8021Feb,"transgene insertion 8021, Francisco E Baralle",MGI:2652472,0,Tg(APOA4)8021Feb,MGI:2652467
Tg(APOA4)8022Feb,"transgene insertion 8022, Francisco E Baralle",MGI:2652475,0,Tg(APOA4)8022Feb,MGI:2652470
Tg(ATXN3*)84.2Cce,"transgene insertion 84.2, Cemal K Cemal",MGI:3838155,0,Tg(ATXN3*)84.2Cce,MGI:3838160
Tg(Acta2-AOC3)#Ubc,"transgene insertion, Uppsala University",MGI:5565601,0,Tg(Acta2-AOC3)#Ubc,MGI:5565600
Tg(Agt)123Uhg,"transgene insertion 123, University of Heidelberg",MGI:4453970,0,Tg(Agt)123Uhg,MGI:4453973
Tg(Alb1-HCVN)35Sml,"transgene insertion 35, Stanley M Lemon",MGI:3513779,0,Tg(Alb1-HCVN)35Sml,MGI:3625827
Tg(Alb1-Prnp)01Cwe,"transgene insertion 01, Charles Weissmann",MGI:2652527,0,Tg(Alb1-Prnp)01Cwe,MGI:2652521
Tg(Alb1-Prnp)19Cwe,"transgene insertion 19, Charles Weissmann",MGI:2652528,0,Tg(Alb1-Prnp)19Cwe,MGI:2652522
Tg(Alb1-cre)7Gsc,"transgene insertion 7, Gunther Schutz",MGI:2177602,0,Tg(Alb1-cre)7Gsc,MGI:2177601
Tg(Aqp2-icre)1Gsc,"transgene insertion 1, Gunther Schutz",MGI:3843825,0,Tg(Aqp2-icre)1Gsc,MGI:3843823
Tg(Avil-cre)1Phep,"transgene insertion 1, Paul A Heppenstall",MGI:5292346,0,Tg(Avil-cre)1Phep,MGI:5298861
Tg(B2m-lacZ)2Cba,"transgene insertion 2, Charles Babinet",MGI:3044122,0,Tg(B2m-lacZ)2Cba,MGI:3044121
Tg(BCL2)36Wehi,"transgene insertion 36, Walter and Eliza Hall Institute of Medical Research",MGI:3052954,0,Tg(BCL2)36Wehi,MGI:3052959
Tg(Bglap-Omd)1Kieg,"transgene insertion 1, Karolinska Institute Unit for Embryology and Genetics",MGI:5516352,0,Tg(Bglap-Omd)1Kieg,MGI:5516351
Tg(CAG-AVEN)1Zrng,"transgene insertion 1, Martin Zoernig",MGI:5317427,0,Tg(CAG-AVEN)1Zrng,MGI:5317426
Tg(CAG-EGFP)1Osb,"transgene insertion 1, Research Institute for Microbial Diseases, Osaka University",MGI:2686773,0,Tg(CAG-EGFP)1Osb,MGI:2686899
Tg(CAG-EGFP*)#Hma,"transgene insertion, Helen M Arthur",MGI:6113799,0,Tg(CAG-EGFP*)#Hma,MGI:6113800
Tg(CAG-Flpo)1Afst,"transgene insertion 1, A Francis Stewart",MGI:4453967,0,Tg(CAG-flpo)1Afst,MGI:4453966
Tg(CAG-GFPuv/AEQ*)30Alns,"transgene insertion 30, Maria Teresa Alonso",MGI:5800664,0,Tg(CAG-GFPuv/AEQ*)30Alns,MGI:5800662
Tg(CAG-LARGE)126Fmu,"transgene insertion 126, Francesco Muntoni",MGI:5556056,0,Tg(CAG-LARGE)126Fmu,MGI:5556055
Tg(CAG-LEPROT)1Blll,"transgene insertion 1, Bernard Bailleul",MGI:5648952,0,Tg(CAG-LEPROT)1Blll,MGI:5648949
Tg(CAG-LEPROTL1)1Blll,"transgene insertion 1, Bernard Bailleul",MGI:5648955,0,Tg(CAG-LEPROTL1)1Blll,MGI:5648950
"Tg(CAG-Otx2,-GFP)21Asim","transgene insertion 21, Antonio Simeone",MGI:4887448,0,"Tg(CAG-Otx2,-GFP)21Asim",MGI:4887463
Tg(CAG-cat-lacZ)1Brn,"transgene insertion 1, Anton Berns",MGI:3044043,0,Tg(CAG-cat-lacZ)1Brn,MGI:3044042
Tg(CAG-cre)1Nagy,"transgene insertion 1, Andras Nagy",MGI:3586452,0,Tg(CAG-cre)1Nagy,MGI:3586450
Tg(CAG-dre)1Afst,"transgene insertion 1, A Francis Stewart",MGI:4367446,0,Tg(CAG-dre)1Afst,MGI:4367435
"Tg(CAMK2A-KCNIP3*,-lacZ)1Cnbc","transgene insertion 1, Centro Nacional de Biotecnologia",MGI:5646261,0,"Tg(CAMK2A-KCNIP3*,-lacZ)1Cnbc",MGI:5646259
"Tg(CAMK2A-KCNIP3*,-lacZ)26Cnbc","transgene insertion 26, Centro Nacional de Biotecnologia",MGI:5699548,0,"Tg(CAMK2A-KCNIP3*,-lacZ)26Cnbc",MGI:5699547
"Tg(CAMK2A-KCNIP3*,-lacZ)33Cnbc","transgene insertion 33, Centro Nacional de Biotecnologia",MGI:5646262,0,"Tg(CAMK2A-KCNIP3*,-lacZ)33Cnbc",MGI:5646260
Tg(CD19-cre/ERT2)1Jsv,"transgene insertion 1, J Sjef Verbeek",MGI:4399751,0,Tg(CD19-cre/ERT2)1Jsv,MGI:4399749
Tg(CD2-NPM/ALK)4Sudt,"transgene insertion 4, Suzanne Turner",MGI:5310806,0,Tg(CD2-NPM/ALK)4Sudt,MGI:5310804
Tg(CD2-Ptpn11*C459S)1Axdr,"transgene insertion 1, Denis R Alexander",MGI:5310938,0,Tg(CD2-Ptpn11*C459S)1Axdr,MGI:5310889
Tg(CD2-icre)4Kio,"transgene insertion 4, Dimitris Kioussis",MGI:2449947,0,Tg(CD2-icre)4Kio,MGI:2449946
Tg(CD2/HBB-TNF*)5453Gkl,"transgene insertion 5453, George Kollias",MGI:4818268,0,Tg(CD2/HBB-TNF*)5453Gkl,MGI:4818262
Tg(CD4-TKdelta)2Kzmn,"transgene insertion 2, David Klatzmann",MGI:5318568,0,Tg(CD4-TKdelta)2Kzmn,MGI:5318567
Tg(CEACAM5)2682Wzm,"transgene insertion 2682, Wolfgang Zimmerman",MGI:2652514,0,Tg(CEACAM5)2682Wzm,MGI:2652510
Tg(CEACAM5-Tag)L5496Wzm,"transgene insertion L5496, Wolfgang Zimmerman",MGI:2652508,0,Tg(CEACAM5-Tag)L5496Wzm,MGI:2652507
Tg(CEBP-luc)15Mgls,"transsgene insertion 15, Charalambos Magoulas",MGI:5435417,0,Tg(CEBP-luc)15Mgls,MGI:5435416
Tg(CEPHY141G6)28Hgc,"transgene insertion 28, Edward M Rubin",MGI:5293437,0,Tg(CEPHY141G6)28Hgc,MGI:5293436
Tg(CEPHY141G6)4Hgc,"transgene insertion 4, Edward M Rubin",MGI:5293441,0,Tg(CEPHY141G6)4Hgc,MGI:5293440
Tg(CEPHY152F7)12Hgc,"transgene insertion 12, Edward M Rubin",MGI:5293446,0,Tg(CEPHY152F7)12Hgc,MGI:5293445
Tg(CEPHY152F7)57Hgc,"transgene insertion 57, Edward Rubin",MGI:5293456,0,Tg(CEPHY152F7)57Hgc,MGI:5293454
Tg(CEPHY230E8)50Hgc,"transgene insertion 50, Edward M Rubin",MGI:5291633,0,Tg(CEPHY230E8)50Hgc,MGI:5291632
Tg(CEPHY230E8)55Hgc,"transgene insertion 55, Edward M Rubin",MGI:5291627,0,Tg(CEPHY230E8)55Hgc,MGI:5291626
Tg(CEPHY285E6)67Hgc,"transgene insertion 67, Edward Rubin",MGI:5293460,0,Tg(CEPHY285E6)67Hgc,MGI:5293459
Tg(CEPHY285E6)84Hgc,"transgene insertion 84, Edward Rubin",MGI:5293466,0,Tg(CEPHY285E6)84Hgc,MGI:5293462
Tg(CKMM-tTA)A3Rhvh,"transgene insertion A3, R Hooft van Huijsduijnen",MGI:2448088,0,Tg(CKMM-tTA)A3Rhvh,MGI:3621121
Tg(CMA1-KIT*D816V)11Libl,"transgene insertion 11, Roland Liblau",MGI:5313458,0,Tg(CMA1-KIT*D816V)11Libl,MGI:5313457
Tg(CMA1-KIT*D816V)18Libl,"transgene insertion 18, Roland Liblau",MGI:5313536,0,Tg(CMA1-KIT*D816V)18Libl,MGI:5313535
Tg(CMV-CAST)PM194Lbau,"transgene insertion PM194, Laurent Baud",MGI:5319093,0,Tg(CMV-CAST)PM194Lbau,MGI:5319178
Tg(CMV-Cux1)#Gbvh,"transgene insertion, Gregory B Vanden Heuvel",MGI:5803883,0,Tg(CMV-Cux1)#Gbvh,MGI:5803872
Tg(CMV-EYFP/DsRed2)1Mklv,"transgene insertion 1, Andrey Mikhailov",MGI:5573173,0,Tg(CMV-EYFP/DsRed2)1Mklv,MGI:5573171
Tg(CMV-Mapkapk5*L337A)AUlm,"transgene insertion A, Ugo Moens",MGI:5432234,0,Tg(CMV-Mapkapk5*L337A)AUlm,MGI:5432233
Tg(CMV-Mapkapk5*L337A)BUlm,"transgene insertion B, Ugo Moens",MGI:5432237,0,Tg(CMV-Mapkapk5*L337A)BUlm,MGI:5432236
Tg(CMV-cre)1Cgn,"transgene insertion 1, University of Cologne",MGI:2176180,0,Tg(CMV-cre)1Cgn,MGI:2176179
Tg(CMV-cre)1Nagy,"transgene insertion 1, Andras Nagy",MGI:2178227,0,Tg(CMV-cre)1Nagy,MGI:2178226
Tg(CMV-rtTA)4Bjd,"transgene insertion 4, Hermann Bujard",MGI:3056891,0,Tg(CMV-rtTA)4Bjd,MGI:3056892
Tg(CRP-Cast)1Lbau,"transgene insertion 1, Laurent Baud",MGI:5789386,0,Tg(CRP-Cast)1Lbau,MGI:5789383
Tg(CRP-Cast)2Lbau,"transgene insertion 2, Laurent Baud",MGI:5789390,0,Tg(CRP-Cast)2Lbau,MGI:5789388
Tg(CRP-cre)1Iz,"transgene insertion 1, Manfred F Rajewsky",MGI:2652465,0,Tg(CRP-cre)1Iz,MGI:2652463
Tg(CYP19A1-icre)3Fcrt,"transgene insertion 3, Sophie Fouchecourt",MGI:5807485,0,Tg(CYP19A1-icre)3Fcrt,MGI:5807484
Tg(Camk2a-Grik2)28Cmul,"transgene insertion 28, Christophe Mulle",MGI:5645814,0,Tg(Camk2a-Grik2)28Cmul,MGI:5645813
Tg(Camk2a-Grin2c/itTA)10Rsp,"transgene insertion 10, Rolf Sprengel",MGI:5708649,0,Tg(Camk2a-Grin2c/itTA)10Rsp,MGI:5708646
Tg(Camk2a-Grin2c/itTA)12Rsp,"transgene insertion 12, Rolf Sprengel",MGI:5432029,0,Tg(Camk2a-Grin2c/itTA)12Rsp,MGI:5432028
Tg(Camk2a-Ppp3ca*)CN98Kndl,"transgene insertion CN98, Eric R Kandel",MGI:3809256,0,Tg(Camk2a-Ppp3ca*)CN98Kndl,MGI:3809269
Tg(Camk2a-cre)2Gsc,"transgene insertion 2, Gunther Schutz",MGI:2181426,0,Tg(Camk2a-cre)2Gsc,MGI:2181425
Tg(Camk2a-cre)93Kln,"transgene insertion 93, Rudiger Klein",MGI:2176754,0,Tg(Camk2a-cre)93Kln,MGI:2176752
Tg(Camk2a-cre/ERT2)2Gsc,"transgene insertion 2, Gunther Schutz",MGI:3759305,0,Tg(Camk2a-cre/ERT2)2Gsc,MGI:3759303
Tg(Camk2a-rtTA)1237Kndl,"transgene insertion 1237, Eric R Kandel",MGI:3716991,0,Tg(Camk2a-rtTA)1237Kndl,MGI:3716990
Tg(Camk2a-rtTA2*M2)2Rsp,"transgene insertion 2, Rolf Sprenger",MGI:5749393,0,Tg(Camk2a-rtTA2*M2)2Rsp,MGI:5749388
Tg(Camk2a-rtTA2*M2)4Rsp,"transgene insertion 4, Rolf Sprenger",MGI:5749403,0,Tg(Camk2a-rtTA2*M2)4Rsp,MGI:5749397
Tg(Ccl19-cre)489Biat,"transgene insertion 489, Biomodels Austria",MGI:5526991,0,Tg(Ccl19-cre)489Biat,MGI:5526990
Tg(Cd4-CD4)2362Litt,"transgene insertion 2362, Dan R Littman",MGI:3702083,0,Tg(Cd4-CD4)2362Litt,MGI:2673105
Tg(Cd4-EGFP)1Lt,"transgene insertion 1, Edward Leiter",MGI:3720219,0,Tg(Cd4-EGFP)1Lt,MGI:3720218
Tg(Cd4-cre)1Cwi,"transgene insertion 1, Christopher B Wilson",MGI:2386448,0,Tg(Cd4-cre)1Cwi,MGI:2448688
Tg(Cd68-BCL2)526Medz,"transgene insertion 526, Ruslan Medzhitov",MGI:5575881,0,Tg(Cd68-BCL2)526Medz,MGI:5575880
Tg(Cd68-BCL2)533Medz,"transgene insertion 533, Ruslan Medzhitov",MGI:5576387,0,Tg(Cd68-BCL2)533Medz,MGI:5576386
Tg(Cd68-BCL2)535Medz,"transgene insertion 535, Ruslan Medzhitov",MGI:5576381,0,Tg(Cd68-BCL2)535Medz,MGI:5576380
Tg(Cd74-rtTA)#Doi,"transgene insertion, Christophe Benoist and Diane Mathis",MGI:4439138,0,Tg(Cd74-rtTA)#Doi,MGI:4439140
"Tg(Cdh5-cre,-GFP)21Msri","transgene insertion 21, Michele Souyri",MGI:5882215,0,"Tg(Cdh5-cre,-GFP)21Msri",MGI:5882212
Tg(Cdx1-cre)23Kem,"transgene insertion 23, Rolf Kemler",MGI:3841474,0,Tg(Cdx1-cre)23Kem,MGI:3841469
Tg(Cebpb-rtTA2S*S2)1Bjd,"transgene insertion 1, Hermann Bujard",MGI:3696443,0,Tg(Cebpb-rtTA2S*S2)1Bjd,MGI:3696442
Tg(Cebpb-tTA)5Bjd,"transgene insertion 5, Hermann Bujard",MGI:3056818,0,Tg(Cebpb-tTA)5Bjd,MGI:3056822
Tg(Chek1)1Ofc,"transgene insertion 1, Oscar Fernandez-Capetillo",MGI:5699590,0,Tg(Chek1)1Ofc,MGI:5699589
Tg(Ckm-Dmd*)11956Chmb,"transgene insertion 11956, Jeffrey S Chamberlain",MGI:5140820,0,Tg(Ckm-Dmd*)11956Chmb,MGI:5140819
Tg(Ckm-Dmd_iDp71)MCA-1Chmb,"transgene insertion MCA-1, Jeffrey S Chamberlain",MGI:5140740,0,Tg(Ckm-Dmd_iDp71)MCA-1Chmb,MGI:5140736
"Tg(Cnp-TVA,-lacZ)B8Ubc","transgene insertion B8, Uppsala University",MGI:5648077,0,"Tg(Cnp-TVA,-lacZ)B8Ubc",MGI:5648074
Tg(Col13a1)1Pih,,MGI:3804040,,,
Tg(Col13a1)2Pih,"transgene insertion 2, Taina Pihlajaniemi",MGI:5645740,0,Tg(Col13a1)2Pih,MGI:5645739
Tg(Col2a1-cre)1Bhr,"transgene insertion 1, Richard R Behringer",MGI:2176070,0,Tg(Col2a1-cre)1Bhr,MGI:2176069
Tg(Col6a1-cre)1Gkl,"transgene insertion 1, George Kollias",MGI:3775430,0,Tg(Col6a1-cre)1Gkl,MGI:3775431
Tg(Cr2-cre)3Cgn,"transgene insertion 3, University of Cologne",MGI:3047571,0,Tg(Cr2-cre)3Cgn,MGI:3708319
Tg(Cryaa-Six3)53Pgr,"transgene insertion 53, Peter Gruss",MGI:3057335,0,Tg(Cryaa-Six3)53Pgr,MGI:3057330
Tg(DO11.10)10Dlo,"transgene insertion 10, Dennis Y Loh",MGI:2664398,0,Tg(DO11.10)10Dlo,MGI:2664401
Tg(Dach1-cre)1Krs,"transgene insertion 1, Stefan Krauss",MGI:2651403,0,Tg(Dach1-cre)1Krs,MGI:2651402
Tg(Des-cre)1Zli,"transgene insertion 1, Zhenlin Li",MGI:4362109,0,Tg(Des-cre)1Zli,MGI:4362108
Tg(Des-lacZ)#Zli,"transgene insertion, Zhenlin Li",MGI:5648241,0,Tg(Des-lacZ)#Zli,MGI:5648240
Tg(Dll1-Dll3)3Gos,"transgene insertion 3, Achim Gossler",MGI:5501066,0,Tg(Dll1-Dll3)3Gos,MGI:5501062
Tg(Drd1a-cre)AGsc,"transgene insertion A, Gunther Schutz",MGI:3761818,0,Tg(Drd1a-cre)AGsc,MGI:3761815
Tg(Dyrk1a)1Jmd,"transgene insertion 1, Jean-Maurice Delabar",MGI:5424160,0,Tg(Dyrk1a)1Jmd,MGI:5424159
Tg(E2F1-luc)1Ech,"transgene insertion 1, Eric C Holland",MGI:5648123,0,Tg(E2F1-luc)1Ech,MGI:5648121
Tg(EEF1A1-Ahr)1Pjvt,"transgene insertion 1, Raimo Pohjanvirta",MGI:5475502,0,Tg(EEF1A1-Ahr)1Pjvt,MGI:5475500
Tg(EEF1A1-Ahr*)1Pjvt,"transgene insertion 1, Raimo Pohjanvirta",MGI:5475374,0,Tg(EEF1A1-Ahr*)1Pjvt,MGI:5475373
Tg(EEF1A1-RNAi:IE-PRV)miL15Gjo,"transgene insertion miL15, Genevieve Jolivet",MGI:5645887,0,Tg(EEF1A1-RNAi:IE-PRV)miL15Gjo,MGI:5645819
Tg(EEF1A1-Socs6)1Pwg,"transgene insertion 1, Ping Wang",MGI:5314513,0,Tg(EEF1A1-Socs6)1Pwg,MGI:5314508
"Tg(Eef1a1-MYC/PGR,-HRAS/ESR1*)1Rdl","transgene insertion 1, Roberto Di Lauro",MGI:5699743,0,"Tg(Eef1a1-MYC/PGR,-HRAS/ESR1*)1Rdl",MGI:5699742
Tg(Eno2-MFN2)L916Ugfm,"transgene insertion L916, University of Geneva Faculty of Medicine",MGI:5476630,0,Tg(Eno2-MFN2)L916Ugfm,MGI:5476629
Tg(Eno2-MFN2*R94Q)L87Ugfm,"transgene insertion L87, University of Geneva Faculty of Medicine",MGI:5476535,0,Tg(Eno2-MFN2*R94Q)L87Ugfm,MGI:5476532
Tg(Eno2-Prnp)#Aag,"transgene insertion, Adriano Aguzzi",MGI:5013941,0,Tg(Eno2-Prnp)#Aag,MGI:5013940
Tg(Fabp1-NTN1)3Mhln,"transgene insertion 3, Patrick Mehlen",MGI:5318079,0,Tg(Fabp1-NTN1)3Mhln,MGI:5318078
Tg(Fabp1-NTN1)6Mhln,"transgene insertion 6, Patrick Mehlen",MGI:5317946,0,Tg(Fabp1-NTN1)6Mhln,MGI:5317945
Tg(Fabp1-cre)1Jig,"transgene insertion 1, Jeffrey I Gordon",MGI:2447212,0,Tg(Fabp1-cre)1Jig,MGI:2447210
Tg(Fabp2-Arg1)1Wla,"transgene insertion 1, Wouters H Lamers",MGI:2446302,0,Tg(Fabp2-Arg1)1Wla,MGI:2652048
Tg(Fabp4-CIDEA)13Npe,"transgene insertion 13, Natasa Petrovic",MGI:5645805,0,Tg(Fabp4-CIDEA)13Npe,MGI:5645801
Tg(Fabp4-CIDEA)67Npe,"transgene insertion 67, Natasa Petrovic",MGI:5645808,0,Tg(Fabp4-CIDEA)67Npe,MGI:5645804
Tg(Fabp4-CIDEA)85Npe,"transgene insertion 85, Natasa Petrovic",MGI:5645807,0,Tg(Fabp4-CIDEA)85Npe,MGI:5645803
Tg(Fgf15/Hsp68-cre)1Bld,"transgene insertion 1, Antonio Baldini",MGI:4365402,0,Tg(Fgf15/Hsp68-cre)1Bld,MGI:4365399
Tg(Flt3-cre)#Ccb,"transgene insertion, Conrad C Bleul",MGI:4462354,0,Tg(Flt3-cre)#Ccb,MGI:4462281
Tg(Frzb-cre)1Tylz,"transgene insertion 1, Przemko Tylzanowski",MGI:3527940,0,Tg(Frzb-cre)1Tylz,MGI:3527938
Tg(GFAP-SRC)2Aag,"transgene insertion 2, Adriano Aguzzi",MGI:2445477,0,Tg(GFAP-SRC)2Aag,MGI:2445481
Tg(GFAP-lacZ)9Nist,"transgene insertion 9, Monica Nister",MGI:5305741,0,Tg(GFAP-lacZ)9Nist,MGI:5305740
Tg(GFP/KRAS2/ALPP)1Brn,"transgene insertion 1, Anton Berns",MGI:2182853,0,Tg(GFP/KRAS2/ALPP)1Brn,MGI:3038964
Tg(GJB1*S26L)S3Fon,"transgene insertion S3, Michel Fontes",MGI:5645767,0,Tg(GJB1*S26L)S3Fon,MGI:5645764
Tg(Gad2-tdTomato)DJhi,"transgene insertion D, Johannes Hirrlinger",MGI:5790577,0,Tg(Gad2-tdTomato)DJhi,MGI:5790715
Tg(Gfap-PTEN*)6Rpm,"transgene insertion 6, Rafael Pulido",MGI:5795663,0,Tg(Gfap-PTEN*)6Rpm,MGI:5795659
Tg(Gfap-TNF*)K21Gkl,"transgene insertion K21, George Kollias",MGI:3766134,0,Tg(Gfap-TNF*)K21Gkl,MGI:3766211
Tg(Gfap-cre)2Brn,"transgene insertion 2, Anton Berns",MGI:2663939,0,Tg(Gfap-cre)2Brn,MGI:2671944
Tg(Gfap-tTA)7Igta,"transgene insertion 7, Ignacio Torres-Aleman",MGI:5645758,0,Tg(Gfap-tTA)7Igta,MGI:5645755
Tg(Ggt1-cre/ERT2)1Pepe,"transgene insertion 1, Petra Pennekamp",MGI:3798834,0,Tg(Ggt1-cre/ERT2)1Pepe,MGI:3798833
Tg(Gjc1/EGFP)L43Kwi,"transgene insertion L43, Klaus Willecke",MGI:5008304,0,Tg(Gjc1/EGFP)L43Kwi,MGI:5008300
Tg(H2-Aa-HLA-DPA1)1Lone,"transgene insertion 1, Yu Chun Lone",MGI:5494673,0,Tg(H2-Aa-HLA-DPA1)1Lone,MGI:5494672
Tg(H2-Ab1-HLA-DPB1)1Lone,"transgene insertion 1, Yu Chun Lone",MGI:5494677,0,Tg(H2-Ab1-HLA-DPB1)1Lone,MGI:5494676
Tg(H2-D<b>)2Bujf,"transgene insertion 2, Jean-Francois Bureau",MGI:5306998,0,Tg(H2-D<b>)2Bujf,MGI:5306997
Tg(H2-D<d>)D8Gja,"transgene insertion D8, Gilbert Jay",MGI:3848820,0,Tg(H2-D<d>)D8Gja,MGI:3848819
Tg(H2-D<d>/H2-L<d>)DL1Ul,"transgene insertion DL1, Urban Lendahl",MGI:5305234,0,Tg(H2-D<d>/H2-L<d>)DL1Ul,MGI:5305233
Tg(H2-Ea-LACK)1Ngkh,"transgene insertion 1, Nicolas Glaichenhaus",MGI:5311331,0,Tg(H2-Ea-LACK)1Ngkh,MGI:5311330
Tg(H2-K-TcrbP14)128Mak,"transgene insertion 128, Tak W Mak",MGI:3762014,0,Tg(H2-K-TcrbP14)128Mak,MGI:3762033
Tg(H2-K1-Ifnb1)10Seif,"transgene insertion 10, Isabelle Seif",MGI:5141611,0,Tg(H2-K1-Ifnb1)10Seif,MGI:5141625
Tg(H2-L<d>)L3Ul,"transgene insertion L3, Urban Lendahl",MGI:5305219,0,Tg(H2-L<d>)L3Ul,MGI:5305218
Tg(H2-L<d>/H2-D<d>)LD8Gja,"transgene insertion LD8, Gilbert Jay",MGI:5305227,0,Tg(H2-L<d>/H2-D<d>)LD8Gja,MGI:5305226
Tg(H2K<b>-lacZ)1Cba,"transgene insertion 1, Charles Babinet",MGI:5645898,0,Tg(H2K<b>-lacZ)1Cba,MGI:5645897
Tg(HK2-luc)231Uku,"transgene insertion 231, University of Kuopio",MGI:3522676,0,Tg(HK2-luc)231Uku,MGI:3522674
Tg(HK2-luc)242Uku,"transgene insertion 242, University of Kuopio",MGI:3522703,0,Tg(HK2-luc)242Uku,MGI:3522701
Tg(HK2-luc)253Uku,"transgene insertion 253, University of Kuopio",MGI:3522707,0,Tg(HK2-luc)253Uku,MGI:3522705
Tg(HK2-luc)279Uku,"transgene insertion 279, University of Kuopio",MGI:3522710,0,Tg(HK2-luc)279Uku,MGI:3522709
Tg(HLA-A/H2-D/B2M)1Bpe,"transgene insertion 1, Beatrice Perarnau",MGI:3711164,0,Tg(HLA-A/H2-D/B2M)1Bpe,MGI:3711152
"Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dma","transgene insertion 1, Daniel M Altmann",MGI:5312109,0,"Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dma",MGI:5312101
Tg(HSE-EYFP)1Mklv,"transgene insertion 1, Andrey Mikhailov",MGI:5573168,0,Tg(HSE-EYFP)1Mklv,MGI:5573167
Tg(Hbb-b1)83Clo,"transgene insertion 83, Cecilia W Lo",MGI:2655271,0,Tg(Hbb-b1)83Clo,MGI:2655277
Tg(Hist1h1t-sb100X)8689Izsv,"transgene insertion 8689, Zsuzsanna Izsvak",MGI:5707267,0,Tg(Hist1h1t-sb100X)8689Izsv,MGI:5707266
Tg(Hmgcr-S100a4)579Elu,"transgene insertion 579, Eugene Lukanidin",MGI:5648066,0,Tg(Hmgcr-S100a4)579Elu,MGI:5648062
Tg(Hmgcr-SLAMF1)1Hrvt,"transgene insertion 1, Branka Horvat",MGI:5476927,0,Tg(Hmgcr-SLAMF1)1Hrvt,MGI:5476926
Tg(Hnrnpa2b1-rtTA2S*M2)4Jstr,"transgene insertion 4, John Strouboulis",MGI:5882798,0,Tg(Hnrnpa2b1-rtTA2S*M2)4Jstr,MGI:5882797
Tg(Hnrnpa2b1-rtTA2S*M2)9Jstr,"transgene insertion 9, John Strouboulis",MGI:5648204,0,Tg(Hnrnpa2b1-rtTA2S*M2)9Jstr,MGI:5648199
Tg(Hoxa7-lacZ)17Pgr,"transgene insertion 17, Peter Gruss",MGI:2655552,0,Tg(Hoxa7-lacZ)17Pgr,MGI:2156984
Tg(Hoxb1-cre)r4Mist,"transgene insertion r4, Michele Studer",MGI:5006714,0,Tg(Hoxb1-cre)r4Mist,MGI:5006713
Tg(Hoxb8-flpo)11Oki,"transgene insertion 11, Ole Kiehn",MGI:6147797,0,Tg(Hoxb8-flpo)11Oki,MGI:6147796
Tg(Hspa1b-luc)NLF1Rjp,"transgene insertion NLF1, Jean-Paul Renard",MGI:3044187,0,Tg(Hspa1b-luc)NLF1Rjp,MGI:3044185
Tg(Hspa1b-mPlum)AAmpla,"transgene insertion 1, Anna Planas",MGI:5575510,0,Tg(Hspa1b-mPlum)AAmpla,MGI:5575508
Tg(Htr1a-icre)1Fto,"transgene insertion 1, Francois Tronche",MGI:3762198,0,Tg(Htr1a-icre)1Fto,MGI:3762192
Tg(IGHMdeltaV)6Corc,"transgene insertion 6, Daniel Corcos",MGI:5305989,0,Tg(IGHMdeltaV)6Corc,MGI:5305988
"Tg(IL3,CSF2)C42Pnc","transgene insertion C42, Peter N Cockerill",MGI:5620606,0,"Tg(IL3,CSF2)C42Pnc",MGI:5620622
Tg(IRBP-HEL)1Rc,"transgene insertion 1, Richard Cornall",MGI:5648245,0,Tg(IRBP-HEL)1Rc,MGI:5648243
Tg(IRF1-Prnp)94Cwe,"transgene insertion 94, Charles Weissmann",MGI:2652523,0,Tg(IRF1-Prnp)94Cwe,MGI:2652517
Tg(ITGAM-PLA2G2A)1Winth,"transgene insertion 1, Menno de Winther",MGI:5648230,0,Tg(ITGAM-PLA2G2A)1Winth,MGI:5648228
Tg(ITGAM-TK)620Zbz,"transgene insertion 620, Universitatsspital Zurich, Biologisches Zentrallaboratorium",MGI:4839616,0,Tg(ITGAM-TK)620Zbz,MGI:4839618
Tg(IVL-tdTomato)1Rase,"transgene insertion 1, Radislav Sedlacek",MGI:5437495,0,Tg(IVL-tdTomato)1Rase,MGI:5437511
Tg(Iap11-1-lacZ)22Thei,"transgene insertion 22, Theirry Heidmann",MGI:5306632,0,Tg(Iap11-1-lacZ)22Thei,MGI:5306628
"Tg(Igf2/LacZ,H19)YZ15Aco","transgene insertion YZ15, Justin Ainscough",MGI:5648556,0,"Tg(Igf2/LacZ,H19)YZ15Aco",MGI:5648551
"Tg(Igf2/LacZ,H19)YZ17Aco","transgene insertion YZ17, Justin Ainscough",MGI:5648555,0,"Tg(Igf2/LacZ,H19)YZ17Aco",MGI:5648549
"Tg(Igf2/LacZ,H19)YZ20Aco","transgene insertion YZ20, Justin Ainscough",MGI:5648554,0,"Tg(Igf2/LacZ,H19)YZ20Aco",MGI:5648548
"Tg(Igf2/LacZ,H19)YZ46Aco","transgene insertion YZ46, Justin Ainscough",MGI:5648553,0,"Tg(Igf2/LacZ,H19)YZ46Aco",MGI:5648550
Tg(Igh-15B3Vh/Ighm*a)502Zbz,"transgene insertion 502, Universitatsspital Zurich, Biologisches Zentrallaboratorium",MGI:5014186,0,Tg(Igh-15B3Vh/Ighm*a)502Zbz,MGI:5014185
Tg(Igh-6H4Vh/Ighm*a)508Zbz,"transgene insertion 508, Universitatsspital Zurich, Biologisches Zentrallaboratorium",MGI:5014082,0,Tg(Igh-6H4Vh/Ighm*a)508Zbz,MGI:5014081
Tg(Igh-6H4Vh/Ighm*a)762Zbz,"transgene insertion 762, Universitatsspital Zurich, Biologisches Zentrallaboratorium",MGI:5014067,0,Tg(Igh-6H4Vh/Ighm*a)762Zbz,MGI:5014060
Tg(Igh-VSp6/IGHM)39Corc,"transgene insertion 39, Daniel Corcos",MGI:5306240,0,Tg(Igh-VSp6/IGHM)39Corc,MGI:5306238
Tg(Igh2<k>3-83)1Nemz,"transgene insertion 3-83, David Nemazee",MGI:3055213,0,Tg(Igh2<k>3-83)1Nemz,MGI:3055214
Tg(IghMyc)186Brn,"transgene insertion 186, Anton Berns",MGI:3039690,0,Tg(IghMyc)186Brn,MGI:3039691
Tg(Igk-VOx1*/Igkj5/Igk-C*)17.96Crey,"transgene insertion 17.96, Claude-Agnes Reynaud",MGI:5505386,0,Tg(Igk-VOx1*/Igkj5/Igk-C*)17.96Crey,MGI:5505310
Tg(Ins1-Frk-Y504F)1Ubc,"transgene insertion 1, Uppsala University",MGI:3487260,0,Tg(Ins1-Frk-Y504F)1Ubc,MGI:3487259
Tg(Ins1-itTA)#Fto,"transgene insertion, Francois Tronche",MGI:5810641,0,Tg(Ins1-itTA)#Fto,MGI:5810408
Tg(Ins2-CD80)3B7Flv,"transgene insertion 3B7, Richard Flavell",MGI:2682826,0,Tg(Ins2-CD80)3B7Flv,MGI:3046790
Tg(Ins2-CR2)F47Vmh,"transgene insertion F47, V Michael Holers",MGI:3525099,0,Tg(Ins2-CR2)F47Vmh,MGI:3525098
Tg(Ins2-CR2)F51Vmh,"transgene insertion F51, V Michael Holers",MGI:3487367,0,Tg(Ins2-CR2)F51Vmh,MGI:3487366
Tg(Ins2-NP)25-3Olds,"transgene insertion 25-3, Michael BA Oldstone, MD",MGI:3573697,0,Tg(Ins2-NP)25-3Olds,MGI:3531505
Tg(Ins2-crmA)27Ngkh,"transgene insertion 27, Nicolas Glaichenhaus",MGI:5308875,0,Tg(Ins2-crmA)27Ngkh,MGI:5308873
Tg(Itgax-BCL2)1Ple,"transgene insertion 1, Philippe Lesnik",MGI:5475551,0,Tg(Itgax-BCL2)1Ple,MGI:5475550
Tg(Itgax-cre/ERT)61Gkl,"transgene insertion 61, George Kollias",MGI:3690924,0,Tg(Itgax-cre/ERT)61Gkl,MGI:3690922
Tg(KRT10-Igf2r*)KippsGfc,"transgene insertion Kipps, Christopher Graham",MGI:5436057,0,Tg(KRT10-Igf2r*)KippsGfc,MGI:5436230
Tg(KRT14-FLT4/IGHG1)#Ali,"transgene insertion, Kari Alitalo",MGI:5522572,0,Tg(KRT14-FLT4/IGHG1)#Ali,MGI:5522573
Tg(KRT14-Figf)1Ali,"transgene insertion 1, Kari Alitalo",MGI:3804466,0,Tg(KRT14-Figf)1Ali,MGI:3804465
Tg(KRT14-HMOX1)78Yah,"transgene insertion 78, Yann Herault",MGI:5648806,0,Tg(KRT14-HMOX1)78Yah,MGI:5648805
Tg(KRT14-Pgf)1Odo,"transgene insertion 1, Teresa Odorisio",MGI:2450137,0,Tg(KRT14-Pgf)1Odo,MGI:2450140
Tg(KRT14-SFN)44Odo,"transgene insertion 44, Teresa Odorisio",MGI:5645775,0,Tg(KRT14-SFN)44Odo,MGI:5645773
Tg(KRT14-TCL1A)1Rso,"transgene insertion 1, Giandomenico Russo",MGI:5804015,0,Tg(KRT14-TCL1A)1Rso,MGI:5804014
Tg(KRT14-cre)1Cgn,"transgene insertion 1, University of Cologne",MGI:2652655,0,Tg(KRT14-cre)1Cgn,MGI:2652653
Tg(KRT5-IKBKB)1Armz,"transgene insertion 1, Angel Ramirez",MGI:4456367,0,Tg(KRT5-IKBKB)1Armz,MGI:4456267
Tg(KRT5-Trp63_iTA)2Gml,"transgene insertion 2, Gerry Melino",MGI:5004702,0,Tg(KRT5-Trp63_iTA)2Gml,MGI:5004695
Tg(KRT5-Trp63_ideltaN)1Gml,"transgene insertion 1, Gerry Melino",MGI:5004712,0,Tg(KRT5-Trp63_ideltaN)1Gml,MGI:5004711
Tg(KRT5-cre)5132Jlj,"transgene insertion 5132, Jose Luis Jorcano",MGI:3050065,0,Tg(KRT5-cre)5132Jlj,MGI:3050066
Tg(Kap)L49Msgr,"transgene insertion L49, Anna Meseguer",MGI:5792809,0,Tg(Kap)L49Msgr,MGI:5792808
Tg(Kit*D814V)1Roer,"transgene insertion 1, Axel Roers",MGI:4942357,0,Tg(Kit*D814V)1Roer,MGI:4942354
Tg(Krt1-15-EGFP)2Cot,"transgene insertion 2, George Cotsarelis",MGI:3511761,0,Tg(Krt1-15-EGFP)2Cot,MGI:3511759
Tg(Krt1-15-cre/PGR)22Cot,"transgene insertion 22, George Cotsarelis",MGI:3511785,0,Tg(Krt1-15-cre/PGR)22Cot,MGI:3511784
Tg(Krt14-Col18a1)J4Pih,"transgene insertion J4, Taina Pihlajaniemi",MGI:5645734,0,Tg(Krt14-Col18a1)J4Pih,MGI:5645733
"Tg(LYS2-rtTA2S*M2,tetO-ELAVL1)632Dkon","transgene insertion 632, Dimitris Kontoyiannis",MGI:5429340,0,"Tg(LYS2-rtTA2S*M2,tetO-ELAVL1)632Dkon",MGI:5429341
Tg(Lck-AVEN)1Zrng,"transgene insertion 1, Martin Zoernig",MGI:5317419,0,Tg(Lck-AVEN)1Zrng,MGI:5317418
Tg(Lck-CFLAR)1Zrng,"transgene insertion 1, Martin Zoernig",MGI:5317724,0,Tg(Lck-CFLAR)1Zrng,MGI:5317723
Tg(Lck-ETS2)1Boul,"transgene insertion 1, Kim E Boulukos",MGI:5306591,0,Tg(Lck-ETS2)1Boul,MGI:5306590
Tg(Lck-Ets2delta)1Boul,"transgene insertion 1, Kim E Boulukos",MGI:5306588,0,Tg(Lck-Ets2delta)1Boul,MGI:5306587
Tg(Lck-FADD)1Hed,"transgene insertion 1, Stephen Hedrick",MGI:3588560,0,Tg(Lck-FADD)1Hed,MGI:3588559
Tg(Lck-Prnp)33Cwe,"transgene insertion 33, Charles Weissmann",MGI:2652525,0,Tg(Lck-Prnp)33Cwe,MGI:2652519
Tg(Lck-Prnp)71Cwe,"transgene insertion 71, Charles Weissmann",MGI:2652526,0,Tg(Lck-Prnp)71Cwe,MGI:2652520
Tg(Ltf-icre)14Mmul,"transgene insertion 14, Mathias Muller",MGI:5571915,0,Tg(Ltf-icre)14Mmul,MGI:5571911
Tg(MMTV-Prlr)3Eder,"transgene insertion 3, Marc Edery",MGI:5304928,0,Tg(MMTV-Prlr)3Eder,MGI:5304921
Tg(MMTV-S100a4)463Oku,"transgene insertion 463, Olle Karlstrom",MGI:3620787,0,Tg(MMTV-S100a4)463Oku,MGI:5141468
Tg(MMTV-VEGFB*)1Sjh,"transgene insertion 1, Steven J Harper",MGI:5660292,0,Tg(MMTV-VEGFB*)1Sjh,MGI:5660296
Tg(MMTV-neu/OT-I/OT-II)CBnel,"transgene insertion C, Brad Nelson",MGI:3761163,0,Tg(MMTV-neu/OT-I/OT-II)CBnel,MGI:3761162
Tg(MMTVtTA)1Mam,"transgene insertion 1, Lothar Hennighausen",MGI:3053958,0,Tg(MMTVtTA)1Mam,MGI:3053971
Tg(MSR1)3Winth,"transgene insertion 3, Menno de Winther",MGI:5648236,0,Tg(MSR1)3Winth,MGI:5648235
Tg(MYOD*-lacZ)#Fdz,"transgene insertion, Anne Fernandez",MGI:5648218,0,Tg(MYOD*-lacZ)#Fdz,MGI:5648217
Tg(Mbp-PDGFB)90Ubc,"transgene insertion 90, Uppsala University",MGI:3044166,0,Tg(Mbp-PDGFB)90Ubc,MGI:3044165
Tg(Mbp-cre)51Gkl,"transgene insertion 51, George Kollias",MGI:5707788,0,Tg(Mbp-cre)51Gkl,MGI:5707785
Tg(Mbp/Prnp)640Zbz,"transgene insertion 640, Universitatsspital Zurich",MGI:5314788,0,Tg(Mbp/Prnp)640Zbz,MGI:5314784
Tg(Mlana-cre)5Bee,"transgene insertion 5, Friedrich Beermann",MGI:4887843,0,Tg(Mlana-cre)5Bee,MGI:5006950
Tg(Mpz*Ala221fs)4Msch,"transgene insertion 4, Melitta Schachner",MGI:5003323,0,Tg(Mpz*Ala221fs)4Msch,MGI:5003322
Tg(Mpz*L106I)1Msch,"transgene insertion 1, Melitta Schachner",MGI:5003283,0,Tg(Mpz*L106I)1Msch,MGI:5003282
Tg(Mpz*L106I)3Msch,"transgene insertion 3, Melitta Schachner",MGI:5003316,0,Tg(Mpz*L106I)3Msch,MGI:5003308
Tg(Mpz-cre)1Brn,"transgene insertion 1, Anton Berns",MGI:2445228,0,Tg(Mpz-cre)1Brn,MGI:2445223
Tg(Mt1-Mecr)#Jkh,"transgene insertion, J Kalervo Hiltunen",MGI:5805677,0,Tg(Mt1-Mecr)#Jkh,MGI:5805676
Tg(Mt1-SERPINE1)1Upj,"transgene insertion 1, The Upjohn Company",MGI:5475344,0,Tg(Mt1-SERPINE1)1Upj,MGI:5475340
Tg(Mx1-cre)1Cgn,"transgene insertion 1, University of Cologne",MGI:2176073,0,Tg(Mx1-cre)1Cgn,MGI:2176072
Tg(Myh6-ADCY8)7Hj,"transgene insertion 7, Jacques Hanoune",MGI:5578165,0,Tg(Myh6-ADCY8)7Hj,MGI:5578164
Tg(Myh6-Htr2b)1Lum,"transgene insertion 1, Luc Maroteaux",MGI:5645783,0,Tg(Myh6-Htr2b)1Lum,MGI:5645782
Tg(Myh6-Kcne1)#Ven,"transgene insertion, Bjorn Vennstrom",MGI:5566532,0,Tg(Myh6-Kcne1)#Ven,MGI:5566530
Tg(Myh6-tTA)6Smbf,"transgene insertion 6, Section of Myocardial Biology - Fishman Lab",MGI:2665551,0,Tg(Myh6-tTA)6Smbf,MGI:2665552
"Tg(NES/TK-PDGFB,-lacZ)310Kfn","transgene insertion 310, Karin Forsberg-Nilsson",MGI:5448202,0,"Tg(NES/TK-PDGFB,-lacZ)310Kfn",MGI:5448200
"Tg(NES/TK-PDGFB,-lacZ)312Kfn","transgene insertion 312, Karin Forsberg-Nilsson",MGI:5648209,0,"Tg(NES/TK-PDGFB,-lacZ)312Kfn",MGI:5648207
Tg(Nefh/EGFP)1Eyer,"transgene insertion 1, Joel Eyer",MGI:5315129,0,Tg(Nefh/EGFP)1Eyer,MGI:5315128
Tg(Nes-cre)1Kln,"transgene insertion 1, Rudiger Klein",MGI:2176173,0,Tg(Nes-cre)1Kln,MGI:2176172
Tg(Nes-rtTA)306Rvs,"transgene insertion 306, Steven A Reeves",MGI:3505574,0,Tg(Nes-rtTA)306Rvs,MGI:2136292
Tg(Nfh/lacZ)44AApt,"transgene insertion 44A, Alan Peterson",MGI:2182128,0,Tg(Nfh/lacZ)44AApt,MGI:2388168
"Tg(Nos2-tdTomato,-cre)1Albe","transgene insertion 1, Alain Bessis",MGI:5645754,0,"Tg(Nos2-tdTomato,-cre)1Albe",MGI:5645753
"Tg(Nr5a1-CHRM4*,-tdTomato)1Cogr","transgene insertion 1, Cornelius Gross",MGI:5796552,0,"Tg(Nr5a1-CHRM4*,-tdTomato)1Cogr",MGI:5796549
Tg(PDGFRA-lacZ)2.2-07Nist,"transgene insertion 2.2-07, Monica Nister",MGI:5305726,0,Tg(PDGFRA-lacZ)2.2-07Nist,MGI:5305724
Tg(PECAM1-TFPI/CD4/SELP)#aAdor,"transgene insertion #a, Anthony Dorling",MGI:5578129,0,Tg(PECAM1-TFPI/CD4/SELP)#aAdor,MGI:5578155
Tg(PECAM1-hir/CD4/SELP)#aAdor,"transgene insertion #a, Anthony Dorling",MGI:5578128,0,Tg(PECAM1-hir/CD4/SELP)#aAdor,MGI:5578153
Tg(PF4-RAPGEF1)6A6Cgu,"transgene insertion 6A6, Maria del Carmen Guerrero Arroyo",MGI:5645686,0,Tg(PF4-RAPGEF1)6A6Cgu,MGI:5645683
Tg(PF4-RAPGEF1*)8A3Cgu,"transgene insertion 8A3, Maria del Carmen Guerrero Arroyo",MGI:5645687,0,Tg(PF4-RAPGEF1*)8A3Cgu,MGI:5645685
Tg(PMP22)C22Clh,"transgene insertion C22, Clare Huxley",MGI:2183770,0,Tg(PMP22)C22Clh,MGI:2388171
Tg(PRNP-DNAJB2_ia)52aMec,"transgene insertion 52a, Michael E Cheetham",MGI:5613188,0,Tg(PRNP-DNAJB2_ia)52aMec,MGI:5613187
Tg(PRNP-DNAJB2_ia)61aMec,"transgene insertion 61a, Michael E Cheetham",MGI:5613160,0,Tg(PRNP-DNAJB2_ia)61aMec,MGI:5613156
Tg(Pax4-lacZ)1Pgr,"transgene insertion 1, Peter Gruss",MGI:3044158,0,Tg(Pax4-lacZ)1Pgr,MGI:3044157
Tg(Pax4-lacZ)2Pgr,"transgene insertion 2, Peter Gruss",MGI:3057320,0,Tg(Pax4-lacZ)2Pgr,MGI:3057319
"Tg(Pax6-cre,GFP)1Pgr","transgene insertion 1, Peter Gruss",MGI:3045749,0,"Tg(Pax6-cre,GFP)1Pgr",MGI:3045750
"Tg(Pax6-cre,GFP)2Pgr","transgene insertion 2, Peter Gruss",MGI:3052661,0,"Tg(Pax6-cre,GFP)2Pgr",MGI:3052668
Tg(Pax8-cre/ERT2)CAmat,"transgene insertion C, Athena Matakidou",MGI:5911838,0,Tg(Pax8-cre/ERT2)CAmat,MGI:5912274
Tg(Pax8-rtTA2S*M2)1Koes,"transgene insertion 1, Robert Koesters",MGI:3709326,0,Tg(Pax8-rtTA2S*M2)1Koes,MGI:3763914
Tg(Pbsn-cre/Esr1*)14Abch,"transgene insertion 14, Andreas Birbach",MGI:5461708,0,Tg(Pbsn-cre/Esr1*)14Abch,MGI:5461707
Tg(Pcp2-Gap43)L1657Fro,"transgene insertion L1657, Ferdinando Rossi",MGI:2652499,0,Tg(Pcp2-Gap43)L1657Fro,MGI:2652497
Tg(Pcp2-Prnp)E330Zbz,"transgene insertion E330, Zurich",MGI:5014494,0,Tg(Pcp2-Prnp)E330Zbz,MGI:5014493
Tg(Pcp2-Prnp)F13Zbz,"transgene insertion F13, Zurich",MGI:5014380,0,Tg(Pcp2-Prnp)F13Zbz,MGI:5014378
Tg(Pcp2-Prnp)F332Zbz,"transgene insertion F332, Zurich",MGI:5014403,0,Tg(Pcp2-Prnp)F332Zbz,MGI:5014394
Tg(Pcp2-cre)756Mro,"transgene insertion 756, Silvia Marino",MGI:3513599,0,Tg(Pcp2-cre)756Mro,MGI:3589278
Tg(Pcp2/Jun)18Dcrl,"transgene insertion 18, Daniella Carulli",MGI:3573864,0,Tg(Pcp2/Jun)18Dcrl,MGI:3573861
Tg(Pdpn-icre)14Biat,"transgene insertion 14, Biomodels Austria",MGI:5526988,0,Tg(Pdpn-icre)14Biat,MGI:5526987
Tg(Pdx1-itTA)#Fto,"transgene insertion, Francois Tronche",MGI:5810712,0,Tg(Pdx1-itTA)#Fto,MGI:5810710
Tg(Phox2b-cre)1Jbr,"transgene insertion 1, Jean-Francois Brunet",MGI:5306618,0,Tg(Phox2b-cre)1Jbr,MGI:5306617
Tg(Pklr-BCL2)BAk,"transgene insertion B, Axel Kahn",MGI:4936850,0,Tg(Pklr-BCL2)BAk,MGI:4936847
Tg(Prm1-Tfam)4Lrsn,"transgene insertion 4, Nils-Goran Larsson",MGI:3525701,0,Tg(Prm1-Tfam)4Lrsn,MGI:3525692
Tg(Prnp)940Zbz,"transgene insertion 940, University Hospital Zurich",MGI:5318492,0,Tg(Prnp)940Zbz,MGI:5318491
Tg(Prnp)941Zbz,"transgene insertion 941, University Hospital Zurich",MGI:5318499,0,Tg(Prnp)941Zbz,MGI:5318498
Tg(Prnp)E1Rchi,"transgene insertion E1, Roberto Chiesa",MGI:5563239,0,Tg(Prnp)E1Rchi,MGI:5563236
Tg(Prnp)a19Cwe,"transgene insertion a19, Charles Weissmann",MGI:2447132,0,Tg(Prnp)a19Cwe,MGI:2652456
Tg(Prnp)a20Cwe,"transgene insertion a20, Charles Weissmann",MGI:2447133,0,Tg(Prnp)a20Cwe,MGI:2652457
Tg(Prnp)d11Cwe,"transgene insertion d11, Charles Weissmann",MGI:2652550,0,Tg(Prnp)d11Cwe,MGI:2652547
Tg(Prnp)e19hCwe,"transgene insertion e19h, Charles Weissmann",MGI:3038611,0,Tg(Prnp)e19hCwe,MGI:3038617
Tg(Prnp*)CDah,"transgene insertion C, David A Harris",MGI:5563233,0,Tg(Prnp*)CDah,MGI:5563232
Tg(Prnp*D177N*M128V)G1Rchi,"transgene insertion G1, Roberto Chiesa",MGI:5614760,0,Tg(Prnp*D177N*M128V)G1Rchi,MGI:5614759
Tg(Prnp*M128*D177N)FFI-10Rchi,"transgene insertion FFI-10, Roberto Chiesa",MGI:5803982,0,Tg(Prnp*M128*D177N)FFI-10Rchi,MGI:5803981
Tg(Prnp-PRNP)001Jmto,"transgene insertion 001, Juan Maria Torres",MGI:5476823,0,Tg(Prnp-PRNP)001Jmto,MGI:5476816
Tg(Prnp-PRNP)110Jmto,"transgene insertion 110, Juan Maria Torres",MGI:5476799,0,Tg(Prnp-PRNP)110Jmto,MGI:5476796
Tg(Prnp-PRNP)340Jmto,"transgene insertion 340, Juan Maria Torres",MGI:5803821,0,Tg(Prnp-PRNP)340Jmto,MGI:5803814
Tg(Prnp-PRNP)361Jmto,"transgene insertion 361, Juan Maria Torres",MGI:5803836,0,Tg(Prnp-PRNP)361Jmto,MGI:5803835
Tg(Prnp-PRNP*6OR)K6M16Pcg,"transgene insertion K6M16, Peter Griffiths",MGI:5775417,0,Tg(Prnp-PRNP*6OR)K6M16Pcg,MGI:5775416
Tg(Prnp-PRNP*6OR)K6M6Pcg,"transgene insertion K6M6, Peter Griffiths",MGI:5775412,0,Tg(Prnp-PRNP*6OR)K6M6Pcg,MGI:5775410
Tg(Prnp-SMN)92Ahmb,"transgene insertion 92, Arthur H M Burghes",MGI:3774945,0,Tg(Prnp-SMN)92Ahmb,MGI:3774942
Tg(Prnp/IGHG1)588Aag,"transgene insertion 588, Adriano Aguzzi",MGI:5003488,0,Tg(Prnp/IGHG1)588Aag,MGI:5003487
Tg(Prnp/PRNP)1Drb,"transgene insertion 1, David R Brown",MGI:5762584,0,Tg(Prnp/PRNP)1Drb,MGI:5762582
Tg(Prnp/PRNP*AHQ)EF50Pcg,"transgene insertion EM50, Peter Griffiths",MGI:5776258,0,Tg(Prnp/PRNP*AHQ)EF50Pcg,MGI:5776257
Tg(Prnp/PRNP*ARR)FM16Pcg,"transgene insertion FM16, Peter Griffiths",MGI:5779528,0,Tg(Prnp/PRNP*ARR)FM16Pcg,MGI:5779527
Tg(Pten)1Srn,"transgene insertion 1, Manuel Serrano",MGI:5645732,0,Tg(Pten)1Srn,MGI:5645731
Tg(PySTdeltaMT)82Poz,"transgene insertion 82, Laura Pozzi",MGI:5142482,0,Tg(PySTdeltaMT)82Poz,MGI:5142481
Tg(RAB27A-EGFP/Rab27a)84Seab,"transgene insertion 84, Miguel C Seabra",MGI:3527487,0,Tg(RAB27A-EGFP/Rab27a)84Seab,MGI:5604138
Tg(RP1-309F20*)48Kel,"transgene insertion 48, Gavin Derek Kelsey",MGI:5308373,0,Tg(RP1-309F20*)48Kel,MGI:5308370
Tg(RP21-186P4)55Jmd,"transgene insertion 55, Jean-Maurice Delabar",MGI:5432362,0,Tg(RP21-186P4)55Jmd,MGI:5432361
Tg(RP3-340H11)29Kel,"transgene insertion 29, Gavin Derek Kelsey",MGI:5308378,0,Tg(RP3-340H11)29Kel,MGI:5308377
Tg(RSV-GH1)1Fgc,"transgene insertion 1, F G Conti",MGI:2652491,0,Tg(RSV-GH1)1Fgc,MGI:2652489
Tg(RasE)290Biat,"transgene insertion 290, Biomodels Austria",MGI:5702681,0,Tg(RasE)290Biat,MGI:5702677
Tg(Rax-cre)1Zkoz,"transgene insertion 1, Zbynek Kozmik",MGI:5505625,0,Tg(Rax-cre)1Zkoz,MGI:5505624
Tg(Rho-tTA)5Vmrg,"transgene insertion 5, Valeria Marigo",MGI:5008627,0,Tg(Rho-tTA)5Vmrg,MGI:5008620
Tg(Rip-RASA1*)1Wid,"transgene insertion 1, Christian Widmann",MGI:5648069,0,Tg(Rip-RASA1*)1Wid,MGI:5648068
Tg(Rnu6-RNAi:IE-PRV)SH03Gjo,"transgene insertion SH03, Genevieve Jolivet",MGI:5645893,0,Tg(Rnu6-RNAi:IE-PRV)SH03Gjo,MGI:5645890
Tg(Rnu6-RNAi:IE-PRV)SH05Gjo,"transgene insertion SH05, Genevieve Jolivet",MGI:5645892,0,Tg(Rnu6-RNAi:IE-PRV)SH05Gjo,MGI:5645889
Tg(Rnu6-RNAi:IE-PRV)SH30Gjo,"transgene insertion SH30, Genevieve Jolivet",MGI:5645894,0,Tg(Rnu6-RNAi:IE-PRV)SH30Gjo,MGI:5645891
Tg(S100b-EGFP)11Lgrv,"transgene insertion 11, Catherine Legraverend",MGI:5648257,0,Tg(S100b-EGFP)11Lgrv,MGI:5648252
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz,"transgene insertion 423, University Hospital, Zurich",MGI:3044038,0,Tg(SERPINA1-IGHG1/Il1rl1)423Zbz,MGI:3055830
Tg(SFFV-Sfpi1)R36Fmg,"transgene insertion R36, Francois Moreau-Gachelin",MGI:3045632,0,Tg(SFFV-Sfpi1)R36Fmg,MGI:3045630
Tg(SIM2)23Jmd,"transgene insertion 23, Jean-Maurice Delabar",MGI:5568592,0,Tg(SIM2)23Jmd,MGI:5568591
Tg(SMN1*E134K)1Tlbt,"transgene insertion 1, Kevin Talbot",MGI:5493441,0,Tg(SMN1*E134K)1Tlbt,MGI:5493438
Tg(Sat1)165bCwp,"transgene insertion 165b, Carl W Porter",MGI:5426516,0,Tg(Sat1)165bCwp,MGI:5426517
Tg(Scgb1a1-cre)1Tauc,"transgene insertion 1, Michael Tauc",MGI:3610310,0,Tg(Scgb1a1-cre)1Tauc,MGI:3610309
Tg(Scgb1a1-cre)1Vart,"transgene insertion 1, Vassilis Aidinis",MGI:3819980,0,Tg(Scgb1a1-cre)1Vart,MGI:3819976
Tg(Scgb1a1-rtTA)2Vart,"transgene insertion 2, Vassilis Aidinis",MGI:3819982,0,Tg(Scgb1a1-rtTA)2Vart,MGI:3819977
Tg(Sftpc-Grem1)105Mmyl,"transgene insertion 105, Marjukka Myllarniemi",MGI:5707177,0,Tg(Sftpc-Grem1)105Mmyl,MGI:5707175
"Tg(Siglech-cre,-mCherry)#Spar","transgene insertion, Tim Sparwasser",MGI:5615447,0,"Tg(Siglech-cre,-mCherry)#Spar",MGI:5615458
Tg(Slc16a1-luc)50Rttr,"transgene insertion 50, Guy Rutter",MGI:5465430,0,Tg(Slc16a1-luc)50Rttr,MGI:5465433
Tg(Slc17a6-icre)1Oki,"transgene insertion 1, Ole Kiehn",MGI:4881727,0,Tg(Slc17a6-icre)1Oki,MGI:4881726
Tg(Slc5a2-cre)1Tauc,"transgene insertion 1, Michel Tauc",MGI:3694735,0,Tg(Slc5a2-cre)1Tauc,MGI:3694734
Tg(Slc6a3-icre)1Fto,"transgene insertion 1, Francois Tronche",MGI:3852083,0,Tg(Slc6a3-icre)1Fto,MGI:3852082
Tg(Sox10-cre)1Wdr,"transgene insertion 1, William D Richardson",MGI:3586900,0,Tg(Sox10-cre)1Wdr,MGI:3586899
Tg(Sox2-Bgeo)1Skn,"transgene insertion 1, Silvia K Nicolis",MGI:5700640,0,Tg(Sox2-Bgeo)1Skn,MGI:5700566
Tg(Sox2-cre/ERT2)1Skn,"transgene insertion 1, Silvia K Nicolis",MGI:4397776,0,Tg(Sox2-cre/ERT2)1Skn,MGI:4397777
Tg(Spo11-cre)D5Mpel,"transgene insertion D5, Manuela Pellegrini",MGI:4850038,0,Tg(Spo11-cre)D5Mpel,MGI:5297497
Tg(TG-Gnas*R201H)1Rho,"transgene insertion 1, Rhone-Poulenc Sante",MGI:5308857,0,Tg(TG-Gnas*R201H)1Rho,MGI:5308854
Tg(TG-KCNIP3*)15Cnbc,"transgene insertion 15, Centro Nacional de Biotecnologia",MGI:5646253,0,Tg(TG-KCNIP3*)15Cnbc,MGI:5646251
Tg(TG-KCNIP3*)7Cnbc,"transgene insertion 7, Centro Nacional de Biotecnologia",MGI:5646252,0,Tg(TG-KCNIP3*)7Cnbc,MGI:5646250
Tg(TNF)197Gkl,"transgene insertion 197, George Kollias",MGI:3053711,0,Tg(TNF)197Gkl,MGI:3053712
Tg(TNF)3647Gkl,"transgene insertion 3647, George Kollias",MGI:4818266,0,Tg(TNF)3647Gkl,MGI:4818260
Tg(TNFRSF1B)1334Gkl,"transgene insertion 1334, George Kollias",MGI:5645560,0,Tg(TNFRSF1B)1334Gkl,MGI:5645558
Tg(TNFRSF1B)1335Gkl,"transgene insertion 1335, George Kollias",MGI:5645569,0,Tg(TNFRSF1B)1335Gkl,MGI:5645567
Tg(TP1-nlacZ)1Cota,"transgene insertion 1, Michel Cohen-Tannoudji",MGI:5648725,0,Tg(TP1-nlacZ)1Cota,MGI:5648723
Tg(Tagln-LacZ)4Zli,"transgene insertion 4, Zhenlin Li",MGI:4835063,0,Tg(Tagln-LacZ)4Zli,MGI:4835062
Tg(Tagln-Nppc)1Wlthr,"transgene insertion 1, Thomas Walther",MGI:5762679,0,Tg(Tagln-Nppc)1Wlthr,MGI:5762675
Tg(Tagln-PLA2G2A)AMrj,"transgene insertion A, Michel Raymondjean",MGI:5575375,0,Tg(Tagln-PLA2G2A)AMrj,MGI:5575374
Tg(Tagln-PLA2G2A)BMrj,"transgene insertion B, Michel Raymondjean",MGI:5575378,0,Tg(Tagln-PLA2G2A)BMrj,MGI:5575377
Tg(Tagln-PLA2G2A*G29S)AMrj,"transgene insertion A, Michel Raymondjean",MGI:5575385,0,Tg(Tagln-PLA2G2A*G29S)AMrj,MGI:5575380
Tg(Tagln-cre)1Zli,"transgene insertion 1, Zhenlin Li",MGI:4365411,0,Tg(Tagln-cre)1Zli,MGI:4365410
Tg(TcrLCMV)327Sdz,"transgene insertion 327, Birgit Ledermann",MGI:2665105,0,Tg(TcrLCMV)327Sdz,MGI:2665109
"Tg(Tcra,Tcrb)562Biat","transgene insertion 562, Biomodels Austria",MGI:5800328,0,"Tg(Tcra,Tcrb)562Biat",MGI:5800327
Tg(Tcra-V19-J33)#Lantz,"transgene insertion, Olivier Lantz",MGI:5829575,0,Tg(Tcra-V19-J33)#Lantz,MGI:5829571
"Tg(Tcra172,Tcrb172)1Wcl","transgene insertion 1, Warren C Ladiges",MGI:3699517,0,"Tg(Tcra172,Tcrb172)1Wcl",MGI:3767797
"Tg(Tcra1H3.1,Tcrb1H3.1)1Vire","transgene insertion 1, Christophe Viret",MGI:3722813,0,"Tg(Tcra1H3.1,Tcrb1H3.1)1Vire",MGI:3722812
"Tg(TcraBM3.3,TcrbBM3.3)1Alm","transgene insertion 1, Andrew L Mellor",MGI:3793487,0,"Tg(TcraBM3.3,TcrbBM3.3)1Alm",MGI:3793488
Tg(TcraCDC35)1Alhn,"transgene insertion 1, Agnes Lehuen",MGI:3528229,0,Tg(TcraCDC35)1Alhn,MGI:3528227
Tg(TcraDN32D3)10Alhn,"transgene insertion 10, Agnes Lehuen",MGI:3505746,0,Tg(TcraDN32D3)10Alhn,MGI:3505713
Tg(TcraDN32D3)78Alhn,"transgene insertion 78, Agnes Lehuen",MGI:3526073,0,Tg(TcraDN32D3)78Alhn,MGI:3526031
Tg(TcraDN32D3)86Alhn,"transgene insertion 86, Agnes Lehuen",MGI:3505887,0,Tg(TcraDN32D3)86Alhn,MGI:3505886
"Tg(TcraH-Y,TcrbH-Y)1Pas","transgene insertion 1, Institut Pasteur",MGI:3045612,0,"Tg(TcraH-Y,TcrbH-Y)1Pas",MGI:3045609
"Tg(TcraH-Y,TcrbH-Y)71Vbo","transgene insertion 71, Harald von Boehmer",MGI:3044562,0,"Tg(TcraH-Y,TcrbH-Y)71Vbo",MGI:3044559
"Tg(TcraMataHari,TcrbMatahari)#Lantz","transgene insertion, Olivier Lantz",MGI:5829381,0,"Tg(TcraMataHari,TcrbMatahari)#Lantz",MGI:5829366
Tg(Tcrb-LMR16.2)1Nglh,"transgene insertion 1, Nicolas Glaichenhaus",MGI:4838256,0,Tg(Tcrb-LMR16.2)1Nglh,MGI:4838255
Tg(Tcrb-V6)#Lantz,"transgene insertion, Olivier Lantz",MGI:5829578,0,Tg(Tcrb-V6)#Lantz,MGI:5829577
Tg(Tek-Nfkbia*S32A*S36A)1Gkl,"transgene insertion 1, George Kollias",MGI:5575645,0,Tg(Tek-Nfkbia*S32A*S36A)1Gkl,MGI:5575644
Tg(Tek-cre)1Ywa,"transgene insertion 1, Masashi Yanagisawa",MGI:2450311,0,Tg(Tek-cre)1Ywa,MGI:2450309
Tg(Tek-cre/ERT2)1Arnd,"transgene insertion 1, Bernd Arnold",MGI:2450312,0,Tg(Tek-cre/ERT2)1Arnd,MGI:2450326
Tg(TetO-Gal)82Wyn,"transgene insertion 82, David Wynick",MGI:5554441,0,Tg(TetO-Gal)82Wyn,MGI:5554440
Tg(Tie1-cre)9Ref,"transgene insertion 9, Reinhard Fassler",MGI:2385916,0,Tg(Tie1-cre)9Ref,MGI:2388301
Tg(Tnf)6074Gkl,"transgene insertion 6074, George Kollias",MGI:3766101,0,Tg(Tnf)6074Gkl,MGI:3766128
Tg(Tnf*)A86Gkl,"transgene insertion A86, George Kollias",MGI:3766228,0,Tg(Tnf*)A86Gkl,MGI:3766240
Tg(Tnfrsf19-cre/ERT2)1Kori,"transgene insertion 1, Vladimir Korinek",MGI:5575757,0,Tg(Tnfrsf19-cre/ERT2)1Kori,MGI:5575756
Tg(Trp53)bSrn,"transgene insertion b, Manuel Serrano",MGI:4948957,0,Tg(Trp53)bSrn,MGI:4948958
Tg(Ttr-NR0B2)1Ital,"transgene insertion 1, Iannis Talianidis",MGI:5645742,0,Tg(Ttr-NR0B2)1Ital,MGI:5645741
Tg(Ttr-SMYD3)1Ital,"transgene insertion 1, Iannis Talianidis",MGI:5749481,0,Tg(Ttr-SMYD3)1Ital,MGI:5749480
Tg(Ttr-cre/Esr1*)1Vco,"transgene insertion 1, Mireille Vasseur-Cognet",MGI:3046546,0,Tg(Ttr-cre/Esr1*)1Vco,MGI:3046545
Tg(Tyr)1999Lmon,"transgene insertion 1999, Lluis Montoliu",MGI:5787939,0,Tg(Tyr)1999Lmon,MGI:5787936
Tg(Tyr)2028Lmon,"transgene insertion 2028, Lluis Montoliu",MGI:5645918,0,Tg(Tyr)2028Lmon,MGI:5645911
Tg(Tyr)2131Lmon,"transgene insertion 2131, Lluis Montoliu",MGI:5645925,0,Tg(Tyr)2131Lmon,MGI:5645913
Tg(Tyr)2222Lmon,"transgene insertion 2222, Lluis Montoliu",MGI:5645915,0,Tg(Tyr)2222Lmon,MGI:5645908
Tg(Tyr)2231Lmon,"transgene insertion 2231, Lluis Montoliu",MGI:5645920,0,Tg(Tyr)2231Lmon,MGI:5645912
Tg(Tyr)2331Lmon,"transgene insertion 2331, Lluis Montoliu",MGI:5645916,0,Tg(Tyr)2331Lmon,MGI:5645909
Tg(Tyr*)2138Lmon,"transgene insertion 2138, Lluis Montoliu",MGI:5787956,0,Tg(Tyr*)2138Lmon,MGI:5787955
Tg(Tyr*)4794Lmon,"transgene insertion 4794, Lluis Montoliu",MGI:5787978,0,Tg(Tyr*)4794Lmon,MGI:5787970
Tg(Tyr*)6968Lmon,"transgene insertion 6968, Lluis Montoliu",MGI:5787961,0,Tg(Tyr*)6968Lmon,MGI:5787960
Tg(Tyr*)8748Lmon,"transgene insertion 8748, Lluis Montoliu",MGI:5787964,0,Tg(Tyr*)8748Lmon,MGI:5787963
Tg(Tyr*)8749Lmon,"transgene insertion 8749, Lluis Montoliu",MGI:5788264,0,Tg(Tyr*)8749Lmon,MGI:5788263
"Tg(Tyr,aEHS1.4)2005Lmon","transgene insertion 2005, Lluis Montoliu",MGI:5645904,0,"Tg(Tyr,aEHS1.4)2005Lmon",MGI:5645901
"Tg(Tyr,aEHS1.4)2017Lmon","transgene insertion 2017, Lluis Montoliu",MGI:5645903,0,"Tg(Tyr,aEHS1.4)2017Lmon",MGI:5645900
Tg(Tyr-NRAS*Q61K)1Bee,"transgene insertion 1, Friedrich Beemann",MGI:3768645,0,Tg(Tyr-NRAS*Q61K)1Bee,MGI:3768643
"Tg(Tyr-Th,-Gch1)6775Lmon","transgene insertion 6775, Lluis Montoliu",MGI:4443311,0,"Tg(Tyr-Th,-Gch1)6775Lmon",MGI:4443324
Tg(Tyr-rtTA)4111Lmon,"transgene insertion 4111, Lluis Montoliu",MGI:4443331,0,Tg(Tyr-rtTA)4111Lmon,MGI:4443327
Tg(UBC-Brainbow1.0L)35Mal,"transgene insertion 35, Bernard Malissen",MGI:5645781,0,Tg(UBC-Brainbow1.0L)35Mal,MGI:5645780
"Tg(UBC-Dclre1c,-GFP)6Jpdv","transgene insertion 6, Jean-Pierre de Villartay",MGI:5314243,0,"Tg(UBC-Dclre1c,-GFP)6Jpdv",MGI:5314242
Tg(UBC-GFP)30Scha,"transgene insertion 30, Brian Schaefer",MGI:3057178,0,Tg(UBC-GFP)30Scha,MGI:3057177
"Tg(UBC-GFP,-Fkbp11)HPsou","transgene insertion H, Pauline Soulas-Sprauel",MGI:5699866,0,"Tg(UBC-GFP,-Fkbp11)HPsou",MGI:5699865
"Tg(UBC-GFP,-Fkbp11)LPsou","transgene insertion L, Pauline Soulas-Sprauel",MGI:5699875,0,"Tg(UBC-GFP,-Fkbp11)LPsou",MGI:5699873
"Tg(UBC-Xrcc4,-GFP)1Jpdv","transgene insertion 1, Jean-Pierre de Villartay",MGI:5314247,0,"Tg(UBC-Xrcc4,-GFP)1Jpdv",MGI:5314246
Tg(UBC-mCherry)1Phbs,"transgene lentiviral insertion 1, Poul Sorensen",MGI:5296812,0,Tg(UBC-mCherry)1Phbs,MGI:5296811
Tg(Vav1-NPM1/ALK)1Sudt,"transgene insertion 1, Suzanne D Turner",MGI:5292256,0,Tg(Vav1-NPM1/ALK)1Sudt,MGI:5292253
Tg(Vav1-cre)1Cgp,"transgene insertion 1, Cristin G Print",MGI:2450339,0,Tg(Vav1-cre)1Cgp,MGI:2450345
Tg(Vpreb1-IL2RB)F133Ilm,"transgene insertion F133, Inga-Lill Martensson",MGI:5505492,0,Tg(Vpreb1-IL2RB)F133Ilm,MGI:5505484
Tg(Vps54)#Mm,"transgene insertion, Miriam Meisler",MGI:5006720,0,Tg(Vps54)#Mm,MGI:5006719
Tg(Wap-HBx)1Gmn,"transgene insertion 1, Marianne Bruggemann",MGI:5312872,0,Tg(Wap-HBx)1Gmn,MGI:5312861
Tg(Wap-Hgf)402Mig,"transgene insertion 402, Marta I Gallego",MGI:3036575,0,Tg(Wap-Hgf)402Mig,MGI:3037894
Tg(Wap-Shh)119Mig,"transgene insertion 119, Marta I Gallego",MGI:5645728,0,Tg(Wap-Shh)119Mig,MGI:5645727
Tg(Wap-Shh)186Mig,"transgene insertion 186, Marta I Gallego",MGI:5645729,0,Tg(Wap-Shh)186Mig,MGI:5645725
Tg(Wap-TAg)12Gmn,"transgene insertion 12, A Graessmann",MGI:5312328,0,Tg(Wap-TAg)12Gmn,MGI:5312327
Tg(Wap-Tag)8Gmn,"transgene insertion 8, A Graessmann",MGI:3621350,0,Tg(Wap-Tag)8Gmn,MGI:3784787
Tg(Wap-cre)1Gsc,"transgene insertion 1, Gunther Schutz",MGI:3527260,0,Tg(Wap-cre)1Gsc,MGI:3527253
Tg(Wap-tAg)1Gmn,"transgene insertion 1, A Graessmann",MGI:5313806,0,Tg(Wap-tAg)1Gmn,MGI:5313805
Tg(dlx5a-cre)1Mekk,"transgene insertion 1, Marc Ekker",MGI:3758328,0,Tg(dlx5a-cre)1Mekk,MGI:3758078
Tg(mIGHMdeltaV)1Corc,"transgene insertion 1, Daniel Corcos",MGI:5305993,0,Tg(mIGHMdeltaV)1Corc,MGI:5305992
Tg(myl2-cre)1118Tmhn,"transgene insertion 1118, Tim Mohun",MGI:3712342,0,Tg(myl2-cre)1118Tmhn,MGI:3712335
Tg(pUR288)1Vij,"transgene insertion 1, Jan Vijg",MGI:3606518,0,Tg(pUR288)1Vij,MGI:3606513
Tg(rtetR-tetO-cre)40Mhz,"transgene insertion 40, Martin Holzenberger",MGI:3513452,0,Tg(rtetR-tetO-cre)40Mhz,MGI:3513449
"Tg(tetO-AGTR1*N111G,-lacZ)1Aco","transgene insertion 1, Justin Ainscough",MGI:5648211,0,"Tg(tetO-AGTR1*N111G,-lacZ)1Aco",MGI:5648210
"Tg(tetO-AGTR1,-lacZ)1Aco","transgene insertion 1, Justin Ainscough",MGI:5648216,0,"Tg(tetO-AGTR1,-lacZ)1Aco",MGI:5648215
Tg(tetO-Cd74/MCC)#Doi,"transgene insertion #, Christophe Benoist and Diane Mathis",MGI:4439134,0,Tg(tetO-Cd74/MCC)#Doi,MGI:4439133
Tg(tetO-Chrnb2*V287L)H3Gica,"transgene insertion H3, Giorgio Casari",MGI:3843695,0,Tg(tetO-Chrnb2*V287L)H3Gica,MGI:3843694
Tg(tetO-Chrnb2*V287L)H5Gica,"transgene insertion H5, Giorgio Casari",MGI:5014761,0,Tg(tetO-Chrnb2*V287L)H5Gica,MGI:5014756
Tg(tetO-Creb*)100Brco,"transgene insertion 100, Angel Barco",MGI:5648341,0,Tg(tetO-Creb*)100Brco,MGI:5648329
Tg(tetO-Creb*)95Brco,"transgene insertion 95, Angel Barco",MGI:5648355,0,Tg(tetO-Creb*)95Brco,MGI:5648344
Tg(tetO-EGFP)18Tgli,"transgene insertion 18, Thierry Galli",MGI:5319520,0,Tg(tetO-EGFP)18Tgli,MGI:5319517
Tg(tetO-EGFP/VAMP7)18Tgli,"transgene insertion 18, Thierry Galli",MGI:5319311,0,Tg(tetO-EGFP/VAMP7)18Tgli,MGI:5319309
Tg(tetO-EGFP/VAMP7)4Tgli,"transgene insertion 4, Thierry Galli",MGI:5319317,0,Tg(tetO-EGFP/VAMP7)4Tgli,MGI:5319316
Tg(tetO-GFP)2Jstr,"transgene insertion 2, John Strouboulis",MGI:5645574,0,Tg(tetO-GFP)2Jstr,MGI:5645572
"Tg(tetO-GFP,-lacZ)G3Rsp","transgene insertion G3, Rolf Sprengel",MGI:3817960,0,"Tg(tetO-GFP,-lacZ)G3Rsp",MGI:3817963
"Tg(tetO-Gja1,-EGFP)L11Kwi","transgene insertion L11, Klaus Willecke",MGI:5754390,0,"Tg(tetO-Gja1,-EGFP)L11Kwi",MGI:5754388
Tg(tetO-HMOX1)57Gkl,"transgene insertion 57, George Kollias",MGI:5707757,0,Tg(tetO-HMOX1)57Gkl,MGI:5707755
"Tg(tetO-Hgf,-EGFP)24Tcre","transgene insertion 24, Tiziana Crepaldi",MGI:5648118,0,"Tg(tetO-Hgf,-EGFP)24Tcre",MGI:5648117
"Tg(tetO-Hspb1,-lacZ)11Mmr","transgene insertion 11, Michele Morange",MGI:5295470,0,"Tg(tetO-Hspb1,-lacZ)11Mmr",MGI:5295467
"Tg(tetO-Hspb1,-lacZ)16Mmr","transgene insertion 16, Michele Morange",MGI:5295473,0,"Tg(tetO-Hspb1,-lacZ)16Mmr",MGI:5295472
"Tg(tetO-Hspb1,-lacZ)1Mmr","transgene insertion 1, Michele Morange",MGI:5284851,0,"Tg(tetO-Hspb1,-lacZ)1Mmr",MGI:5284848
"Tg(tetO-LINE1*,-lacZ)#Ggs","transgene insertion, Gerald G Schumann",MGI:6220704,0,"Tg(tetO-LINE1*,-lacZ)#Ggs",MGI:6220703
"Tg(tetO-MYC,-OVAL)#Gtgm","transgene insertion, Ines Guetgemann",MGI:5811153,0,"Tg(tetO-MYC,-OVAL)#Gtgm",MGI:5811148
Tg(tetO-NR3C1)#Frje,"transgene insertion, Federic Jaisser",MGI:4437593,0,Tg(tetO-NR3C1)#Frje,MGI:5491011
Tg(tetO-Ppp3ca*)5Igta,"transgene insertion 5, Ignacio Torres-Aleman",MGI:5645759,0,Tg(tetO-Ppp3ca*)5Igta,MGI:5645756
Tg(tetO-Spp1)5Gad,"transgene insertion 5, Alain Gadeau",MGI:5475548,0,Tg(tetO-Spp1)5Gad,MGI:5475547
Tg(tetO-TNF)15Wxlr,"transgene insertion 15, Viktor Wixler",MGI:5804529,0,Tg(tetO-TNF)15Wxlr,MGI:5804456
"Tg(tetO-TPR/MET,-EGFP)12Tcre","transgene insertion 12, Tiziana Crepaldi",MGI:4949465,0,"Tg(tetO-TPR/MET,-EGFP)12Tcre",MGI:4949460
Tg(tetO-Tyr)1335Lmon,"transgene insertion 1335,  Lluis Montoliu",MGI:4443329,0,Tg(tetO-Tyr)1335Lmon,MGI:4443325
Tg(tetO-Utrn)1Ked,,MGI:2448084,,,
Tg(tetO-cre)1Lin,"transgene insertion 1, Jonas Lindeberg",MGI:3046554,0,Tg(tetO-cre)1Lin,MGI:3046552
Tg(tetO-cre)LC1Bjd,"transgene insertion LC1, Hermann Bujard",MGI:2448952,0,Tg(tetO-cre)LC1Bjd,MGI:2671943
"Tg(tetO-lacZ,-GFP/Gria1)A1.1Rsp","transgene insertion A1.1, Rolf Sprengel",MGI:4839474,0,"Tg(tetO-lacZ,-GFP/Gria1)A1.1Rsp",MGI:5495025
"Tg(tetO-lacZ,-GFP/Gria2)1Rsp","transgene insertion 1, Rolf Sprengel",MGI:5708835,0,"Tg(tetO-lacZ,-GFP/Gria2)1Rsp",MGI:5708832
"Tg(tetO-lacZ,-GFP/Gria2)6Rsp","transgene insertion 6, Rolf Sprengel",MGI:5708839,0,"Tg(tetO-lacZ,-GFP/Gria2)6Rsp",MGI:5708838
Tg(tetO/CMV-CFTR)TC35Clh,"transgene insertion TC35, Clare Huxley",MGI:5318248,0,Tg(tetO/CMV-CFTR)TC35Clh,MGI:5318246
Tgfb1i1<tm1a(KOMP)Wtsi>,"transforming growth factor beta 1 induced transcript 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050851,KOMP-CSD,Tgfb1i1,MGI:102784
Tgfb1i1<tm1b(KOMP)Wtsi>,"transforming growth factor beta 1 induced transcript 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636887,KOMP-CSD,Tgfb1i1,MGI:102784
Tgfbr2<tm1Roes>,"transforming growth factor, beta receptor II; targeted mutation 1, Jurgen Roes",MGI:3045693,0,Tgfbr2,MGI:98729
Tgif2<tm1a(EUCOMM)Wtsi>,"TGFB-induced factor homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433717,EUCOMM,Tgif2,MGI:1915299
Tgm2<tm1Gml>,"transglutaminase 2, C polypeptide; targeted mutation 1, Gerry Melino",MGI:2180638,0,Tgm2,MGI:98731
Tgm6<tm1a(KOMP)Wtsi>,"transglutaminase 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841076,KOMP-CSD,Tgm6,MGI:3044321
Th<tm1(cre)Te>,"tyrosine hydroxylase; targeted mutation 1, Ted Ebendal",MGI:3056580,0,Th,MGI:98735
Th<tm2Te>,"tyrosine hydroxylase; targeted mutation 2, Ted Ebendal",MGI:3487230,0,Th,MGI:98735
Thada<tm1a(KOMP)Wtsi>,"thyroid adenoma associated; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887588,KOMP-CSD,Thada,MGI:3039623
Themis2<tm1a(KOMP)Wtsi>,"thymocyte selection associated family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364708,KOMP-CSD,Themis2,MGI:2446213
Thra<tm1a(EUCOMM)Wtsi>,"thyroid hormone receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455948,EUCOMM,Thra,MGI:98742
Thra<tm2Jas>,"thyroid hormone receptor alpha; targeted mutation 2, Jacques Samarut",MGI:2183135,0,Thra,MGI:98742
Thra<tm2Ven>,"thyroid hormone receptor alpha; targeted mutation 2, Bjorn Vennstrom",MGI:2654864,0,Thra,MGI:98742
Thra<tm4.1Ven>,"thyroid hormone receptor alpha; targeted mutation 4.1, Bjorn Vennstrom",MGI:4847930,0,Thra,MGI:98742
Thrb<tm1Olc>,"thyroid hormone receptor beta; targeted mutation 1, Olivier Chassande",MGI:1860407,0,Thrb,MGI:98743
Thy1<a>,"thymus cell antigen 1, theta; a variant",MGI:3579311,0,Thy1,MGI:98747
Thy1<tm1Rjmo>,"thymus cell antigen 1, theta; targeted mutation 1, R J Morris",MGI:3586862,0,Thy1,MGI:98747
Tial1<tm1a(EUCOMM)Wtsi>,"Tia1 cytotoxic granule-associated RNA binding protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432495,EUCOMM,Tial1,MGI:107913
Tiam1<tm1Jgc>,"T cell lymphoma invasion and metastasis 1; targeted mutation 1, John G Collard",MGI:2183309,0,Tiam1,MGI:103306
Tie1<tm1Jpa>,"tyrosine kinase with immunoglobulin-like and EGF-like domains 1; targeted mutation 1, Juha Partanen",MGI:2159370,0,Tie1,MGI:99906
Tigar<tm1a(EUCOMM)Wtsi>,"Trp53 induced glycolysis repulatory phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441746,EUCOMM,Tigar,MGI:2442752
Tigit<tm1.1(IMPC)Wtsi>,,MGI:3642260,,,
Timeless<tm1a(EUCOMM)Hmgu>,"timeless circadian clock 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286357,EUCOMM,Timeless,MGI:1321393
Timm23<Gt(W023C08)Wrst>,"translocase of inner mitochondrial membrane 23; gene trap W023C08, Wolfgang Wurst",MGI:3848025,0,Timm23,MGI:1858317
Timm50<tm1a(EUCOMM)Wtsi>,"translocase of inner mitochondrial membrane 50; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433575,EUCOMM,Timm50,MGI:1913775
Timm9<tm1a(EUCOMM)Wtsi>,"translocase of inner mitochondrial membrane 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820271,EUCOMM,Timm9,MGI:1353436
Timmdc1<tm1a(EUCOMM)Wtsi>,"translocase of inner mitochondrial membrane domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441702,EUCOMM,Timmdc1,MGI:1922139
Timmdc1<tm1b(EUCOMM)Wtsi>,"translocase of inner mitochondrial membrane domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637083,EUCOMM,Timmdc1,MGI:1922139
Timp1<tm1a(EUCOMM)Hmgu>,"tissue inhibitor of metalloproteinase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841598,EUCOMM,Timp1,MGI:98752
Tkt<Gt(W126C03)Wrst>,"transketolase; gene trap W126C03, German Gene Trap Consortium",MGI:4123501,0,Tkt,MGI:105992
Tln1<tm1Crit>,"talin 1; targeted mutation 1, David R Critchley",MGI:2429594,0,Tln1,MGI:1099832
Tln1<tm1a(EUCOMM)Wtsi>,"talin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433023,EUCOMM,Tln1,MGI:1099832
Tln1<tm4.1Crit>,"talin 1; targeted mutation 4.1, David R Critchley",MGI:3770513,0,Tln1,MGI:1099832
Tln2<tm2Crit>,"talin 2; targeted mutation 2, David R Critchley",MGI:4358373,0,Tln2,MGI:1917799
Tlr4<lps-del>,"toll-like receptor 4; defective lipopolysaccharide response, deletion",MGI:1860755,0,Tlr4,MGI:96824
Tlx1<tm1Thr>,"T cell leukemia, homeobox 1; targeted mutation 1, Terence H Rabbitts",MGI:3581680,0,Tlx1,MGI:98769
Tm13,mutant Tm13,MGI:5646519,0,Tm13,MGI:5646513
Tm4,mutant Tm4,MGI:5646499,0,Tm4,MGI:5646400
Tm45,mutant Tm45; mutation Tm45,MGI:5646550,0,Tm45,MGI:5646410
Tm47,mutant Tm47,MGI:5646570,0,Tm47,MGI:5646423
Tm4sf1<tm1a(KOMP)Wtsi>,"transmembrane 4 superfamily member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052392,KOMP-CSD,Tm4sf1,MGI:104678
Tm4sf1<tm1b(KOMP)Wtsi>,,MGI:104678,,,
Tm58,mutant Tm58,MGI:5646529,0,Tm58,MGI:5646406
Tm59,mutant Tm59; mutation Tm59,MGI:5646555,0,Tm59,MGI:5646412
Tm60,mutant Tm60,MGI:5646558,0,Tm60,MGI:5646413
Tm7sf2<tm1Riro>,"transmembrane 7 superfamily member 2; targeted mutation 1, Rita Roberti",MGI:3826687,0,Tm7sf2,MGI:1920416
Tm7sf3<tm1a(EUCOMM)Hmgu>,"transmembrane 7 superfamily member 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5085423,EUCOMM,Tm7sf3,MGI:1914873
Tm9sf4<tm1a(KOMP)Wtsi>,"transmembrane 9 superfamily protein member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363779,KOMP-CSD,Tm9sf4,MGI:2139220
Tmbim1<tm1a(EUCOMM)Wtsi>,"transmembrane BAX inhibitor motif containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5284926,EUCOMM,Tmbim1,MGI:1916910
Tmc1<Mhdabth>,transmembrane channel-like gene family 1; Martin Hrabe de Angelis beethoven,MGI:2177263,0,Tmc1,MGI:2151016
Tmc1<dn>,transmembrane channel-like gene family 1; deafness,MGI:1856845,0,Tmc1,MGI:2151016
Tmc3<tm2a(KOMP)Wtsi>,"transmembrane channel-like gene family 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4455516,KOMP-CSD,Tmc3,MGI:2669033
Tmc3<tm2b(KOMP)Wtsi>,"transmembrane channel-like gene family 3; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548850,KOMP-CSD,Tmc3,MGI:2669033
Tmc6<tm1a(EUCOMM)Wtsi>,"transmembrane channel-like gene family 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434247,EUCOMM,Tmc6,MGI:1098686
Tmc8<tm1a(EUCOMM)Wtsi>,"transmembrane channel-like gene family 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432152,EUCOMM,Tmc8,MGI:2669037
Tmco2<tm1a(KOMP)Wtsi>,"transmembrane and coiled-coil domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419673,KOMP-CSD,Tmco2,MGI:1916719
Tmem108<tm1a(EUCOMM)Wtsi>,"transmembrane protein 108; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441635,EUCOMM,Tmem108,MGI:1932411
Tmem110<tm2a(KOMP)Wtsi>,"STIM activating enhancer; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4451382,KOMP-CSD,Stimate,MGI:1921500
Tmem110<tm2b(KOMP)Wtsi>,"STIM activating enhancer; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637076,KOMP-CSD,Stimate,MGI:1921500
Tmem116<tm1a(EUCOMM)Hmgu>,"transmembrane protein 116; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5085387,EUCOMM,Tmem116,MGI:1924712
Tmem126a<tm1a(EUCOMM)Wtsi>,"transmembrane protein 126A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432149,EUCOMM,Tmem126a,MGI:1913521
Tmem127<tm1(KOMP)Wtsi>,"transmembrane protein 127; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419725,KOMP-CSD,Tmem127,MGI:1916720
Tmem132a<tm1a(KOMP)Wtsi>,"transmembrane protein 132A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362366,KOMP-CSD,Tmem132a,MGI:2147810
Tmem165<tm1e(EUCOMM)Wtsi>,"transmembrane protein 165; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4432756,EUCOMM,Tmem165,MGI:894407
Tmem167<tm1a(EUCOMM)Hmgu>,"transmembrane protein 167; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435969,EUCOMM,Tmem167,MGI:1913324
Tmem185a<tm1a(KOMP)Wtsi>,"transmembrane protein 185A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431478,KOMP-CSD,Tmem185a,MGI:2448555
Tmem189<tm1a(KOMP)Wtsi>,"transmembrane protein 189; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363077,KOMP-CSD,Tmem189,MGI:2142624
Tmem18<tm1a(EUCOMM)Wtsi>,"transmembrane protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842746,EUCOMM,Tmem18,MGI:2387176
Tmem18<tm1b(EUCOMM)Wtsi>,"transmembrane protein 18; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637133,EUCOMM,Tmem18,MGI:2387176
Tmem211<m1Mhda>,"transmembrane protein 211; mutation 1, Martin Hrabe de Angelis",MGI:5818772,0,Tmem211,MGI:2685700
Tmem211<tm1a(KOMP)Wtsi>,"transmembrane protein 211; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4888873,KOMP-CSD,Tmem211,MGI:2685700
Tmem211<tm1b(KOMP)Wtsi>,,MGI:2685700,,,
Tmem240<m1Mhda>,"transmembrane protein 240; mutation 1, Martin Hrabe de Angelis",MGI:5818736,0,Tmem240,MGI:3648074
Tmem241<tm1a(EUCOMM)Wtsi>,"transmembrane protein 241; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4948650,EUCOMM,Tmem241,MGI:2442435
Tmem241<tm1b(EUCOMM)Wtsi>,"transmembrane protein 241; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637138,EUCOMM,Tmem241,MGI:2442435
Tmem254b<tm1a(KOMP)Wtsi>,"transmembrane protein 254b; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944325,KOMP-CSD,Tmem254b,MGI:3710397
Tmem255b<tm1a(EUCOMM)Hmgu>,"transmembrane protein 255B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436032,EUCOMM,Tmem255b,MGI:2685533
Tmem260<tm1a(KOMP)Wtsi>,"transmembrane protein 260; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4365196,KOMP-CSD,Tmem260,MGI:2443219
Tmem30a<tm1a(KOMP)Wtsi>,"transmembrane protein 30A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286179,KOMP-CSD,Tmem30a,MGI:106402
Tmem37<tm1a(EUCOMM)Wtsi>,"transmembrane protein 37; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441685,EUCOMM,Tmem37,MGI:2157899
Tmem42<tm1a(KOMP)Wtsi>,"transmembrane protein 42; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052383,KOMP-CSD,Tmem42,MGI:1277176
Tmem42<tm1b(KOMP)Wtsi>,"transmembrane protein 42; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636939,KOMP-CSD,Tmem42,MGI:1277176
Tmem51<tm1a(EUCOMM)Hmgu>,"transmembrane protein 51; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4951020,EUCOMM,Tmem51,MGI:2384874
Tmem54<tm1a(KOMP)Wtsi>,"transmembrane protein 54; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362446,KOMP-CSD,Tmem54,MGI:1913510
Tmem63b<tm1a(EUCOMM)Wtsi>,"transmembrane protein 63b; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433726,EUCOMM,Tmem63b,MGI:2387609
Tmem67<tm1Dgen>,"transmembrane protein 67; targeted mutation 1, Deltagen",MGI:5292220,Deltagen,Tmem67,MGI:1923928
Tmem68<tm1a(EUCOMM)Wtsi>,"transmembrane protein 68; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431978,EUCOMM,Tmem68,MGI:1919348
Tmem71<tm1a(KOMP)Wtsi>,"transmembrane protein 71; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4849968,KOMP-CSD,Tmem71,MGI:2146049
Tmem74b<tm1e(KOMP)Wtsi>,"transmembrane protein 74B; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4455528,KOMP-CSD,Tmem74b,MGI:1918629
Tmem98<tm1a(EUCOMM)Wtsi>,"transmembrane protein 98; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432615,EUCOMM,Tmem98,MGI:1923457
Tmem9<tm1a(EUCOMM)Wtsi>,"transmembrane protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433014,EUCOMM,Tmem9,MGI:1913491
Tmod3<tm1a(EUCOMM)Hmgu>,"tropomodulin 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435232,EUCOMM,Tmod3,MGI:1355315
Tmprss11c<tm2a(KOMP)Wtsi>,"transmembrane protease, serine 11c; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5299570,KOMP-CSD,Tmprss11c,MGI:3521861
Tmprss15<tm1a(KOMP)Wtsi>,"transmembrane protease, serine 15; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364308,KOMP-CSD,Tmprss15,MGI:1197523
Tmr10,mutant Tmr10,MGI:5646574,0,Tmr10,MGI:5646427
Tnf<tm1Gkl>,"tumor necrosis factor; targeted mutation 1, George Kollias",MGI:2149024,0,Tnf,MGI:104798
Tnf<tm1Ljo>,"tumor necrosis factor; targeted mutation 1, Lloyd J Old",MGI:1860250,0,Tnf,MGI:104798
Tnf<tm2.1Gkl>,"tumor necrosis factor; targeted mutation 2.1, George Kollias",MGI:3625620,0,Tnf,MGI:104798
Tnf<tm2Gkl>,"tumor necrosis factor; targeted mutation 2, George Kollias",MGI:2388715,0,Tnf,MGI:104798
Tnf<tm3Gkl>,"tumor necrosis factor; targeted mutation 3, George Kollias",MGI:3692522,0,Tnf,MGI:104798
Tnfaip1<tm1a(EUCOMM)Wtsi>,"tumor necrosis factor, alpha-induced protein 1 (endothelial); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433727,EUCOMM,Tnfaip1,MGI:104961
Tnfrsf1a<tm1Blt>,"tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1, Horst Bluethmann",MGI:1861040,0,Tnfrsf1a,MGI:1314884
Tnfrsf1a<tm1Gkl>,"tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1, George Kollias",MGI:3053140,0,Tnfrsf1a,MGI:1314884
Tnfrsf1a<tm2Gkl>,"tumor necrosis factor receptor superfamily, member 1a; targeted mutation 2, George Kollias",MGI:3686874,0,Tnfrsf1a,MGI:1314884
Tnfrsf1a<tm2a(EUCOMM)Wtsi>,"tumor necrosis factor receptor superfamily, member 1a; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5473067,EUCOMM,Tnfrsf1a,MGI:1314884
Tnfrsf1a<tm3.1Gkl>,"tumor necrosis factor receptor superfamily, member 1a; targeted mutation 3.1, George Kollias",MGI:5572949,0,Tnfrsf1a,MGI:1314884
Tnfrsf1b<tm1Mwm>,"tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1, Mark Moore",MGI:1857262,0,Tnfrsf1b,MGI:1314883
Tnfrsf1b<tm1a(EUCOMM)Wtsi>,"tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433096,EUCOMM,Tnfrsf1b,MGI:1314883
Tnfrsf9<tm1a(EUCOMM)Wtsi>,"tumor necrosis factor receptor superfamily, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432147,EUCOMM,Tnfrsf9,MGI:1101059
Tnfsf11<tles>,"tumor necrosis factor (ligand) superfamily, member 11; toothless",MGI:5307891,0,Tnfsf11,MGI:1100089
Tnfsf15<tm1Lex>,"tumor necrosis factor (ligand) superfamily, member 15; targeted mutation 1, Lexicon Genetics",MGI:5431588,Lexicon,Tnfsf15,MGI:2180140
Tnik<tm3a(EUCOMM)Wtsi>,"TRAF2 and NCK interacting kinase; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:5002995,EUCOMM,Tnik,MGI:1916264
Tnxb<tm1a(EUCOMM)Hmgu>,"tenascin XB; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451866,EUCOMM,Tnxb,MGI:1932137
Tollip<tm1Kbns>,"toll interacting protein; targeted mutation 1, Kimberly Burns",MGI:3619521,0,Tollip,MGI:1891808
Tomm20l<tm1a(EUCOMM)Wtsi>,"translocase of outer mitochondrial membrane 20-like; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441690,EUCOMM,Tomm20l,MGI:1922516
Tomm20l<tm1b(EUCOMM)Wtsi>,"translocase of outer mitochondrial membrane 20-like; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548653,EUCOMM,Tomm20l,MGI:1922516
Tomm6<tm1a(KOMP)Wtsi>,"translocase of outer mitochondrial membrane 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4940754,KOMP-CSD,Tomm6,MGI:1913369
Tor1aip1<tm1a(EUCOMM)Hmgu>,"torsin A interacting protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5514583,EUCOMM,Tor1aip1,MGI:3582693
Tor3a<tm1a(EUCOMM)Wtsi>,"torsin family 3, member A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820314,EUCOMM,Tor3a,MGI:1353652
Tox3<tm1b(KOMP)Mbp>,"TOX high mobility group box family member 3; targeted mutation 1b, Mouse Biology Program, UCDavis",MGI:5548886,KOMP-CSD,Tox3,MGI:3039593
Tox3<tm1d(KOMP)Mbp>,"TOX high mobility group box family member 3; targeted mutation 1d, Mouse Biology Program, UCDavis",MGI:6119413,KOMP-CSD,Tox3,MGI:3039593
Tpcn1<Gt(OST359423)Lex>,"two pore channel 1; gene trap OST359423, Lexicon Genetics",MGI:3529820,Lexicon,Tpcn1,MGI:2182472
Tpcn1<tm1Dgen>,"two pore channel 1; targeted mutation 1, Deltagen",MGI:5427695,Deltagen,Tpcn1,MGI:2182472
Tpcn2<tm1Lex>,"two pore segment channel 2; targeted mutation 1, Lexicon Genetics",MGI:3528890,Lexicon,Tpcn2,MGI:2385297
Tpcn2<tm1a(EUCOMM)Hmgu>,"two pore segment channel 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4842149,EUCOMM,Tpcn2,MGI:2385297
Tpd52l2<tm1a(KOMP)Wtsi>,"tumor protein D52-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363000,KOMP-CSD,Tpd52l2,MGI:1913564
Tpi1<a-M1Neu>,"triosephosphate isomerase 1; mutation 1, Neuherberg",MGI:2183489,0,Tpi1,MGI:98797
Tpi1<a-M3Neu>,"triosephosphate isomerase 1; mutation 3, Neuherberg",MGI:2183492,0,Tpi1,MGI:98797
Tpi1<a-M4Neu>,"triosephosphate isomerase 1; mutation 4, Neuherberg",MGI:2183493,0,Tpi1,MGI:98797
Tpi1<a-m6Neu>,"triosephosphate isomerase 1; mutation 6, Neuherberg",MGI:4821798,0,Tpi1,MGI:98797
Tpi1<tm1a(EUCOMM)Wtsi>,"triosephosphate isomerase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432885,EUCOMM,Tpi1,MGI:98797
Tpm1<tm1a(EUCOMM)Wtsi>,"tropomyosin 1, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842867,EUCOMM,Tpm1,MGI:98809
Traf2<tm1a(EUCOMM)Wtsi>,"TNF receptor-associated factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452008,EUCOMM,Traf2,MGI:101835
Traf3ip3<tm1a(KOMP)Wtsi>,"TRAF3 interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363678,KOMP-CSD,Traf3ip3,MGI:2441706
Traf6<tm2a(EUCOMM)Wtsi>,"TNF receptor-associated factor 6; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840586,EUCOMM,Traf6,MGI:108072
Trafd1<tm1a(EUCOMM)Wtsi>,"TRAF type zinc finger domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432441,EUCOMM,Trafd1,MGI:1923551
Tram2<tm1a(KOMP)Wtsi>,"translocating chain-associating membrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4949327,KOMP-CSD,Tram2,MGI:1924817
Trap1a<tm1Jvde>,"tumor rejection antigen P1A; targeted mutation 1, Benoit Van den Eynd",MGI:5645784,0,Trap1a,MGI:98818
Trappc10<tm1a(KOMP)Wtsi>,"trafficking protein particle complex 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419611,KOMP-CSD,Trappc10,MGI:1336209
Trappc10<tm1b(KOMP)Wtsi>,"trafficking protein particle complex 10; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636961,KOMP-CSD,Trappc10,MGI:1336209
Trappc9<tm1a(EUCOMM)Wtsi>,"trafficking protein particle complex 9; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461737,EUCOMM,Trappc9,MGI:1923760
Trdn<tm1.2Isma>,"triadin; targeted mutation 1.2, Isabelle Marty",MGI:4437311,0,Trdn,MGI:1924007
Treml1<tm1a(EUCOMM)Hmgu>,"triggering receptor expressed on myeloid cells-like 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436002,EUCOMM,Treml1,MGI:1918576
Trex1<tm1(KOMP)Wtsi>,"three prime repair exonuclease 1; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4362876,KOMP-CSD,Trex1,MGI:1328317
Trib2<tm1Lex>,"tribbles pseudokinase 2; targeted mutation 1, Lexicon Genetics",MGI:5430770,Lexicon,Trib2,MGI:2145021
Trib3<Gt(OST324148)Lex>,"tribbles pseudokinase 3; gene trap OST324148, Lexicon Genetics",MGI:4280770,Lexicon,Trib3,MGI:1345675
Trib3<tm1a(EUCOMM)Hmgu>,"tribbles pseudokinase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435061,EUCOMM,Trib3,MGI:1345675
Trim15<tm1a(EUCOMM)Hmgu>,"tripartite motif-containing 15; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5428629,EUCOMM,Trim15,MGI:1916347
Trim15<tm1b(EUCOMM)Hmgu>,"tripartite motif-containing 15; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5588277,EUCOMM,Trim15,MGI:1916347
Trim17<tm1e(EUCOMM)Wtsi>,"tripartite motif-containing 17; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4452788,EUCOMM,Trim17,MGI:1861440
Trim25<tm2a(EUCOMM)Hmgu>,"tripartite motif-containing 25; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511539,EUCOMM,Trim25,MGI:102749
Trim29<tm1a(EUCOMM)Wtsi>,"tripartite motif-containing 29; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434517,EUCOMM,Trim29,MGI:1919419
Trim29<tm1b(EUCOMM)Wtsi>,"tripartite motif-containing 29; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548617,EUCOMM,Trim29,MGI:1919419
Trim39<tm1a(EUCOMM)Hmgu>,"tripartite motif-containing 39; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434684,EUCOMM,Trim39,MGI:1890659
Trim3<tm1Mak>,"tripartite motif-containing 3; targeted mutation 1, Tak Mak",MGI:4459821,0,Trim3,MGI:1860040
Trim45<tm3a(KOMP)Wtsi>,"tripartite motif-containing 45; targeted mutation 3a, Wellcome Trust Sanger Institute",MGI:5002917,KOMP-CSD,Trim45,MGI:1918187
Trim56<tm1a(EUCOMM)Wtsi>,"tripartite motif-containing 56; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5527611,EUCOMM,Trim56,MGI:2685298
Trim65<tm1a(KOMP)Wtsi>,"tripartite motif-containing 65; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363168,KOMP-CSD,Trim65,MGI:2442815
Trim65<tm1b(KOMP)Wtsi>,"tripartite motif-containing 65; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637142,KOMP-CSD,Trim65,MGI:2442815
Trim66<tm1a(EUCOMM)Wtsi>,"tripartite motif-containing 66; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431799,EUCOMM,Trim66,MGI:2152406
Trmt10a<tm1a(EUCOMM)Wtsi>,"tRNA methyltransferase 10A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432852,EUCOMM,Trmt10a,MGI:1920421
Trmt2a<tm2a(EUCOMM)Wtsi>,"TRM2 tRNA methyltransferase 2A; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840625,EUCOMM,Trmt2a,MGI:96270
Trmt2a<tm2b(EUCOMM)Wtsi>,"TRM2 tRNA methyltransferase 2A; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548943,EUCOMM,Trmt2a,MGI:96270
Trnt1<tm1a(EUCOMM)Hmgu>,"tRNA nucleotidyl transferase, CCA-adding, 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435001,EUCOMM,Trnt1,MGI:1917297
Trp53<tm1Brd>,"transformation related protein 53; targeted mutation 1, Allan Bradley",MGI:1857590,0,Trp53,MGI:98834
Trp53<tm1Brn>,"transformation related protein 53; targeted mutation 1, Anton Berns",MGI:1931011,0,Trp53,MGI:98834
Trp53<tm1Holl>,"transformation related protein 53; targeted mutation 1, Monica Hollstein",MGI:2157167,0,Trp53,MGI:98834
Trp53<tm1a(EUCOMM)Hmgu>,"transformation related protein 53; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451930,EUCOMM,Trp53,MGI:98834
Trp53<tm4Holl>,"transformation related protein 53; targeted mutation 4, Monica Hollstein",MGI:5645787,0,Trp53,MGI:98834
Trp53inp1<tm1Acar>,"transformation related protein 53 inducible nuclear protein 1; targeted mutation 1, Alice Carrier",MGI:3700974,0,Trp53inp1,MGI:1926609
Trp53rkb<tm1a(EUCOMM)Wtsi>,"transformation related protein 53 regulating kinase B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820320,EUCOMM,Trp53rkb,MGI:1914050
Trp53tg5<tm1a(KOMP)Wtsi>,"transformation related protein 53 target 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363427,KOMP-CSD,Trp53tg5,MGI:1920853
Trp63<m1Mhda>,"transformation related protein 63; mutation 1, Martin Hrabe de Angelis",MGI:5702898,0,Trp63,MGI:1330810
Trpc3<Mwk>,"transient receptor potential cation channel, subfamily C, member 3; moonwalker",MGI:3689326,0,Trpc3,MGI:109526
Trpc4<tm1Dgen>,"transient receptor potential cation channel, subfamily C, member 4; targeted mutation 1, Deltagen",MGI:5427696,Deltagen,Trpc4,MGI:109525
Trpc6<tm1Dgen>,"transient receptor potential cation channel, subfamily C, member 6; targeted mutation 1, Deltagen",MGI:5427697,Deltagen,Trpc6,MGI:109523
Trpm1<tm1Lex>,"transient receptor potential cation channel, subfamily M, member 1; targeted mutation 1, Lexicon Genetics",MGI:3528857,Lexicon,Trpm1,MGI:1330305
Trpm1<tm1a(KOMP)Wtsi>,"transient receptor potential cation channel, subfamily M, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5287780,KOMP-CSD,Trpm1,MGI:1330305
Trpm3<tm1Lex>,"transient receptor potential cation channel, subfamily M, member 3; targeted mutation 1, Lexicon Genetics",MGI:3528836,Lexicon,Trpm3,MGI:2443101
Trrap<tm1.1Zqw>,"transformation/transcription domain-associated protein; targeted mutation 1.1, Zhao-Qi Wang",MGI:2446468,0,Trrap,MGI:2153272
Trrap<tm1a(EUCOMM)Wtsi>,"transformation/transcription domain-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433230,EUCOMM,Trrap,MGI:2153272
Trub2<tm2a(EUCOMM)Wtsi>,"TruB pseudouridine (psi) synthase family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840623,EUCOMM,Trub2,MGI:2442186
Tsfm<tm1a(EUCOMM)Wtsi>,"Ts translation elongation factor, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432572,EUCOMM,Tsfm,MGI:1913649
Tspo<tm1a(EUCOMM)Wtsi>,"translocator protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5009653,EUCOMM,Tspo,MGI:88222
Tspo<tm1b(EUCOMM)Wtsi>,"translocator protein; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5614711,EUCOMM,Tspo,MGI:88222
Tspyl2<tm1a(KOMP)Wtsi>,"TSPY-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880895,KOMP-CSD,Tspyl2,MGI:106244
Ttc39b<tm1e(EUCOMM)Wtsi>,"tetratricopeptide repeat domain 39B; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4431723,EUCOMM,Ttc39b,MGI:1917113
Ttf2<tm1a(EUCOMM)Wtsi>,"transcription termination factor, RNA polymerase II; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441689,EUCOMM,Ttf2,MGI:1921294
Ttll11<tm1a(EUCOMM)Wtsi>,"tubulin tyrosine ligase-like family, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820338,EUCOMM,Ttll11,MGI:1921660
Ttll12<tm1e(EUCOMM)Wtsi>,"tubulin tyrosine ligase-like family, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4433627,EUCOMM,Ttll12,MGI:3039573
Ttll12<tm1e.1(EUCOMM)Wtsi>,,MGI:3039573,,,
Ttll1<tm1a(EUCOMM)Wtsi>,"tubulin tyrosine ligase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432051,EUCOMM,Ttll1,MGI:2443047
Ttll3<tm1a(EUCOMM)Wtsi>,"tubulin tyrosine ligase-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433856,EUCOMM,Ttll3,MGI:2141418
Ttll4<tm1a(EUCOMM)Wtsi>,"tubulin tyrosine ligase-like family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433211,EUCOMM,Ttll4,MGI:1914784
Tuba1a<Jna>,"tubulin, alpha 1A; jenna",MGI:3617352,Harwell ENU Mutagenesis,Tuba1a,MGI:98869
Tuba3a<tm1a(KOMP)Wtsi>,"tubulin, alpha 3A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5052393,KOMP-CSD,Tuba3a,MGI:1095406
Tuba3a<tm1b(KOMP)Wtsi>,"tubulin, alpha 3A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636920,KOMP-CSD,Tuba3a,MGI:1095406
Tuft1<tm1a(KOMP)Wtsi>,"tuftelin 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419443,KOMP-CSD,Tuft1,MGI:109572
Tulp3<tm1a(EUCOMM)Hmgu>,"tubby-like protein 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435073,EUCOMM,Tulp3,MGI:1329045
Tulp4<tm1a(KOMP)Wtsi>,"tubby like protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4365109,KOMP-CSD,Tulp4,MGI:1916092
Tut4<tm1a(KOMP)Wtsi>,"terminal uridylyl transferase 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5296547,KOMP-CSD,Tut4,MGI:2445126
Tvp23a<tm1a(KOMP)Wtsi>,"trans-golgi network vesicle protein 23A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419354,KOMP-CSD,Tvp23a,MGI:3665441
Twf1<tm1a(EUCOMM)Wtsi>,"twinfilin actin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434218,EUCOMM,Twf1,MGI:1100520
Twist1<Pas>,twist basic helix-loop-helix transcription factor 1; Pasteur,MGI:2684436,0,Twist1,MGI:98872
Txnip<tm1a(EUCOMM)Hmgu>,"thioredoxin interacting protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5008885,EUCOMM,Txnip,MGI:1889549
Txnrd1<tm1Marc>,"thioredoxin reductase 1; targeted mutation 1, Marcus Conrad",MGI:3574358,0,Txnrd1,MGI:1354175
Tyk2<tm1Biat>,"tyrosine kinase 2; targeted mutation 1, Biomodels Austria",MGI:5438711,0,Tyk2,MGI:1929470
Tyk2<tm1Mmul>,"tyrosine kinase 2; targeted mutation 1, Mathias Muller",MGI:5636662,0,Tyk2,MGI:1929470
Tyk2<tm2b(EUCOMM)Hmgu>,,MGI:1929470,,,
Tyk2<tm3.1Biat>,"tyrosine kinase 2; targeted mutation 3.1, Biomodels Austria",MGI:5438771,0,Tyk2,MGI:1929470
Tyr<c-32DSD>,"tyrosinase; albino deletion 32DSD, Oak Ridge",MGI:2153771,0,Tyr,MGI:98880
Tyr<c-Brd>,"tyrosinase; albino, Allan Bradley",MGI:3640303,0,Tyr,MGI:98880
Tyr<c-ch62H>,tyrosinase; chinchilla 62 Harwell,MGI:5288227,0,Tyr,MGI:98880
Tyr<c-em>,tyrosinase; extreme dilution mottled,MGI:2683485,0,Tyr,MGI:98880
Tyr<c-m>,tyrosinase; chinchilla mottled,MGI:1855980,0,Tyr,MGI:98880
Tyr<c>,tyrosinase; albino,MGI:1855976,0,Tyr,MGI:98880
Tyrobp<tm1.1Viv>,"TYRO protein tyrosine kinase binding protein; targeted mutation 1.1, Eric Vivier",MGI:2386271,0,Tyrobp,MGI:1277211
Uba2<tm1a(KOMP)Wtsi>,"ubiquitin-like modifier activating enzyme 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362341,KOMP-CSD,Uba2,MGI:1858313
Ubac2<tm1e.1(EUCOMM)Hmgu>,,MGI:1916139,,,
Ubap1<tm1a(EUCOMM)Wtsi>,"ubiquitin-associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433059,EUCOMM,Ubap1,MGI:2149543
Ubash3a<tm1a(KOMP)Wtsi>,"ubiquitin associated and SH3 domain containing, A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4940752,KOMP-CSD,Ubash3a,MGI:1926074
Ubash3a<tm1b(KOMP)Wtsi>,"ubiquitin associated and SH3 domain containing, A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5605803,KOMP-CSD,Ubash3a,MGI:1926074
Ube2b<tm1a(EUCOMM)Wtsi>,"ubiquitin-conjugating enzyme E2B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431903,EUCOMM,Ube2b,MGI:102944
Ube2t<tm1a(EUCOMM)Hmgu>,"ubiquitin-conjugating enzyme E2T; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5000371,EUCOMM,Ube2t,MGI:1914446
Ube2u<tm1e(KOMP)Wtsi>,"ubiquitin-conjugating enzyme E2U (putative); targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4363149,KOMP-CSD,Ube2u,MGI:3588216
Ube3b<Gt(RRJ142)Byg>,"ubiquitin protein ligase E3B; gene trap RRJ142, BayGenomics",MGI:4129255,0,Ube3b,MGI:1891295
Ubxn10<tm1a(EUCOMM)Wtsi>,"UBX domain protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458847,EUCOMM,Ubxn10,MGI:2443123
Ubxn10<tm1b(EUCOMM)Wtsi>,"UBX domain protein 10; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637146,EUCOMM,Ubxn10,MGI:2443123
Uchl1<tm1a(EUCOMM)Hmgu>,"ubiquitin carboxy-terminal hydrolase L1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4451787,EUCOMM,Uchl1,MGI:103149
Uck1<tm2a(KOMP)Wtsi>,"uridine-cytidine kinase 1; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4362314,KOMP-CSD,Uck1,MGI:98904
Ucn2<tm1.1Jde>,"urocortin 2; targeted mutation 1.1, Jan Deussing",MGI:4818656,0,Ucn2,MGI:2176375
Ucn3<tm1.1Jde>,"urocortin 3; targeted mutation 1.1, Jan Deussing",MGI:4818652,0,Ucn3,MGI:1932970
Ucp1<tm1a(EUCOMM)Hmgu>,"uncoupling protein 1 (mitochondrial, proton carrier); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4841543,EUCOMM,Ucp1,MGI:98894
Uevld<tm1a(EUCOMM)Wtsi>,"UEV and lactate/malate dehyrogenase domains; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434449,EUCOMM,Uevld,MGI:1860490
Ufd1<tm1Bld>,"ubiquitin recognition factor in ER-associated degradation 1; targeted mutation 1, Antonio Baldini",MGI:3640091,0,Ufd1,MGI:109353
Ufl1<tm1a(EUCOMM)Wtsi>,"UFM1 specific ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432479,EUCOMM,Ufl1,MGI:1914740
Ugt2b1<tm1a(KOMP)Wtsi>,"UDP glucuronosyltransferase 2 family, polypeptide B1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362666,KOMP-CSD,Ugt2b1,MGI:1919023
Ugt2b1<tm1b(KOMP)Wtsi>,,MGI:1919023,,,
Ugt2b5<tm1a(KOMP)Wtsi>,"UDP glucuronosyltransferase 2 family, polypeptide B5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362467,KOMP-CSD,Ugt2b5,MGI:98900
Uhrf1<Gt(XL796)Byg>,"ubiquitin-like, containing PHD and RING finger domains, 1; gene trap XL796, BayGenomics",MGI:4128501,0,Uhrf1,MGI:1338889
Uhrf1<tm1a(EUCOMM)Wtsi>,"ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434100,EUCOMM,Uhrf1,MGI:1338889
Umodl1<tm1a(KOMP)Wtsi>,"uromodulin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5289814,KOMP-CSD,Umodl1,MGI:1929785
Unc13a<tm1Bros>,"unc-13 homolog A; targeted mutation 1, Nils Brose",MGI:2449468,0,Unc13a,MGI:3051532
Unc13b<tm1Rmnd>,"unc-13 homolog B; targeted mutation 1, Christian Rosenmund",MGI:2449706,0,Unc13b,MGI:1342278
Unc13c<tm1Bros>,"unc-13 homolog C; targeted mutation 1, Nils Brose",MGI:2449467,0,Unc13c,MGI:2149021
Unc45a<tm1a(EUCOMM)Hmgu>,"unc-45 myosin chaperone A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434645,EUCOMM,Unc45a,MGI:2142246
Unk<tm1a(KOMP)Wtsi>,"unkempt family zinc finger; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4880910,KOMP-CSD,Unk,MGI:2442456
Upb1<tm1a(EUCOMM)Wtsi>,"ureidopropionase, beta; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441733,EUCOMM,Upb1,MGI:2143535
Upk1b<tm1a(KOMP)Wtsi>,"uroplakin 1B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5287790,KOMP-CSD,Upk1b,MGI:98912
Uqcr11<tm1a(EUCOMM)Wtsi>,"ubiquinol-cytochrome c reductase, complex III subunit XI; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4434286,EUCOMM,Uqcr11,MGI:1913844
Uqcrb<tm1a(EUCOMM)Wtsi>,"ubiquinol-cytochrome c reductase binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5006762,EUCOMM,Uqcrb,MGI:1914780
Uqcrb<tm1b(EUCOMM)Wtsi>,"ubiquinol-cytochrome c reductase binding protein; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548543,EUCOMM,Uqcrb,MGI:1914780
Uri1<tm1a(EUCOMM)Wtsi>,"URI1, prefoldin-like chaperone; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4942141,EUCOMM,Uri1,MGI:1342294
Uros<tm1Cged>,"uroporphyrinogen III synthase; targeted mutation 1, Cecile Ged",MGI:3619379,0,Uros,MGI:98917
Uros<tm1a(EUCOMM)Wtsi>,"uroporphyrinogen III synthase; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433834,EUCOMM,Uros,MGI:98917
Ush1c<tm1a(KOMP)Wtsi>,"USH1 protein network component harmonin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363497,KOMP-CSD,Ush1c,MGI:1919338
Ushbp1<tm1a(EUCOMM)Wtsi>,"USH1 protein network component harmonin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460519,EUCOMM,Ushbp1,MGI:1922920
Usmg5<tm1a(EUCOMM)Wtsi>,"ATP synthase membrane subunit DAPIT; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4820248,EUCOMM,Atp5md,MGI:1891435
Usp11<tm1(KOMP)Wtsi>,"ubiquitin specific peptidase 11; targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419682,KOMP-CSD,Usp11,MGI:2384312
Usp12<tm1a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 12; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434551,EUCOMM,Usp12,MGI:1270128
Usp12<tm1b(EUCOMM)Hmgu>,"ubiquitin specific peptidase 12; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548414,EUCOMM,Usp12,MGI:1270128
Usp13<tm1a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 13 (isopeptidase T-3); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5544972,EUCOMM,Usp13,MGI:1919857
Usp14<tm2a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 14; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4460420,EUCOMM,Usp14,MGI:1928898
Usp15<tm1a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 15; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008042,EUCOMM,Usp15,MGI:101857
Usp20<tm1a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 20; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434938,EUCOMM,Usp20,MGI:1921520
Usp21<tm1a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 21; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887724,EUCOMM,Usp21,MGI:1353665
Usp22<tm1a(KOMP)Wtsi>,"ubiquitin specific peptidase 22; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364127,KOMP-CSD,Usp22,MGI:2144157
Usp24<tm1a(KOMP)Wtsi>,"ubiquitin specific peptidase 24; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4847688,KOMP-CSD,Usp24,MGI:1919936
Usp25<tm1a(KOMP)Mbp>,"ubiquitin specific peptidase 25; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4455349,KOMP-CSD,Usp25,MGI:1353655
Usp2<tm1a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286393,EUCOMM,Usp2,MGI:1858178
Usp30<tm2a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 30; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH",MGI:5511766,EUCOMM,Usp30,MGI:2140991
Usp33<tm1a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 33; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433766,EUCOMM,Usp33,MGI:2159711
Usp38<tm1a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 38; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455680,EUCOMM,Usp38,MGI:1922091
Usp3<tm1a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432395,EUCOMM,Usp3,MGI:2152450
Usp42<tm2a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 42; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4432706,EUCOMM,Usp42,MGI:1924050
Usp44<tm1a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 44; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455886,EUCOMM,Usp44,MGI:3045318
Usp4<tm1a(EUCOMM)Wtsi>,"ubiquitin specific peptidase 4 (proto-oncogene); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431578,EUCOMM,Usp4,MGI:98905
Usp54<tm1a(KOMP)Wtsi>,"ubiquitin specific peptidase 54; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5286230,KOMP-CSD,Usp54,MGI:1926037
Usp5<tm1a(EUCOMM)Hmgu>,"ubiquitin specific peptidase 5 (isopeptidase T); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4942058,EUCOMM,Usp5,MGI:1347343
Utrn<tm1Ked>,"utrophin; targeted mutation 1, Kay E Davies",MGI:2148589,0,Utrn,MGI:104631
Vamp3<tm2a(EUCOMM)Wtsi>,"vesicle-associated membrane protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527590,EUCOMM,Vamp3,MGI:1321389
Vangl1<tm1e(KOMP)Wtsi>,"VANGL planar cell polarity 1; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4365105,KOMP-CSD,Vangl1,MGI:2159344
Vat1l<tm1a(EUCOMM)Hmgu>,"vesicle amine transport protein 1 like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436304,EUCOMM,Vat1l,MGI:2142534
Vav1<tm2Bbd>,"vav 1 oncogene; targeted mutation 2, Mariano Barbacid",MGI:2387840,0,Vav1,MGI:98923
Vav2<tm1Kdf>,"vav 2 oncogene; targeted mutation 1, Klaus-Dieter Fischer",MGI:2387822,0,Vav2,MGI:102718
Vax1<tm1Pgr>,"ventral anterior homeobox 1; targeted mutation 1, Peter Gruss",MGI:1859922,0,Vax1,MGI:1277163
Vax2<tm1Sba>,"ventral anterior homeobox 2; targeted mutation 1, Sandro Banfi",MGI:2159246,0,Vax2,MGI:1346018
Vdac1<Gt(A023F03)Wrst>,"voltage-dependent anion channel 1; gene trap A023F03, German Gene Trap Consortium",MGI:4122712,0,Vdac1,MGI:106919
Vdac1<tm1a(EUCOMM)Wtsi>,"voltage-dependent anion channel 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432270,EUCOMM,Vdac1,MGI:106919
Vegfc<tm1Ali>,"vascular endothelial growth factor C; targeted mutation 1, Kari Alitalo",MGI:3026650,0,Vegfc,MGI:109124
Vezt<tm1.1Smc>,"vezatin, adherens junctions transmembrane protein; targeted mutation 1.1, Marie C Simmler",MGI:3618234,0,Vezt,MGI:2143698
Vezt<tm1.2Smc>,"vezatin, adherens junctions transmembrane protein; targeted mutation 1.2, Marie C Simmler",MGI:5749802,0,Vezt,MGI:2143698
Vezt<tm1Smc>,"vezatin, adherens junctions transmembrane protein; targeted mutation 1, Marie C Simmler",MGI:3618233,0,Vezt,MGI:2143698
Vgll4<tm1b(EUCOMM)Hmgu>,,MGI:2652840,,,
Vim<tm1Cba>,"vimentin; targeted mutation 1, Charles Babinet",MGI:1931877,0,Vim,MGI:98932
Vim<tm2Cba>,"vimentin; targeted mutation 2, Charles Babinet",MGI:1931879,0,Vim,MGI:98932
Vipr1<tm1Dgen>,"vasoactive intestinal peptide receptor 1; targeted mutation 1, Deltagen",MGI:5427698,Deltagen,Vipr1,MGI:109272
Vng,van gogh; van Gogh,MGI:1862013,Harwell ENU Mutagenesis,Vng,MGI:1861989
Vps13a<tm1a(EUCOMM)Wtsi>,"vacuolar protein sorting 13A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842502,EUCOMM,Vps13a,MGI:2444304
Vps13a<tm1b(EUCOMM)Wtsi>,"vacuolar protein sorting 13A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637150,EUCOMM,Vps13a,MGI:2444304
Vps13c<tm1a(EUCOMM)Hmgu>,"vacuolar protein sorting 13C; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4460376,EUCOMM,Vps13c,MGI:2444207
Vps13c<tm1b(EUCOMM)Hmgu>,"vacuolar protein sorting 13C; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548822,EUCOMM,Vps13c,MGI:2444207
Vps33b<tm1a(EUCOMM)Wtsi>,"vacuolar protein sorting 33B; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431968,EUCOMM,Vps33b,MGI:2446237
Vps51<tm1a(KOMP)Wtsi>,"VPS51 GARP complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4458528,KOMP-CSD,Vps51,MGI:1915755
Vps53<tm1a(KOMP)Wtsi>,"VPS53 GARP complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4451513,KOMP-CSD,Vps53,MGI:1915549
Vps54<Gt(RRI497)Byg>,"VPS54 GARP complex subunit; gene trap RRI497, BayGenomics",MGI:3613397,0,Vps54,MGI:2178798
Vps54<wr>,VPS54 GARP complex subunit; wobbler,MGI:1857091,0,Vps54,MGI:2178798
Vps72<tm1a(EUCOMM)Wtsi>,"vacuolar protein sorting 72; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5008033,EUCOMM,Vps72,MGI:1202305
Vwa3a<tm1a(KOMP)Wtsi>,"von Willebrand factor A domain containing 3A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363306,KOMP-CSD,Vwa3a,MGI:3041229
Vwa3a<tm1b(KOMP)Wtsi>,"von Willebrand factor A domain containing 3A; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637178,KOMP-CSD,Vwa3a,MGI:3041229
Vwa5b1<tm1a(KOMP)Wtsi>,"von Willebrand factor A domain containing 5B1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460271,KOMP-CSD,Vwa5b1,MGI:1922968
Vwa5b2<tm1a(KOMP)Wtsi>,"von Willebrand factor A domain containing 5B2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419897,KOMP-CSD,Vwa5b2,MGI:2681859
Vwa8<tm1a(EUCOMM)Wtsi>,"von Willebrand factor A domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441772,EUCOMM,Vwa8,MGI:1919008
Vwa8<tm1b(EUCOMM)Wtsi>,"von Willebrand factor A domain containing 8; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5614704,EUCOMM,Vwa8,MGI:1919008
Vxn<tm1a(KOMP)Wtsi>,"vexin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4843828,KOMP-CSD,Vxn,MGI:1924232
Vxn<tm1b(KOMP)Wtsi>,,MGI:1924232,,,
Wac<tm2a(EUCOMM)Wtsi>,"WW domain containing adaptor with coiled-coil; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:5527595,EUCOMM,Wac,MGI:2387357
Wac<tm2b(EUCOMM)Wtsi>,"WW domain containing adaptor with coiled-coil; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637134,EUCOMM,Wac,MGI:2387357
Wac<tm2c(EUCOMM)Wtsi>,,MGI:2387357,,,
Wars<tm1a(EUCOMM)Hmgu>,"tryptophanyl-tRNA synthetase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435065,EUCOMM,Wars,MGI:104630
Wars<tm1b(EUCOMM)Hmgu>,"tryptophanyl-tRNA synthetase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548346,EUCOMM,Wars,MGI:104630
Washc2<tm2b(KOMP)Wtsi>,,MGI:106463,,,
Wbp2<tm2a(EUCOMM)Wtsi>,"WW domain binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4847848,EUCOMM,Wbp2,MGI:104709
Wc2,waved coat 2,MGI:4834171,0,Wc2,MGI:4834173
Wdr37<tm1a(KOMP)Wtsi>,"WD repeat domain 37; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4452651,KOMP-CSD,Wdr37,MGI:1920393
Wdr3<tm1a(KOMP)Wtsi>,"WD repeat domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362309,KOMP-CSD,Wdr3,MGI:2443143
Wdr47<tm1a(EUCOMM)Wtsi>,"WD repeat domain 47; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433065,EUCOMM,Wdr47,MGI:2139593
Wdr59<tm1a(EUCOMM)Wtsi>,"WD repeat domain 59; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4461692,EUCOMM,Wdr59,MGI:2442115
Wdr89<tm1a(KOMP)Wtsi>,"WD repeat domain 89; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944354,KOMP-CSD,Wdr89,MGI:1919588
Wdsub1<tm1a(EUCOMM)Wtsi>,"WD repeat, SAM and U-box domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453693,EUCOMM,Wdsub1,MGI:1919387
Wdsub1<tm1b(EUCOMM)Wtsi>,"WD repeat, SAM and U-box domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5588281,EUCOMM,Wdsub1,MGI:1919387
Wdtc1<tm1a(KOMP)Wtsi>,"WD and tetratricopeptide repeats 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362336,KOMP-CSD,Wdtc1,MGI:2685541
Wfdc18<tm1a(KOMP)Wtsi>,"WAP four-disulfide core domain 18; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363398,KOMP-CSD,Wfdc18,MGI:107506
Wfdc6a<tm1a(EUCOMM)Wtsi>,"WAP four-disulfide core domain 6A; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5141846,EUCOMM,Wfdc6a,MGI:2684968
Wfikkn2<tm1a(EUCOMM)Wtsi>,"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4455985,EUCOMM,Wfikkn2,MGI:2669209
Wfikkn2<tm1b(EUCOMM)Wtsi>,"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637164,EUCOMM,Wfikkn2,MGI:2669209
Whrn<tm1a(EUCOMM)Wtsi>,"whirlin; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432119,EUCOMM,Whrn,MGI:2682003
Whrn<wi>,whirlin; whirler,MGI:1857090,0,Whrn,MGI:2682003
Whto,white toes; whitetoes,MGI:1862008,0,Whto,MGI:1861986
Wisp1<tm1Lex>,"cellular communication network factor 4; targeted mutation 1, Lexicon Genetics",MGI:5430817,Lexicon,Ccn4,MGI:1197008
Wls<tm1a(EUCOMM)Hmgu>,"wntless WNT ligand secretion mediator; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4455675,EUCOMM,Wls,MGI:1915401
Wnt11<tm1Amc>,"wingless-type MMTV integration site family, member 11; targeted mutation 1, Andrew P McMahon",MGI:2665014,0,Wnt11,MGI:101948
Wnt16<tm2a(EUCOMM)Wtsi>,"wingless-type MMTV integration site family, member 16; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4840661,EUCOMM,Wnt16,MGI:2136018
Wnt16<tm2b(EUCOMM)Wtsi>,"wingless-type MMTV integration site family, member 16; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5548733,EUCOMM,Wnt16,MGI:2136018
Wnt3<tm2a(EUCOMM)Wtsi>,"wingless-type MMTV integration site family, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4455951,EUCOMM,Wnt3,MGI:98955
Wnt4<tm1.1Svo>,"wingless-type MMTV integration site family, member 4; targeted mutation 1.1, Seppo Vainio",MGI:4399114,0,Wnt4,MGI:98957
Wnt4<tm2(EGFP/cre)Svo>,"wingless-type MMTV integration site family, member 4; targeted mutation 2, Seppo Vainio",MGI:4399121,0,Wnt4,MGI:98957
Wnt7a<px>,"wingless-type MMTV integration site family, member 7A; postaxial hemimelia",MGI:1857009,0,Wnt7a,MGI:98961
Wrap53<tm1a(EUCOMM)Wtsi>,"WD repeat containing, antisense to Trp53; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4842597,EUCOMM,Wrap53,MGI:2384933
Wrap53<tm1b(EUCOMM)Wtsi>,"WD repeat containing, antisense to Trp53; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637129,EUCOMM,Wrap53,MGI:2384933
Wrnip1<tm1a(EUCOMM)Wtsi>,"Werner helicase interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432335,EUCOMM,Wrnip1,MGI:1926153
Wsb2<tm1a(EUCOMM)Hmgu>,"WD repeat and SOCS box-containing 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434956,EUCOMM,Wsb2,MGI:2144041
Wsb2<tm1b(EUCOMM)Hmgu>,"WD repeat and SOCS box-containing 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548747,EUCOMM,Wsb2,MGI:2144041
Wt1<tm1Hst>,"Wilms tumor 1 homolog; targeted mutation 1, Nicholas D Hastie",MGI:2654351,0,Wt1,MGI:98968
Wt1<tm1Mlh>,"Wilms tumor 1 homolog; targeted mutation 1, Martin L Hooper",MGI:3794650,0,Wt1,MGI:98968
Wtap<tm1a(EUCOMM)Hmgu>,"Wilms tumour 1-associating protein; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434984,EUCOMM,Wtap,MGI:1926395
Wwox<Gt(W088C04)Wrst>,"WW domain-containing oxidoreductase; gene trap W088C04, German Gene Trap Consortium",MGI:4123234,0,Wwox,MGI:1931237
Xbp1<tm1a(EUCOMM)Wtsi>,"X-box binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432347,EUCOMM,Xbp1,MGI:98970
Xdh<renf>,xanthine dehydrogenase; Renal Failure,MGI:5435289,0,Xdh,MGI:98973
Xiap<tm1a(EUCOMM)Hmgu>,"X-linked inhibitor of apoptosis; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435758,EUCOMM,Xiap,MGI:107572
Xkr5<tm1a(KOMP)Mbp>,"X-linked Kx blood group related 5; targeted mutation 1a, Mouse Biology Program, UCDavis",MGI:4840884,KOMP-CSD,Xkr5,MGI:2442327
Xkr5<tm1b(KOMP)Mbp>,"X-linked Kx blood group related 5; targeted mutation 1b, Mouse Biology Program, UCDavis",MGI:5613662,KOMP-CSD,Xkr5,MGI:2442327
Xkrx<tm1a(EUCOMM)Wtsi>,"X-linked Kx blood group related, X-linked; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4453683,EUCOMM,Xkrx,MGI:3584011
Xkrx<tm1b(EUCOMM)Wtsi>,"X-linked Kx blood group related, X-linked; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637183,EUCOMM,Xkrx,MGI:3584011
Xndc1<tm1a(EUCOMM)Wtsi>,"Xrcc1 N-terminal domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441710,EUCOMM,Xndc1,MGI:5546359
Xpa<tm1Hvs>,"xeroderma pigmentosum, complementation group A; targeted mutation 1, Harry van Steeg",MGI:1857939,0,Xpa,MGI:99135
Xpna,X-linked pre- and neonatal anemia,MGI:5318196,Harwell ENU Mutagenesis,Xpna,MGI:5318193
Xpnpep1<tm1a(KOMP)Wtsi>,"X-prolyl aminopeptidase (aminopeptidase P) 1, soluble; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419636,KOMP-CSD,Xpnpep1,MGI:2180003
Xpo4<Gt(PT1-ATG)3EVal>,"exportin 4; gene trap mutation 3E, Katherine A Vallis",MGI:5490885,0,Xpo4,MGI:1888526
Xpo6<tm1a(KOMP)Wtsi>,"exportin 6; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362245,KOMP-CSD,Xpo6,MGI:2429950
Xpr1<tm1a(KOMP)Wtsi>,"xenotropic and polytropic retrovirus receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362650,KOMP-CSD,Xpr1,MGI:97932
Xxylt1<tm1a(EUCOMM)Hmgu>,"xyloside xylosyltransferase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4456689,EUCOMM,Xxylt1,MGI:2146443
Xylb<tm1a(EUCOMM)Hmgu>,"xylulokinase homolog (H. influenzae); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435322,EUCOMM,Xylb,MGI:2142985
Yae1d1<tm1a(EUCOMM)Hmgu>,"Yae1 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4888902,EUCOMM,Yae1d1,MGI:1914258
Yae1d1<tm1b(EUCOMM)Hmgu>,"Yae1 domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548529,EUCOMM,Yae1d1,MGI:1914258
Ydjc<tm1(KOMP)Wtsi>,"YdjC homolog (bacterial); targeted mutation 1, Wellcome Trust Sanger Institute",MGI:4419362,KOMP-CSD,Ydjc,MGI:1916351
Yipf1<tm1a(EUCOMM)Wtsi>,"Yip1 domain family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432914,EUCOMM,Yipf1,MGI:1915532
Yipf5<tm1a(EUCOMM)Hmgu>,"Yip1 domain family, member 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436322,EUCOMM,Yipf5,MGI:1914430
Yipf7<tm1e(KOMP)Wtsi>,"Yip1 domain family, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4452709,KOMP-CSD,Yipf7,MGI:1922831
Ypel4<tm1a(EUCOMM)Wtsi>,"yippee like 4; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4456736,EUCOMM,Ypel4,MGI:3605071
Ythdc2<em2Embrp>,"YTH domain containing 2; endonuclease-mediated mutation 2, Ramesh Pillai",MGI:5911568,0,Ythdc2,MGI:2448561
Ywhab<tm1a(EUCOMM)Hmgu>,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435431,EUCOMM,Ywhab,MGI:1891917
Ywhae<tm1e(EUCOMM)Wtsi>,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4432379,EUCOMM,Ywhae,MGI:894689
Zap70<mrtle>,zeta-chain (TCR) associated protein kinase; mr t-less,MGI:3614790,APF ENU Mutagenesis,Zap70,MGI:99613
Zap70<mur>,zeta-chain (TCR) associated protein kinase; murdoch,MGI:3614796,APF ENU Mutagenesis,Zap70,MGI:99613
Zbed5<tm1a(EUCOMM)Wtsi>,"zinc finger, BED type containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460500,EUCOMM,Zbed5,MGI:1919220
Zbed5<tm1b(EUCOMM)Wtsi>,"zinc finger, BED type containing 5; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637059,EUCOMM,Zbed5,MGI:1919220
Zbtb1<tm1e(EUCOMM)Wtsi>,"zinc finger and BTB domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute",MGI:4441870,EUCOMM,Zbtb1,MGI:2442326
Zbtb24<tm1a(EUCOMM)Hmgu>,"zinc finger and BTB domain containing 24; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458660,EUCOMM,Zbtb24,MGI:3039618
Zbtb24<tm1b(EUCOMM)Hmgu>,"zinc finger and BTB domain containing 24; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548888,EUCOMM,Zbtb24,MGI:3039618
Zc3h12a<tm1a(EUCOMM)Hmgu>,"zinc finger CCCH type containing 12A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4434879,EUCOMM,Zc3h12a,MGI:2385891
Zc3h14<tm1a(KOMP)Wtsi>,"zinc finger CCCH type containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4419828,KOMP-CSD,Zc3h14,MGI:1919824
Zc3hc1<tm1a(KOMP)Wtsi>,"zinc finger, C3HC type 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362278,KOMP-CSD,Zc3hc1,MGI:1916023
Zcchc14<tm1a(KOMP)Wtsi>,"zinc finger, CCHC domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362839,KOMP-CSD,Zcchc14,MGI:2159407
Zdhhc24<tm1a(EUCOMM)Hmgu>,"zinc finger, DHHC domain containing 24; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435901,EUCOMM,Zdhhc24,MGI:1917855
Zdhhc5<tm1e(EUCOMM)Hmgu>,"zinc finger, DHHC domain containing 5; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH",MGI:4841863,EUCOMM,Zdhhc5,MGI:1923573
Zdhhc5<tm1e.1(EUCOMM)Hmgu>,,MGI:1923573,,,
Zfhx3<Sci>,zinc finger homeobox 3; short circuit,MGI:2679554,0,Zfhx3,MGI:99948
Zfp110<tm1Mpin>,"zinc finger protein 110; targeted mutation 1, Max-Planck-Institute for Neurobiology",MGI:2156881,0,Zfp110,MGI:1890378
Zfp119a<tm1a(EUCOMM)Hmgu>,"zinc finger protein 119a; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4458716,EUCOMM,Zfp119a,MGI:1345189
Zfp119a<tm1b(EUCOMM)Hmgu>,"zinc finger protein 119a; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5548456,EUCOMM,Zfp119a,MGI:1345189
Zfp128<tm1a(EUCOMM)Wtsi>,"zinc finger protein 128; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441721,EUCOMM,Zfp128,MGI:2389445
Zfp13<tm1a(EUCOMM)Hmgu>,"zinc finger protein 13; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435325,EUCOMM,Zfp13,MGI:99159
Zfp142<tm1a(EUCOMM)Wtsi>,"zinc finger protein 142; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4460442,EUCOMM,Zfp142,MGI:1924514
Zfp182<tm1a(KOMP)Wtsi>,"zinc finger protein 182; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841252,KOMP-CSD,Zfp182,MGI:2442220
Zfp182<tm1b(KOMP)Wtsi>,"zinc finger protein 182; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5552020,KOMP-CSD,Zfp182,MGI:2442220
Zfp184<tm1a(KOMP)Wtsi>,"zinc finger protein 184 (Kruppel-like); targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362182,KOMP-CSD,Zfp184,MGI:1922244
Zfp207<tm1a(EUCOMM)Hmgu>,"zinc finger protein 207; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4847731,EUCOMM,Zfp207,MGI:1340045
Zfp239<tm1a(KOMP)Wtsi>,"zinc finger protein 239; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5050161,KOMP-CSD,Zfp239,MGI:1306812
Zfp239<tm1b(KOMP)Wtsi>,"zinc finger protein 239; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636945,KOMP-CSD,Zfp239,MGI:1306812
Zfp266<tm1a(EUCOMM)Wtsi>,"zinc finger protein 266; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4441662,EUCOMM,Zfp266,MGI:1924769
Zfp266<tm1b(EUCOMM)Wtsi>,"zinc finger protein 266; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637091,EUCOMM,Zfp266,MGI:1924769
Zfp287<tm1a(EUCOMM)Wtsi>,"zinc finger protein 287; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433358,EUCOMM,Zfp287,MGI:2176561
Zfp287<tm1b(EUCOMM)Wtsi>,"zinc finger protein 287; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548771,EUCOMM,Zfp287,MGI:2176561
Zfp341<tm1a(KOMP)Wtsi>,"zinc finger protein 341; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362726,KOMP-CSD,Zfp341,MGI:2682937
Zfp365<tm1a(KOMP)Wtsi>,"zinc finger protein 365; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4364171,KOMP-CSD,Zfp365,MGI:2143676
Zfp367<tm1a(KOMP)Wtsi>,"zinc finger protein 367; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363813,KOMP-CSD,Zfp367,MGI:2442266
Zfp36<tm1Pjb>,"zinc finger protein 36; targeted mutation 1, Perry J Blackshear",MGI:2652418,0,Zfp36,MGI:99180
Zfp382<tm1a(KOMP)Wtsi>,"zinc finger protein 382; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4362785,KOMP-CSD,Zfp382,MGI:3588204
Zfp408<tm1a(EUCOMM)Wtsi>,"zinc finger protein 408; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433343,EUCOMM,Zfp408,MGI:2685857
Zfp408<tm1b(EUCOMM)Wtsi>,"zinc finger protein 408; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637174,EUCOMM,Zfp408,MGI:2685857
Zfp423<Gt(pT1Betageo)1Ruiz>,"zinc finger protein 423; gene trap 1, Patricia Ruiz",MGI:2678434,0,Zfp423,MGI:1891217
Zfp426<tm1a(KOMP)Wtsi>,"zinc finger protein 426; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363568,KOMP-CSD,Zfp426,MGI:1920248
Zfp445<tm1a(EUCOMM)Hmgu>,"zinc finger protein 445; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4849402,EUCOMM,Zfp445,MGI:2143340
Zfp445<tm1b(EUCOMM)Hmgu>,"zinc finger protein 445; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:5613658,EUCOMM,Zfp445,MGI:2143340
Zfp523<tm1a(EUCOMM)Wtsi>,"zinc finger protein 523; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432173,EUCOMM,Zfp523,MGI:2687278
Zfp616<tm1a(KOMP)Wtsi>,"zinc finger protein 616; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944324,KOMP-CSD,Zfp616,MGI:3650906
Zfp616<tm1b(KOMP)Wtsi>,"zinc finger protein 616; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548908,KOMP-CSD,Zfp616,MGI:3650906
Zfp618<tm1a(KOMP)Wtsi>,"zinc finger protein 618; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4841054,KOMP-CSD,Zfp618,MGI:1919950
Zfp61<tm1a(EUCOMM)Hmgu>,"zinc finger protein 61; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436153,EUCOMM,Zfp61,MGI:99663
Zfp647<Gt(ES492)Hgs>,"zinc finger protein 647; gene trap ES492, Heidi Sutherland",MGI:4353070,0,Zfp647,MGI:3052806
Zfp658<tm1a(EUCOMM)Wtsi>,"zinc finger protein 658; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433212,EUCOMM,Zfp658,MGI:2652821
Zfp658<tm1b(EUCOMM)Wtsi>,"zinc finger protein 658; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637160,EUCOMM,Zfp658,MGI:2652821
Zfp664<tm1a(EUCOMM)Wtsi>,"zinc finger protein 664; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4887721,EUCOMM,Zfp664,MGI:2442505
Zfp69<tm1a(EUCOMM)Hmgu>,"zinc finger protein 69; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:5286360,EUCOMM,Zfp69,MGI:107794
Zfp704<tm1a(EUCOMM)Wtsi>,"zinc finger protein 704; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431765,EUCOMM,Zfp704,MGI:2180715
Zfp715<tm1a(EUCOMM)Hmgu>,"zinc finger protein 715; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435328,EUCOMM,Zfp715,MGI:1917180
Zfp719<tm1a(EUCOMM)Wtsi>,"zinc finger protein 719; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431958,EUCOMM,Zfp719,MGI:2444708
Zfp719<tm1b(EUCOMM)Wtsi>,"zinc finger protein 719; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548829,EUCOMM,Zfp719,MGI:2444708
Zfp760<tm1a(EUCOMM)Hmgu>,"zinc finger protein 760; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4436640,EUCOMM,Zfp760,MGI:2679257
Zfp791<tm1a(KOMP)Wtsi>,"zinc finger protein 791; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4939698,KOMP-CSD,Zfp791,MGI:3648473
Zfp84<tm1a(KOMP)Wtsi>,"zinc finger protein 84; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4944422,KOMP-CSD,Zfp84,MGI:107780
Zfp84<tm1b(KOMP)Wtsi>,"zinc finger protein 84; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5636909,KOMP-CSD,Zfp84,MGI:107780
Zfp879<tm2a(KOMP)Wtsi>,"zinc finger protein 879; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4451426,KOMP-CSD,Zfp879,MGI:3053099
Zfp879<tm2b(KOMP)Wtsi>,"zinc finger protein 879; targeted mutation 2b, Wellcome Trust Sanger Institute",MGI:5637179,KOMP-CSD,Zfp879,MGI:3053099
Zfyve28<tm1a(EUCOMM)Wtsi>,"zinc finger, FYVE domain containing 28; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432231,EUCOMM,Zfyve28,MGI:2684992
Zfyve28<tm1b(EUCOMM)Wtsi>,"zinc finger, FYVE domain containing 28; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5637169,EUCOMM,Zfyve28,MGI:2684992
Zic2<Ku>,zinc finger protein of the cerebellum 2; kumba,MGI:1862004,0,Zic2,MGI:106679
Zkscan14<tm1a(EUCOMM)Wtsi>,"zinc finger with KRAB and SCAN domains 14; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432778,EUCOMM,Zkscan14,MGI:1914485
Zkscan17<tm1a(EUCOMM)Wtsi>,"zinc finger with KRAB and SCAN domains 17; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4431816,EUCOMM,Zkscan17,MGI:2679270
Zkscan17<tm1b(EUCOMM)Wtsi>,"zinc finger with KRAB and SCAN domains 17; targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:5548856,EUCOMM,Zkscan17,MGI:2679270
Zmynd8<tm1a(EUCOMM)Wtsi>,"zinc finger, MYND-type containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4433147,EUCOMM,Zmynd8,MGI:1918025
Zp1<tm1a(KOMP)Wtsi>,"zona pellucida glycoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4454080,KOMP-CSD,Zp1,MGI:103073
Zranb1<tm1a(EUCOMM)Hmgu>,"zinc finger, RAN-binding domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH",MGI:4435532,EUCOMM,Zranb1,MGI:106441
Zranb2<tm1a(EUCOMM)Wtsi>,"zinc finger, RAN-binding domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432383,EUCOMM,Zranb2,MGI:1858211
Zscan10<tm2a(EUCOMM)Wtsi>,"zinc finger and SCAN domain containing 10; targeted mutation 2a, Wellcome Trust Sanger Institute",MGI:4431612,EUCOMM,Zscan10,MGI:3040700
Zscan2<tm1a(KOMP)Wtsi>,"zinc finger and SCAN domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4363795,KOMP-CSD,Zscan2,MGI:99176
Zswim7<tm1a(KOMP)Wtsi>,"zinc finger SWIM-type containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:5287783,KOMP-CSD,Zswim7,MGI:1916997
Zzz3<tm1a(EUCOMM)Wtsi>,"zinc finger, ZZ domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:4432089,EUCOMM,Zzz3,MGI:1920453
a,nonagouti,MGI:1855937,0,a,MGI:87853
a<18H>,nonagouti; 18 Harwell,MGI:1856404,0,a,MGI:87853
blst,blast,MGI:3851199,0,blst,MGI:3851197
cholr1b,recessive hypocholesterolemia 1b,MGI:5644295,0,cholr1b,MGI:5644292
gem224,gem 224 mutant,MGI:5762644,0,gem224,MGI:5762642
gem225,gem 225 mutant,MGI:5762650,0,gem225,MGI:5762648
mhdaali17,Martin Hrabe de Angelis abnormal limbs 17,MGI:5619312,0,mhdaali17,MGI:5619308
mhdabcc4,Martin Hrabe de Angelis bright coat color 4,MGI:5619943,0,mhdabcc4,MGI:5619941
mhdabcc5,Martin Hrabe de Angelis bright coat color 5,MGI:5619953,0,mhdabcc5,MGI:5619945
mhdacra5,Martin Hrabe de Angelis cramping 5,MGI:5620254,0,mhdacra5,MGI:5620251
mhdacra6,Martin Hrabe de Angelis cramping 6,MGI:5620258,0,mhdacra6,MGI:5620256
mhdadcc5,Martin Hrabe de Angelis dark coat color 5,MGI:5620452,0,mhdadcc5,MGI:5620448
mhdadcc6,Martin Hrabe de Angelis dark coat color 6,MGI:5620468,0,mhdadcc6,MGI:5620466
mhdakta43,Martin Hrabe de Angelis kinked tail 43,MGI:5620779,0,mhdakta43,MGI:5620777
mhdakta44,Martin Hrabe de Angelis kinked tail 44,MGI:5620784,0,mhdakta44,MGI:5620782
mhdarco14,Martin Hrabe de Angelis reduced coat 14,MGI:5621280,0,mhdarco14,MGI:5621278
mhdatre1,Martin Hrabe de Angelis tremor mutant 1,MGI:5629424,0,mhdatre1,MGI:5629421
plt,paucity of lymph node T cells; paucity of lymph node T-cells,MGI:1857881,0,plt,MGI:3664332
sau,sauron,MGI:3607721,0,sau,MGI:3607718
yahsmts2,Yann Herault small testis mutant 2,MGI:5760314,0,yahsmts2,MGI:5760312
yahsmts3,Yann Herault small testis mutant 3,MGI:5760299,0,yahsmts3,MGI:5760296
yahsmts4,Yann Herault small testis mutant 4,MGI:5760343,0,yahsmts4,MGI:5760341
yahsmts5,Yann Herault small testis mutant 5,MGI:5760337,0,yahsmts5,MGI:5760335
yahsmts6,Yann Herault small testis mutant 6,MGI:5760332,0,yahsmts6,MGI:5760330